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           “During	   the	   past	   few	  months	  we	   have	   conducted	   several	   behavioral	   tests	   to	   evaluate	  how	  far	  the	  European	  tree	  frog	  can	  jump.	  During	  initial	  trials	  we	  trained	  frogs	  to	  jump	  when	  given	  the	  command	  “Jump	  frog,	  jump!”.	  We	  then	  used	  a	  tabletop	  setup	  with	  a	  start	  line	   to	   carefully	  measure	   their	   jumping	   distance.	   The	   frogs	   reliably	   responded	   to	   the	  command,	  and	   jumped	  on	  average	  0.52	  meters.	  Next,	  we	  surgically	  removed	  the	   frogs’	  hind	  legs,	  and	  placed	  them	  back	  on	  the	  test	  setup.	  When	  given	  the	  command	  “Jump	  frog,	  jump!”	  the	  frogs	  now	  only	  waddled	  around	  aimlessly.	  We	  have	  from	  this	  concluded	  that	  the	  surgery	  made	  the	  frogs	  deaf.”	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Summaries	  Summaries	  	  Summary	  (English)	  Huntington	   disease	   is	   an	   autosomal-­‐dominantly	   inherited,	   neurodegenerative	   disease	  that	   is	   caused	   by	   a	   specific	   mutation	   in	   the	   gene	   encoding	   the	   huntingtin	   protein.	  Expression	   of	   the	   mutated	   protein	   results	   in	   extensive	   neuronal	   loss	   throughout	   the	  brain,	   although	   certain	   brain	   regions	   are	  more	   heavily	   affected.	   The	   resulting	   clinical	  symptoms	  include	  a	  range	  of	  motoric,	  psychiatric,	  cognitive,	  and	  metabolic	  changes	  that	  progress	  until	  the	  patients	  are	  unable	  to	  care	  for	  themselves,	  and	  ultimately	  result	  in	  an	  early	   death.	   There	   is	   currently	   no	   disease-­‐modifying	   treatment	   available.	   Thus,	  continued	  efforts	  in	  both	  clinical	  and	  preclinical	  research	  are	  of	  importance.	  	  	  Several	   animal	   models	   of	   Huntington	   disease	   have	   been	   established	   following	   the	  discovery	   of	   the	   huntingtin	   gene	   and	   the	   disease-­‐causing	   mutation.	   Each	   model	   has	  strengths	   and	   weaknesses,	   and	   their	   combined	   use	   is	   of	   importance	   for	   preclinical	  research	   concerning	   disease	   mechanisms	   and	   potential	   therapeutics.	   Thorough	  characterization	  of	   a	   given	  animal	  model	   is	   important	   in	  order	   to	  understand	   to	  what	  extent	  it	  models	  the	  actual	  disease	  and	  how	  to	  work	  with	  it	  in	  an	  appropriate	  way.	  	  	  	  The	   current	   thesis	   includes	   a	   series	   of	   studies	   focusing	   on	   the	   characterization	   of	   a	  recently	  established	  rat	  model	  for	  Huntington	  disease,	  called	  the	  BACHD	  rats.	  These	  rats	  carry	   a	   transgenic	   construct,	   which	   expresses	   the	   full-­‐length	   mutated	   protein	   that	  causes	  Huntington	  disease.	  The	  project	   included	  the	  assessment	  of	  body	  size	  and	  body	  composition	  as	  well	  as	  investigations	  of	  motivational	  and	  cognitive	  phenotypes.	  Results	  indicated	   that	   male	   BACHD	   rats	   were	   obese,	   while	   simultaneously	   showing	   discreet	  developmental	   deficits.	   These	   phenotypes	   might	   be	   caused	   by	   neuropathology	   of	   the	  hypothalamus,	   which	   has	   also	   been	   noted	   among	   Huntington	   disease	   patients.	  Assessment	  of	  the	  BACHD	  rats’	  performance	  on	  a	  test	  of	  motivation	  suggested	  that	  the	  rats’	  altered	  body	  composition	  might	  affect	   their	   interest	   in	  working	   for	   food	  rewards.	  Strategies	   to	   circumvent	   this	   influence	   were	   evaluated,	   as	   motivational	   differences	  might	   confound	   investigations	  of	  other	  behavioral	   aspects.	  Through	   the	  use	  of	   control	  tests,	   robust	   phenotypes	   of	   cognitive	   impairments	   among	   the	   BACHD	   rats	   were	  characterized.	   Similar	   phenotypes	   have	   been	   found	   among	   rats	   with	   fronto-­‐striatal	  lesions,	   suggesting	   that	   disease-­‐related	   neuropathology	   might	   be	   causing	   the	   BACHD	  rat’s	  phenotypes.	  	  	  Ultimately,	   the	  work	  presented	   in	   the	  current	   thesis	  served	   to	   further	   the	  research	  on	  how	   to	   work	   with	   Huntington	   disease	   models	   in	   general,	   and	   the	   BACHD	   rats	   in	  particular.	   In	   addition,	   the	   noted	   phenotypes	   would	   likely	   be	   suitable	   in	   future	  preclinical	   testing	   of	   potential	   therapeutic	   agents,	   although	   specific	   investigations	   to	  determine	  the	  underlying	  neuropathology	  are	  still	  of	  importance.	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Summaries	  	  	  Zusammenfassung	  (Deutsch)	  Die	  Huntington	   Erkrankung	   ist	   eine	   autosomal	   dominant	   vererbte,	   neurodegenerative	  Erkrankung,	   die	   durch	   eine	   spezifische	   Mutation	   im	   Gen	   des	   Huntington-­‐Proteins	  verursacht	  wird.	  Die	  Expression	  des	  mutierten	  Proteins	  führt	  zum	  dramatischen	  Verlust	  von	  Nervenzellen	   im	   gesamten	   Gehirn,	  wobei	   bestimmte	  Hirnareale	   stärker	   betroffen	  sind	  als	  andere.	  Die	  daraus	  resultierenden	  klinischen	  Symptome	  beinhalten	  eine	  Reihe	  motorischer,	  psychiatrischer,	  kognitiver	  und	  metabolischer	  Beeinträchtigungen,	  die	  mit	  voranschreitender	  Krankheit	  zunehmen,	  bis	  die	  Patienten	  nicht	  mehr	  in	  der	  Lage	  sind,	  sich	   um	   sich	   selbst	   zu	   kümmern	   und	   schließlich	   frühzeitig	   versterben.	   Zurzeit	   gibt	   es	  keine	   krankheitsmodulierende	   Therapie,	   weshalb	   die	   präklinische	   und	   klinische	  Forschung	  von	  enormer	  Wichtigkeit	  sind.	  	  Seit	   der	   Entdeckung	   des	   krankheitsauslösenden	   Gens	   wurden	   zahlreiche	   Tiermodelle	  für	   die	   Huntington	   Erkrankung	   etabliert.	   Jedes	   Tiermodell	   besitzt	   Vorzüge	   und	  Nachteile,	  und	  für	  die	  präklinische	  Forschung	  hinsichtlich	  Krankheitsmechanismen	  und	  potentieller	  Therapeutika	   ist	  die	  Ausschöpfung	  aller	  Modelle	   gemeinsam	  von	  enormer	  Wichtigkeit.	   Die	   gründliche	   Charakterisierung	   eines	   jeden	  Tiermodells	   ist	  maßgeblich,	  um	  den	  Grad	  der	  Übereinstimmung	  mit	   der	  menschlichen	  Erkrankung	   einschätzen	   zu	  können	  und	  zu	  wissen	  wie	  mit	  den	  Tieren	  gearbeitet	  werden	  sollte.	  	  Die	   vorliegende	   Arbeit	   beinhaltet	   eine	   Reihe	   von	   Studien,	   die	   sich	   auf	   die	  Charakterisierung	  des	  jüngsten	  Rattenmodells	  der	  Huntington	  Erkrankung,	  die	  BACHD-­‐Ratte,	   beziehen.	   Diese	   Tiere	   tragen	   ein	   transgenes	   Konstrukt,	   welches	   das	   gesamte,	  mutierte	   Huntingtin-­‐Gen	   exprimiert.	   Die	   Arbeit	   beinhaltet	   die	   Untersuchung	   der	  Körpergröße	   und	   Körperzusammensetzung	   sowie	   der	   Ausprägung	   von	  Verhaltensphänotypen	   hinsichtlich	   Motivation	   und	   Kognition.	   Die	   Ergebnisse	   zeigen,	  dass	   die	   BACHD-­‐Ratten	   fettleibig	   sind	   und	   ein	   Wachstumsdefizit	   aufweisen,	   was	  möglicherweise	   auf	   eine	   Pathologie	   im	   Hypothalamus	   zurückzuführen	   ist	   wie	   sie	   bei	  Huntington-­‐Patienten	  vorliegt.	  Ein	  Test	  zur	  Untersuchung	  der	  Motivation	  deutete	  ferner	  darauf	  hin,	  dass	  die	  Fettleibigkeit	  der	  BACHD-­‐Ratten	  womöglich	  zu	  einem	  verminderten	  Interesse	   führt	   für	   Futterbelohnungen	   zu	   arbeiten	   und	   somit	   möglicherweise	   andere	  Verhaltensparameter	  beeinflusst.	  Daraufhin	  wurden	  Vorgehensweisen	  getestet,	  um	  dies	  zu	   unterbinden	   und	   eine	   unverfälschte	   Verhaltenscharakterisierung	   zu	   ermöglichen.	  Durch	  den	  Einsatz	  von	  Kontrolltests	  konnten	  schließlich	  robuste,	  kognitive	  Phänotypen	  beschrieben	  werden.	  Ähnliche	  Einbußen	  sind	  von	  Ratten	  mit	  fronto-­‐striatalen	  Läsionen	  bekannt,	  was	  darauf	  hindeutet,	  dass	  eine	  krankheitsbedingte	  Neuropathologie	  zugrunde	  liegen	  könnte.	  	  Der	   Nutzen	   der	   vorliegenden	   Arbeit	   liegt	   insbesondere	   darin,	   die	   Forschung	   an	  Huntington-­‐Tiermodellen,	   insbesondere	   der	   BACHD-­‐Ratte,	   im	   Hinblick	   auf	   deren	  adäquate	  Nutzung	  voranzutreiben.	  Die	  beschriebenen	  Phänotypen	  können	  weiterhin	  in	  präklinischen	  Studien	  zur	  Evaluierung	  von	  potentiellen	  Therapeutika	  von	  Nutzen	  sein.	  	  Untersuchungen	   zur	   zugrundeliegenden	   Neuropathologie	   wären	   nachfolgend	   von	  Wichtigkeit.	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Abbreviations	  Abbreviations	  	  BAC	   	   	   Bacterial	  artificial	  chromosome	  BACHD	   	   BAC-­‐containing	  full-­‐length	  huntingtin	  D1	   	   	   Dopamine	  receptor	  1	  D2	   	   	   Dopamine	  receptor	  2	  DNA	  	   	   	   Deoxyribonucleic	  acid	   	  	  GABA	   	   	   γ-­‐amino	  butyric	  acid	  GPe	   	   	   Globus	  pallidus	  pars	  externa	  GPi	   	   	   Globus	  pallidus	  pars	  interna	  HD	   	   	   Huntington	  disease	  IGF-­‐1	   	   	   Insulin-­‐like	  growth	  factor	  1	  IT15	   	   	   Interesting	  transcript	  15	  /	  Huntingtin	  gene	  PR	   	   	   Progressive	  ratio	  TG5	   	   	   BACHD	  rat,	  transgenic	  line	  5	  TG9	   	   	   BACHD	  rat,	  transgenic	  line	  9	  WT	   	   	   Wild	  type	  YAC	   	   	   Yeast	  artificial	  chromosome	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  Introduction	  	  Huntington	  disease	  	  Epidemiology	  and	  cause	  of	  disease	  Huntington	   disease	   (HD)	   is	   an	   autosomal-­‐dominantly	   inherited	   neurodegenerative	  disease,	  which	  affects	  approximately	  6	  out	  of	  100,000	  people	  in	  Europe,	  North	  America	  and	  Australia1,2.	  Although	  genetic	  modifiers	  have	  been	  identified3,4	  the	  sole	  genetic	  cause	  of	  the	  disease	  is	  the	  expansion	  of	  an	  unstable	  CAG	  repeat	  sequence	  in	  the	  protein-­‐coding	  region	   of	   the	   IT15	   gene	   (consequently	   termed	   the	  Huntingtin	   gene,	   for	   the	   huntingtin	  protein),	  on	  chromosome	  45.	  Alleles	  with	  up	  to	  34	  CAG	  repeats	  are	  considered	  to	  lie	  in	  the	   normal	   range,	   and	   do	   not	   confer	   any	   disease	   risk6,7.	   Alleles	   with	   longer	   repeat	  sequences	  have	  been	  found	  to	  cause	  HD,	  although	  full	  penetrance	  is	  primarily	  seen	  for	  alleles	   with	   more	   than	   42	   CAG	   repeats6.	   In	   addition	   to	   being	   the	   primary	   cause	   for	  disease	  development,	  the	  length	  of	  the	  CAG	  repeat	  sequence	  is	  known	  to	  affect	  the	  age	  at	  onset	   of	   HD7–10.	   Thus,	   patients	   carrying	   an	   allele	   with	   40	   CAG	   repeats	   have	   a	   50%	  probability	  to	  develop	  the	  disease	  around	  the	  age	  of	  60,	  while	  this	  decreases	  to	  an	  age	  of	  40	  and	  30	  for	  alleles	  with	  about	  45	  and	  50	  CAG	  repeats	  respectively6.	  Patients	  who	  show	  an	   age	   at	   onset	   younger	   than	   20	   are	   considered	   to	   have	   juvenile	   HD,	   which	   is	   often	  associated	  with	  CAG	  repeat	  lengths	  above	  6011,12.	  Still,	  CAG	  repeat	  length	  only	  explains	  about	  50%	  of	  the	  variation	  in	  the	  age	  at	  onset	  of	  HD8,10.	  Thus,	  although	  it	  is	  crucial	  to	  the	  development	  of	  HD,	  additional	  genetic	  and	  environmental	   factors	  appear	  to	  contribute	  to	   the	   appearance	   of	   the	   disease3,4,13,14.	   It	   should	   also	   be	   noted	   that	   in	   contrast	   to	   its	  clear	   effect	   on	   age	   at	   onset,	   the	   effect	   of	   CAG	   repeat	   length	   of	   the	   rate	   of	   clinical	  progression	  is	  somewhat	  unclear15–19.	  	  	  Most	   HD	   patients	   carry	   one	   mutated	   allele,	   which	   they	   inherited	   from	   one	   of	   their	  parents.	   The	   incidence	   of	  de	   novo	  mutation	   has	   been	   estimated	   to	   be	   about	   0.1%	   for	  transmission	  from	  a	  father	  with	  a	  high,	  but	  normal,	  CAG	  repeat	  sequence20.	  Still,	  de	  novo	  mutations	  are	  estimated	  to	  account	  for	  up	  to	  10%	  of	  diagnosed	  patients21.	  Interestingly,	  intergenerational	  changes	   in	  CAG	  repeat	   lengths	  often	  concern	  expansions	  rather	   than	  contractions,	  particularly	  when	  being	  inherited	  paternally22,23.	  Although	  there	  currently	  are	  symptomatic	  treatments	  that	  can	  reduce	  the	  disease	  burden	  for	  patients24,	   there	  is	  no	  disease-­‐modifying	  treatment	  available.	  Thus,	  HD	  is	  at	  this	  time	  invariably	  fatal.	  	  Protein	  function	  and	  neuropathology	  The	  huntingtin	  gene	  is	  expressed	  in	  most	  tissues	  of	  the	  body	  with	  highest	  protein	  levels	  found	   in	   testes	   and	   neurons25–28.	   The	   protein	   is	   present	   both	   in	   the	   cytoplasm	   and	  nucleus	  of	  cells29,30,	  where	  it	   is	  thought	  to	  function	  as	  a	  scaffold	  protein,	  as	   it	  has	  been	  found	  to	  interact	  with	  several	  other	  proteins31–33.	  Through	  these	  interactions	  huntingtin	  appears	   to	   take	   part	   in	   a	   range	   of	   cellular	   processes,	   including	   endocytosis,	   vesicle	  transport,	   synaptic	   plasticity,	   gene	   transcription,	   cell	   metabolism,	   mitosis	   and	  apoptosis31–33.	  As	  noted,	  the	  mutated	  form	  of	  the	  huntingtin	  gene	  has	  an	  elongated	  CAG	  repeat	  sequence,	  which	  in	  the	  translated	  protein	  gives	  an	  elongated	  stretch	  of	  glutamine	  amino	  acids.	  This	   is	  thought	  to	  confer	  both	  toxic	  gain	  of	  function	  and	  disruption	  of	  the	  protein’s	  normal	  function31–34.	  Although	  the	  exact	  interplay	  between	  these	  aspects	  is	  not	  clear,	  both	  are	  likely	  important	  for	  shaping	  the	  specific	  pathology	  of	  HD34.	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  Huntington	  disease	  	  	  	  	  	  The	   neuropathology	   of	   HD	   primarily	   affects	   the	   basal	   ganglia,	   although	   several	   other	  brain	   regions	  are	   involved	  during	   the	   late	   stages	  of	   the	  disease35–37.	   The	  basal	   ganglia	  comprise	  several	  subcortical	  nuclei	  within	  the	  cerebrum,	  which	  together	  play	  a	  crucial	  role	   in	  coordinating	  various	  kinds	  of	  behaviors	  (Figure	  1-­‐4).	   In	  brief,	   the	  basal	  ganglia	  are	   thought	   to	   inhibit	   inappropriate	  behaviors	  while	  promoting	   appropriate	   ones38–42.	  This	  is	  primarily	  thought	  to	  function	  through	  different	  neuronal	  signaling	  loops,	  where	  cortical	   neurons	   convey	   information	   concerning	   the	   current	   situation	   and	   possible	  behaviors	  to	  the	  basal	  ganglia.	  As	  the	  basal	  ganglia	  receive	  input	  from	  most	  parts	  of	  the	  cortex	   it	  offers	  an	  anatomically	  convenient	   location	  where	  the	  diverse	   information	  can	  be	   weighed.	   Ultimately,	   signals	   promoting	   appropriate	   (or	   at	   least	   the	   selected)	  behaviors	   will	   be	   relayed	   back	   to	   the	   cortex	   via	   the	   thalamus,	   while	   inappropriate	  behaviors	  are	  silenced38–42.	  The	  signaling	  loops	  that	  connect	  the	  cortex	  and	  basal	  ganglia	  are	   thought	   to	   be	   arranged	   in	   a	   parallel	   manner,	   with	   some	   level	   of	   cross-­‐communication.	   As	   separate	   loops	   connect	   different	   regions	   of	   the	   cortex	   and	   basal	  ganglia,	  they	  are	  also	  thought	  to	  govern	  different	  behaviors43,44.	  	  Within	  the	  basal	  ganglia	  it	  is	  primarily	  the	  projection	  neurons	  in	  the	  striatum	  that	  directly	  receive	  the	  excitatory	  glutamatergic	   signals	   from	   the	   cortex42	   (the	   aforementioned	   signaling	   loops	   are	   thus	  generally	  referred	  to	  as	  cortico-­‐striatal	  loops).	  These	  neurons	  (known	  as	  medium-­‐sized	  spiny	   neurons)	   have	   in	   turn	   axonal	   connections	   with	   other	   nuclei	   within	   the	   basal	  ganglia,	   and	   form	   one	   of	   the	   primary	   sites	   of	   basal	   ganglia	   signal	   modulation41,45.	  Notably,	  the	  striatum	  is	  the	  main	  site	  of	  HD	  pathology,	  where	  there	  is	  extensive	  loss	  of	  medium	  spiny	  projection	  neurons35-­‐37,46.	  More	  specifically,	  the	  most	  striking	  pathology	  is	  found	   in	   the	   dorsal	   striatum,	   which	   is	   composed	   of	   two	   interconnected	   but	   distinct	  nuclei	   called	   the	   caudate	   and	  putamen.	  Neuronal	   loss	   is	   first	   evident	   in	   the	   tail	   of	   the	  caudate	   nucleus,	   and	   later	   extends	   in	   caudo-­‐rostral,	   dorso-­‐ventral	   and	   medio-­‐lateral	  directions	  to	  include	  both	  the	  body	  and	  the	  head	  of	  the	  caudate	  nucleus35-­‐37,46.	  Neuronal	  loss	  within	   the	  putamen	  shows	  a	   similar	  progression,	  and	  occurs	   largely	   in	  parallel	   to	  the	   involvement	   of	   the	   body	   and	   head	   of	   the	   caudate	   nucleus37,46.	   As	   noted,	   it	   is	  primarily	   projection	   neurons	   that	   are	   lost	   within	   the	   striatum,	   while	   interneurons	  remain	  largely	  spared47–53.	  In	  addition,	  different	  projection	  neuron	  populations	  are	  lost	  at	   different	   points	   of	   disease	   progression35,36,50.	   Thus,	   neurons	   that	   synapse	   on	   the	  globus	  pallidus	  pars	  externa	  (GPe)	  and	  contain	  dopamine	  2	  (D2)	  receptors	  are	  the	  more	  susceptible	   than	   neurons	   that	   synapse	   on	   the	   globus	   pallidus	   pars	   interna	   (GPi)	   and	  contain	  dopamine	  1	  (D1)	  receptors.	  This	  selective	  neuropathology	  is	  not	  in	  line	  with	  the	  ubiquitous	   expression	  of	  mutant	  huntingtin	   and	   the	   exact	   cause	   for	   it	   is	  not	   yet	   clear.	  Recent	   hypotheses	   suggest	   that	   the	   medium	   spiny	   neurons	   might	   be	   particularly	  sensitive	   to	   excitotoxicity,	   due	   to	   the	   extensive	   glutamatergic	   input	   they	   receive	   in	  combination	  with	  several	  effects	  of	  mutant	  huntingtin47,54,55.	  	  	  Clinical	  symptoms	  of	  HD	  HD	   presents	   with	   a	   range	   of	   clinical	   symptoms	   that	   include	   motoric,	   psychiatric,	  cognitive	  and	  metabolic	  disturbances.	  The	  motoric	  symptoms	  are	  diverse,	  and	  concern	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  both	  difficulties	  with	  voluntary	  and	  involuntary	  movements.	  Thus,	  patients	  often	  display	  a	  mixture	   of	   chorea	   (irregular	   involuntary	  movements	   classically	   likened	  with	   dance-­‐like	  movements),	   dystonia	   (involuntary	   twisting	   and	   repetitive	  movements	   caused	   by	  co-­‐contractions	   of	   opposing	   muscle	   groups),	   rigidity	   and	   bradykinesia	   (slowed	  movement)56–58.	  Due	  to	  this,	  several	  aspects	  of	  normal	  life	  are	  affected	  for	  HD	  patients.	  One	  aspect	  that	  is	  of	  particular	  relevance	  for	  the	  work	  presented	  in	  this	  thesis	  concerns	  difficulties	  with	  eating,	  where	  patients	  have	  problems	  with	  moving	   food	  towards	  their	  mouths,	  chewing,	  and	  swallowing59–62.	  	  	  Psychiatric	   symptoms	  of	  HD	   frequently	   include	  apathy,	  depression,	   irritability,	  anxiety	  and	  obsessive-­‐compulsive	  disorder.	   Psychosis	   (i.e.	   delusions	   and	  hallucinations)	   is,	   on	  the	  other	  hand,	  rare63–68.	  	  	  Cognition	   is	   a	   broad	   term	   that	   is	   used	   to	   refer	   to	   a	   range	   of	   mental	   processes	   that	  concern	   the	   acquisition,	   storage,	   manipulation	   and	   retrieval	   of	   information69.	   It	   thus	  relates	  to	  several	  higher	  functions	  of	  the	  central	  nervous	  system,	   including	  perception,	  memory,	  language,	  problem	  solving	  and	  abstract	  thinking70.	  Several	  aspects	  of	  cognitive	  function	  are	  impaired	  in	  HD71–73.	  First,	  HD	  patients	  have	  repeatedly	  been	  shown	  to	  have	  a	   reduced	   psychomotor	   speed74–80	   (mental	   aspect	   of	   reaction	   time).	   In	   addition,	   HD	  patients	   show	  deficits	   in	  both	  episodic81–83	   (events	  and	  experiences)	  and	   semantic84,85	  	  	  (facts	  and	  concepts)	  memory	  functions.	  These	  deficits	  are	  generally	  thought	  to	  be	  due	  to	  patients	  having	  difficulties	  with	  efficiently	  retrieving	  information	  rather	  than	  forgetting	  it81–90,	   although	   this	   hypothesis	   has	   been	   questioned91,92.	   In	   relation	   to	   their	   general	  memory	  problems,	  HD	  patients	  have	  difficulties	  to	  acquire	  both	  motor-­‐related	  and	  non-­‐motor	  related	  skills90,93,94.	  A	  final	  memory-­‐related	  aspect	  of	  HD	  concerns	  their	  impaired	  working	  memory89,95–101.	  Working	  memory	  is	  commonly	  considered	  to	  be	  the	  cognitive	  function	   that	   allows	   for	   temporary	   storage	   and	  online	  manipulation	  of	   information102.	  Due	  to	  its	  complexity,	  there	  are	  several	  aspects	  of	  the	  information	  or	  task	  at	  hand	  that	  affect	   the	   overall	   strain	   that	   is	   put	   on	   the	   system.	   Among	   other	   things	   it	   includes	  temporal	   (the	   time	   something	   needs	   to	   be	   remembered)	   and	   span	   (the	   amount	   of	  information	   that	   needs	   to	   be	   remembered)	   aspects102.	   HD	   patients	   have	   shown	  consistently	  impaired	  span	  capacity89,96,98–101	  while	  temporal	  capacity	  appears	  to	  be	  less	  impaired97,99.	  Working	  memory	  is	  considered	  to	  be	  one	  of	  the	  components	  of	  the	  central	  nervous	   system’s	  executive	   function103.	  This	   is	   in	   turn	  a	   function	   that	   is	   thought	   to	  be	  fundamental	   for	   optimizing	   and	   maintaining	   appropriate	   behaviors	   in	   general103.	   In	  addition	   to	  working	  memory,	   it	   incorporates	   cognitive	   flexibility	   (the	   ability	   to	   adjust	  attention,	  strategies	  and	  behaviors)	  and	  inhibitory	  control	  (includes	  selective	  attention,	  and	   inhibition	   of	   inappropriate	   responses	   and	   behaviors).	   These	   functions	   then	   allow	  for	   higher	   cognitive	   processes	   such	   as	   the	   ability	   to	   plan	   responses	   or	   behaviors103.	  There	  is	  extensive	  data	  indicating	  that	  several	  aspects	  of	  executive	  control	  is	  impaired	  in	  HD,	   including	  working	  memory	  (as	  noted	  above),	  cognitive	   flexibility96,104–106,	   selective	  attention106,107	   response	   inhibitition106,108–110	   behavioral	   inhibition	   (not	   extensively	  reported	   and	   changes	   in	   risk-­‐taking	   are	   unclear111)112	   and	   planning113,114.	   A	   final	  cognitive	  aspect	  of	  HD,	  which	  does	  not	  necessarily	   fit	   into	   the	  categories	  of	  symptoms	  described	   above,	   is	   that	   patients	   frequently	   have	   difficulties	   to	   recognize	   emotions,	  particularly	  negative	  ones74-­‐79,115–117.	  	  The	  main	  metabolic	   symptom	   found	  among	  HD	  patients	   is	   considered	   to	  be	   extensive	  weight	   loss118–122.	   It	   is	   generally	   thought	   that	   this	   is	  due	   to	  a	   loss	  of	  both	  adipose	  and	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  disease	  muscle	   tissue120,121,123,	   although	   this	   has	   not	   been	   extensively	   investigated.	   Thus,	  although	   there	   are	   clear	   indications	   of	  muscle	   dysfunction	   in	  HD,	   the	   extent	   of	   actual	  muscle	  atrophy	  is	  not	  yet	  clear124.	  The	  exact	  cause	  of	  weight	  loss	  has	  also	  not	  been	  fully	  elucidated	  yet,	  but	  is	  likely	  multifaceted.	  It	  has	  been	  argued	  that	  due	  to	  their	  problems	  with	  eating,	  HD	  patients	  might	  have	  difficulties	   to	  consume	  enough	  food	  to	  maintain	  a	  stable	  body	  weight125.	  Still,	  HD	  patients	  have	  been	  found	  to	  lose	  weight	  when	  consuming	  diets	  with	  comparable126	  and	  higher120	  caloric	  content	  than	  healthy	  persons.	  There	  are	  also	  indications	  that	  HD	  patients	  have	  higher	  energy	  expenditure	  due	  (in	  part)	  to	  their	  choreatic	  movements127,128.	  Still,	  weight	  loss	  has	  also	  been	  found	  among	  patients	  that	  do	  not	   suffer	   from	   overt	   choreatic	  movements118,121.	   Thus,	   although	   reduced	   food	   intake	  and	  chorea	  are	   likely	   to	  affect	   the	  symptoms,	  recent	  hypotheses	  suggest	   that	   the	  body	  weight	  loss	  is	  primarily	  caused	  by	  an	  underlying	  hypermetabolic	  state121,123,129.	  This	  has,	  in	  turn,	  been	  suggested	  to	  be	  due	  to	  neuropathology	  of	  the	  hypothalamus,	  although	  it	  is	  likely	  that	  pathology	  in	  peripheral	  tissues	  also	  play	  a	  role123.	  Finally,	  it	  should	  be	  pointed	  out	  that	  progressive	  weight	  loss	  is	  not	  always	  present	  in	  HD	  patients130,131.	  	  	  Clinical	  progression	  of	  HD	  As	  noted,	  HD	  is	  a	  progressive	  disease.	  Thus,	  the	  symptoms	  listed	  above	  initially	  appear	  as	   discreet	   impairments	   and	   then	  progressively	  worsen	  with	   time.	   The	   appearance	   of	  choreatic	  movements	  was	  initially	  used	  to	  mark	  the	  onset	  of	  the	  disease,	  although	  this	  has	   been	   replaced	   by	   a	   scoring	   method	   that	   takes	   several	   motoric	   aspects	   into	  account132,133.	   Still,	   more	   discrete	   motoric	   impairments,	   as	   well	   as	   psychiatric	   and	  cognitive	  symptoms	  are	  known	  to	  be	  present	  in	  earlier	  stages	  of	  the	  disease	  (see	  below).	  Neuronal	   loss	   and	   dysfunction	   within	   the	   striatum	   is	   likely	   apparent	   at	   even	   earlier	  stages75,78,132,134.	  	  Motor	  symptoms	  appear	  to	  start	  as	  discreet	  impairments	  in	  oculomotor	  function135,136,	  and	  movement	   correction	   abilities137	   (7-­‐10	  years	  before	   clinical	   onset).	   This	   is	   closely	  followed	   by	   the	   appearance	   of	   chorea	   and	   bradykinesia	   (which	   commonly	   coincides	  with	   the	   clinical	   onset	   of	   the	   disease),	  while	   dystonia	   appears	   slightly	   later135	   (2	   to	   4	  years	  after	  clinical	  onset).	  In	  late	  stages	  of	  the	  disease,	  the	  chorea	  subsides,	  leaving	  the	  patients	   largely	   akinetic138–140.	   A	   notable	   exception	   to	   this	   clinical	   progression	   is	   seen	  among	  patients	  with	   juvenile	  HD,	  as	  they	  present	  primarily	  with	  stiffness	  and	  akinesia	  from	  the	  start,	  and	  only	  rarely	  display	  choreatic	  movements141.	   It	  should	  still	  be	  noted	  that	  similar	  clinical	  progression	  is	  also	  seen	  in	  a	  subset	  of	  adult-­‐onset	  HD	  patients138,142.	  	  	  All	  aforementioned	  psychiatric	  symptoms	  of	  HD	  have	  been	   found	  to	  be	  present	  before	  clinical	  onset	  of	   the	  disease	  (up	  to	  at	   least	  10	  years)	   134,143,144.	  Although	  the	  exact	   time	  course	  of	   their	  development	   is	  unclear	   there	  are	   indications	   that	  apathy	  progressively	  worsens	   with	   general	   progression	   of	   HD,	   while	   depression	   does	   not78,145–147.	   Thus,	  apathy	  might	  be	  closely	  related	  to	  the	  progressive	  neuropathology.	  	  Several	  cognitive	  symptoms	  are	  also	  present	   long	  before	  clinical	  onset	  of	  HD,	  although	  once	  again	  the	  exact	  time	  course	  for	  their	  development	  is	  uncertain71,73,78,79,148,149.	  Still,	  impaired	  psychomotor	  speed,	  cognitive	  flexibility	  and	  emotion	  recognition	  appear	  to	  be	  among	   the	   earliest	   symptoms78,79,104,149	   (10-­‐15	   years	   before	   clinical	   onset).	   As	   the	  disease	  progresses,	  these	  impairments	  become	  more	  apparent	  and	  additional	  cognitive	  symptoms	   manifest	   (described	   above).	   Ultimately,	   HD	   patients	   develop	   a	   general	  dementia71,73.	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Introduction	  Huntington	  disease	  As	   described	   above,	   the	   neuronal	   loss	   in	  HD	   is	   first	   present	   in	   the	   tail	   of	   the	   caudate	  nucleus.	  It	  then	  develops	  in	  caudo-­‐rostral,	  dorso-­‐ventral	  and	  medio-­‐lateral	  directions	  to	  encompass	   the	  body	  and	  head	  of	   the	   caudate	   as	  well	   as	   the	  putamen37,46.	   As	  different	  parts	  of	  the	  caudate	  and	  putamen	  are	  involved	  in	  different	  cortico-­‐striatal	  loops43,44,	  this	  gradual	   neuronal	   loss	   should	   have	   some	   connection	   to	   the	   time	   course	   of	   symptom	  development.	   It	   is,	  however,	   important	   to	  note	   that	  HD	  patients	  appear	   to	   suffer	   from	  additional	   discreet	   neuronal	   dysfunction,	   which	   might	   show	   different	   temporal	   and	  spatial	  progression150.	  In	  addition,	  the	  exact	  function	  of	  cortico-­‐striatal	  loops	  in	  relation	  to	   behavior	   is	   not	   fully	   elucidated151.	   Still,	   it	   is	   worth	   mentioning	   that	   the	   caudate	  nucleus	   is	   thought	   to	   be	   strongly	   linked	   to	   cortico-­‐striatal	   loops	   involved	   in	   cognitive	  and	  oculomotor	  function,	  while	  putamen	  is	  more	  linked	  to	  sensorimotor	  tasks151.	  Thus,	  the	  current	  consensus	  of	  cognitive	  and	  oculomotor	  symptoms	  being	  among	  the	  earliest	  behavioral	   changes	   in	   HD	   patients	   is	   in	   line	   with	   the	   early	   appearance	   of	   caudate	  nucleus	  pathology	  in	  HD	  progression.	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Introduction	  Models	  of	  Huntington	  disease	  Models	  of	  Huntington	  disease	  	  General	  introduction	  A	  multitude	  of	  model	  systems	  are	  used	  in	  HD	  research.	  These	  include	  cell-­‐based	  models	  such	   as	   transient	   or	   stable	   transfection	   of	   mammalian	   cell	   lines152,153,	   cell	   lines	  established	   from	   genetically	   engineered	   animal	   models154	   (see	   below),	   stably	  transfected	   embryonic	   stem	   cells155,	   transient	   transfection	   of	   primary	   cultures156	   and	  inducible	  pluripotent	  stem	  cells	  from	  HD	  patients157.	  In	  addition,	  there	  is	  a	  range	  of	  HD	  animal	   models	   using	   both	   invertebrates	   (Caenorhabditis	   elegans158	   and	   Drosophila	  melanogaster159)	  and	  vertebrates	  (primarily	  mammalian,	  such	  as	  mouse160–167,	  rat168–174,	  sheep175,	   pig176	   and	  monkey177).	   Rodent	  models	   are	   among	   the	  most	   frequently	   used	  ones,	  and	  will	  be	  the	  main	  focus	  of	  this	  introduction	  section.	  	  Rodent	  models	  of	  HD	  Before	   the	   identification	   of	   the	   disease-­‐causing	   gene,	   rodent	   models	   of	   HD	   were	  primarily	   based	   on	   various	   forms	   of	   striatal	   lesions54,168–172,178.	   Although	   crude,	   this	  research	   was	   central	   in	   shaping	   the	   excitotoxicity-­‐based	   hypothesis	   of	   HD’s	  neuropathology168–172.	  Following	  the	  discovery	  of	  the	  huntingtin	  gene,	  however,	  a	  range	  of	   animal	   models	   based	   on	   different	   forms	   of	   genetic	   manipulation	   were	  established178,179.	   It	   is	  thus	  of	   interest	  to	  note	  that	  wild	  type	  (WT)	  alleles	  of	  huntingtin	  homologue	  genes	  in	  mice	  and	  rats	  contain	  seven	  and	  eight	  CAG	  repeats	  respectively180.	  	  	  The	   first	   transgenic	   rodent	   models	   that	   were	   established	   used	   constructs	   that	   only	  expressed	   a	   fragment	   of	   the	   disease-­‐causing	   gene160,161,173,178.	   For	   these	   models,	   the	  transgene	   rarely	  exceeds	  past	  huntingtin’s	   first	   exon,	  where	   the	  elongated	  CAG	  repeat	  sequence	   resides.	   The	  models	   generally	   confer	   strong	   and	   early	   phenotypes54,178	   (see	  below).	  Common	  models	  include	  the	  R6/1160,	  R6/2160	  and	  N171-­‐82Q161	  mouse	  models,	  as	   well	   as	   the	   TgHD173	   rat	   model.	   The	   models	   are	   generally	   referred	   to	   as	   fragment	  models,	   due	   to	   the	  nature	  of	   their	   transgene.	  There	   are	   also	   rodent	  models	   that	   carry	  transgenic	   constructs	   that	   express	   the	   full	   huntingtin	   gene162–164,174.	   These	   models	  generally	   show	   milder	   phenotypes	   than	   the	   fragment	   models54,178	   (see	   below).	   The	  genetic	   constructs	   used	   to	   create	   these	  models	   used	  high	   capacity	  DNA	  vectors	   called	  yeast	  and	  bacterial	  artificial	  chromosomes	  (YAC	  and	  BAC	  respectively),	  due	  to	  the	  large	  size	   of	   the	   huntingtin	   gene.	   This	   is	   referenced	   in	   the	   names	   of	   common	   full-­‐length	  models,	   such	  as	   the	  YAC128163	   and	  BACHD164	  mice,	   as	  well	   as	   the	  BACHD174	   rats.	  The	  aforementioned	   models	   were	   created	   through	   classical	   transgenic	   methods,	   where	  genetic	  material	  is	  injected	  into	  fertilized	  oocytes,	  whereupon	  it	  incorporates	  at	  random	  position	  in	  the	  host	  animal’s	  genome181.	  Thus,	  the	  disease-­‐related	  transgene	  is	  expressed	  in	  addition	  to	  the	  two	  endogenous	  WT	  huntingtin	  alleles	  of	  the	  host	  animal.	  A	  final	  kind	  of	  animal	  models	  was	  established	  with	  the	  aim	  to	  more	  closely	  model	  the	  genetic	  aspects	  of	   HD.	   Rather	   than	   introducing	   an	   exogenous	   genetic	   material	   through	   a	   transgenic	  construct,	  these	  models	  are	  based	  on	  specifically	  modifying	  the	  length	  of	  the	  CAG	  repeat	  sequence	   of	   the	   endogenous	   huntingtin	   alleles165–167.	   These	   models	   are	   generally	  thought	   to	   confer	   more	   subtle	   phenotypes	   compared	   to	   full-­‐length	   models54,178,179,	  although	   careful	   characterization	   still	   reliably	   reveals	   them	   (see	   below).	   This	   kind	   of	  model,	  known	  as	  knock-­‐in	  model,	  has	  so	   far	  only	  been	  established	   in	  mice.	  Commonly	  used	  strains	  are	  the	  HdhQ92-­‐111165,	  HdhQ140166	  and	  HdH(CAG)150167	  mice.	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  Models	  of	  Huntington	  disease	  As	   noted,	   the	   general	   consensus	   is	   that	   fragment	   models	   confer	   the	   strongest	  phenotypes,	  while	  full-­‐length	  models	  show	  milder	  ones,	  and	  knock-­‐in	  models	  show	  very	  discreet	  ones54.	  It	  should,	  however,	  be	  noted	  that	  models	  are	  frequently	  established	  on	  different	  genetic	  backgrounds,	  use	  different	  promoter	  sequences	  to	  drive	  the	  expression	  of	  their	  genetic	  construct,	  have	  different	  numbers	  of	  CAG	  repeats,	  and	  are	  differentially	  susceptible	   to	   positional	  mutagenesis160-­‐167,173,174.	   Naturally,	   these	   factors	   are	   likely	   to	  influence	  the	  overall	  phenotype,	  just	  like	  the	  specific	  nature	  of	  the	  genetic	  modification	  itself	   (i.e	   fragment,	   full-­‐length	   or	   knock-­‐in).	   It	   is	   also	   noteworthy	   that	   several	   of	   the	  genetically	  modified	  rodent	  models	  carry	  constructs	  with	  repeat	  lengths	  that	  exceed	  the	  ones	   commonly	   found	   in	   HD	   patients	   (80	   to	   150	   CAG	   repeats	   for	   most	   models160-­‐167,173,174	  compared	  to	  about	  40	  to	  50	  CAG	  repeats	  for	  adult	  onset	  HD6).	  As	  noted	  above,	  patients	   with	   repeat	   lengths	   above	   60	   commonly	   develop	   juvenile	   HD,	   which	   differs	  somewhat	  from	  adult	  onset	  HD11,12.	  One	  of	  the	  exceptions	  is	  the	  TgHD	  rat,	  which	  carries	  51	  CAG	  repeats173.	  	  	  Disease-­‐related	  phenotypes	  of	  genetic	  HD	  rodent	  models	  All	   genetic	   rodent	   models	   of	   HD	   show	   a	   widespread	   expression	   of	   their	   respective	  disease-­‐related	   protein	   product160-­‐167,173,174.	   Indications	   of	   HD-­‐related	   neuropathology	  have	  also	  been	  found	  in	  most	  models,	  although	  the	  onset	  and	  extent	  of	  neuropathology	  varies.	   Specifically,	   fragment	  mouse	  models	  have	  been	   found	   to	   show	  early	  onset	   (2-­‐5	  months	   of	   age)	   of	   progressively	   reduced	   striatal	   volumes	   and	   numbers	   of	   striatal	  neurons182–189.	   Similar	   phenotypes	   have	   been	   found	   for	   the	   TgHD	   rats190,191,	   although	  they	   appear	   at	   an	   older	   age	   (9-­‐12	   months)	   and	   seem	   to	   be	   somewhat	   difficult	   to	  reproduce192,193.	  HD-­‐related	  neuropathology	  has	  also	  been	  found	  in	  the	  YAC128163,194–197	  and	  BACHD164,197	  mice,	  although	  the	  phenotypes	  appear	  at	  older	  ages	  (6-­‐12	  months	  of	  age)	   compared	   to	   fragment	  mouse	  models,	   and	   extensive	   neuronal	   loss	   has	   not	   been	  found	   in	   BACHD	  mice164,197.	   In	   addition,	   the	   neuropathology	   of	   BACHD	  mice	   does	   not	  appear	   to	   be	   reliably	   reproducible198,199.	   BACHD	   rats	   also	   appear	   to	   have	   mild	  neuropathological	   phenotypes	  with	   late	   onset174	   (see	   below).	   Finally,	   knock-­‐in	  mouse	  models	   were	   initially	   not	   thought	   to	   have	   any	   strong	   neuropathology	   at	   all165-­‐167,	  although	   more	   recent	   studies	   have	   found	   loss	   of	   striatal	   volume	   and	   neurons	   at	  advanced	  ages200,201	  (12-­‐26	  months).	  	  	  As	  described	  above,	  HD	  is	  a	  fatal	  disease.	  This	  does,	  however,	  not	  appear	  to	  be	  a	  general	  phenotype	  among	  genetic	  rodent	  models54.	  Fragment	  models	  generally	  show	  a	  reduced	  life	  span,	  although	  this	  is	  more	  apparent	  in	  the	  mouse	  models160,161,183	  (life	  span	  of	  about	  3-­‐10	  months)	   compared	   to	   the	   rat	  model173	   (life	   span	   of	   at	   least	   15	  months).	   The	   life	  span	  of	  full-­‐length	  and	  knock-­‐in	  models	  is	  generally	  reported	  to	  be	  normal54.	  It	  should,	  however,	  be	  noted	  that	  many	  characterization	  studies	  do	  not	  specifically	  investigate	  life	  span,	  but	  rather	  follow	  the	  animals	  until	  a	  certain	  specified	  age	  and	  collect	  tissue	  sample	  at	  this	  arbitrarily	  chosen	  end	  point162-­‐167,174,194-­‐201.	  Some	  authors	  have	  specifically	  noted	  that	  there	  is	  no	  apparently	  reduced	  survival	  among	  knock-­‐in	  and	  BACHD	  mice,	  up	  to	  two	  years	  of	  age198,202.	  Still,	  a	  reduced	  life	  span	  has	  been	  noted	  for	  YAC128	  mice203	  (becoming	  apparent	   at	   about	   one	   year	   of	   age),	   although	   it	   is	   not	   generally	   reported163,194-­‐197.	  Regardless,	  the	  current	  consensus	  is	  that	  life	  span	  does	  not	  constitute	  a	  useful	  readout	  for	  full-­‐length	  or	  knock-­‐in	  models	  of	  HD.	  	  	  Motoric	  impairments	  of	  some	  form	  are	  found	  in	  all	  types	  of	  genetic	  rodent	  models	  of	  HD.	  It	   should,	   however,	   be	  noted	   that	   the	  motor	   tests	   used	   for	   rodents	  do	  not	   necessarily	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  of	  Huntington	  disease	  evaluate	   impairments	   that	   directly	   relate	   to	   symptoms	   seen	   in	   patients.	   Thus,	   genetic	  rodent	  models	  commonly	  show	  hind	   limb	  clasping,	  meaning	   that	   they	  do	  not	  properly	  stretch	  out	  their	  limbs	  when	  being	  suspended	  by	  their	  tails160-­‐162,167,174,183,189,202,204	  (this	  can	   be	   caused	   by	   striatal	   dysfunction,	   although	   other	   brain	   regions	  might	   also	   play	   a	  part205).	   Another	   common	   test	   where	   genetic	   rodent	   models	   of	   HD	   show	   impaired	  performance	   is	   the	   Rotarod	   test161,163,164,167,173,174,183,189-­‐190,194,197-­‐200,202-­‐204,206–210.	   In	   this	  test,	  animals	  are	  trained	  to	  walk	  on	  a	  rotating	  rod	  where,	  commonly,	  the	  rotation	  speed	  gradually	  increases.	  The	  number	  of	  times	  that	  animals	  fall	  off	  the	  rod,	  and/or	  the	  latency	  and	   rotation	   speed	   at	   their	   first	   fall,	   serves	   as	   the	   main	   readouts	   of	   the	   test211.	   In	  addition	  to	  these	  phenotypes,	  genetic	  animal	  models	  of	  HD	  frequently	  show	  a	  disturbed	  gait	   when	   walking161,162,166,167,174,200,202,209,212–215.	   Notably,	   chorea-­‐like	   motoric	  phenotypes	  are	  rare,	  and	  have	  so	  far	  primarily	  been	  found	  and	  investigated	  in	  the	  TgHD	  rats173,216–218.	  	  	  Characterization	   of	   psychiatric	   phenotypes	   found	   in	   genetic	   rodent	  models	   of	   HD	   has	  primarily	   focused	   on	   characterization	   of	   depression-­‐	   and	   anxiety-­‐related	   phenotypes.	  Thus,	   several	   models	   have	   shown	   indications	   of	   anhedonia	   or	   depression-­‐like	  behaviors197,199,219–225,	  which	  would	  be	  in	  line	  with	  symptoms	  found	  in	  patients.	  Reduced	  locomotor	   activity	   has	   also	   been	   found	   in	   several	   models163,174,198,203,206,208,226–232,	  although	   it	   is	   unclear	   to	   what	   extent	   these	   phenotypes	   are	   caused	   by	   psychiatric	  phenotypes	   (such	   as	   apathy)	   rather	   than	   motoric	   impairments.	   There	   are	   several	  behavioral	  protocols	   for	  assessing	  anxiety	   in	   rodents233.	  However,	   research	  on	  genetic	  HD	   models	   has	   primarily	   focused	   on	   tests	   of	   exploration	   anxiety173,174,190,192,199,	  200,204,214,220,221,224,226,231,234–238.	   Findings	   from	   these	   studies	   have	   indicated	   both	  increased199,200,214,220,221,224-­‐226,	   decreased173,174,190,192,204,234-­‐237	   and	   unchanged220,231	  anxiety	   among	   HD	   models.	   Importantly,	   models	   with	   the	   same	   kind	   of	   genetic	  modification	   (i.e	   fragment,	   full-­‐length	   of	   knock-­‐in)	   do	   not	   necessarily	   show	   the	   same	  anxiety	   phenotype.	   It	   should	   also	   be	   noted	   that	   some	  HD	  models	   have	   been	   found	   to	  show	  inconsistent	  anxiety	  phenotypes	  between	  studies190,200,221,226,234,236,237.	  	  	  Cognitive	  impairments	  are	  also	  frequently	  present	  among	  genetic	  rodent	  models	  of	  HD.	  The	   discovered	   deficits	   include	   impaired	   motor	   learning197,199,207,208,238,239,	   procedural	  learning192,207,240,241,	   attention216,212,242–246,	   spatial	   learning247–251,	   memory	   retention207,	  228,236,237,252–256,	   reversal	   learning195,199,204,207,251,	   strategy	   shifting195,257,258,	   working	  memory173,190,259,260,	  	  reaction	  time239,243,244,	  and	  impaired	  performance	  on	  tasks	  that	  are	  dependent	   on	   fronto-­‐striatal	   circuits216,218,245,261–264.	   In	   general,	   it	   is	   unclear	   if	   models	  with	   the	   same	   kind	   of	   genetic	  modification	   show	   comparable	   phenotypes,	   due	   to	   the	  range	  of	   different	   behavioral	   tests	   that	   have	  been	  used.	   Similarly,	   it	   is	   not	   necessarily	  possible	   to	   give	   general	   comments	   concerning	   which	   animal	   model	   shows	   the	   most	  severe	  phenotypes.	  However,	   it	  should	  be	  noted	  that	  the	  more	  slowly	  progressing	  full-­‐length	   and	   knock-­‐in	   models	   are	   generally	   better	   suited	   for	   extensive	   cognitive	  characterization,	  as	  certain	  behavioral	  protocols	  can	  take	  weeks	  or	  months	  to	  complete	  (which	  is	  not	  always	  manageable	  with	  fragment	  models	  due	  to	  their	  short	  life-­‐span).	  	  	  	  The	   main	   metabolic	   phenotypes	   vary	   between	   the	   genetic	   rodent	   models	   of	   HD.	  Fragment	  mouse	  models	   generally	   show	  comparable	   growth	   to	  WT	  mice	  during	   early	  life,	   but	   develop	   a	   phenotype	   of	   progressive	   weight	   loss	   as	   they	   deteriorate	   and	  approach	  death160,161,183,209,220,225,226,232,235,249,258,259,265.	  TgHD	  rats	  were	  initially	  reported	  to	  show	  a	  stunted	  growth173,	  although	  later	  studies	  indicated	  largely	  unchanged	  growth	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  of	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  disease	  and	   weight192,266,267.	   Inconsistent	   body	   weight	   phenotypes	   have	   been	   found	   among	  knock-­‐in	   models,	   indicating	   unchanged	   weight201,	   stunted	   growth167,226,268–271,	   or	  progressive	   weight	   loss	   at	   older	   ages202,225,236,270–273	   (some	   of	   these	   discrepancies	   are	  likely	  due	  to	  differences	  in	  CAG	  repeat	  length	  and	  gender	  among	  the	  animals	  used	  in	  the	  studies).	   Full-­‐length	  mouse	  models,	   on	   the	   other	   hand,	   commonly	   show	   an	   increased	  body	   weight	   compared	   to	   their	   WT	   littermates163,164,197-­‐199,208,214,220,222,224,226,274–276	  (although	  this	  is	  known	  to	  depend	  on	  the	  genetic	  background208,248).	  This	  appears	  to	  be	  primarily	  due	  to	  an	  increase	  in	  adipose	  tissue274,275.	   Interestingly,	  there	  are	  indications	  that	  fragment	  mouse	  models	  also	  carry	  high	  amounts	  of	  adipose	  tissue	  both	  prior	  to	  and	  during	  early	  stages	  of	  weight	  loss277–279.	  Thus,	  an	  increase	  in	  adipose	  tissue	  might	  be	  a	  quite	  general	  phenotype	   in	  genetic	   rodent	  models	  of	  HD.	  The	  weight	   loss	   seen	  among	  fragment	  models	  ultimately	  includes	  loss	  of	  both	  adipose	  and	  lean	  mass278,279.	  	  	  Behavioral	   characterization	   projects	   with	   genetic	   rodent	   models	   of	   HD	   have	   to	   be	  planned,	   performed	   and	   interpreted	   carefully	   due	   to	   the	   wide	   range	   of	   behavioral	  phenotypes	   that	   can	   be	   expected.	   One	   aspect	   to	   consider	   is	   that	   although	   many	  behavioral	   tests	  are	  considered	   to	  be	  highly	   specific,	  performance	   frequently	   relies	  on	  several	  cognitive	  processes	  (as	  an	  example,	  see280	   for	  discussion	  on	  spatial	  navigation,	  which	   is	   often	   referred	   to	   as	   a	   hippocampal	   function,	   although	   several	   processes	   and	  brain	   regions	   are	   involved).	   Another	   important	   aspect	   is	   that	   some	   phenotypes	   can	  confound	  the	  readouts	  used	  for	  assessing	  other	  phenotypes	  (as	  an	  example,	  see281	  for	  a	  discussion	   on	   the	   influence	   of	   body	   weight	   and	   body	   size	   on	   Rotarod	   performance).	  Thus,	  behavioral	   characterization	  of	  HD	  models	   should	  utilize	   suitable	   control	   tests	   in	  order	   to	   ensure	   valid	   interpretations	   (see198,199,208,220,226,282	   for	   examples	   concerning	  better	  standards	  for	  motor	  characterization	  in	  relation	  to281).	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  The	  BACHD	  rat	  The	  BACHD	  rat	  The	  project	  presented	   in	   the	   current	   thesis	   focused	  on	   characterization	  of	   the	  BACHD	  rat.	  Because	  of	  this,	  this	  animal	  model	  will	  be	  given	  a	  more	  detailed	  introduction.	  	  	  The	   BACHD	   rat	   model	   is	   a	   recently	   established	   transgenic	   rat	   model	   of	   HD174.	   The	  transgenic	  construct	  that	  was	  used	  to	  create	  it	  is	  identical	  to	  the	  one	  used	  in	  the	  BACHD	  mouse164.	  This	  construct	  contains	  the	  genomic	  sequence	  for	  the	  entire	  human	  huntingtin	  protein	   in	   addition	   to	   human	   huntingtin’s	   endogenous	   5’	   and	   3’	   flanking	   sequences	  (about	  20	  and	  50	  kilo	  basepairs	  respectively).	  These	  regions	  are	  thought	  to	  contain	  the	  majority	   of	   the	   endogenous	   transcription	   regulatory	   sequences,	   and	   thus	   drive	   the	  expression	  of	  mutant	  huntingtin	   in	   the	  BACHD	  rodent	  models.	  The	  construct	  does	  not	  contain	   a	   pure	   CAG	   repeat	   sequence,	   but	   rather	   a	   CAG/CAA	   mixed	   sequence.	   Both	  codons	   are	   translated	   to	   glutamine	   during	   protein	   synthesis	   and	   this	   genetic	   setup	  should	  not	  have	  a	  major	   impact	  on	  the	  disease	  modeling	  aspects	  of	   the	  rats.	  However,	  the	   CAG/CAA	   mixed	   sequence	   is	   more	   stable	   when	   inherited,	   meaning	   that	   BACHD	  rodent	   colonies	   are	   unlikely	   to	   have	   large	   variations	   in	   repeat	   lengths	   between	  generations	   (which	   is	   an	  aspect	   to	   consider	   in	  other	  HD	  models160,165,200).	   In	   total,	   the	  CAG/CAA	  sequence	  of	  the	  BACHD	  construct	  is	  97	  repeats	  long.	  A	  final	  interesting	  aspect	  of	  the	  construct	  itself	  is	  that	  exon	  1	  (which	  contains	  the	  CAG/CAA	  sequence)	  is	  flanked	  by	  LoxP	  sites,	  enabling	   it	   to	  be	   turned	   into	  a	  non-­‐HD	  related	  huntingtin	  allele	   through	  use	  of	   the	  Cre	   recombinase.	  Through	   this,	   the	   specific	   involvement	  of	   individual	  brain	  regions	  in	  a	  given	  phenotype	  can	  be	  investigated.	  	  	  There	  are	  currently	  twelve	  publications	  available	  on	  the	  BACHD	  rat174,204,206,283–291.	  The	  work	   presented	   here	   concerns	   three	   of	   those	   publications289-­‐291.	   As	   this	   work	   was	  performed	  largely	  in	  parallel	  to	  the	  other	  published	  studies,	  the	  introduction	  will	  focus	  on	   the	  background	   information	   that	  was	  available	  at	   the	  outset	  of	   the	  current	  project.	  This	   largely	   encompasses	   the	   original	   publication174	   and	   some	   unpublished	   results.	  Additional	   publications	   of	   interest	   will	   be	   discussed	   in	   the	   results	   and	   discussion	  section.	  	  	  Two	   of	   the	   initial	   BACHD	   rat	   founders	   were	   kept	   for	   further	   breeding,	   and	   used	   to	  establish	   two	   separate	   BACHD	   rat	   lines174.	   The	   TG5	   line	   was	   kept	   due	   to	   its	   high	  expression	  level	  of	  mutant	  huntingtin,	  while	  the	  TG9	  line	  was	  kept	  as	  its	  expression	  level	  of	  mutant	  huntingtin	  was	  similar	   to	   that	  of	   the	  already	  established	  BACHD	  mice.	  Both	  lines	  overexpress	  mutant	  huntingtin	  relative	  to	  the	  endogenous	  rat	  hungtintin.	  TG5	  and	  TG9	   rats	   show	   approximately	   4.5	   and	   2.5	   fold	   higher	   expression	   of	   the	   transgene	  respectively174.	  	  	  The	   transgene	   is	   heavily	   expressed	   throughout	   the	   central	   nervous	   system174,204,	  although	  the	  rats	  do	  not	  appear	  to	  suffer	  from	  extensive	  neuronal	  loss.	  Still,	  BACHD	  rats	  display	  dispersed	  degenerated	  neurons	  that	  are	  not	  found	  among	  WT	  rats174,	  and	  there	  are	   volumetric	   changes	   found	   in	   the	   brain204.	   Specifically,	   the	   volume	   of	   cerebrum,	  striatal	  volume,	  and	  thickness	  of	  frontal	  cortex	  are	  all	  reduced	  among	  BACHD	  rats204.	  It	  should,	   however,	   be	   noted	   that	   longitudinal	   MRI	   studies	   have	   indicated	   that	   these	  volumetric	  changes	  are	  likely	  related	  to	  developmental	  deficits,	  rather	  than	  progressive	  neuronal	  loss	  (unpublished	  data).	  However,	  loss	  of	  D2	  receptor	  binding	  has	  been	  noted	  among	  18	  months	  old	  rats174,	   indicating	  that	  progressive	  neuronal	  degeneration	  might	  occur	  at	  advanced	  ages.	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Introduction	  The	  BACHD	  rat	  The	  BACHD	  rats	  still	  display	  clear	  and	  early	  behavioral	  changes,	  despite	   their	  discreet	  neuropathology.	   Specifically,	   they	   show	   an	   impaired	   performance	   on	   the	   Rotarod	  already	  at	  one	  to	  two	  months	  of	  age174,204,206.	  More	  discreet	  gait	  impairments,	  however,	  appear	   to	   be	   present	   first	   when	   rats	   are	   older	   than	   a	   year174,206.	   BACHD	   rats	   show	  reduced	  anxiety	  in	  certain	  exploration	  anxiety	  tests174,204.	  This	  phenotype	  is	  also	  present	  at	  young	  ages	  (from	  about	  four	  months	  and	  onwards)	  and	  becomes	  more	  apparent	  with	  age174.	   Initial	   investigation	   into	   metabolic	   aspects	   indicated	   that	   BACHD	   rats	   showed	  unchanged	  body	  weight,	  despite	  having	  an	  obese	  appearance	  and	  consuming	   less	   food	  than	  WT	   litter	   mates174.	   Unpublished	   results	   also	   showed	   that	   BACHD	   rats	   carried	   a	  larger	  amount	  of	  adipose	  tissues	  compared	  to	  WT	  rats.	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Aims	  of	  the	  current	  project	  Aims	  of	  the	  current	  project	  	  The	   project	   presented	   in	   the	   current	   thesis	   had	   several	   aims.	   These	   aims,	   and	   their	  backgrounds,	   are	   summarized	   below.	   Briefly,	   aims	   I-­‐III	   focus	   on	   how	   to	   work	   with	  BACHD	  rats	   in	   food-­‐based	  behavioral	   tests,	  while	  aim	  IV	   focuses	  on	  obtaining	  proof	  of	  concept	  results	  for	  the	  strategies	  developed	  under	  aims	  I-­‐III.	  	  	  I.	  	  Confirm	  previous	  results	  concerning	  metabolic	  phenotypes	  of	  BACHD	  rats	  As	  described	   in	   the	   introduction,	   BACHD	   rats	   had	   initially	   been	  noted	   to	   have	   similar	  body	   weights	   as	   their	   WT	   littermates,	   despite	   having	   an	   obese	   appearance	   and	  consuming	  lower	  amounts	  of	  food174.	  From	  this	  initial	  data	  our	  research	  group	  formed	  a	  hypothesis	   that	  BACHD	  rats	  were	   indeed	  obese	  but	   that	  presence	  of	  other	  phenotypes	  ultimately	  resulted	  in	  unchanged	  body	  weights.	  To	  evaluate	  this,	  we	  performed	  detailed	  dissections	  on	  rats	  of	  several	  different	  ages	  in	  order	  to	  obtain	  measurements	  of	  the	  rats’	  body	  composition.	  In	  addition,	  food	  and	  water	  consumption	  was	  evaluated	  as	  initial	  data	  was	   obtained	   through	   an	   automated	   homecage	   system	  with	   debatable	   validity292.	   The	  results	  from	  this	  are	  summarized	  in	  Publication	  I	  and	  Appendix	  I.	  	  II.	  Evaluate	  if	  metabolic	  phenotypes	  might	  confound	  results	  from	  food-­‐based	  operant	  conditioning	  protocols	  As	   described	   above,	   some	   phenotypes	  might	   confound	   proper	   measurement	   of	   other	  phenotypes.	   An	   overarching	   aim	   in	   our	   research	   group	   was	   to	   assess	   BACHD	   rats’	  performance	  in	  several	  tests	  that	  evaluated	  cognitive	  functions,	  all	  of	  which	  were	  based	  on	  training	  rats	  to	  perform	  tasks	  in	  exchange	  for	  food	  rewards.	  However,	  if	  BACHD	  rats	  indeed	   were	   obese	   and	   consumed	   less	   food	   than	   WT	   rats,	   they	   might	   also	   be	   less	  motivated	  to	  perform	  food-­‐based	  behavioral	  tests.	  Such	  motivational	  differences	  might	  result	   in	  profound	  differences	   in	  behavior,	  which	  could	  be	  misinterpreted	  as	  cognitive	  phenotypes293.	  To	  evaluate	  whether	  BACHD	  and	  WT	  rats	  were	  differently	  motivated	  to	  perform	  food-­‐based	  behavioral	  tests	  we	  investigated	  their	  performance	  in	  a	  progressive	  ratio	  protocol	  for	  Skinner	  boxes.	  The	  results	  from	  this	  are	  summarized	  in	  Publication	  I	  and	  II.	  	  III.	  Evaluate	   strategies	   for	   circumventing	   motivational	   differences	   between	   BACHD	  and	  WT	  rats	  	  If	  WT	   and	   BACHD	   rats	  were	   indeed	   differently	  motivated	   to	   perform	   the	   progressive	  ratio	  test,	  one	  could	  reasonably	  assume	  that	  similar	  motivational	  differences	  would	  be	  present	  in	  other	  tests	  of	  cognitive	  function.	  As	  noted,	  such	  motivational	  differences	  can	  result	   in	   behavioral	   changes,	   which	   might	   in	   turn	   be	   misinterpreted	   as	   cognitive	  phenotypes293.	   Because	   of	   this,	   a	   general	   strategy	   of	   how	   to	   handle	   motivational	  differences	  would	  be	  needed	  in	  order	  to	  ensure	  that	  valid	  behavioral	  characterization	  of	  the	   BACHD	   rats	   could	   still	   be	   performed.	   One	   such	   strategy	   would	   be	   to	   work	   with	  unconventional	   food	   restriction	   protocols	   in	   order	   to	   better	   match	   the	   hunger	   and	  motivation	  among	  WT	  and	  BACHD	  rats.	  Further	  tests	  with	  the	  progressive	  ratio	  protocol	  were	  performed	  to	  evaluate	  whether	  or	  not	  this	  approach	  was	  suitable.	  The	  results	  from	  this	  are	  summarized	  in	  Publication	  I	  and	  II.	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Aims	  of	  the	  current	  project	  	  	  IV.	  Use	   the	  developed	   strategies	   to	   obtain	   valid	  behavioral	   characterization	  data	   of	  BACHD	  rats	  As	  noted,	  a	  major	  aim	  for	  our	  research	  group	  was	  to	  assess	  BACHD	  rats’	  performance	  in	  several	   food-­‐based	   tests	   of	   cognitive	   function.	   Thus,	   once	   a	   strategy	   for	   how	   to	  work	  with	   BACHD	   rats	   in	   these	   tests	   had	   been	   developed	   (through	   completing	   the	   aims	  described	   above),	   the	   aim	   was	   to	   continue	   with	   the	   main	   characterization.	   Although	  several	  behavioral	  protocols	  were	  initially	  included	  in	  this	  characterization,	  only	  results	  from	  the	  short-­‐term	  memory	  and	   inhibitory	  control	  protocols	  will	  be	  considered	  here.	  The	  results	  from	  this	  are	  summarized	  in	  Publication	  III,	  Appendix	  II	  and	  Appendix	  III.	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Ethical	  statement	  Ethical	  statement	  	  All	   tests	  of	   the	  current	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   that	   involved	  animals	  were	  approved	  by	   the	   local	  ethics	  committee	   (Regierungspraesidium	  Tuebingen)	   and	   carried	  out	   in	   accordance	  with	   the	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   Animal	   Welfare	   Act	   and	   the	   guidelines	   of	   the	   Federation	   of	   European	  Laboratory	  Animal	  Science	  Associations,	  based	  on	  European	  Union	  legislation	  (Directive	  2010/63/EU).	  All	  procedures	  were	  carried	  out	  by	  persons	  with	  appropriate	  training	  in	  order	  to	  minimize	  stress	  and	  suffering	  among	  animals.	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Results	  and	  discussion	  Body	  composition	  and	  physiology	  of	  BACHD	  rats	  Results	  and	  discussion	  	  I.	  	  Male	  BACHD	  rats	  are	  obese,	  consume	  less	  food	  and	  water	  than	  WT	  rats,	  and	  show	  signs	  of	  discreet	  developmental	  deficits	  	  Current	  findings	  As	  described,	  initial	  characterization	  of	  the	  male	  BACHD	  rats	  noted	  that	  they	  appeared	  to	  be	  obese,	  while	  showing	  unchanged	  body	  weight	  and	  decreased	  food	  consumption174.	  These	   results	   were	   further	   investigated	   in	   both	   unpublished	   dissection	   studies	  performed	  at	  our	  institute,	  as	  well	  as	  the	  dissection	  study	  presented	  in	  Publication	  I	  of	  the	  current	  thesis.	  	  	  In	  short,	  our	  results	  have	  indicated	  that	  male	  BACHD	  rats	  of	  the	  line	  TG5	  are	  obese	  and	  suffer	   from	   discreet	   developmental	   deficits.	   These	   phenotypes	   counteract	   each	   other	  and	  frequently	  result	   in	  the	  transgenic	  rats	  showing	  comparable	  body	  weights	  to	  their	  WT	  littermates	  (Publication	  I).	  It	  should,	  however,	  be	  noted	  that	  male	  BACHD	  rats	  are	  on	  occasion	   found	   to	   be	   lighter	   than	   their	   WT	   littermates,	   while	   we	   have	   so	   far	   not	  encountered	   litters	  where	   the	   opposite	   phenotype	   is	   present	   (unpublished	   results).	   It	  thus	   appears	   as	   if	   the	  developmental	  deficits	   are	  on	  occasion	  more	   apparent	   than	   the	  obesity.	   The	   developmental	   deficits	   appear	   to	   primarily	   result	   in	   an	   overall	   growth	  impairment	  among	  male	  BACHD	  rats,	  as	  evident	  from	  their	  smaller	  body	  sizes,	  reduced	  muscle	  and	  bone	  mass,	  as	  well	  as	  generally	  smaller	  organs	  (see	  Appendix	  I).	  However,	  certain	   tissues	   appear	   to	   be	   particularly	   affected,	   as	   their	   reduced	   weight	   was	  disproportionate	  to	  the	  BACHD	  rats’	  smaller	  body	  size.	  This	  concerned	  the	  BACHD	  rats’	  brain,	   kidneys,	  muscle	   tissues,	   pancreas	   and	   testicles.	   Finally,	   it	   should	   be	   noted	   that	  while	  BACHD	  males	  appeared	  to	  consume	  more	  food	  than	  their	  WT	  littermates	  until	  the	  age	  of	  about	  three	  months,	  the	  opposite	  phenotype	  was	  present	  at	  older	  ages.	  	  	  Connection	  to	  other	  HD	  models,	  and	  HD	  patients	  Genetic	   animal	   models	   of	   HD	   differ	   in	   terms	   of	   body	   weight	   phenotypes.	   In	   general,	  fragment	  models160,161,183,209,220,225,226,232,235,249,258,259,265	  and	  knock-­‐in	  models202,225,236,270-­‐273	  appear	  to	  show	  phenotypes	  of	  progressive	  weight	  loss	  while	  full-­‐length	  models	  show	  stably	   increased	   body	   weights163,164,197-­‐199,208,214,220,222,224,226,274-­‐276.	   Further,	   unchanged	  body	  weights	  have	  been	  reported	  for	  the	  fragment	  rat	  model	  of	  HD192,266,267,	  and	  in	  some	  studies	   of	   knock-­‐in	   mice201.	   HD	   patients	   are	   primarily	   thought	   to	   gradually	   lose	  weight118-­‐122,	  which	  relates	  well	  to	  findings	  in	  fragment	  and	  knock-­‐in	  models.	  It	  should,	  however,	   be	   noted	   that	   a	   recent	   study	   of	   HD	   patients	   failed	   to	   reveal	   a	   progressive	  weight	   loss,	  although	   lower	  body	  weights	  and	  a	  clear	  deficit	   in	  reliably	  gaining	  weight	  was	   found130.	   Notably,	   the	   BACHD	   rats	   have	   so	   far	   primarily	   been	   found	   to	   display	  unchanged	  body	  weights,	  which	  is	  similar	  to	  the	  fragment	  rat	  model,	  and	  some	  reports	  on	  the	  knock-­‐in	  mice.	  However,	  a	  clear	  outcome	  from	  our	  initial	  study	  of	  the	  BACHD	  rats	  is	  that	  body	  weight	  is	  a	  quite	  limited	  parameter	  to	  work	  with,	  as	  it	  does	  not	  necessarily	  reflect	  differences	  in	  body	  composition.	  	  	  The	  BACHD	  rats	  were	  found	  to	  carry	  an	  increased	  amount	  of	  adipose	  tissue	  compared	  to	  their	  WT	  littermates.	  Similar	  phenotypes	  have	  been	  found	  in	  full-­‐length	  mouse	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  rats	  	  	  	  models274,275,	  but	  also	  among	  fragment277-­‐279	  and	  knock-­‐in277	  mouse	  models,	  during	  ages	  where	   clear	   weight	   loss	   is	   not	   yet	   present.	   In	   line	   with	   this,	   a	   recent	   study	   of	   body	  composition	   in	   HD	   patients	   found	   a	   trend	   suggesting	   that	   premanifest	   patients	   have	  increased	  amount	  of	  subcutaneous	  fat294.	  Thus,	  the	  increase	  in	  adipose	  tissue	  might	  be	  a	  quite	  general	  component	  in	  both	  animal	  models	  and	  HD	  patients,	  at	  least	  during	  initial	  stages	  of	  the	  disease.	  	  	  As	   noted,	   fragment	   and	   knock-­‐in	   mouse	   models,	   as	   well	   as	   HD	   patients	   eventually	  develop	  weight	  loss	  symptoms,	  which	  is	  thought	  to	  be	  due	  to	  a	  combined	  loss	  of	  adipose	  and	  muscle	   tissues120,121,123,278,279,295.	   Full-­‐length	  models	   on	   the	   other	   hand	  maintain	   a	  stably	  increased	  body	  weight,	  which	  is	  in	  line	  with	  them	  carrying	  an	  increased	  amount	  of	   adipose	   tissues,	   while	   having	   unchanged	   lean	  mass275.	   Thus,	   overt	  muscle	   atrophy	  does	  not	  appear	   to	  be	  a	  phenotype	  among	   full-­‐length	  mouse	  models.	   In	  contrast,	  male	  BACHD	   rats	   were	   found	   to	   show	   a	   specific	   developmental	   deficit,	   resulting	   in	  disproportionally	   lower	  muscle	  mass	  (Publication	  I).	  Although	  this	  phenotype	  is	  not	   in	  line	  with	  the	  general	   idea	  of	  HD	  patients	  suffering	  from	  progressive	  muscle	  atrophy,	   it	  should	   be	   noted	   that	   the	   presence	   and	   development	   of	   this	   symptom	   has	   been	  questioned124.	   Specifically,	   while	   there	   are	   several	   indications	   of	   functional	  abnormalities	  in	  myocytes296–300,	  the	  studies	  indicating	  muscle	  atrophy	  are	  generally	  old	  (i.e.	   published	  before	   the	   identification	  of	   the	  disease-­‐causing	   gene)	   and/or	  used	   low-­‐tech	   measurements119,120,295	   (i.e.	   arm	   circumferences).	   Thus,	   it	   is	   unclear	   how	   the	  BACHD	  rat	  phenotype	  relates	  to	  patient	  symptoms.	  	  	  BACHD	  rats	  also	  showed	  specific	  malformation	  of	  brain,	  testicles,	  kidneys	  and	  pancreas	  (Appendix	   I).	   Specific	   investigation	   of	   brain	   development	   has,	   to	   our	   knowledge,	   not	  been	  extensively	  studied	  in	  either	  HD	  patients	  or	  animal	  models.	  Still,	  studies	  focused	  on	  the	   function	   of	   huntingtin	   have	   indicated	   a	   role	   during	   brain	   development301,302,	  although	  mutant	   hungtintin	   appears	   to	   retain	   this	   developmental	   function301.	   Smaller	  testicles	   have	   been	   found	   among	   YAC128	   mice203,275,303,	   R6/2	   mice304,305	   and	   HD	  patients303.	   The	   phenotype	   appears	   to	   be	   due	   to	   a	   progressive	   degeneration303,304.	  Although	  testicle	  size	  is	  also	  affected	  in	  BACHD	  rats,	  it	  should	  once	  again	  be	  emphasized	  that	   the	   current	   phenotype	   appears	   to	   concern	   an	   impaired	   growth	   rather	   than	   a	  progressive	  degeneration.	  Renal	   function	  or	  pathology	  has	   to	  our	  knowledge	  not	  been	  extensively	   investigated	   in	   HD,	   although	   kidney	   weight	   has	   been	   reported	   to	   be	  unchanged	   in	   YAC128	   mice275,	   and	   to	   progressively	   deteriorate	   in	   R6/2	   mice304.	  Pancreas	  function	  has	  been	  investigated	  in	  greater	  details,	  although	  the	  main	  emphasis	  appears	  to	  be	  on	  its	  endocrine	  rather	  than	  exocrine	  function306.	  Thus,	  insulin	  secretion	  appears	   to	   be	   impaired	   in	   both	   R6/2	   mice307	   and	   HD	   patients308.	   In	   line	   with	   this,	  diabetes	  mellitus	   has	   been	   reported	   to	   be	  more	   prevalent	   among	   both	  HD	  patients309	  and	   R6/2	   mice307,310	   compared	   to	   their	   respective	   controls.	   Still,	   the	   findings	   among	  patients	   are	   debated311,312.	   Finally,	   it	   should	   be	   noted	   that	   despite	   the	   apparent	  pancreatic	  pathology,	  we	  have	   found	  BACHD	  rats	   to	  show	  normal	  glucose	   tolerance	   in	  resting	  and	  challenged	  states	  (unpublished	  data).	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  In	  addition	  to	  specific	  pathologies	  of	  certain	  tissues,	  the	  BACHD	  rats	  showed	  an	  overall	  growth	  deficit	  (Publication	  I).	  Similar	  phenotypes	  have	  been	  noted	  for	  knock-­‐in	  mice167	  as	  well	  as	  the	  fragment	  rat	  model	  of	  HD173,	  and	  are	  not	  surprising	  given	  that	  huntingtin	  appears	   to	   be	   important	   for	   embryonic	   development313,314.	   In	   line	   with	   this,	   discreet	  developmental	  deficits	  have	  been	  found	  among	  HD	  patients	  as	  well315,316.	  	  	  BACHD	   rats	   appear	   to	   consume	  more	   food	   than	   their	  WT	   littermates	   until	   the	   age	   of	  about	  three	  months	  (Publication	  I).	  At	  older	  ages,	  they	  have	  consistently	  been	  found	  to	  consume	  less	  food	  and	  water	  than	  their	  WT	  littermates	  (Publication	  I,	  ref.	  174).	  Notably,	  this	   is	   in	   contrast	   to	   their	   obesity,	   although	   the	   eventually	   reduced	   food	   consumption	  might	  be	   in	   line	  with	   their	  overall	   smaller	  body	   size.	  Other	  HD	  models	   show	  different	  food	   consumption	   phenotypes,	   with	   BACHD	   mice274	   and	   fragment	   rats266	   consuming	  more	   food	   than	   their	   WT	   littermates,	   while	   others	   have	   been	   found	   to	   show	   largely	  unchanged	  food	  consumption236,275,278.	  	  	  It	   should	   be	   noted	   that	   the	   current	   results	   only	   concern	   male	   BACHD	   rats,	   and	   that	  detailed	  analysis	  of	  the	  same	  parameters	  in	  female	  BACHD	  rats	  has	  not	  been	  performed	  yet.	  However,	  we	  have	   in	   several	   cohorts	   found	   that	  BACHD	   females	   are	  heavier	   than	  their	   WT	   littermates,	   suggesting	   a	   slightly	   different	   phenotype	   from	   the	   transgenic	  males	   (unpublished	   data).	   Interestingly,	   the	   body	   fat	   and	   body	   weight	   phenotype	   of	  BACHD	  mice	  also	  appears	  to	  be	  more	  apparent	  among	  females274.	  	  	  Possible	  mechanisms	  As	   increased	   food	   consumption	   does	   not	   explain	   the	   obesity	   among	   BACHD	   rats,	   the	  cause	   for	   this	   phenotype	   could	   be	   reduced	   home	   cage	   activity,	   or	   an	   underlying	  metabolic	   condition.	   Home	   cage	   and	   exploratory	   activity	   has	   been	   investigated	   in	   the	  BACHD	  rats,	  although	  no	  conclusive	  phenotype	  has	  been	  found174,204,206.	  Still,	  the	  results	  do	  not	  at	  this	  point	  appear	  to	  indicate	  that	  BACHD	  rats	  show	  strongly	  reduced	  activity	  in	  their	   home	   cages,	   suggesting	   that	   the	   likely	   cause	   of	   obesity	   in	   BACHD	   rats	   is	   an	  underlying	   hypometabolic	   state.	   The	   hypothalamus	   is	   known	   to	   be	   important	   for	  systemic	  metabolism317–319	  and	  hypothalamic	  pathologies	  have	  been	  suggested	  to	  play	  a	  role	   in	  metabolic	  symptoms	  of	  HD320–323.	   In	  addition,	   the	  obesity	  phenotype	  of	  BACHD	  mice	   appears	   to	   be	   dependent	   on	   expression	   of	   mutant	   huntingtin	   in	   specific	  hypothalamic	  neuronal	  populations274,324–326.	  Although	   the	  BACHD	  mice	  can	  be	  argued	  to	  show	   largely	  different	  metabolic	  symptoms	   than	  HD	  patients	   (see	  above),	   there	  are	  indications	   that	   they	   might	   suffer	   from	   dysfunction	   of	   overlapping	   brain	  regions322,323,326.	  Thus,	  it	  is	  also	  possible	  that	  the	  BACHD	  rats’	  metabolic	  phenotypes	  are	  caused	  by	  hypothalamic	  impairments.	  Interestingly,	  lesions	  to	  the	  arcuate	  nucleus	  of	  the	  hypothalamus	  have	  been	  found	  to	  result	  in	  obesity	  despite	  a	  reduced	  or	  unchanged	  food	  intake327–330.	   This	   specific	   nucleus	   is	   important	   for	   several	   metabolic	   processes,	  including	  the	  systemic	  release	  of	  growth	  hormone	  and	  central	  governing	  of	  hunger	  and	  satiety331–333.	   Interestingly,	   reduced	   growth	   hormone	   levels,	   and	   blocking	   of	   specific	  receptors	   of	   arcuate	   nucleus	   derived	   signaling	  molecules,	   result	   in	   animals	   displaying	  growth	  deficits,	  unchanged	  or	  reduced	  food	  intake,	  and	  obesity334–339.	  	  	  In	   addition	   to	   its	   direct	   peripheral	   effects,	   growth	   hormone	   stimulates	   the	   release	   of	  insulin-­‐like	  growth	  factor	  1	  (IGF-­‐1)	  from	  the	  liver340.	  These	  two	  factors	  play	  major	  roles	  in	  growth	  and	  postnatal	  development341–345.	   Interestingly,	  male	  BACHD	  rats	  have	  been	  found	  to	  show	  reduced	  IGF-­‐1	  levels	  (unpublished	  data),	  which	  suggest	  a	  reduced	  level	  of	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  growth	  hormone.	  As	  noted,	  a	  growth	  hormone	  deficit	  could	  explain	  their	  physiological	  and	  metabolic	  phenotypes.	   Importantly,	   other	   studies	  have	   also	   indicated	   connections	  between	  HD	  and	  growth	  hormone.	  Studies	  on	  the	  YAC	  mouse	  model	  have	  indicated	  that	  full-­‐length	  huntingtin	  induces	  growth	  of	  specific	  tissues	  through	  increased	  IGF-­‐1	  levels.	  275,276.	  Other	  studies	  have	  repeatedly	  shown	  increased	  levels	  of	  growth	  hormone	  in	  HD	  patients346,347.	  This	  might	  be	  an	  important	  component	  to	  their	  apparent	  hypermetabolic	  state,	  as	  growth	  hormone	  is	  known	  to	  induce	  lipolysis340.	  	  	  Summary	  and	  Outlook	  The	   BACHD	   rats	   show	   a	   range	   of	   physiological	   phenotypes	   that	   are	   to	   some	   degree	  comparable	   to	   phenotypes	   in	   other	   models,	   and	   symptoms	   in	   HD	   patients.	   As	   noted,	  pathology	   in	   the	   arcuate	   nucleus	   of	   the	   hypothalamus	  might	   be	   central	   in	   the	  BACHD	  rats’	  phenotypes.	  As	  histological	  methods	  have	  not	  revealed	  extensive	  neuronal	   loss	   in	  the	   BACHD	   rats,	   specific	   immunohistochemistry	   of	   the	   arcuate	   nucleus	   is	   unlikely	   to	  offer	   conclusive	   results	   regarding	   its	   involvement	   in	   the	   current	   phenotypes.	   A	  more	  suitable	  approach	  would	  be	  to	  inactivate	  the	  expression	  of	  mutant	  huntingtin	  within	  the	  hypothalamus	   and	   arcuate	   nucleus,	   through	   the	   use	   of	   Cre-­‐expressing	   viruses.	   If	   the	  resulting	   rats	   show	  normalized	  physiology,	   it	  would	   suggest	   that	   the	  hypothalamus	   is	  central	   to	  the	  phenotypes.	   If	  so,	   further	   investigations	  should	  put	  specific	  emphasis	  on	  the	  growth	  hormone/IGF-­‐1	  axis.	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  rats’	  performance	  in	  a	  food-­‐based	  test	  of	  motivation	  II.	  	  BACHD	  rats	  are	  less	  motivated	  than	  WT	  rats	  in	  the	  progressive	  ratio	  test,	  although	  the	  nature	  of	  the	  phenotype	  is	  unclear	  	  Current	  findings	  Before	  starting	  a	  large-­‐scale	  behavioral	  characterization	  project	  we	  sought	  to	  investigate	  if	  BACHD	  and	  WT	  rats	  were	  differently	  motivated	  to	  perform	  a	  simple	   food-­‐reinforced	  test.	   The	   main	   aim	   was	   to	   better	   understand	   how	   to	   efficiently	   work	   with	   the	   rats,	  considering	   the	  presence	  of	   their	  metabolic	  phenotype.	  The	   results	   from	  our	  work	  on	  this	  topic	  are	  presented	  in	  detail	  in	  Publication	  I	  and	  II	  of	  this	  thesis.	  	  	  In	   short,	   we	   followed	   a	   group	   of	  male	   BACHD	   rats	   from	   line	   TG5,	   and	   assessed	   their	  performance	  in	  a	  progressive	  ratio	  (PR)	  protocol	  for	  Skinner	  boxes	  (see	  Figure	  5)	  at	  four	  different	  ages.	  In	  this	  protocol,	  rats	  are	  taught	  that	  pushing	  a	  lever	  results	  in	  the	  delivery	  of	  a	  small	  food	  pellet.	  During	  each	  daily	  session,	  the	  number	  of	  pushes	  required	  for	  food	  pellet	   delivery	   is	   initially	   low,	   but	   gradually	   increases	   as	   the	   rats	   obtain	   rewards.	  Because	  of	  this,	  the	  rats	  will	  eventually	  lose	  interest	  in	  performing	  lever	  pushes,	  and	  will	  take	  gradually	   longer	  breaks	   from	  doing	   it.	  These	  breaks	  serve	  as	   the	  main	  readout	  of	  the	   test.	   Thus,	   rats	   that	   take	   breaks	   of	   a	   given	   duration	   at	   an	   earlier	   point	   in	   the	  progression	  of	  required	  lever	  pushes	  (i.e.	  after	  obtaining	  fewer	  rewards)	  are	  considered	  to	  be	  less	  motivated	  than	  rats	  that	  performs	  breaks	  of	  the	  same	  duration	  at	  later	  points	  in	  the	  progression.	  	  	  We	  consistently	  found	  that	  BACHD	  rats	  were	  less	  motivated	  than	  their	  WT	  littermates	  to	  perform	  the	  PR	  test	  (Publication	  I).	  The	  phenotype	  did	  not	  noticeably	  change	  with	  age,	  and	  was	  not	  dependent	  on	  BACHD	  rats	  becoming	  satiated	  or	  fatigued	  (Publication	  II).	  It	  was,	  however,	  clearly	  dependent	  on	  which	  food	  restriction	  strategy	  that	  was	  used.	  Apart	  from	  the	  lower	  motivation,	  BACHD	  rats	  were	  also	  found	  to	  have	  an	  increased	  tendency	  to	  perform	  perseverative	  lever	  responses	  (unnecessary	  lever	  responses	  performed	  after	  pellet	   delivery)	   and	   were	   slower	   at	   retrieving	   the	   reward	   pellets	   (Publication	   II).	  Importantly,	   these	   phenotypes	  were	   not	   dependent	   on	  which	   type	   of	   food	   restriction	  strategy	  that	  was	  used.	  	  	  Connection	  to	  other	  HD	  models,	  and	  HD	  patients	  The	  phenotype	  of	   reduced	  motivation	   is	   interesting	  on	   its	  own,	   as	   it	   can	  be	  argued	   to	  constitute	  an	  apathy-­‐	  or	  depression-­‐related	  phenotype.	  As	  noted,	  apathy	  and	  depression	  are	  common	  psychiatric	  symptoms	  among	  HD	  patients63-­‐68,144-­‐147.	  Reduced	  motivation	  to	  perform	   the	   progressive	   ratio	   test	   has	   also	   been	   found	   in	   BACHD348	   and	   knock-­‐in245	  mouse	  models	   of	  HD.	   Although	   similar	   trends	   have	   been	   seen	   for	   TgHD	   rats349,	   these	  findings	  are	  not	  consistent267.	  Still,	  it	  is	  interesting	  to	  note	  that	  TgHD	  rats	  have	  also	  been	  found	  to	  be	  slower	  at	  retrieving	  the	  reward	  pellets349.	  	  	  Possible	  mechanisms	  The	  neurobiological	  basis	  of	  PR	  performance	  has	  not	  been	  fully	  elucidated,	  and	  several	  brain	   regions	   appear	   to	   be	   involved	   in	   governing	   the	   rats’	   behavior.	   In	   this	   regard,	  lesions	  to	  the	  hippocampus350,	  subthalamic	  nucleus351	  and	  ventral	  striatum352	  have	  been	  found	  to	  increase	  motivation.	  Interestingly,	  lesions	  to	  the	  dorsal	  striatum	  (i.e.	  the	  region	  most	   heavily	   degenerated	   in	   HD)	   do	   not	   appear	   to	   have	   overt	   effects	   on	   motivation,	  although	  lesioned	  rats	  were	  found	  to	  perform	  an	  increased	  number	  of	  perseverative	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  test	  of	  motivation	  	  lever	   responses353.	   Specific	   lesions	   to	   the	   dorsolateral	   striatum	   have	   in	   addition	   been	  shown	   to	   result	   in	   increased	   latency	   to	   retrieve	   reward	   pellets353.	   More	   careful	  manipulations	  of	  specific	  signaling	  pathways	  have	  offered	  additional	  insights,	  indicating	  that	  dopamine	  signaling	  in	  both	  dorsal354–357	  and	  ventral	  striatum	  357–359	  are	  important	  for	  maintaining	  proper	  motivation	  on	  the	  progressive	  ratio	  test.	  	  	  As	  noted,	  a	  reduced	  motivation	  could	  also	  be	  argued	  to	  be	  a	  depression-­‐like	  phenotype.	  However,	   the	   influence	   of	   serotonin	   on	   progressive	   ratio	   performance	   is	   somewhat	  unclear.	   A	   general	   increase360	   or	   decrease361	   in	   signaling	   has	   been	   found	   to	   result	   in	  reduced	   and	   increased	  motivation	   respectively	   (although	   it	   has	   been	   suggested	   to	   be	  due	   to	   changes	   in	   general	   activity360).	   Thus,	   reduced	   motivation	   on	   the	   PR	   test	   does	  rather	   not	   connect	   to	   a	   lower	   serotonin	   level	   (i.e.	   the	   expected	   depression-­‐related	  change	   of	   serotonin).	   Still,	   specific	   serotonin	   receptor	   agonists	   within	   the	   dorsal	  striatum	  have	  been	  found	  to	   increase	  motivation,	  suggesting	  that	   there	  might	  be	  some	  connection362.	  	  	  All	  in	  all,	  it	  is	  possible	  that	  all	  phenotypes	  found	  among	  BACHD	  rats’	  performance	  in	  the	  progressive	  ratio	   test	  are	  caused	  by	  striatal	   impairments.	  This	   is	   further	  supported	  by	  the	   fact	   that	   similar	   phenotypes	   have	   been	   found	   in	   other	   animal	  models	   of	   HD	   (see	  above).	  	  	  However,	   the	   metabolic	   phenotypes	   described	   in	   the	   previous	   section	   constitute	  potential	   confounding	   factors	   for	   the	   PR	   test,	   and	   also	   have	   to	   be	   addressed.	   First,	  obesity	  has	  been	  found	  to	  result	  in	  reduced	  availability	  of	  D2	  receptors	  in	  the	  stiatum363.	  Second,	  adipose	  tissue	  has	  certain	  secretory	  functions,	  and	  is	  in	  particular	  secreting	  the	  protein	  leptin364,365.	  Leptin	  secretion	  increases	  with	  adipose	  mass,	  and	  acts	  on	  neurons	  within	   the	   hypothalamus	   to	   reduce	   food	   intake,	   and	   govern	   metabolism364,365.	   Leptin	  receptors	   are	   also	   available	   at	   several	   additional	   sites	   of	   the	   central	   nervous	  system366,367,	   and	  apart	   from	   its	   function	   in	  hypothalamic	  control	  of	  metabolism	   it	  has	  been	   implicated	  as	  an	   important	  modulator	  of	  neuron	  excitability	   in	   the	  hippocampus,	  central	   reward	   circuits	   and	  mood	   regulation368–374.	   In	   line	  with	   this,	   changes	   in	   leptin	  signaling	  have	  been	  found	  to	  have	  an	  effect	  on	  PR	  performance375–378.	  Specifically,	  acute	  administration	  of	   leptin	  has	  been	   found	  to	  reduce	  motivation375-­‐377,	  while	  knock-­‐down	  of	   leptin	   receptors	  has	  been	   found	   to	   increase	  motivation378.	  BACHD	  rats	  have,	   in	   line	  with	  their	  obesity,	  been	  found	  to	  have	  higher	  serum	  leptin	  levels	  compared	  to	  their	  WT	  littermates	   (unpublished	   data,	   Publication	   II).	   Thus,	   their	   lower	  motivation	   on	   the	   PR	  test	  could	  also	  be	  explained	  by	  their	  metabolic	  phenotypes.	  We	  further	  evaluated	  this	  by	  adding	  additional	  control	  tests	  to	  our	  study.	  	  	  Most	  protocols	  for	  food-­‐based	  cognitive	  tests	  use	  food	  restriction	  in	  order	  to	  ensure	  that	  rats	  are	  motivated	  to	  perform	  the	  test	  at	  hand.	  For	  long-­‐term	  Skinner	  box-­‐based	  tests,	  it	  is	  common	  to	  restrict	  daily	  food	  intake	  to	  a	  point	  where	  animals	  weigh	  80-­‐95%	  of	  their	  free-­‐feeding	  body	  weight.	  For	  our	  initial	  tests	  we	  maintained	  all	  rats	  at	  85%.	  However,	  this	  would	  likely	  mean	  that	  BACHD	  rats	  still	  have	  higher	  serum	  levels	  of	  leptin	  than	  WT	  rats,	  as	  they	  have	  a	  higher	  fat	  mass	  at	  baseline	  (this	  was	  confirmed	  by	  data	  gathered	  and	  displayed	  in	  Publication	  II).	  Thus,	  a	  difference	  in	  leptin	  levels	  and	  motivation	  might	  still	  be	  present	  despite	  the	  food	  restriction.	  A	  possible	  method	  for	  dealing	  with	  this	  has	  been	  used	   when	   working	   with	   BACHD	   mice264,348,	   and	   was	   also	   suggested	   to	   us	   in	   open	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  discussions	  during	  HD	  conferences.	  The	  basic	   idea	   is	   to	   first	   investigate	   if	  BACHD	  rats	  appear	   to	  be	   less	  hungry	   than	   their	  WT	   littermates,	  by	  measuring	   the	  amount	  of	   food	  they	   consume	  during	  a	  brief	  moment	  of	   free	  access.	   Several	   studies	  have	  used	   similar	  tests	   as	   control	   test	   for	   PR	   performance267,379–381.	   It	   was	   then	   suggested	   that	   in	   case	  there	   is	   a	   difference	   between	  WT	   and	   BACHD	   rats’	   food	   consumption	   rates,	   the	   food	  restriction	  should	  be	  adjusted	  until	   this	  difference	   is	  no	   longer	  present.	  Thus,	   the	   food	  restriction	  would	   be	   based	   on	  matching	   the	   apparent	   hunger	   of	  WT	   and	  BACHD	   rats,	  rather	   than	   their	   relative	   body	  weights.	  During	   our	   studies	  we	  have	   repeatedly	   found	  that	  BACHD	  rats	  consume	  less	  food	  than	  WT	  rats	  in	  these	  brief	  control	  tests,	  when	  both	  genotypes	  are	   food	  restricted	   to	  85%	  of	   their	   free-­‐feeding	  body	  weights	   (Publication	   I	  and	  II).	  Adjusting	  the	   food	  restriction	  so	  that	  WT	  and	  BACHD	  rats	  display	  similar	   food	  consumption	  rates	  (i.e.	  apparent	  hunger)	  reliably	  resulted	  in	  the	  two	  genotypes	  showing	  equal	  motivation	  in	  the	  PR	  test.	  However,	  the	  food	  restriction	  adjustment	  did	  not	  affect	  the	   higher	   tendency	   of	   performing	   perseverative	   lever	   pushes,	   or	   the	   longer	   pellet	  retrieval	   latencies	   seen	   among	   BACHD	   rats	   (Publication	   I	   and	   II).	   Thus,	   BACHD	   rats	  displayed	   a	   set	   of	   phenotypes	   comparable	   to	   rats	   with	   lesions	   to	   the	   dorsolateral	  striatum	  when	  maintained	  on	  the	  alternative	  food	  restriction	  protocol353.	  	  	  Ultimately,	  while	  the	  reduced	  motivation	  seen	  among	  BACHD	  rats	  could	  have	  been	  the	  consequence	   of	   HD-­‐related	   neuropathology	   of	   the	   striatum	   (as	   discussed	   above),	   our	  control	   tests	   indicated	   that	   it	  might	   also	   be	   related	   to	   their	  metabolic	   phenotypes.	   In	  contrast,	   the	   more	   discreet	   phenotypes	   concerning	   perseverative	   lever	   pushes	   and	  pellet	  retrieval	  are	  likely	  unrelated	  to	  motivational	  or	  metabolic	  phenotypes.	  Still,	  these	  control	   tests	   were	   not	   without	   their	   own	   shortcomings.	   First,	   the	   food	   restriction	  adjustment	   did	   not	   fully	   resolve	   the	   difference	   in	   serum	   leptin	   levels	   (Publication	   II).	  Second,	  the	  control	  tests	  were	  based	  on	  consumption	  speed,	  and	  it	   is	  possible	  that	  the	  BACHD	  rats’	   lower	   food	  consumption	  rate	  was	  caused	  by	  motoric	   impairments,	   rather	  than	   a	   difference	   in	   hunger.	   The	   rats’	   food	   consumption	   behavior	  was	   investigated	   in	  further	  detail,	  and	  we	  did	  indeed	  find	  indications	  that	  non-­‐hunger	  related	  factors	  likely	  influenced	  the	  BACHD	  rats’	  lower	  consumption	  rates	  (Publication	  II),	  although	  the	  exact	  nature	  of	  this	  deficit	  remains	  uncertain.	  It	  should	  also	  be	  noted	  that	  these	  impairments	  were	  very	  discreet,	  and	  it	   is	  unclear	  if	  they	  in	  the	  end	  had	  any	  significant	  effect	  on	  the	  consumption	  rate	  in	  the	  control	  tests	  (discussed	  in	  detail	  in	  Publication	  II).	  	  	  Finally,	   it	   is	   interesting	   to	   note	   that	   animal	   models	   of	   obesity	   have	   shown	   both	  increased382–388,	  decreased389–391	  and	  unchanged392	  motivation	  in	  the	  PR	  test.	  The	  exact	  reason	   for	   this	  discrepancy	   in	  motivation	  phenotypes	   is	  not	   clear,	   although	   it	   is	   likely	  based	  on	  differences	  concerning	   the	  cause	  of	   their	  obesity	  phenotype,	  and	   the	  specific	  set	   of	   metabolic	   impairments	   that	   follow	   (as	   an	   example,	   models	   that	   display	  hyperphagia	  frequently	  show	  increased	  motivation	  in	  the	  PR	  test382-­‐386).	  Thus,	  like	  most	  other	  behaviors,	  motivation	  to	  work	  for	  a	  food	  reward	  is	  governed	  by	  several	  processes.	  In	  order	  to	  understand	  the	  exact	  nature	  of	  the	  BACHD	  rats’	  motivational	  phenotype,	  and	  the	  potential	  involvement	  of	  metabolic	  phenotypes,	  more	  extensive	  investigation	  of	  the	  rats’	  metabolic	  phenotypes	  are	  needed.	  	  Summary	  and	  Outlook	  The	  BACHD	  rats	  consistently	  showed	  a	  reduced	  motivation	  in	  the	  PR	  test,	  although	  the	  phenotype	   was	   dependent	   on	   the	   specific	   food	   restriction	   protocol	   being	   used.	   In	  addition,	   the	   rats	   displayed	   an	   increased	   tendency	   to	   perform	   perseverative	   lever	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  of	  motivation	  responses,	  and	  slowed	  pellet	  retrieval	   latencies.	  These	  phenotypes	  were,	   in	  contrast	  to	  the	   motivational	   phenotype,	   independent	   of	   the	   food	   restriction	   protocol.	   The	   latter	  phenotype	   has	   been	   present	   in	   almost	   all	   Skinner	   box	   based	   tests	   performed	   at	   our	  institute	  (a	  total	  of	  nine	  tests,	  each	  using	  a	  12	  vs	  12	  setup	  for	  WT	  and	  BACHD	  rats).	  The	  exact	   nature	   of	   the	   BACHD	   rats’	   motivational	   phenotype	   is	   still	   unclear	   and	   might	  involve	   both	   hypothalamus-­‐driven	   metabolic	   phenotypes,	   and	   striatum-­‐driven	  psychiatric	  phenotypes.	  The	  other	  noted	  phenotypes	  are,	  however,	  unlikely	  to	  be	  related	  to	  metabolic	  phenotypes	  and	  suggest	  that	  striatal	  dysfunction	  is	  present	  among	  BACHD	  rats.	   Further	   studies	   are,	   however,	   necessary	   to	   better	   investigate	   the	   underlying	  neuropathology.	  It	  is	  unlikely	  that	  histology-­‐based	  investigations	  will	  be	  of	  great	  benefit,	  due	  to	  the	  discreet	  neuropathology	  among	  BACHD	  rats.	  Thus,	  a	  more	  suitable	  approach	  would	  be	  to	  inactive	  the	  expression	  of	  mutant	  huntingtin	  within	  selected	  brain	  regions,	  to	   investigate	  how	  the	  PR	  phenotypes	  are	  affected.	  These	  studies	  should	  be	  conducted	  together	   with	   investigations	   of	   the	   BACHD	   rats’	   metabolic	   phenotypes.	   Specifically,	   if	  switching	   off	   the	   expression	   of	   mutant	   huntingtin	   in	   the	   hypothalamus	   is	   found	   to	  resolve	  the	  BACHD	  rats’	  metabolic	  phenotypes	  (as	  discussed	  above),	   the	  resulting	  lean	  rats	   should	   be	   assessed	   in	   the	   PR	   test.	   Subsequent	   inactivation	   of	   mutant	   huntingtin	  expression	  in	  the	  dorsolateral	  striatum	  should	  be	  performed	  if	  some	  or	  all	  of	  the	  noted	  PR	  phenotypes	  persist	  among	  the	  lean	  rats.	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  food	  restriction	  III.	  	  The	  optimal	  strategy	  for	  working	  with	  BACHD	  rats	  in	  food-­‐based	  tests	  concerns	  the	  use	  of	  appropriate	  control	  tests	  rather	  than	  unconventional	  food	  restriction	  protocols	  	  Background	  As	  discussed	  above,	  there	  is	  a	  consistent	  phenotype	  indicating	  that	  BACHD	  rats	  are	  less	  motivated	   than	  WT	  rats	   in	   the	  progressive	  ratio	   test	  when	  a	  standard	   food	  restriction	  protocol	  is	  used.	  This	  phenotype	  constitutes	  a	  potential	  problem	  for	  further	  behavioral	  characterization	  of	  the	  BACHD	  rats,	  regardless	  of	  whether	  it	  is	  caused	  by	  psychiatric	  or	  metabolic	   disturbances.	   Specifically,	   based	   on	   the	   current	   results	   one	   should	   expect	  BACHD	  rats	  to	  be	   less	  motivated	  than	  WT	  rats	  to	  perform	  food-­‐based	  tasks	   in	  general.	  Although	  other	  protocols	  might	  involve	  less	  physical	  effort	  than	  the	  PR	  test,	  there	  would	  always	  be	  the	  chance	  of	  discreet	  motivational	  differences	  being	  present.	  Because	  of	  this,	  results	   from	   food-­‐based	   tests	   should	   be	   interpreted	   carefully,	   as	   motivational	  differences	   can	  have	   strong	   influences	  on	   readouts	   such	   as	   success	   rate	   and	   choice	  of	  strategy293.	  However,	  the	  exact	  influence	  that	  motivational	  differences	  might	  have	  on	  a	  given	  test’s	  readouts	  is	  often	  not	  known.	  	  	  When	  we	  interpreted	  our	  initial	  findings	  we	  argued	  that	  the	  alternative	  food	  restriction	  protocol	   (where	   apparent	   hunger,	   rather	   than	   relative	   body	  weight,	   was	  matched	   for	  WT	  and	  BACHD	  rats)	  could	  be	  used	  for	  reliably	  achieving	  an	  experiment	  setting	  where	  the	  motivational	  difference	  between	  WT	  and	  BACHD	   rats	  was	  minimal.	   Such	  a	   setting	  would	   likely	   improve	   the	   overall	   validity	   of	   our	   characterization	   work,	   as	   it	   would	  minimize	  motivation-­‐based	  artifacts	  in	  our	  data.	  This	  idea	  was	  published	  in	  Publication	  I.	  However,	  as	  we	  later	  found	  that	  BACHD	  rats	  suffered	  from	  an	  underlying	  phenotype	  of	  impaired	  food	  consumption,	  this	  idea	  was	  abandoned.	  Thus,	  the	  ideas	  concerning	  how	  to	  optimally	  work	  with	   the	   BACHD	   rats	   in	   food-­‐based	   tests	  were	   revised,	   and	   the	  more	  recent	  ideas	  were	  published	  in	  Publication	  II.	  	  	  Suggested	  work	  strategy	  As	   neither	   the	   standard	   or	   alternative	   food	   restriction	   strategy	   is	   entirely	   optimal,	   all	  characterization	   tests	  of	   the	  BACHD	  rats	   that	  use	   food-­‐based	  protocols	   should	   include	  appropriate	   control	   tests	   to	   evaluate	   which	   readouts	   are	   affected	   by	   differences	   and	  changes	  in	  motivation.	  	  	  The	  suggested	  approach	  includes	  an	  initial	  behavioral	  evaluation	  using	  a	  standard	  food	  restriction	  protocol	  (i.e.	  with	  both	  WT	  and	  BACHD	  rats	  restricted	  to	  85%	  of	  their	  free-­‐feeding	  body	  weight,	  meaning	   that	   a	  motivational	   difference	   is	   likely	   present).	   This	   is	  followed	  by	  a	  step	  where	  the	  daily	  amount	  of	  food	  given	  to	  WT	  rats	  is	  increased,	  so	  that	  they	   reach	   roughly	  95%	  of	   their	   free-­‐feeding	  body	  weight.	  By	  comparing	   the	  WT	  rats’	  performance	  on	  the	  two	  baselines	  one	  should	  be	  able	  to	  evaluate	  which	  readouts	  from	  the	  given	  test	  that	  are	  affected	  by	  a	  shift	  in	  motivation.	  BACHD	  rat	  phenotypes	  that	  are	  based	   on	   readouts	   that	   are	   sensitive	   to	   motivational	   shifts	   should	   be	   deemed	   less	  reliable	  than	  phenotypes	  in	  readouts	  that	  are	  not	  sensitive	  to	  motivational	  shifts.	  Taking	  the	   current	   results	   from	  progressive	   ratio	   performance	   as	   an	   example,	   the	  number	   of	  perseverative	   lever	  pushes	   and	   the	   latency	   to	   retrieve	   reward	  pellets	   likely	   constitute	  actual	  cognitive	  and/or	  motoric	  impairments,	  as	  the	  parameters	  were	  not	  sensitive	  to	  a	  motivational	  shift.	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  The	  strategy	  described	  above	  is	  primarily	  suited	  for	  tests	  where	  baseline	  performance,	  rather	  than	  training	  and	  learning,	  is	  being	  evaluated.	  For	  the	  latter	  it	  would	  be	  necessary	  to	   include	   separate	   control	   groups	   with	   different	   motivation	   levels	   (i.e.	   restriction	  levels),	  that	  all	  go	  through	  the	  same	  learning	  process.	  An	  alternative	  approach	  could	  be	  to	   maintain	   WT	   and	   BACHD	   rats	   on	   different	   restriction	   levels	   (95%	   and	   85%	  respectively)	  and	  after	  evaluating	  their	  performance	  in	  the	  given	  test	  of	  interest	  assess	  their	  motivation	  in	  a	  PR	  test.	  	  	  The	   remaining	   two	   sections	   of	   current	   results	   deal	   directly	   with	   detailed	   behavioral	  characterization	   of	   the	   BACHD	   rats.	   Both	   projects	   included	   some	   evaluation	   of	   the	  possible	   influence	   of	   motivational	   differences,	   using	   strategies	   and	   control	   tests	  discussed	  here.	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Results	  and	  discussion	  BACHD	  rats’	  performance	  in	  two	  tests	  of	  short-­‐term	  memory	  function	  IV.	  BACHD	  rats	  show	  indications	  of	  impaired	  fronto-­‐striatal	  function	  in	  two	  tests	  of	  short-­‐term	  memory	  	  Current	  findings	  Once	  a	  reasonable	  method	   for	  working	  with	   the	  BACHD	  rats	  had	  been	  established,	  we	  aimed	  to	  assess	  the	  rats’	  performance	   in	  a	  series	  of	  cognitive	  tests.	  Two	  of	   these	  were	  commonly	  used	  protocols	   for	   assessing	   short-­‐term	  memory	   in	   rodents,	   called	  delayed	  alternation	   and	   delayed	   non-­‐matching	   to	   position.	   As	   noted	   in	   the	   introduction,	   HD	  patients	  are	  thought	  to	  largely	  retain	  the	  temporal	  aspects	  of	  their	  working	  memory97,99.	  However,	   general	   performance	   in	   the	   delayed	   alternation	   and	   non-­‐matching	   tests	   are	  known	  to	  be	  dependent	  on	  fronto-­‐striatal	  circuits393–401,	  and	  thus	  they	  are	  still	  suitable	  for	  evaluating	  the	  presence	  of	  HD-­‐related	  neuropathology.	  	  	  Both	  test	  protocols	  used	  Skinner	  box	  setups,	  where	  an	  interactive	  wall	  was	  set	  up	  with	  one	  centrally	  placed	  food	  pellet	  receptacle	  and	  two	  retractable	  levers	  (one	  on	  each	  side	  of	  the	  pellet	  receptacle)	  (Figure	  5).	  The	  two	  protocols	  followed	  similar	  structures,	  with	  sessions	   split	   into	   discrete	   trials	  where	   the	   levers	  were	   inserted	   and	   available	   to	   the	  rats,	   separated	   by	   inter-­‐trial	   intervals	   where	   levers	   were	   retracted.	   In	   the	   delayed	  alternation	   test,	   all	   trials	   contained	  a	   single	   step	  where	  both	   levers	  were	   inserted	  and	  the	  rats	  were	  allowed	  to	  make	  one	  response.	  On	  the	  first	  trial	  of	  each	  session,	  the	  rats	  were	  rewarded	  for	  pushing	  either	  lever.	  On	  all	  subsequent	  trials,	  the	  rats	  were	  rewarded	  for	  responding	  to	  the	  lever	  they	  did	  not	  respond	  to	  on	  the	  previous	  trial,	  forcing	  them	  to	  alternate	   their	   responses	   on	   the	   two	   levers.	   Once	   the	   rats	  were	   performing	   at	   a	   high	  success	   rate,	   delays	   were	   added	   in	   order	   to	   vary	   the	   trials’	   temporal	   spacing	   in	   a	  structured	   manner.	   Through	   this,	   the	   rats’	   short-­‐term	   memory	   was	   assessed.	   In	   the	  delayed	  non-­‐matching	  to	  position	  test,	  each	  trial	  consisted	  of	  two	  steps.	  During	  the	  first	  step,	  only	  one	  of	  the	  levers	  was	  inserted.	  Once	  the	  rats	  had	  responded	  to	  it,	  it	  retracted,	  without	   a	   reward	   being	   delivered.	   During	   the	   second	   step,	   both	   levers	  were	   inserted.	  The	   rats	   were	   rewarded	   for	   responding	   to	   the	   lever	   that	   was	   not	   presented	   to	   them	  during	  the	  first	  step	  of	  the	  trial.	   	  Once	  the	  rats	  were	  performing	  at	  a	  high	  success	  rate,	  delays	  of	   structurally	   varied	  durations	  were	   added	  between	   the	   two	   steps	   in	  order	   to	  assess	  the	  rats’	  short-­‐term	  memory	  function.	  Both	  behavioral	  protocols	  were	  designed	  so	  that	  rats	  were	  triggered	  to	  perform	  repeated	  head	  entries	   into	  the	  pellet	  receptacle	  during	  delays.	  	  	  BACHD	   rats	   showed	   impaired	   performance	   in	   both	   tests	   (Publication	   III).	   The	  phenotypes	  were	  present	  at	  early	  ages	  (2-­‐4	  months),	  but	  did	  not	  appear	  to	  progressively	  worsen	  as	  the	  rats	  grew	  older	  (three	  additional	  ages	  were	  assessed,	  with	  the	  oldest	  age	  being	   17-­‐19	   months).	   BACHD	   rats	   were	   found	   to	   have	   difficulties	   learning	   the	   basic	  alternation	   behavior,	   while	   learning	   the	   non-­‐matching	   was	   unimpaired.	   During	   the	  delayed	  alternation	  test,	  BACHD	  rats	  continued	  to	  show	  indications	  of	  having	  problems	  with	  the	  general	  alternation	  task,	  while	  their	  short-­‐term	  memory	  appeared	  to	  be	  intact.	  Despite	   being	   unimpaired	  when	   performing	   the	   basic	   non-­‐matching	   task,	   BACHD	   rats	  showed	  a	  discreet	  general	  impairment	  during	  the	  delayed	  non-­‐matching	  task.	  Although	  the	   deficit	   was	   dependent	   on	   the	   presence	   of	   delays,	   it	   did	   not	   worsen	   with	   longer	  delays,	   indicating	   once	   again	   that	   BACHD	   rats	   had	   intact	   short-­‐term	   memory.	  Performance	  in	  both	  tests	  was	  evaluated	  using	  both	  a	  standard	  food	  restriction	  protocol,	  and	  a	  control	  setting	  where	  the	  WT	  rats’	  restriction	  level	  had	  been	  adjusted	  to	  95%.	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  function	  	  None	   of	   the	   phenotypes	  were	   sensitive	   to	   this	  motivational	   shift,	   indicating	   that	   they	  were	  likely	  unrelated	  to	  metabolic	  and/or	  motivational	  changes	  among	  BACHD	  rats.	  	  	  To	   further	   investigate	   the	  behavioral	   basis	   of	   the	  phenotypes,	   video	   recordings	   of	   the	  rats’	   performances	   were	   made,	   and	   scored	   manually.	   These	   indicated	   that	   rats	   used	  certain	  strategic	  movements	  during	  the	  delays	  of	  both	  tests,	  to	  aid	  their	  responses.	  The	  use	   of	   these	   strategies	  was	   especially	   pronounced	   in	   the	  non-­‐matching	   test.	  However,	  there	  were	  no	  clear	  differences	  between	  WT	  and	  BACHD	  rats	  in	  this	  regard.	  The	  videos	  further	  revealed	  that	  rats	  of	  both	  genotypes	  displayed	  specific	  behaviors	  when	  they	  had	  to	  make	  a	  decision	  regarding	  which	  lever	  to	  push	  (i.e.	  at	  the	  end	  of	  the	  delay,	  when	  both	  levers	  were	  inserted	  again).	  In	  the	  delayed	  non-­‐matching	  test,	  almost	  all	  responses	  were	  made	  without	   hesitation	   or	   apparent	   interest	   in	   the	   other	   lever.	   This	  was	  most	   likely	  connected	  to	  the	  rats	  having	  well-­‐developed	  strategies	  for	  remembering	  which	  lever	  to	  push.	  In	  contrast,	  the	  rats	  in	  the	  delayed	  alternation	  test	  frequently	  showed	  a	  correction	  behavior.	   During	   this,	   the	   rats	   would	   initially	   move	   towards	   one	   lever,	   but	   abruptly	  change	   their	   focus	   and	   ultimately	   respond	   to	   the	   other	   one.	   This	   was	   considered	   a	  correction	   behavior	   as	   it	   resulted	   in	   a	   correct	   response	   in	   over	   90%	   of	   the	   cases.	  Interestingly,	  WT	  rats	  showed	  this	  behavior	  more	  frequently	  than	  BACHD	  rats.	  Further,	  investigation	   of	   hypothetical	   data	   where	   all	   rats	   responded	   according	   to	   their	   initial	  lever	  focus	  indicated	  no	  performance	  difference	  between	  the	  genotypes.	  Thus,	  although	  the	  behavioral	  basis	   for	   the	  BACHD	  rats’	   impairment	   in	   the	  delayed	  non-­‐matching	  test	  remains	   unclear,	   the	   cause	   of	   their	   general	   alternation	   deficit	   was	   likely	   related	   to	   a	  reduced	   ability	   to	   inhibit	   ongoing	   erroneous	   motor	   responses.	   This	   could	   in	   turn	   be	  related	  to	  impairments	  in	  various	  sub	  processes,	  such	  as	  impaired	  attention	  (i.e.	  failure	  to	   realize	   that	   they	   are	   about	   to	   make	   a	   mistake),	   or	   more	   directly	   impaired	   motor	  inhibition	  (i.e	  failure	  to	  inhibit	  a	  response,	  once	  the	  rat	  has	  realizes	  that	  it	  is	  erroneous).	  As	   described	   in	   detail	   in	   the	   publication,	   there	   were	   additional	   behavioral	   changes	  among	   BACHD	   rats,	   although	   their	   contribution	   to	   the	   overall	   impairment	   was	   likely	  small.	  	  	  Connection	  to	  other	  HD	  models,	  and	  HD	  patients	  An	  overall	   reduced	  performance,	  without	   indications	  of	   impaired	   short-­‐term	  memory,	  has	   previously	   been	   seen	   for	   knock-­‐in	   mouse	   models	   of	   HD	   in	   both	   the	   delayed	  alternation	   and	   the	   non-­‐matching	   tests262,263.	   No	   detailed	   investigation	   of	   the	   exact	  behavioral	   basis	   of	   these	  phenotypes	  was	  made.	  Delayed	  alternation	  performance	  has	  also	  been	  assessed	  in	  the	  TgHD	  rats,	  although	  they	  were	  found	  to	  not	  be	  impaired402.	  	  	  The	  two	  specific	  test	  protocols	  applied	  here	  are	  rarely	  used	  in	  studies	  on	  humans,	  due	  to	  their	   simplicity.	   However,	   HD	   patients	   have	   been	   assessed	   in	   the	   arguably	   similar	  pattern	   matching	   to	   sample	   test97.	   In	   this	   test,	   patients	   are	   first	   shown	   an	   abstract	  pattern	   and	   are	   then	   asked	   to	   select	   it	   from	   a	   set	   of	   four	   patterns,	   displayed	   after	   a	  certain	   delay.	   Similar	   to	   the	   current	   results,	   HD	   patients	   appeared	   to	   be	   generally	  impaired	  in	  the	  pattern-­‐matching	  task,	  while	  showing	  intact	  short-­‐term	  memory97.	  	  The	  ability	   to	   stop	  an	   initiated	  motor	   response	   can	  be	   specifically	  assessed	  with	   stop-­‐signal	  tests403–407.	  Briefly,	  test	  subjects	  are	  first	  trained	  to	  perform	  a	  specific	  movement	  (or	  series	  of	  movements)	  during	  a	  set	  of	  training	  trials.	  Afterwards,	  their	  ability	  to	  stop	  the	   movement	   is	   assessed	   by	   presenting	   a	   stop	   signal,	   while	   the	   movement	   is	   being	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  of	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  memory	  function	  performed.	  The	   test	   usually	   involves	  presenting	   the	   stop	   signal	   during	  both	   early	   and	  late	  phases	  of	  the	  movement,	  to	  estimate	  the	  test	  subject’s	  reaction	  time.	  Interestingly,	  there	   are	   indications	   that	  HD	  patients	   are	   impaired	   in	   such	   tests,	   suggesting	   a	   similar	  pathology	  as	  the	  one	  found	  for	  the	  BACHD	  rats108.	  	  	  Possible	  mechanisms	  Performance	  in	  the	  delayed	  alternation	  and	  delayed	  non-­‐matching	  to	  position	  test	  have	  been	  found	  to	  be	  sensitive	  to	  lesions	  of	  several	  brain	  structures,	  including	  the	  prefrontal	  cortex,	   striatum	   and	   hippocampus393–401.	   Lesions	   have	   been	   found	   to	   result	   in	   both	  delay-­‐dependent	  and	  delay-­‐independent	  deficits,	   likely	  depending	  on	   the	  extent	  of	   the	  lesions	   and	   the	   specific	   neuron	   populations	   that	   are	   affected.	   However,	   the	   exact	  neuronal	   circuits	   responsible	   for	  optimal	  performance	   in	   the	   tests	   are	  not	   clear.	  More	  detailed	   findings	  have	  been	  made	  on	  stop-­‐signal	  protocols	  adapted	   for	  rodents,	  where	  performance	   appears	   to	   be	   governed	   by	   circuits	   involving	   the	   orbitofrontal	   cortex,	  dorsomedial	   striatum	   and	   subthalamic	   nucleus403-­‐407.	   Thus,	   the	   BACHD	   rats’	  performance	  deficit	  in	  the	  delayed	  alternation	  test	  might	  stem	  from	  pathology	  in	  these	  brain	  regions.	  	  	  As	   BACHD	   rats	   were	   found	   to	   be	   specifically	   impaired	   on	   delayed	   non-­‐matching	   to	  position	   trials,	   rather	   than	   the	   basic	   non-­‐matching	   task,	   we	   hypothesized	   that	   the	  behavioral	  basis	  of	  their	  impairment	  would	  relate	  to	  a	  specific	  change	  in	  their	  behavior	  during	   the	   delay	   steps.	   As	   noted,	   both	   WT	   and	   BACHD	   rats	   used	   specific	   body	  movements	   during	   the	   delays,	   which	   clearly	   indicated	   which	   lever	   they	   intended	   to	  respond	  to.	  Successful	  trials	  were	  generally	  connected	  to	  rats	  maintaining	  a	  strong	  focus	  on	   the	   correct	   lever.	   Only	   limited	   research	   has	   been	   made	   regarding	   mediating	  behaviors	  and	  strategies	  used	  by	  rats	  in	  the	  delayed	  alternation	  and	  non-­‐matching	  tests.	  However,	   one	   study	   described	   similar	   behaviors	   as	   the	   ones	   discussed	   here	   for	   the	  delayed	   non-­‐matching	   to	   position	   test408.	   The	   authors	   further	   noted	   that	   an	   overall	  impaired	   performance	   was	   connected	   to	   the	   rats	   having	   an	   increased	   frequency	   of	  changing	   their	   focus	   from	   one	   lever	   to	   another	   during	   the	   delays.	   Such	   a	   behavioral	  change	  could	  explain	  the	  generally	  reduced	  success	  rate	  among	  BACHD	  rats,	  although	  it	  was	  not	  apparent	   in	   the	  video	  scoring	  results.	   It	   is,	  however,	  possible	   that	   the	  current	  analysis	  simply	  failed	  to	  reveal	  it	  due	  to	  the	  limited	  data	  available	  and	  the	  subtle	  success	  rate	  phenotype.	  	  	  	  Summary	  and	  Outlook	  The	  BACHD	  rats	  showed	  impaired	  performance	  in	  both	  the	  delayed	  alternation	  and	  the	  delayed	   non-­‐matching	   to	   position	   tests.	   Neither	   deficit	   was	   affected	   by	   a	   shift	   in	  motivational	   state	   among	   WT	   rats,	   suggesting	   that	   the	   phenotypes	   were	   caused	   by	  cognitive	   differences,	   rather	   than	   motivational.	   The	   impaired	   alternation	   behavior	  among	   BACHD	   rats	   appeared	   to	   be	   caused	   by	   an	   inability	   to	   stop	   ongoing	   motor	  responses,	  which	  is	  similar	  to	  symptoms	  found	  in	  HD	  patients.	  The	  behavioral	  basis	  of	  the	   impairment	   seen	   in	   the	   delayed	   non-­‐matching	   to	   position	   test	   is	   still	   unclear,	  although	  it	  likely	  differs	  from	  the	  delayed	  alternation	  impairment.	  	  Further	  work	  should	  focus	  on	  the	  delayed	  alternation	  phenotype,	  as	  that	  was	  the	  more	  apparent	   one.	   Inactivation	   studies	   should	   be	   performed	   to	   evaluate	   if	   expression	   of	  mutant	   huntingtin	   in	   the	   orbitofrontal	   cortex,	   dorsomedial	   striatum	   and	   subthalamic	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  BACHD	  rats	  show	  impaired	  response	  inhibition	  in	  specific	  situations	  	  	  Current	  findings	  Response	  inhibition	  can	  be	  divided	  into	  two	  separate	  processes,	  withholding	  responses	  and	   stopping	   already	   initiated	   responses405,409.	   These	   aspects	   can	   be	   assessed	   with	  different	   Skinner	   box-­‐based	   behavioral	   protocols405,410–420.	   The	   ability	   to	   withhold	  responses	  can	  be	  evaluated	   in	  different	  versions	  of	  differential	   reinforcements	  of	   low-­‐rates	   of	   responding	   (DRL)	   protocols410-­‐415,	   and	   Go/No-­‐Go	   protocols264,416-­‐418.	   As	   noted	  above,	  the	  ability	  to	  stop	  initiated	  motor	  responses	  is	  commonly	  assessed	  in	  stop	  signal	  tests403-­‐406,419,420.	  	  	  In	  DRL	  protocols	   the	   Skinner	  boxes	   are	   typically	   set	   up	  with	  one	   lever	  being	   inserted	  and	   available	   to	   the	   rat	   during	   the	   full	   test	   session410-­‐415.	   At	   the	   start	   of	   the	   session,	  pushing	   the	   lever	   once	  will	   result	   in	   a	   reward	   pellet	   being	   delivered.	   Afterwards,	   the	  lever	  is	  inactive	  for	  a	  predetermined	  and	  fixed	  length	  of	  time.	  Pushing	  the	  lever	  during	  this	  inactive	  phase	  does	  not	  result	  in	  the	  delivery	  of	  a	  reward	  pellet.	  Instead,	  it	  restarts	  the	  timer	  for	  the	  inactive	  phase.	  Thus,	  in	  order	  for	  the	  lever	  to	  once	  again	  be	  active,	  the	  rats	  have	  to	  withhold	  lever	  responses	  for	  the	  full	  duration	  of	  the	  inactive	  phase.	  Notably,	  the	  active/inactive	  status	  of	  the	  lever	  is	  generally	  not	  signaled	  to	  the	  rat,	  meaning	  that	  they	   have	   to	   rely	   on	   their	   internal	   time-­‐assessment	   abilities410-­‐415.	  We	   have	   evaluated	  the	  BACHD	  rats’	  performance	  in	  different	  DRL	  protocols	  (Appendix	  III).	  Our	  initial	  study	  used	  a	  protocol	  where	   the	   lever’s	  active	  status	  was	   indicated	  with	  a	  cue	   light,	  and	   the	  inactive	   phase	   was	   set	   to	   five	   seconds.	   The	   BACHD	   rats	   showed	   a	   stable	   impaired	  performance	   in	   the	   test,	   suggesting	   that	   they	  had	   general	   problems	  withholding	   lever	  responses.	   However,	   the	   rats	   had	   been	   given	   extensive	   training	   on	   a	   continuous	  reinforcement	  protocol	  (where	  each	   lever	  push	  results	   in	  pellet	  delivery)	  prior	  to	  DRL	  training.	   Thus,	   it	  was	  unclear	   if	   the	  BACHD	   rats’	   impaired	  performance	   represented	   a	  difficulty	   in	   strategy	   adjustment,	   rather	   than	   a	   general	   inhibitory	   control	   deficit.	   In	   a	  follow-­‐up	   study	   we	   gave	   rats	   only	   a	   brief	   training	   on	   the	   continuous	   reinforcement	  protocol	   (some	   training	   is	   necessary	   as	   a	   part	   of	   shaping	   the	   basic	   lever	   response),	  before	  presenting	  them	  with	  a	  DRL	  protocol	  that	  used	  cue	  lights	  and	  inactive	  phases	  of	  varied	  duration.	  Interestingly,	  the	  BACHD	  rats	  showed	  comparable	  performance	  to	  WT	  rats,	  with	   very	  high	   success	   rates,	   despite	   the	   inactive	  phases	  being	  up	   to	  20	   seconds	  long.	   Thus,	   BACHD	   rats	   did	   not	   appear	   to	   have	   general	   problems	   to	   withhold	   lever	  responses,	  although	  such	  phenotypes	  might	  become	  apparent	  when	  rats	  need	  to	  apply	  inhibitory	  control	  to	  situations	  that	  have	  previously	  not	  required	  it.	  	  	  The	  results	  from	  our	  DRL	  tests	  are	  largely	  in	  line	  with	  results	  from	  a	  Go/No-­‐Go	  test	  that	  was	  performed	  in	  parallel	  (Appendix	  II).	  Go/No-­‐Go	  tests	  also	  evaluate	  the	  rats’	  ability	  to	  withhold	  lever	  responses,	  but	  through	  a	  slightly	  different	  approach.	  In	  general,	  Go/No-­‐Go	   protocols	   are	   based	   on	   training	   animals	   to	   discriminate	   between	   two	   different	  cues416	   or	   conditions264,415,417,418.	   These	   indicate	   if	   responses	   will	   be	   rewarded	   (Go	  condition/cue)	  or	  not	  (No-­‐Go	  condition/cue).	  Protocols	  differ	   in	  terms	  of	  their	  specific	  trial	   structure,	   and	   whether	   withholding	   responses	   during	   No-­‐Go	   condition/cues	   is	  reinforced415,416	  or	  not264,417,418.	   In	  addition,	  the	  protocols	  generally	  switch	  between	  Go	  and	  No-­‐Go	  conditions	  regardless	  of	  the	  rats’	  responses264,416-­‐418.	  We	  assessed	  the	  BACHD	  rats’	  performance	  in	  a	  symmetrically	  reinforced	  Go/No-­‐Go	  test	  (Appendix	  II),	  using	  the	  same	  Skinner	  box	  setup	  as	  described	  for	  the	  short-­‐term	  memory	  tests.	  The	  test	  sessions	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  were	  divided	   into	   several	   separate	   trials.	  The	   response	   levers	   remained	   retracted	  and	  unavailable	  to	  the	  rats	  between	  trials.	  Each	  trial	  followed	  a	  similar	  structure,	  where	  one	  of	  two	  light	  cues	  was	  first	  presented	  for	  five	  seconds.	  This	  was	  followed	  by	  the	  insertion	  of	  one	  lever.	  One	  of	  the	  cues	  was	  used	  to	  signal	  Go	  trials,	  meaning	  that	  the	  rats	  needed	  to	  respond	  to	  the	  lever	  in	  order	  to	  obtain	  a	  food	  reward.	  The	  other	  cue	  was	  used	  to	  signal	  No-­‐Go	   trials,	   meaning	   that	   the	   rats	   needed	   to	   withhold	   a	   lever	   response	   in	   order	   to	  obtain	  a	  food	  reward.	  Time	  limits	  were	  set	  during	  the	  lever	  presentation	  phase,	  so	  that	  rats	   had	   to	   perform	   a	   lever	   response	   within	   a	   certain	   amount	   of	   time,	   or	   withhold	  responses	  for	  a	  certain	  amount	  of	  time,	   in	  order	  to	  obtain	  rewards.	  The	  rats	  were	  first	  given	   brief	   training	   aimed	   at	   shaping	   a	   reliable	   response	   on	   Go	   trials.	   Afterwards,	  sessions	  contained	  an	  equal	  number	  of	  Go	  and	  No-­‐Go	  trials.	  Due	  to	  their	  initial	  training,	  rats	   frequently	   responded	   to	   the	   lever	   during	   No-­‐Go	   trials.	   In	   order	   to	   facilitate	  association	  of	  the	  No-­‐Go	  cue	  with	  the	  possibility	  of	  getting	  a	  pellet	  reward	  if	  no	  response	  was	  performed,	   the	  duration	  of	  No-­‐Go	   trials	  was	   initially	  kept	  short.	  Through	   this,	   the	  rats	  would	  frequently	  not	  manage	  to	  respond	  to	  the	  lever	  before	  the	  trial	  was	  over	  and	  were	   thus	   presented	   with	   several	   accidental	   successes.	   This	   still	   only	   resulted	   in	   a	  success	  rate	  of	  roughly	  chance	  level,	  and	  rats	  had	  to	  learn	  to	  discriminate	  the	  two	  cues	  and	  respond	  accordingly	  to	  reach	  higher	  success	  rates.	  Once	  the	  rats	  achieved	  this,	  they	  progressed	   trough	   a	   series	   of	   protocols	   where	   the	   duration	   of	   No-­‐Go	   trials	   gradually	  increased.	   Our	   findings	   indicated	   that	   BACHD	   rats	   were	   reliably	   impaired	   during	   the	  initial	  stages	  of	  this	  training,	  where	  they	  had	  to	  learn	  to	  discriminate	  the	  two	  light	  cues	  and	  respond	  accordingly.	  The	  impairment	  was	  primarily	  evident	  as	  a	  failure	  to	  withhold	  responses	  during	  No-­‐Go	  trials.	  However,	  once	  they	  had	  learned	  to	  do	  this,	  they	  appeared	  to	  be	  unimpaired	  when	  forced	  to	  withhold	  responses	  for	  longer	  periods	  of	  time.	  	  	  The	   control	   test	   used	   in	   the	   progressive	   ratio,	   delayed	   alternation	   and	   delayed	   non-­‐matching	   to	   position	   tests	   (i.e.	   assessing	  WT	   rats’	   performance	   on	   two	   different	   food	  restriction	  levels)	  was	  not	  suitable	  to	  evaluate	  the	  influence	  of	  motivation	  on	  the	  Go/No-­‐Go	   test’s	   readouts.	   This	   was	   primarily	   due	   to	   the	   former	   tests	   focusing	   on	   baseline	  behaviors,	   while	   the	   latter	   focused	   on	   learning.	   Instead,	   WT	   and	   BACHD	   rats	   were	  maintained	   on	   different	   restriction	   levels	   from	   the	   outset	   of	   the	   test	   (95%	   and	   85%	  respectively).	  The	  rats	  were	  assessed	  in	  a	  progressive	  ratio	  test	  at	  the	  end	  of	  the	  study,	  in	  order	   to	  evaluate	   if	   this	  had	   indeed	  avoided	  motivational	  differences.	  The	  results	  of	  this	   indicated	   that	   WT	   and	   BACHD	   rats	   were	   equally	   motivated	   to	   work	   for	   a	   food	  reward	  (Appendix	  II).	  	  	  Ultimately,	  our	  results	  indicated	  that	  BACHD	  rats	  are	  not	  generally	  impaired	  concerning	  withholding	   lever	   responses,	   although	   they	   appear	   to	   have	   some	   deficits	   in	   applying	  inhibitory	  control	  to	  settings	  that	  previously	  did	  not	  require	  any.	  The	  exact	  point	  where	  this	  becomes	  apparent	  appears	   to	  differ	  between	  protocols	   (i.e.	   reliably	  present	  at	   the	  outset	   of	   the	  Go/No-­‐Go	   test,	   but	   for	  DRL	   tests	   only	  when	   extensive	   lever	   training	  has	  been	  given),	  which	   likely	  relates	   to	  differences	   in	  where	   the	  main	   inhibitory	  challenge	  lies	   in	   the	  given	  protocols.	  Notably,	   the	   transient	  nature	  of	   this	  phenotype	   is	  different	  from	   the	   BACHD	   rats’	   likely	   impairment	   in	   inhibiting	   ongoing	   motor	   responses	   (as	  discussed	   for	   the	   delayed	   alternation	   test),	   as	   that	   phenotype	   appears	   to	   be	   a	   stable	  baseline	  phenotype	  rather	  than	  a	  learning	  impairment.	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  to	  other	  HD	  models,	  and	  HD	  patients	  Only	  limited	  amounts	  of	  work	  has	  been	  performed	  on	  inhibitory	  control	  and	  HD	  animal	  models.	  Still,	  one	  study	  found	  subtle	  impairments	  in	  a	  Go/No-­‐Go	  protocol	  among	  knock-­‐in	   and	   fragment	   mouse	   models,	   while	   the	   performance	   of	   BACHD	   mice	   was	  unimpaired264.	   The	   particular	   protocol	   used	   in	   that	   study	   was,	   however,	   not	   directly	  comparable	  to	  the	  one	  used	  in	  our	  study.	  HD	  patients	  have	  been	  found	  to	  show	  impaired	  abilities	  to	  withhold	  responses	  on	  a	  Go/No-­‐Go	  protocol	  more	  similar	  to	  the	  one	  used	  by	  us109.	  However,	  only	  a	  brief	  test	  was	  performed	  in	  that	  study,	  and	  it	  is	  unclear	  if	  patients	  could	  have	  reached	  normal	  accuracy	  if	  given	  enough	  training.	  	  	  Others	  have	  assessed	  the	  BACHD	  rats	  in	  a	  series	  of	  inhibitory	  control	  tests,	  including	  the	  DRL	   test287,288.	   Their	   study	   used	   a	   more	   classical	   DRL	   protocol,	   with	   a	   fixed	   inactive	  phase	   for	   the	   lever,	   and	   without	   light	   cues.	   Interestingly,	   they	   did	   not	   find	   any	  impairment	  during	  the	  initial	  training,	  when	  the	  inactive	  phase	  was	  set	  to	  five	  seconds,	  but	  only	  when	  the	  rats	  were	  switched	  to	  a	  protocol	  where	  the	  inactive	  phase	  was	  set	  to	  ten	  seconds.	  Although	   their	   interpretation	  was	   that	   the	  phenotype	   indicated	  a	  general	  deficit	  in	  response	  inhibition,	  their	  study	  did	  not	  include	  any	  control	  tests	  for	  evaluating	  if	  the	  phenotype	  was	  caused	  by	  a	  deficit	  in	  strategy	  adjustment	  (as	  indicated	  by	  our	  DRL	  results).	  	  	  Possible	  mechanisms	  As	   noted,	   the	   ability	   to	   stop	   an	   initiated	  motor	   response	   appears	   to	   be	   dependent	   on	  circuits	   involving	   the	   orbitofrontal	   cortex,	   the	   dorsomedial	   striatum,	   and	   the	  subthalamic	   nucleus403-­‐405,407,419.	   The	   involvement	   of	   the	   orbitofrontal	   cortex	   in	  performance	   on	   Go/No-­‐Go	   protocols	   is	   unclear405,407,	   while	   the	   subthalamic	   nucleus	  appears	  to	  be	  involved403,421,422.	  As	  noted,	  BACHD	  rats	  appear	  to	  have	  a	  general	  deficit	  in	  stopping	  ongoing	  motor	   responses	  but	   largely	   intact	   ability	   to	  withhold	   inappropriate	  responses.	  Thus,	   it	   is	  possible	   that	   the	  neuropathology	  of	   the	  orbitofrontal	   cortex	  and	  dorsomedial	  striatum	  is	  more	  pronounced	  that	  pathology	  of	  the	  subthalamic	  nucleus	  in	  the	   BACHD	   rats.	   Involvement	   of	   the	   striatum	   in	   Go/No-­‐Go	   protocols	   is	   unclear405,407,	  while	  DRL	  performance	  is	  primarily	  governed	  by	  the	  ventral	  striatum412-­‐414.	  As	  no	  overt	  DRL	  impairment	  appears	  to	  be	  present	  among	  BACHD	  rats	  it	  is	  likely	  that	  pathology	  in	  the	  ventral	  striatum	  is	  also	  limited.	  	  	  As	  noted,	  the	  BACHD	  rats’	  deficits	  concerning	  withholding	  lever	  responses	  appear	  to	  be	  dependent	  on	  situations	  where	  they	  have	  to	  apply	   inhibitory	  control	   to	  situations	  that	  previously	  have	  not	   required	   it.	  This	  deficit	  might	   relate	   to	   the	   impaired	  performance	  during	   attentional	   set-­‐shifting	   tasks,	   which	   has	   been	   seen	   among	   HD	   patients104,105.	  During	   these	   tests,	   patients	   are	   trained	   to	   respond	   to	   one	   kind	   of	   visual	   stimuli,	   but	  ignore	   another	   kind.	   At	   certain	   points	   the	   protocol	   changes,	   so	   that	   patients	   have	   to	  respond	   to	   the	   previously	   ignored	   stimulus,	   while	   ignoring	   the	   previously	   important	  one.	  The	  processes	  of	  learning	  to	  respond	  to	  a	  previously	  unimportant	  stimulus	  while	  at	  the	  same	  time	  inhibiting	  responses	  to	  the	  previously	  important	  stimulus	  are	  thought	  to	  be	  dissociable105.	  Interestingly,	  HD	  patients	  appear	  to	  show	  specific	  impairments	  in	  the	  latter	  process105.	  Similar	  deficits	  have	  been	  found	  in	  rats	  with	  lesions	  to	  the	  dorsomedial	  striatum,	  medial	  prefrontal	   cortex,	   and	  orbitofrontal	   cortex423–425.	   Still,	   as	  discussed	   in	  Appendix	  II,	  the	  BACHD	  rats’	  impaired	  performance	  in	  the	  Go/No-­‐Go	  protocol	  could	  also	  be	  due	  to	  deficits	  in	  attention	  and	  visual	  acuity.	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  Summary	  and	  Outlook	  The	  BACHD	  rats’	  exact	  impairment	  in	  inhibitory	  control	  is	  still	  largely	  unclear,	  although	  our	   results	   indicate	   a	   general	   impairment	   in	   inhibiting	   ongoing	   motor	   responses,	  combined	   with	   slowed	   learning	   to	   withhold	   responses	   in	   certain	   situations.	   Still,	   the	  validity	  of	  this	  hypothesis	  has	  to	  be	  evaluated.	  The	  Go/No-­‐Go	  study	  was	  well	  designed,	  but	  proper	  studies	  of	  the	  rats’	  performance	  in	  DRL	  and	  stop-­‐signal	  tests	  are	  needed.	  In	  addition,	  control	  tests	  that	  specifically	  evaluate	  the	  rats’	  attention	  and	  visual	  acuity	  have	  to	   be	   performed.	   Once,	   this	   has	   been	   achieved,	   and	   the	   phenotypes	   have	   been	  determined,	   inactivation	   studies	   of	   brain	   regions	   such	   as	   the	   orbitofrontal	   cortex	   and	  dorsomedial	  striatum	  might	  be	  of	  interest.	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  VI.	  Concluding	  remarks	  Phenotype	  overview	  In	   summary,	   the	   current	   project	   achieved	   several	   aspects	   of	   the	   initial	   aims.	   The	  overarching	  metabolic	   phenotype	   of	  male	  BACHD	   rats	  was	   confirmed,	   suggesting	  HD-­‐related	   pathology	   of	   the	   hypothalamus	   in	   general,	   and	   of	   the	   arcuate	   nucleus	   in	  particular.	   Strategies	   for	   how	   to	   efficiently	   work	   with	   BACHD	   rats	   in	   food-­‐reinforced	  operant	   conditioning	   tests	  were	   evaluated,	   concluding	   that	   the	   use	   of	   control	   tests	   is	  critical,	  as	  there	  is	  likely	  no	  optimal	  food	  restriction	  protocol	  available.	  The	  use	  of	  such	  control	  tests	  aided	  the	  identification	  of	  phenotypes	  that	  are	   likely	  to	  be	  caused	  by	  HD-­‐related	  pathology	  of	  fronto-­‐striatal	  circuits.	  These	  concerned	  slowed	  pellet	  retrieval	  and	  an	   increased	   tendency	   to	   perform	  perseverative	   lever	   pushes	   in	   the	   progressive	   ratio	  test,	  which	  might	  indicate	  pathology	  of	  the	  dorsolateral	  striatum.	  It	  further	  concerned	  an	  overall	   impaired	   performance	   on	   the	   delayed	   alternation	   test,	   which	   appeared	   to	   be	  connected	   to	   BACHD	   rats’	   inability	   to	   stop	   ongoing	   motor	   responses.	   As	   noted,	   this	  impairment	   could	   be	   caused	   by	   HD-­‐related	   pathology	   of	   the	   orbitofrontal	   cortex	   and	  dorsomedial	  striatum.	  	  	  Lack	  of	  progressive	  phenotypes	  As	   HD	   is	   a	   progressive	   disease	   one	   would	   expect	   that	   disease-­‐related	   phenotypes	   of	  BACHD	  rats	  would	  also	  worsen	  with	  age.	  This	  was,	  however,	  not	  generally	  seen	  for	  the	  phenotypes	   described	   above	   (Publication	   I-­‐III,	   Appendix	   II).	   Progressive	   change	   in	  phenotype	   severity	   among	   BACHD	   rats	   has	   been	   found	   in	   several	   tests,	   including	   the	  Rotarod174,206,	  Elevated	  plus	  maze174,	  gait	  analysis174,206,	  and	  Open	  field	  activity206.	  These	  studies	   used	   age-­‐spans	   comparable	   to	   what	   was	   used	   in	   the	   current	   project,	   so	   a	  progression	  was	  expected.	  The	  current	  studies	  did,	  however,	  involve	  intense	  training	  in	  operant	   conditioning	   protocols,	   which	   could	   be	   argued	   to	   constitute	   a	   kind	   of	  environmental	  enrichment.	  As	  environmental	  enrichment	  has	  been	  found	  to	  have	  strong	  therapeutic	  effects	  in	  both	  HD14,258,261,426,427	  and	  other	  neurodegenerative	  diseases428,429,	  it	   is	  possible	  that	  the	  BACHD	  rats’	  intense	  training	  had	  a	  prophylactic	  effect	  on	  disease	  progression.	   It	   should	   also	   be	   considered	   that	   no	   overt	   cell	   loss	   has	   been	   found	   in	  BACHD	   rats,	   and	   the	   noted	   progressive	   neuropathology	   primarily	   concerns	   gradual	  accumulation	   of	   huntingtin	   aggregates	   and	   a	   late-­‐onset	   loss	   of	   D2	   receptors174.	   Thus,	  while	   the	  neuropathology	  causing	  the	  noted	  progressive	  phenotypes	  might	  be	  affected	  by	   the	  gradual	  accumulation	  of	  aggregates,	   this	  process	  might	  not	  have	  any	   impact	  on	  the	  phenotypes	  discussed	  in	  the	  current	  thesis.	  Such	  non-­‐progressive	  pathologies	  might	  instead	   be	   due	   to	   developmental	   deficits.	   Finally,	   it	   should	   be	   considered	   that	   the	  apparent	  age	  progression	  seen	  in	  other	  behavioral	  tests	  might	  be	  confounded	  by	  other	  factors.	  As	  an	  example,	  BACHD	  rats	  that	  are	  trained	  on	  the	  Rotarod	  have	  been	  found	  to	  become	  increasingly	  anxious	  with	  repeated	  exposure,	  and	  the	  apparent	  age	  progression	  could	   be	   caused	   by	   psychiatric	   rather	   than	   motoric	   phenotypes	   (unpublished	   data).	  Similarly,	  Open	  field	  activity	  has	  been	  assessed	  by	  repeatedly	  exposing	  rats	  to	  a	  specific	  arena,	   and	   the	   apparent	   age	   progression	   might	   be	   influenced	   by	   differences	   in	  habituation.	  	  	  	  Limitations	  and	  weak	  points	  The	  current	  project	  is	  not	  without	  shortcomings	  and	  weak	  points.	  A	  major	  limitation	  is	  that	  only	  male	  BACHD	  rats	  were	  assessed.	  This	  was	  primarily	  due	  to	  convenience,	  and	  the	  fact	  that	  all	  characterization	  made	  prior	  to	  the	  start	  of	  this	  project	  had	  focused	  on	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  males.	   Current	   efforts	   are	   being	  made	   to	   also	   characterize	   females,	  which	   have	   so	   far	  indicated	   that	   their	  metabolic	   phenotype	   differs	   somewhat	   from	  males’	   (unpublished	  data).	   Similar	   discrepancies	   have	   been	   seen	   in	   BACHD	   mice274.	   Another	   clear	  shortcoming	  is	  that	  although	  the	  discussion	  above	  has	  pointed	  out	  several	  brain	  regions	  of	   interest,	   there	   was	   no	   possibility	   to	   properly	   investigate	   their	   involvement	   in	   the	  noted	  phenotypes.	  This	  was	  primarily	  due	  to	  time	  constraints.	  The	  major	  weak	  point	  of	  the	   study	   is	   that	   no	   controls	   were	   made	   to	   evaluate	   if	   phenotypes	   were	   caused	   by	  insertional	   mutagenesis	   (i.e.	   the	   process	   of	   transgenic	   constructs	   affecting	   the	  expression	   of	   genes	   at	   their	   insertion	   site430–432).	   Previous	   studies	   have	   included	   rats	  from	  the	  TG9	  line	  as	  controls174,	  as	  phenotypes	  caused	  by	  mutant	  huntingtin	  expression	  should	  be	  present	  but	  weaker	  compared	  to	  the	  TG5	  line.	  This	  was	  omitted	  in	  the	  current	  study	  due	  to	  time	  and	  space	   limitations.	  However,	   the	  behavioral	  phenotypes	   found	  in	  the	  current	  study	  were	   largely	   in	   line	  with	   literature	  concerning	  other	  HD	  models	  and	  animals	  with	  HD-­‐related	  brain	   lesions.	  Thus,	   it	   is	  unlikely	  that	   insertional	  mutagenesis	  had	  a	  major	  influence.	  	  	  BACHD	  rats	  as	  a	  model	  for	  HD	  A	  large	  part	  of	  the	  characterization	  work	  of	  any	  disease	  model	  aims	  to	  evaluate	  to	  what	  extent	  it	  models	  the	  actual	  disease.	  In	  this	  aspect,	  the	  BACHD	  rats	  show	  both	  similarities	  and	  differences	  according	  to	  the	  discussion	  above.	  It	  is	  important	  to	  note	  that	  symptoms	  vary	  strongly	  between	  HD	  patients56–58,64	  and	  it	  is	  arguable	  that	  an	  animal	  model	  based	  on	   inbred	  animals	   is	   likely	   to	  only	  model	   a	   subgroup	  of	  patients.	  Unfortunately,	   there	  has	  to	  our	  knowledge	  not	  been	  extensive	  studies	  done	  on	  subtyping	  HD	  patients	  based	  on	   their	   symptoms.	   Thus,	   specific	   knowledge	   of	   which	   patient	   group	   might	   be	   well	  modeled	  by	  the	  BACHD	  rats	  is	  unclear.	  	  	  Another	   important	   aspect	   is	   to	   understand	   the	   strengths	   and	   weaknesses	   of	   a	   given	  animal	  model.	  BACHD	  rats	  were	  established	  primarily	  due	  to	  rats	  having	  certain	  benefits	  over	   mice	   in	   general.	   In	   brief,	   rats’	   larger	   size	   means	   that	   imaging	   techniques	   and	  intracranial	  injections	  can	  be	  made	  with	  greater	  ease433–435.	  In	  addition,	  larger	  volumes	  of	  tissue	  samples	  can	  be	  gathered433,436.	  Finally,	  rats	  are	  more	  convenient	  to	  work	  with	  in	  operant	  conditioning	  tests262,393,433.	  These	  factors	  can	  to	  a	  large	  extent	  not	  be	  refuted,	  and	  thus	  constitute	  clear	  benefits	  of	  the	  BACHD	  rats.	  A	  weakness	  of	  a	  similar	  kind	  is	  that	  rats	   require	   more	   space,	   and	   thus	   put	   higher	   demands	   on	   housing	   facilities.	   When	  considering	   strengths	   and	   weaknesses	   in	   terms	   of	   behavioral	   work,	   BACHD	   rats	   are	  likely	   comparable	   to	   other	   animal	   models	   of	   HD.	   Thus,	   when	   assessing	   activity	   one	  would	   always	   have	   to	   consider	   that	   a	   reduced	   activity	   in	   an	   HD	   model	   could	   be	  influenced	  by	   both	  motoric	   and	  psychiatric	   impairments.	   The	   same	  would	   be	   true	   for	  motivational	   phenotypes	   in	   the	   progressive	   ratio	   test.	   Similarly,	   a	   reduced	   food	  consumption	   rate	   does	   not	   necessarily	   mean	   that	   rats	   are	   less	   hungry.	   This	   list	   of	  examples	  can	  be	  made	  long.	  Ultimately,	  although	  the	  current	  thesis	  has	  focused	  much	  on	  the	  difficulty	  of	  obtaining	  valid	  results	  for	  BACHD	  rats,	  the	  possible	  confounding	  factors	  that	  have	  been	  considered	  are	  quite	  general	  to	  HD	  models.	  Thus,	  the	  current	  project	  has	  benefitted	   the	  BACHD	  rat	  project	  as	  a	  whole,	  and	  put	  us	  ahead	  of	   the	  characterization	  work	  of	  many	  other	  models,	  as	  these	  topics	  are	  only	  rarely	  brought	  up282.	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  General	  outlook	  As	  noted,	   the	  BACHD	  rats	   show	  several	  phenotypes	   that	   could	  be	  of	  use	   in	  preclinical	  evaluation	  of	  HD	  treatments.	  However,	  the	  exact	  validity	  of	  these	  phenotypes	  still	  has	  to	  be	  confirmed	  by	  evaluating	  the	  underlying	  neuropathology.	  Histological	  analysis	  is	  likely	  of	   little	   use	   for	   this	   purpose,	   as	   BACHD	   rats	   do	   not	   show	   any	   extensive	  neuropathology174.	   Instead,	   further	   research	   should	   focus	   on	   evaluating	   behavioral	  performance	   in	  BACHD	  rats,	   following	  an	   inactivation	  of	  mutant	  huntingtin	  expression	  in	  the	  brain	  regions	  of	  interest.	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Figures   Figure 1. The human basal ganglia and frontal cortex, part I.  A displays a list of the different neuronal nuclei that make up the basal ganglia of humans [1,2]. B displays the classic concept of how neuronal signals pass through the basal ganglia. Solid arrows indicate tonic signals, while transient signals are indicated with dotted arrows. Excitatory signals are indicated with pointy arrowheads, while inhibitory signals are indicated with blunt arrowheads. Neuronal signaling through the basal ganglia can be considered to start with the excitatory glutamatergic signals that come from cortical neurons and target the medium spiny projection neurons of the striatum. Stimulation of these neurons results in subsequent inhibition of the internal and external segments of the globus pallidus, targeted by D1- and D2-containing neurons, respectively. These signals serve to reduce the tonic inhibition that the internal and external segments of globus pallidus exert on the thalamus and subthalamic nucleus, respectively. The Dͳ neurons’ signaling to the internal segment of globus pallidus makes up the so-called direct pathway. The Dʹ neurons’ signaling through the external segment of globus pallidus and subthalamic nucleus makes up the so-called indirect pathway. These two pathways counteract each other, as stimulation of the direct pathway results in reduced inhibition of the thalamus, while stimulation of the indirect pathway results in increased inhibition of the thalamus, through the disinhibition of the subthalamic nucleus, which subsequently stimulates the external segment of globus pallidus. A given action/movement is promoted when the ultimate result of signaling through the basal ganglia results in reduced inhibition of the thalamus. As such, increased signaling through the direct pathway promotes actions/movements while increased signaling through the indirect pathway inhibits it. The striatum also receives dopaminergic input from the substantia nigra pars compacta and ventral tegmental area. This serves an important modulatory effect, as dopamine stimulates D1 neurons (i.e. promotes signaling through the direct pathway) and inhibits D2 neurons (i.e. inhibits signaling through the indirect pathway) [1]. C displays anatomical sketches of various brain regions that are of interest for the current thesis [1]. Abbreviations (in chronological order): D1 – Dopamine receptor 1, D2 – Dopamine receptor 2, GPi – Globus pallidus pars interna (internal segment), GPe – Globus pallidus pars externa (external segment), SNc – Substantia nigra pars compacta, VTA – Ventral tegmental area, STN – Subthalamic nucleus, FPC – Frontal pole cortex, dmPFC – dorsomedial Prefrontal cortex, PrMc – Premotor cortex, MC – Motor cortex, vmPFC – ventromedial Prefrontal cortex, dACC – dorsal Anterior cingulate cortex, OFC – Orbitofrontal cortex, vlPFC – ventrolateral Prefrontal cortex, dlPFC – dorsolateral Prefrontal cortex, N. accumbens – Nucleus accumbens.   
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Figures   Figure 2. The human basal ganglia and frontal cortex, part II.  A displays anatomical sketches of two coronal sections taken at different locations along the rostro-caudal axis of the human brain. The locations of various basal ganglia components are indicated. B displays a sketch indicating where cortical projection neurons from different regions of the prefrontal cortex synapse on striatal neurons. Note that the sketch displays the rostral striatum, comparable to the leftmost sketch in A [1]. C displays a short list of suggested functions for different regions of the prefrontal cortex that are of interest for the current thesis. Abbreviations (in chronological order): N. accumbens – Nucleus accumbens, PrM – Premotor cortex, M – Motor cortex, dPFC – dorsal Prefrontal cortex, dACC – dorsal Anterior cingulate cortex, OFC – Orbitofrontal cortex, vmPFC – ventromedial Prefrontal cortex, dlPFC – dorsolateral Prefrontal cortex, vlPFC – ventrolateral Prefrontal cortex.   
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Figures   Figure 3. The rat basal ganglia and frontal cortex, part I.  A displays a list of the different neuronal nuclei that make up the basal ganglia of rats. Notable differences between the rat and human anatomy are described [1]. B displays a series of sketches that indicate the anatomical location of various cortical regions of interest, and basal ganglia components, along the rostro-caudal axis of the rat brain [2]. Abbreviations (in chronological order): IL – Infralimbic cortex, PrL – Prelimbic cortex, Cg1 – Cingulate cortex area 1, Cg2 – Cingulate cortex area 2, M1 – Motor cortex 1, M2 – Motor cortex 2, Fr3 – Frontal cortex area 3, LO – Lateroorbital cortex, VO – Ventroorbital cortex, N.Accumbens – Nucleus accumbens.   
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Figures   Figure 4. The rat basal ganglia and frontal cortex, part II.  A displays a sketch indicating where cortical projection neurons from different regions of the prefrontal cortex snapse on striatal neurons. Note that the sketch displays the rostral striatum, comparable to the middle sketch in Figure 3B [1]. B displays a short list of suggested functions for different regions of the prefrontal cortex that are of interest for the current thesis. Abbreviations (in chronological order): M1/2 – Motor cortex 1/2, ACg – Anterior cingulate cortex (Includes Cg1 and Cg2), dPrL – dorsal Prelimbic cortex, vPrL – ventral Prelimbic cortex, IL – Infralimbic cortex, mPFC – medial Prefrontal cortex, OFC – Orbitofrontal cortex.   
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Figures    Figure 5. Skinner box system used in the current thesis A shows a sketch of one of the Skinner boxes used for the various behavioral tests described in Publication I-III, and Appendix II and III. The noted components are a reward pellet feeder (1), a pellet receptacle (2), a large cue light (3), a retractable lever (4), a house light (5) and a water bottle (6). Note that the sidewalls and door of the Skinner box have been omitted from the sketch. B shows a photo from inside the Skinner box, with a rat interacting with one of the response levers.  
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Abstract
Huntington disease (HD) is an inherited neurodegenerative disease characterized by motor, cognitive, psychiatric and
metabolic symptoms. Animal models of HD show phenotypes that can be divided into similar categories, with the
metabolic phenotype of certain models being characterized by obesity. Although interesting in terms of modeling
metabolic symptoms of HD, the obesity phenotype can be problematic as it might confound the results of certain
behavioral tests. This concerns the assessment of cognitive function in particular, as tests for such phenotypes are often
based on food depriving the animals and having them perform tasks for food rewards. The BACHD rat is a recently
established animal model of HD, and in order to ensure that behavioral characterization of these rats is done in a reliable
way, a basic understanding of their physiology is needed. Here, we show that BACHD rats are obese and suffer from discrete
developmental deficits. When assessing the motivation to lever push for a food reward, BACHD rats were found to be less
motivated than wild type rats, although this phenotype was dependent on the food deprivation strategy. Specifically, the
phenotype was present when rats of both genotypes were deprived to 85% of their respective free-feeding body weight,
but not when deprivation levels were adjusted in order to match the rats’ apparent hunger levels. The study emphasizes the
importance of considering metabolic abnormalities as a confounding factor when performing behavioral characterization of
HD animal models.
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Introduction
Huntington disease (HD) is an autosomal dominantly inherited
neurodegenerative disease with a prevalence of 6 per 100,000 in
Europe and North America [1]. Development of HD is dependent
on a single mutation that results in the extension of the CAG
repeat sequence present in the gene for the Huntingtin protein [2].
HD patients display a range of symptoms that can be grouped into
motor, psychiatric, cognitive and metabolic symptoms. Symptoms
gradually worsen as the disease progresses, and due to the lack of
disease modifying treatments HD is invariably fatal.
There are numerous transgenic animal models of HD [3], and
as with any disease model, a major focus of working with these is to
assess how well their phenotypes mirror symptoms found in HD
patients. This is complicated due to the multitude of phenotypes
that are often present, and the potential risk of some phenotypes
confounding the assessment of others. The metabolic phenotypes
are especially interesting in this regard. While HD patients
typically lose weight [4,5,6,7,8,9], the body weight and body
composition phenotypes of transgenic animal models of HD vary
[3]. Animals that express the full-length mutant huntingtin gene
typically show an increased body weight, due to increased fat mass
[10,11]. Although this is interesting in terms of modeling the
metabolic symptoms of HD, an increase in body weight has been
suggested to result in reduced performance on the rotarod [12,13],
a common test of motor capacity and limb coordination.
Metabolic phenotypes are also of interest when considering tests
of cognitive function, as these are often based on having food
deprived animals perform certain tasks to retrieve food rewards
[14]. Ideally, animals should be equally hungry and interested in
food rewards when performing such tests, as studies where
motivational differences are present can give misleading results
[15]. Changes in body composition, such as the ones seen in HD
models, are likely to either be caused by or lead to a change in ad
libitum food consumption. Unless careful adjustments are made,
such phenotypes might persist even after food deprivation. One
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proposed method to avoid this when working with HD models is
to adjust food deprivation levels until animals show similar
consumption rates in tests where they are given brief access to food
[16,17]. Similar tests are occasionally used to assess hunger and
food interest, [18,19,20,21] although in HD research one should
also consider that a slowed consumption rate could be caused by
motor impairments. Thus, detailed knowledge about body
composition and feeding behavior of an animal model, both when
deprived and ad libitum fed, is important for planning and
interpreting a variety of behavioral tests.
The BACHD rat is a recently established animal model for HD.
These rats carry a large construct containing the full-length gene
for human mutant Huntingtin, with its endogenous regulatory
sequences [22]. Previous studies have shown that BACHD rats
have motor impairments and neuropathological phenotypes
reminiscent of symptoms seen among HD patients [22]. In
addition, BACHD rats appear to be impaired in some cognitive
tests [23]. Previous studies have indicated that BACHD rats eat
less than WT rats [22], although the setup used for that particular
study demanded social isolation, and its validity for assessing
natural behavior has been questioned [24]. Further, although it
has been pointed out that BACHD rats appear obese [22], there
has not been any study on their body composition. Therefore, we
performed a longitudinal study where food intake was measured in
a social homecage setup, and body composition was assessed
through detailed dissections. As further behavioral characteriza-
tion of the BACHD rats will be dependent on tests that require
food deprivation, we also sought to evaluate an optimal food
deprivation strategy for BACHD rats. For this, consumption rate
of reward pellets and regular food, as well as performance in a
progressive ratio test with prefeedings was assessed at different
levels of food deprivation.
Materials and Methods
Animals
A total of 168 male rats were used for the study. These were
acquired from three separate in-house breeding events, with
heterozygous BACHD males from the TG5 line [22] paired with
WT females. All animals were on Sprague Dawley background.
Animals were genotyped according to previously published
protocols [22] and housed in type IV cages (38655 cm), with
high lids (24.5 cm from cage floor), and free access to water. Food
availability and social conditions differed between the experimen-
tal groups. Rats used for ad libitum food intake and body
composition measurements were housed in genotype-matched
pairs, and had free access to food (SNIFF V1534-000 standard
chow) during the entire length of their respective test. Importantly,
food was provided on the cage floor and not on the cage top. Body
weight was measured weekly to assess general health, and cages
were changed twice per week. Rats used for hunger assessment
and PR tests were housed in genotype-matched groups of three
rats per cage. They had free access to food from the cage top until
the age of ten weeks. At that point, the rats were food deprived as
described below. Body weight was measured daily in order to
assess food deprivation levels, and cages were changed weekly.
The animal facility kept 21–23uC, 55–10% humidity, and was set
to a partially inverted light/dark cycle with lights on/off at 02:00/
14:00 during summer, and 01:00/13:00 during winter.
The seven groups of animals were used in different tests, as
described below. An overview of the animal groups, and the tests,
is shown in Figure 1. All experiments were approved by the local
ethics committee (Regierungspraesidium Tuebingen) and carried
out in accordance with the German Animal Welfare Act and the
guidelines of the Federation of European Laboratory Animal
Science Associations, based on European Union legislation
(Directive 2010/63/EU).
Ad libitum food consumption in a social homecage
environment
Ad libitum food consumption was measured using a total of 72
rats, acquired from one breeding event. At the age of five weeks,
all rats were arranged into genotype-matched pairs, and housed as
described above. This gave a total of 36 cages, 18 cages per
genotype. Cages with WT and BACHD rats were evenly
distributed over two racks, which were placed next to each other
in the same housing room. Food and water intake was assessed
Figure 1. Overview of study groups. A total of seven groups of rats were used in the current study. These were derived from different breeding
events and used in different tests, as shown in the figure. The ‘‘n’’ indicates the number of animals used from each genotype. Note that a total of two
animals were excluded during analysis, as explained in detail under ‘‘Statistical analysis’’.
doi:10.1371/journal.pone.0105662.g001
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twice weekly, when cages were changed. Cages were changed on
Mondays and Thursdays during the last two hours of the light
phase. At each cage-changing event, a known amount of food was
placed inside each new cage, and the fresh water bottles were
weighed. The weights of the old water bottles as well as the weight
of the food left in each old cage were then measured to assess the
amount of food and water consumed since the last cage change.
The food was manually collected from the bedding of the old
cages. After removing large food pieces, the bedding was sifted in a
homemade sieve with a 1 mm mesh in order to collect small food
pieces generated by food grinding. The animals’ food and water
consumption was followed in this way until the age of 26 weeks.
Sifting of bedding materials started when animals were 15 weeks
old.
Dissection for body composition assessment
A detailed dissection was performed in order to study the body
composition of BACHD rats. Five different rat groups were
sacrificed at 1, 3, 6, 9, and 12 months of age respectively, with
each group being composed of 12 WT and 12 BACHD rats. The
rat groups used for dissection at 6, 9, and 12 months of age were
the same rats that were followed during the ad libitum food
consumption test. The rat groups used for dissection at 1 and 3
months of age were acquired from a separate breeding. Housing
conditions were identical for all animals, and according to the
description above. Aside from the weekly food and water
consumption assessment made during the ad libitum food intake
test, food and water consumption were measured monthly as
animals aged. When rats reached an age of interest, a dissection
group was arranged based on the animals’ food consumption,
water intake, and body weights, so that the dissected group well
represented the full group.
Rats were sacrificed in a carbon dioxide chamber two to four
hours before dark-phase onset. Blood samples were collected after
sacrifice, through retro-orbital bleeding. Body lengths and body
weights were measured on the intact animals, with body length
measured from nose tip to tail tip. Additional measurements of
head, trunk, and tail lengths were measured from nose tip to back
of the head, back of the head to anus, and anus to tail tip,
respectively. After these external measurements, skin and subcu-
taneous adipose tissue deposits were removed and weighed. Then,
internal organs and adipose deposits located in the abdomen and
chest cavities were removed and weighed. The remaining carcass
was weighed before removal of the brain. By later subtracting the
brain weight, a measurement of bone and muscle weight (denoted
bone/muscle) was acquired for each rat. Dissection of a given age
group was carried out during four to six days, with rats of both
genotypes being assessed on each day.
Hunger assessment tests
Two tests were used to assess hunger levels in WT and BACHD
rats at three different food deprivation levels. A group of 24
animals with equal numbers of WT and BACHD rats was used for
both tests. This group was acquired from a breeding separate from
the ones used for the ad libitum food consumption and body
composition measurements. As mentioned above, food deprivation
started when the rats were ten weeks old. Body weights were
compared to control data from age- and genotype-matched free-
feeding animals, on a weekly basis, in order to acquire
measurements of food deprivation levels (relative body weight).
It should be noted that the control data was not gathered in the
current study, but in previous tests. Rats were given small daily
amounts of food inside their social homecages, approximately four
hours after dark phase onset, to maintain food deprivation. During
the first week of food deprivation, animals were habituated to the
reward pellets (Bio-Serv, Dustless Precision PelletsH F0021,
purchased through Bilaney Consultants, Duesseldorf, Germany)
by daily giving each cage a spoon-full of reward pellets together
with the daily amount of food. Behavior assessment started one
hour after dark phase onset, and was performed in the animals’
housing room, using soft red light. Rats were 13 weeks old when
behavioral assessment started.
Rats were assessed in both tests on each given testing occasion.
The first test assessed the rats’ interest in consuming 100 reward
pellets. The test used a glass cage (28.5629629.5 cm) with
mirrors, which allowed a good view of the feeding animals. At the
start of each trial, a rat was placed inside the cage, and was
allowed two explore it freely during two minutes. Afterwards, a
glass Petri dish containing 100 reward pellets was placed inside the
cage, in one of the corners that faced the experimenter. The rats
were then given a total of five minutes to consume the reward
pellets, while the experimenter scored their behavior. The
experimenter used two timers to separately record the total time
taken to consume the reward pellets, and the time each rat actually
spent eating. Thus, one timer was started when the rat first
discovered the pellets, and stopped either when all pellets were
consumed or when five minutes had passed. The second timer was
also started when the rat first discovered the pellets, but was
stopped whenever the rat stopped eating, and explored the test
arena. Roughly three hours were needed to assess all 24 rats. The
test schedule was arranged so that entire cages of BACHD and
WT rats were assessed in an alternating manner. Thus, three rats
of a given genotype were assessed in sequence, followed by three
rats of the other genotype. The experimenter was blinded to the
animals’ genotypes.
The second test assessed the rats’ interest in regular food. In this
test, rats were given free access to a large amount of food in their
homecages. Food was made available to the rats when four hours
remained of the dark phase. Identical amounts of food were placed
in the cage tops, with one-minute spacing between cages,
alternating between BACHD and WT cages. The remaining food
was then measured each half hour, until the end of the dark phase.
A final measurement was made at the end of the subsequent light
phase. At each measurement, the cages were briefly inspected for
larger pieces of food, as they occasionally dropped between the
bars of the cage lids.
The rats were assessed in these two tests on three separate
occasions. On the first, both WT and BACHD rats were deprived
to 85% of their respective free-feeding body weights. In an attempt
to reverse the phenotypes that were found, the food deprivation
levels were then adjusted so WT and BACHD rats were at 95 and
80% of their respective free-feeding body weights. On the final
trial, the previous deprivation levels were switched, so that WT
and BACHD rats were at 80 and 95% of their respective free-
feeding body weights. Each test occasion was separated by a week
of food deprivation, to allow gradual adjustment of deprivation
levels.
Progressive ratio test
A progressive ratio (PR) test was run to assess the rats’
motivation to work for a food reward at two different food
deprivation settings. A group of 24 animals with equal numbers of
WT and BACHD rats was used for the test. This group was
acquired from the same breeding as the group used for the hunger
tests described above. Food deprivation was initiated and
maintained as described above. Behavioral assessment started 30
minutes after dark phase onset, in a room separate from the
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animals’ housing room, using soft red light. Rats were 11 weeks old
when behavioral assessment started.
A bank of six operant conditioning chambers (Coulbourn
Instruments, H10-11R-TC with H10-24 isolation boxes, pur-
chased through Bilaney Consultants, Duesseldorf, Germany) was
used to run the test. Each chamber was equipped with two
retractable levers, placed 6 cm above the chamber floor,
protruding 2 cm from the wall. The levers were placed on either
side of a central pellet receptacle trough, which was placed 2 cm
above the chamber floor. The pellet receptacle trough contained a
yellow light, which was used to signal the delivery of a reward
pellet in all protocols described below. The chambers also
contained a red house light, on the wall opposite from the levers
and pellet receptacle trough, which shined during the full duration
of the training sessions. A water bottle was also available on this
wall, to ensure ad libitum access to water during testing. All
protocols were designed and run with Graphic State 4.1.04. Rats
were given single daily sessions, meaning that a total of four daily
runs with all six operant chambers were needed to assess the whole
group. Each run assessed three WT and three BACHD rats in a
determined order, so that a given rat was trained on the same time
of day through the entire test. Each rat was assigned to a specific
operant chamber, although this was arranged so that each operant
chamber was used to assess equal numbers of WT and BACHD
rats. Rats received their daily regimen of regular food four hours
after the completion of the last run of the day.
During initial training, rats of both genotypes were deprived to
85% of their respective free-feeding body weights. Afterwards, all
rats received two habituation sessions in the conditioning
chambers. During these, both levers were retracted and a single
reward pellet was delivered to the pellet trough at 10, 15, 20, 25,
or 30-second intervals. The pellet delivery interval varied in a
pseudo-randomized fashion so that each set of five deliveries used
each given interval once. Pellet retrieval, or failure to retrieve the
pellet within five seconds after delivery, lead to the start of the next
pellet delivery interval. After the habituation sessions, rats were
trained to lever push for a pellet reward. During these sessions,
both levers were extended into the chamber, but only one was
reinforced. Rats were either trained to push the right or the left
lever, with the reinforced lever position being counter-balanced
within the genotype groups. During training, the experimenter
would reward rats for approaching, sniffing and touching the
reinforced lever, until rats started to reliably push the lever on their
own. During this, each lever push was rewarded with one pellet.
Training continued until rats completed 100 lever pushes within a
30-minute session, without any help from the experimenter. The
rats were then trained on an FR3 protocol, where they had to push
the reinforced lever three times before being rewarded with a
pellet. When a rat completed 100 ratios within a 30-minute
session, it progressed to an FR5 protocol. Rats now had to push
the reinforced lever five times before being rewarded with a pellet.
Training on the FR5 protocol continued until rats completed 100
ratios within a 30-minute session, on three consecutive sessions.
Afterwards, rats were trained on a PR protocol adapted from [16].
In the current protocol, the ten first ratios were of FR5 type.
Afterwards, the required number of lever pushes increased after
each completed ratio. During this progression, the required
number of lever pushes increased in an arithmetic fashion within
each block of ten ratios, but also changed between the blocks, to
give an overall exponential progression. Thus, during the first,
second and third block of ten ratios, the ratio requirement
increased with one, three and five pushes per completed ratio,
respectively. The PR sessions lasted 80 minutes. The main
behavioral parameter of interest was a set of break points, defined
as the first ratio where a rat made no responses on the reinforced
lever during 10, 25, 50, 100, 300 or 600 seconds. Rats were
trained until both genotype groups reached a stable performance,
which in this case required 18 sessions. Performance during the six
last sessions was defined as baseline performance.
Once stable PR performance had been reached, the rats were
challenged in a set of four prefeeding tests. During these tests, the
rats were fed specific amounts of reward pellets or regular food,
just prior to their daily PR session. Rats were prefed by placing
them in individual cages that contained the specified amount of
food. Each prefeeding condition was assessed once, in the
following order: 100 reward pellets, 250 reward pellets, 4.5 g of
regular food, 11.25 g of regular food. Each prefeeding test was
separated by two regular PR sessions to ensure that rats returned
to their baseline performance.
After completion of the first round of prefeeding tests, the food
deprivation level of WT rats was adjusted until they consumed
food at the same rate as BACHD rats. Consumption rate was
assessed daily by measuring the amount of food consumed during
15 minutes of free access to regular food, placed in the cage tops of
the rats’ homecages. The rats were still given daily PR sessions
during food deprivation adjustments. The food consumption tests
were run four hours after completion of the last PR run, i.e. at the
time when the rats were usually given their daily food ration.
When WT rats had reached a consumption rate equal to that of
BACHD rats, six additional PR sessions were run to establish a
new baseline. The prefeeding tests were then repeated in the same
manner as described above. Rats were 20 weeks old at the end of
the test.
Statistical analyses
All statistical analyses were conducted using GraphPad Prism
v.6.01 (GraphPad Software, San Diego California USA, http://
www.graphpad.com).
Food consumption in the ad libitum food consumption test was
analyzed both in terms of the absolute amount of food consumed
and the amount of food consumed relative to the animals’ body
weight. The main analysis of food consumption was based on the
weight of large food pieces, as the food debris gathered through
sifting of the bedding material also contained hair and bedding
pieces. A separate analysis where food consumption was corrected
for the amount of food debris was still performed. For this, the
mean amount of food debris was calculated for each cage, based
on their longitudinal data. This was then added to the weight of
the large food pieces measured at each cage changing. For the
relative food consumption, rats in a given cage were assumed to
eat equal amounts of food. The approximate amount of food
consumed by one of the rats was subsequently related to the mean
body weight of the two rats. Two-way repeated measures
ANVOAs were used to analyze body weight as well as absolute
and relative food consumption. Age was used as within-subject
factor, and genotype as between-subject factor.
For data gathered in the dissection study, body weight, absolute
weight of adipose and bone/muscle tissues, as well as bone/muscle
weight relative to body length were analyzed using regular two-
way ANOVAs. The factors of interest were still age and genotype.
The weights of adipose tissue, bone/muscle tissue and internal
organs relative to body weight were analyzed in individual t-tests,
or Mann-Whitney tests, between genotypes, within each age
group. As the observed phenotypes did not vary between different
adipose tissue deposits, only the combined weight of all deposits
will be addressed here. One BACHD rat meant for the dissection
of six months old animals died before the dissection, making that
particular age group 12 WT and 11 BACHD rats.
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Results from the two hunger tests were analyzed both within
and between each testing occasion. For each test occasion of the
reward pellet consumption test, the time needed to consume the
pellets was analyzed with t-tests to compare the two genotypes.
The time spent exploring the test arena was only analyzed on the
first test occasion, using t-test, as rats showed essentially no interest
in exploring the arena on later trials. One BACHD rat was
excluded from the analysis of the last trial, as he failed to consume
all reward pellets within the maximum trial time. The amount of
food consumed during the food consumption test was on each test
occasion analyzed with two-way repeated measures ANOVA,
using time as within-subject factor, and genotype as between-
subject factor. To better understand the effect of repeated testing
and food deprivation levels, the time needed to consume 100
reward pellets, and the amount of food consumed during the first
30 minutes of the food consumption test were analyzed in
additional detail. Thus, data from all three test-occasions were
analyzed in two-way repeated measures ANOVAs, using genotype
as between-subject factor, and either session number or food
deprivation level as within-subject factor. Analysis of baseline
performance during the PR test was also made with repeated
measures two-way ANOVAs, with break point as within-subject
factor, and genotype as between-subject factor. Drops in
motivation during prefeeding sessions were analyzed for the 600-
seconds break point, as a percentage of the ratio reached during
the two preceding PR sessions. Once again, repeated two-way
ANOVAs were used to analyze the results, using prefeeding
condition as within-subject factor, and genotype as between-
subject factor. Separate analyses were performed for prefeeding
with reward pellets, and regular food. Bonferroni post-hoc test was
used to follow up any significant effects of genotype, or interaction
effects found in the two-way ANOVAs. Alpha for all analyses was
set to 0.05.
Results
Ad libitum food consumption
To assess BACHD rats’ growth and food consumption in a low-
stress and social environment, we housed genotype-matched rats
in pairs (Figure 2A), and measured their weekly body weight and
food consumption. Rats of both genotypes grew steadily during the
test, as indicated by the significant effect of age on body weight
(p,0.0001, F(21,1449) =2766) (Figure 2B). BACHD and WT rats
grew at a similar rate, and showed similar body weights through
the entire test, with no significant genotype effect or age x
genotype interaction. The rats’ food consumption also changed
with age (p,0.0001, F(20,680) =110.5) (Figure 2C). In general,
food consumption increased gradually until the age of nine weeks,
and then slowly dropped. Importantly, WT and BACHD rats
consumed equal amounts of food between six and eight weeks of
age, but there were a number of differences seen at older ages. At
nine and ten weeks of age, BACHD rats appeared to consume
more food that WT rats, although this did not reach statistical
significance. Directly following this, food consumption dropped
steadily among BACHD rats, while WT rats remained arguably
stable until the age of 16 weeks. Due to this, BACHD rats
eventually ate less than WT rats, as indicated by the significant
results from the post-hoc analysis at 17 weeks of age and onwards
(p,0.05–0.01). The difference in how food consumption changed
with age among BACHD and WT rats was also evident in a
significant age x genotype interaction (p,0.0001, F(20,680) =
19.06). Relating food consumption to the rats’ body weight gave
largely the same results, with a significant age effect (p,0.0001,
F(60,680) =1930) and age x genotype interaction (p,0.0001,
F(20,680) =12.99) (Figure 2D). However, this analysis made the
increased food intake among young BACHD rats more apparent,
with the post-hoc test indicating significant differences between
BACHD and WT at seven to ten weeks of age (p,0.01–0.0001).
In contrast, the decreased food consumption among old BACHD
rats was less apparent, with the post-hoc test only indicating a few
significant data points at 18 to 21 weeks of age (p,0.05–0.01). It
should be noted that BACHD rats produced less food debris
compared to WT rats (Figure S1A and B). Correcting for this did
not dramatically affect the food consumption phenotype, although
the genotype differences became less apparent (Figure S1C).
Finally, BACHD rats consumed dramatically less water compared
to WT rats (Figure S1D).
Body composition of BACHD rats
In order to assess BACHD rats’ body composition, we dissected
BACHD and WT rats at five different ages. As expected, older rats
weighed more, leading to a significant age effect on body weight
(p,0.0001, F(4,109) =444.1) (Figure 3A). In line with previous
data, there were no differences in body weight between the
genotypes in any age group, and also no significant difference in
apparent growth. The body composition of BACHD rats was
however different from that of WT rats. BACHD rats had
significantly lower percentage of bone and muscle (p,0.001, all
ages), and higher percentage of adipose tissue (p,0.05–0.001) in
all age groups (Figure 3B). These differences were also apparent
when analyzing the absolute weights of the respective tissues. Both
WT and BACHD rats gained adipose tissue with age, as indicated
by a significant age effect on the weight of total adipose tissue (p,
0.0001, F(4,109) =142) (Figure 3C). However, BACHD rats carried
an excess amount of adipose tissue, as indicated by both a
significant genotype effect (p,0.0001, F(1,109) =81.25), and
significant results from the post-hoc analysis of all groups, except
the one-month old rats (p,0.05–0.0001). There was also a
significant age x genotype interaction (p,0.0001, F(4,109) =7.686)
that was dependent on data from the one and three months old
groups. The bone/muscle weight also increased with age for both
genotypes (p,0.0001, F(4,109) =555.4) (Figure 3D). However,
BACHD rats were found to have significantly less bone/muscle
tissue compared to WT rats in all but the one-month old age
groups. This was indicated both by a significant genotype effect
(p,0.0001, F(1,109) =70.69), and significant results from the post-
hoc analysis (p,0.01–0.0001). A significant age x genotype
interaction (p,0.001, F(4,109) =4.18) also indicated that there
was a difference in the rats’ growth. Importantly, this effect was
dependent on the data of the one–month old group.
The rats’ body length also increased with age for both genotypes
(p,0.0001, F(4,109) =1517), although a significant genotype effect
(p,0.0001, F(1,109) =86.46) and post-hoc tests (p,0.01–0.0001)
revealed that BACHD rats were smaller than WT (Figure 3E).
This was apparent in all age groups except the one-month old
animals. It should, however, be noted that one-month old
BACHD rats were shorter than WT rats when analyzing litter-
matched groups (data not shown). The reduced body length
among BACHD rats was mainly due to them having shorter tails
and heads compared to WT rats (Figure S2).
BACHD rats also showed a lower amount of bone/muscle
tissues in relation to their body length (Figure 3F). Rats of both
genotypes gained relative amounts of bone and muscle with age
(p,0.0001, F(4,109) =570.6). However, BACHD rats had lower
relative amounts of bone and muscle from three months of age, as
evident from a significant genotype effect (p,0.0001, F(1,109) =
47.32) and post-hoc analysis (p,0.05–0.0001).
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Assessment of hunger during food deprivation of BACHD
rats
Two tests based on voluntary consumption of reward pellets and
regular food, were run to assess BACHD rats’ hunger level at
different levels of food deprivation (Figure 4A). When both WT
and BACHD rats were deprived to 85% of their respective free-
feeding body weights, BACHD rats were found to consume both
reward pellets and regular food at a slower rate than WT rats
(Figure 4B). In the pellet consumption test, BACHD rats needed
longer time to eat the reward pellets (p,0.01), but did not spend
more time exploring the arena, compared to WT rats. The slower
feeding speed led to a significant increase in trial time for BACHD
rats (data not shown). In the food consumption test, BACHD rats
were found to have eaten less than WT rats at almost all
investigated intervals, as evident from the significant genotype
effect (p,0.01, F(1,6) =14.62), and the significant results from the
post-hoc analysis (p,0.05–0.01). It should be noted that a
difference in actual consumption rate was only seen during the
first 30 minutes, resulting in an initial difference in the amount of
food consumed, which then persisted through the remaining part
of the test. This difference in behavior gave a significant time x
genotype interaction (p,0.01, F(9,54) =2.840) in the amount of
food consumed by the rats.
In an attempt to reverse the phenotypes described above, the
food deprivation levels were adjusted so that BACHD and WT
rats were at 80 and 95% of their respective free-feeding body
weights (Figure 4C). In the pellet consumption tests, BACHD rats
now needed a similar amount of time to consume the reward
pellets, although there was a borderline significant trend towards
BACHD rats needing more time (p= 0.0535). With the exception
of one WT rat, all rats spent the entire trial eating, and showed
minimal interest in exploring the test arena. In the food
Figure 2. Body weight and food consumption. (A) Housing conditions during the ad libitum food consumption test. (B) Body weight of rats
plotted against their age. (C) Approximate daily food consumption per rat (calculated from weekly food consumption per cage), plotted against the
age of the animals. (D) Relative daily food consumption per rat (calculated from weekly food consumption and average body weight per cage),
plotted against the age of the animals. The graphs show group mean plus standard error of the mean. Two-way ANOVA results are displayed above
each graph, and significant results from post-hoc analysis are displayed for individual data points. Genotype differences are indicated by (p,0.05)
*, (p,0.01) **, (p,0.001) *** and (p,0.0001) ****.
doi:10.1371/journal.pone.0105662.g002
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consumption tests, BACHD and WT rats consumed food at the
same rate during the first 150 minutes. During the remaining part
of the test, WT rats ate more, eventually leading to a significant
difference in the total amount of food consumed during the test
(p,0.01). The behavioral differences led to a significant time x
genotype interaction effect (p,0.0001, F(9,54) =8.642).
In a final test, the food deprivation levels were adjusted so that
BACHD and WT rats were at 95 and 80% of their respective free-
feeding body weights (Figure 4D). At this point, BACHD rats
consumed the reward pellets at the same rate as WT rats, as the
aforementioned trend was no longer present. With the exception
of two BACHD rats, all rats spent the entire trial eating, and
showed minimal interest in exploring the test arena. One BACHD
rat did not consume all reward pellets within five minutes. In the
food consumption test, BACHD rats were once again found to
have consumed less food than WT at all investigated intervals,
resulting in a significant genotype effect (p,0.001, F(1,6) =42.52),
and significant results from the post-hoc analysis (p,0.05–0.0001).
BACHD rats ate at a slower rate during the first hour. The
consumption rate gradually declined among WT rats, while it
gradually increased among BACHD rats, ending up at similar
levels after 150 minutes. This difference in behavior gave a
significant time x genotype interaction (p,0.0001, F(9,54) =8.47)
in the amount of food consumed by the rats.
A more detailed analysis of the results was performed with the
aim of better assessing the impact of food deprivation levels on the
consumption rate in the two tests. Separate two-way ANOVA
analysis of the time needed to consume 100 reward pellets, using
genotype as between-subject factor, and either food deprivation
level or the number of test sessions as within-subject factor,
revealed similar statistical results (Figure 5A). In either case, there
was a significant genotype effect (p,0.05, F(1,21) =5.476), and
performance on the first session, where both genotypes were
deprived to 85%, differed significantly between genotype groups
(p,0.05). Both analyses also revealed a significant effect of their
respective within-subject parameter (p,0.01, F(2,42) =7.861 and
6.6333 for session and deprivation level, respectively). However,
inspection of the graphed data indicated that the time needed to
consume the reward pellets did not clearly decrease with
increasing food deprivation levels, but did so with increased
numbers of test sessions. Performing the same analyses on the
amount of food consumed during the first 30 minutes of the food
consumption test revealed different results (Figure 5B). Both
analyses once again revealed a significant genotype effect (p,
0.01, F(1,6) =15.59), and significant effects of their respective
within-subject parameters (p,0.01, F(2,12) =8.220 and 17.04 for
session and deprivation level, respectively). Post-hoc analysis of
data analyzed in terms of food deprivation level revealed a
significant difference in consumption rate when rats of both
genotypes were deprived to 85% of their free-feeding body weight.
This was also found when analyzing the data in terms of the
number of test sessions given to the rats, although that analysis also
revealed a significant difference in consumption rate during the
third session. In contrast to the results from the pellet consumption
test, the consumption rate in the food consumption test appeared
to gradually increase with an increased food deprivation level,
while not showing any gradual change during repeated testing.
Progressive ratio performance during different levels of
food deprivation
To better assess differences in the motivational state among the
rats, a progressive ratio test was run with two different food
deprivation settings. All rats learned to push the lever in order to
obtain a reward pellet, although there were some discrete
behavioral differences between WT and BACHD rats during the
initial training steps. During habituation, BACHD rats made
fewer entries into the pellet receptacle (Figure S3A, B) and were
initially slower at retrieving the pellets (Figure S3C). During CRF,
FR3 and FR5 training, BACHD rats were generally slower at both
retrieving the pellets, and returning to the reinforced lever (Figure
S4 and S5).
During the fixed ratio part of the PR protocol, BACHD rats
were still slower at retrieving the reward pellets, but they no longer
showed an increase in lever return latencies (Figure S6). These
results were largely unaffected when food deprivation levels were
adjusted. WT rats tended to take longer time to complete the FR5
ratios, although this became significant only after adjustment of
their deprivation level (Figure S6). Importantly, there were no
overt differences between genotypes in the overall response
frequency on the rewarded lever during the fixed ratios (Figure
S6). The same was true for the mean number of lever pushes made
on the non-reinforced lever during the entire PR session (Figure
S7).
Analysis of how the rats reached a series of break points, when
all were deprived to 85% of their free-feeding body weight,
revealed both a significant genotype effect (p,0.01, F(1,22)
=10.66) and differences in the three highest break points (p,
0.01), with BACHD rats reaching lower ratios (Figure 6A). These
differences were not present when the food deprivation level of
WT rats had been adjusted so that their food consumption rate
matched that of BACHD rats. Similarly, when all rats were
deprived to 85% of their free-feeding body weight, BACHD rats
responded with more pronounced drops in motivation during
prefeeding of both reward pellets and regular food, as indicated by
significant genotype effects (p,0.01, F(1,22) =9.461 and p,0.01,
F(1,21) =8.343 for reward pellet and regular food prefeeding,
respectively) and prefeeding x genotype interactions (p,0.001,
F(2,44) =11.19 and p,0.05, F(1,21) =8.341 for reward pellet and
regular food prefeeding, respectively) (Figure 6B). Once again,
these phenotypes were not present when the food deprivation level
of WT rats had been adjusted, leading to identical responses in the
prefeeding tests. It should be noted that only the last break point,
break point 600, was suitable for prefeeding analysis. Prefeeding
induced a strong interest in water among WT rats, which
dramatically affected their early break points (data not shown). It
should also be noted that there was a significant difference in body
weight once the food deprivation levels had been adjusted, with
WT rats being significantly heavier than BACHD rats (data not
shown). The WT rats weighed roughly 50 g more than BACHD
rats, resulting in them being at 95% of their free-feeding body
weight.
Figure 3. Body composition assessed through dissection. (A–F) Data from the dissection groups as stated in the graph titles. The graphs
show group mean plus standard error of the mean. Two-way ANOVA results are displayed above each graph, and significant results from post-hoc
analysis are displayed inside each graph. Significant genotype differences are indicated by (p,0.05) *, (p,0.01) **, (p,0.001) *** and (p,0.0001) ****.
For (B), ANOVA was not performed, and the indicated differences concern single comparisons between WT and BACHD rats within the age groups.
Significant differences are indicated with ‘‘a’’ and ‘‘b’’ for differences in the relative amount of adipose and bone/muscle tissue respectively, written
according to the same grading as above.
doi:10.1371/journal.pone.0105662.g003
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Figure 4. Hunger and food interest assessment. Setups (A) and performance in the two consumption tests during the first (B), second (C) and
third test session (D), with the different food deprivation levels stated in the title of each figure panel. The time needed to eat 100 reward pellets and
the time spent exploring in the reward pellet consumption setup, are displayed in the top left and right graphs of each panel, respectively. The
bottom graph of each panel shows the cumulative food consumed per rat during the regular food consumption test. Scatter plots for reward pellet
consumption test results indicate individual values and group mean. Line graphs for regular food consumption indicate group mean plus standard
error of the mean. Statistical test results are given inside the graphs. For the regular food consumption test, two-way ANOVA results are displayed in
the bottom right corner, and results from post-hoc analysis are shown for individual data points. Significant genotype differences are indicated by
(p,0.05) *, (p,0.01) **, (p,0.001) *** and (p,0.0001) ****.
doi:10.1371/journal.pone.0105662.g004
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Discussion
Body composition and food intake of BACHD rats
Many transgenic animal models of HD show an altered body
weight compared to their WT littermates. Animals that express a
fragment of the disease-causing gene typically have a reduced
body weight [25,26,27], while the ones that express the full-length
gene typically have an increased body weight [10,11]. We show
here, that although BACHD rats did not differ from WT rats in
terms of body weight, they displayed several changes in body
composition. Strikingly, BACHD rats carried an excess amount of
adipose tissue. This is in line with phenotypes of other full-length
models of HD, as the increased body weight of BACHD and
YAC128 mice has been shown to at least in part be due to an
increase in adipose tissue mass [28,29]. It should be pointed out
that R6/2 and N171-82Q mice, which only express a fragment of
the disease-causing gene, also carry excess amounts of adipose
tissue [25,30]. R6/2 mice have further been shown to maintain
this increased fat mass even when they start to lose weight [25].
Thus, the increase in adipose tissue seems to be a common
phenotype of transgenic HD models, although it does not always
result in obesity.
Increased amounts of adipose tissue could theoretically be the
result of increased food intake, decreased home cage activity,
metabolic disturbances, or a combination of the three. While
BACHD mice have been shown to eat more than their WT
littermates [28], R6/2 and YAC128 mice have been found to have
unchanged food intake [25,29]. A previous study on BACHD rats,
in which food intake was followed from three to eighteen months
of age, indicated that the transgenic rats ate less than their WT
littermates [22]. These results were well reproduced here, despite
the different housing conditions. The current study also assessed
food intake at ages younger than three months, where BACHD
rats appeared to consume more food compared to WT rats. It
should be noted, however, that the appearance of the food
consumption phenotypes was to some degree dependent on
whether or not the weight of the consumed food was normalized to
the animals’ body weight. The aim of this normalization was to
relate the rats’ food intake to a measurement of their body size,
and through this investigate if the reduced food intake among
Figure 5. Impact of repeated testing and food deprivation on consumption tests. (A) The time needed to consume 100 reward pellets is
plotted against the deprivation level (left graph) and session number (right graph). (B) The food consumed during the first 30 minutes of the regular
food consumption test is plotted against the deprivation level (left graph) and session number (right graph). The graphs show mean plus standard
error of the mean. Two-way ANOVA results are displayed above each graph, and results from post-hoc analysis are shown for individual data points.
Significant genotype differences are indicated by (p,0.05) *, (p,0.01) **, (p,0.001) *** and (p,0.0001) ****.
doi:10.1371/journal.pone.0105662.g005
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Figure 6. Progressive ratio test performance. Performance in the PR test is shown for when animals of both genotypes were deprived to 85% of
their free-feeding body weight (graphs to the left in each figure panel) and when the deprivation level of WT rats had been adjusted to achieve equal
food consumption rates between genotypes (graphs on the right of each figure panel). (A) Baseline performance during six consecutive PR sessions
preceding the prefeeding tests. The ratio, where a given break point was reached, is indicated. (B) Performance during prefeeding with reward pellets
(top panel) and regular food (bottom panel). The drop in motivation is displayed as percentage of baseline performance for break point 600. The
graphs show group mean plus standard error of the mean. Two-way ANOVA results are displayed above each graph, and results from post-hoc
analysis are shown for individual data points. Significant genotype differences are indicated by (p,0.05) *, (p,0.01) **, (p,0.001) *** and (p,0.0001)
****.
doi:10.1371/journal.pone.0105662.g006
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BACHD rats could be due to them being smaller than WT rats.
Using body weight as an approximation of body size is, however,
probably only suitable at young ages, as the body weight of older
BACHD rats is distorted due to obesity. Thus, further studies are
needed to reach conclusions on this matter. In addition, as food
intake phenotypes are unlikely to explain the increase in adipose
tissue, metabolic parameters of BACHD rats need to be further
characterized. In this regard, it is important to note that the
obesity phenotype of BACHD mice was abolished when the
expression of mutant Huntingtin was silenced in the hypothalamus
[28]. Interestingly, hypothalamic lesions can induce obesity that is
not always associated with increased food intake, but can persist
despite unchanged or even reduced food intake [31,32,33,34,35].
The differential effects appear to depend on which specific
neuronal population is damaged [35,36], which might relate to the
common phenotype of increased fat mass, but varied food intake
seen across HD animal models.
In the current study, BACHD rats were shown to have a smaller
body size and disproportionately lower amount of bone/muscle
tissue compared to WT rats. Information about similar parameters
is scarce for other HD models, although YAC128 mice have been
shown to have unchanged lean body mass [29], while R6/2 mice
show a progressive reduction in lean body mass as they age [25].
These are both in contrast to the bone/muscle phenotype seen in
BACHD rats, as the lower amount of bone/muscle tissue seen in
the current study did not seem to progress with age. Instead, the
body size and bone/muscle phenotypes seen in the BACHD rats
appeared to be caused by discrete developmental deficits and
stunted growth. It is unlikely that these phenotypes were the result
of malnutrition during testing, as food was available ad libitum on
the cage floor. It is possible, however, that BACHD pups might
have had difficulties when competing for mothers’ milk, leading to
malnutrition at early ages. Such factors have been shown to affect
the growth of animals from large litters [37]. Alternatively, the
growth of BACHD rats might be disturbed on a molecular level, as
Huntingtin has been shown to be important during fetal
development [38]. The fact that BACHD rats had smaller heads
compared to WT rats is particularly interesting, as similar
symptoms have been seen in HD gene-carriers [39]. Thus, the
discrete developmental deficits found in the BACHD rats might be
closely connected to developmental deficits of human patients.
Food deprivation and motivation of BACHD rats
Behavioral assessment of HD animal models through the use of
operant conditioning tests is of interest, as cognitive symptoms are
common in HD patients and might become valuable to clinically
track disease progression and treatment effects [40,41,42]. Many
conditioning protocols require food deprivation in order to both
efficiently train the animals to perform a given task and to
maintain high performance. However, food deprivation of HD
models requires extra care as they can be expected to have
changes in body composition. To better understand how to
optimally food deprive BACHD rats, we assessed their interest in
food in a total of three different tests.
Free intake of reward pellets and regular food is sometimes used
to assess an animal’s hunger level and interest in food
[18,19,20,21]. In the current study, WT and BACHD rats
deprived to 85% of their free-feeding body weight did not seem to
differ in their interest in consuming 100 reward pellets, although
BACHD rats needed more time to eat all pellets. Food deprivation
levels were then adjusted in an attempt to reverse the phenotypes,
however, this did not seem to affect the rats’ behavior. Instead,
both the time spent exploring the arena and the time needed to
consume all pellets decreased with repeated testing. The training
effect on the consumption rate eventually led to BACHD rats
consuming the reward pellets at an equal rate compared to WT
rats. There were indications that rats deprived to 95% of their
free-feeding body weight spent more time exploring the arena
compared to rats deprived to 80%, but this generally concerned
one or two rats of an entire group of twelve. As the current
protocol did not appear to be sensitive even to large changes in
food deprivation levels, it is unlikely to be a suitable test for
assessing discrete differences in food interest. It is also clear that
the apparent training effect could be misinterpreted as a food
deprivation effect, if one assessed a given group of animals
repeatedly with the aim of gradually adjusting their food
deprivation level. The slowed consumption speed seen among
BACHD rats in the pellet consumption test is, however, an
interesting phenotype on its own. While eating, rats typically stood
on all four paws and used their tongue to pick up the pellets. Thus,
the slower feeding rate among BACHD rats is likely due to
impairments in quite basic processes that are needed for eating.
These could include impaired chewing, swallowing or tongue
movements as well as reduced saliva production. It is tempting to
hypothesize that the slower feeding speed among BACHD rats
could be due to phenotypes similar to the tongue protrusion
symptoms that are often seen among HD patients [43,44].
Interestingly, there are protocols for measuring tongue protrusion
[45] in rats, although these tests must be performed carefully, as
the smaller head size of BACHD rats likely means that they have
shorter tongues as well.
In the regular food consumption test, BACHD rats consumed
less food than WT rats when both groups were deprived to 85% of
their respective free-feeding body weight. Consumption rate
during the first 30 minutes of the test changed in a predictable
way when deprivation levels were adjusted, with more deprived
rats eating at a faster rate. This suggests that the protocol was well
suited for the assessment of food interest and hunger levels. Our
results further showed that when BACHD and WT rats were
deprived to 80 and 95% of their respective free-feeding body
weights, they consumed food at an identical rate for the initial 150
minutes, indicating that the rats were equally hungry. As the test
session continued, BACHD rats once again ate less than WT rats,
which likely reflected differences in the rats’ satiety levels. It should
be noted that the feeding behavior of either genotype did not
significantly differ when comparing their 80 and 85% food
deprivation test sessions. Thus, although the test seems suitable to
assess food interest, it does not appear to be very sensitive.
Assessing food consumption in single animals, rather than in
groups, would most likely improve the test’s sensitivity. It would
further allow separate scoring of the time spent eating and the time
spent not eating, as it was done in the reward pellet consumption
test. However, despite extensive habituation, we have found it
difficult to get our rats to efficiently consume regular food in any
other setup than their home cages. As the test did not allow
separate scoring of the time the rats spent feeding and doing other
activities, it was not possible to conclude if the difference in
consumption rate was strictly due to a difference in hunger and
food interest. This idea is especially difficult to support when
considering the results of the pellet consumption test. In an
attempt to reach a conclusion on the matter, we ran a PR test with
prefeedings.
When both WT and BACHD rats were deprived to 85% of
their respective free-feeding body weight, BACHD rats were
clearly less motivated to work for food rewards in the PR test.
Similar phenotypes have been found in other HD models [16,46]
and they are typically discussed in terms of apathy, which is a
common symptom among HD patients [47,48]. However,
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BACHD rats also responded with more pronounced drops in
motivation during the prefeeding tests, which would typically be
interpreted as BACHD rats being less hungry compared to WT
rats [49,50,51]. This would also support the idea that the BACHD
rats’ lower consumption rate in the first session of the food
consumption test was to some degree caused by lower hunger and
food interest. When the food deprivation level of WT rats was
adjusted to achieve equal food consumption rates to those of the
BACHD rats, all genotype differences that were previously seen in
the PR test disappeared. As WT and BACHD rats did not differ
during prefeeding tests, it is reasonable to assume that they were
equally hungry and that the food consumption test was suitable for
establishing food deprivation levels that ensured this. As they also
no longer differed in baseline performance, the motivational deficit
seen in the first PR test was likely dependent on a difference in
hunger levels, rather than an apathy-related phenotype. It is
interesting to note that after the food deprivation levels had been
adjusted, BACHD rats weighed approximately 50 g less than WT
rats. This difference was similar to the one found in bone/muscle
tissue, suggesting that WT and BACHD rats carried a similar
amount of adipose tissue. Secretion of leptin, which affects satiety
and food intake [52,53], is proportional to adipose tissue mass
[54], and it is possible that the food deprivation adjustment led to
equal hunger and food interest due to equal levels of leptin.
Importantly, higher leptin levels have been shown to reduce
motivation in PR tests [55], which gives a possible explanation for
the initial motivational difference.
Most of the conclusions above are based on the idea that
prefeeding responses depend exclusively on hunger levels and not
on other aspects of motivation. One could argue that animals that
suffer from motivational deficits not related to hunger, might also
respond stronger on the prefeeding tests. Thus, seeking a situation
where animals respond equally to prefeeding could in itself lead to
the lack of differences in PR performance. It is therefore important
to note that other studies have found motivational differences
despite identical responses on prefeeding tests [51], and that
motivational deficits have been found in BACHD mice after
adjusting deprivation levels until animals consumed food at the
same rate [16]. It should also be noted that the true nature of the
motivational phenotype seen here is mainly of importance when
such phenotypes are being characterized. If one simply wishes to
minimize motivational differences when working with BACHD
rats, regardless if these are due to hunger levels or other aspects of
motivation, adjusting deprivation levels so that WT and BACHD
rats consume regular food at a comparable rate should suffice.
Still, the current study only considered quite young animals. It is
possible that older BACHD rats suffer from motor impairments
that could affect the validity of the food consumption test. Also,
motivational phenotypes not related to hunger might become
apparent among older BACHD rats. We aim at addressing these
ideas in a longitudinal study of PR performance.
Summary
In the current study, BACHD rats were found to have
metabolic disturbances, which is in line with other animal models
of HD. We further found that unless these phenotypes were taken
into consideration during food deprivation, BACHD rats were less
motivated than WT rats in a progressive ratio test. Thus,
metabolic phenotypes are important to consider as possible
confounding factors when assessing apathy-related phenotypes of
BACHD rats. The same is likely true for other HD animal models
with metabolic abnormalities.
Our results further indicated that basing the animals’ food
deprivation levels on their consumption rates of regular food was a
convenient way to avoid motivational differences between
BACHD and WT rats. Thus, previous studies that applied this
method when studying apathy in HD animal models [16] likely
avoided hunger-based motivational differences, and our results
support the future use of this method. It is also important to
consider its use in behavioral tests where the main readout is not
directly related to apathy or motivation, such as [17], as
motivational differences have been shown to affect animals’
behavior in such tests too [15].
Supporting Information
Figure S1 Food debris and water consumption during
the ad libitum food consumption test. (A) The approximate
daily amount of food debris produced per cage (calculated from a
three- to four-day average), plotted against the age of the rats. (B)
The approximate amount of food debris per cage relative to the
average food consumption per cage, plotted against the age of the
rats. (C) The approximate daily food consumption per rat
(calculated from the weekly food consumption per cage) after
accounting for food debris left in the cages, plotted against the age
of the rats. (D) The approximate daily water consumption per rat
(calculated from the weekly water consumption per cage), plotted
against the age of the rats. The graphs indicate group mean plus
standard error of the mean. Two-way ANOVA results are
displayed above each graph, and results from post-hoc analysis
are shown for individual data points. Significant genotype
differences are indicated by (p,0.05) *, (p,0.01) **, (p,0.001)
*** and (p,0.0001) ****. For (D), WT and BACHD rats differed
highly significant (****) for all data points between 11 and 26
weeks of age.
(TIF)
Figure S2 Body length measurements. (A–D) Data from
length measurement as stated in the graph titles. The graphs show
group mean plus standard error of the mean. Two-way ANOVA
results are displayed above each graph, and significant results from
post-hoc analysis are displayed inside each graph. Significant
genotype differences are indicated by (p,0.05) *, (p,0.01) **, (p,
0.001) *** and (p,0.0001) ****.
(TIF)
Figure S3 Habituation to the operant conditioning
boxes. (A) The total number of head entries made into the pellet
receptacle during habituation sessions. (B) The total time spent
with the head inside of the pellet receptacle during habituation
sessions as a measurement of the duration of receptacle visits. (C)
The mean latency to enter the pellet receptacle after the delivery
of a reward pellet. The graphs indicate group mean plus standard
error of the mean. Two-way ANOVA results are displayed above
each graph, and results from post-hoc analysis are shown for
individual data points. Significant genotype differences are
indicated by (p,0.05) *, (p,0.01) **, (p,0.001) *** and (p,
0.0001) ****.
(TIF)
Figure S4 Performance on the CRF protocol. Results from
the final session of CRF training are shown as indicated by graph
titles. Session duration measured the time the rats needed to
complete 100 ratios. Retrieval latency measured the time between
the release of the reinforced lever and the entry into the pellet
receptacle. Lever return latency was defined as the interval
between the first receptacle entry following reward delivery and
the lever push that followed. Graphs indicate the performance of
individual rats and group mean. Results from t-tests or Mann-
Whitney tests are indicated in the graphs. Significant genotype
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differences are indicated by (p,0.05) *, (p,0.01) **, (p,0.001) ***
and (p,0.0001) ****.
(TIF)
Figure S5 Performance on fixed ratio protocols. Results
for several basic parameters of FR3 and FR5 protocols are shown
as indicated by the graph titles. Session duration measured the
time the rats needed to complete 100 ratios. Ratio duration
measured the time between the first and last lever push of each
ratio. Ratio interval was defined as the time between the last lever
push of one ratio and the first lever push of the ratio that followed.
Retrieval latency measured the time between the release of the
reinforced lever and the entry into the pellet receptacle. Lever
return was defined as the interval between the first receptacle entry
following reward delivery and the first lever push of the ratio that
followed. Scatter plots of FR3 results indicate the performance of
individual rats and group mean. Results from t-tests or Mann-
Whitney tests are indicated in the graphs. Only results from the
final session, where rats performed at criterion, are displayed. Line
graphs of FR5 results indicate group mean plus standard error of
the mean, plotted against the training session. Only the three final
sessions, where rats performed at criterion, are included. Two-way
ANOVA results are displayed at the top right corner of each FR5
graph, and significant results from post-hoc analysis are shown for
individual data points. Significant genotype differences are
indicated by (p,0.05) *, (p,0.01) **, (p,0.001) *** and (p,
0.0001) ****.
(TIF)
Figure S6 Performance on the fixed ratio part of the
progressive ratio protocol. Results for the basic parameters of
the ten FR5 ratios run at the start of each PR session. (A) Data
from sessions where BACHD and WT rats were both deprived to
85% of their respective free-feeding body weights. (B) Data from
sessions where food deprivation was adjusted to match the food
consumption rate of BACHD and WT rats. Details for each
parameter are described in the figure legend of Figure S4 and S5.
Lever push frequency was calculated based on the pushes made on
the reinforced lever during the full length of a ratio, i.e. the ratio
duration plus interval to subsequent ratio. Results displayed were
obtained from the sessions used for baseline curves in Figure 6A.
The graphs indicate group mean plus standard error of the mean.
Two-way ANOVA results are displayed at the top right corner of
each graph, and results from post-hoc analysis are shown for
individual data points. Significant genotype differences are
indicated by (p,0.05) *, (p,0.01) **, (p,0.001) *** and (p,
0.0001) ****.
(TIF)
Figure S7 Mean number of errors for the fixed ratio
part of the progressive ratio protocol. Errors made by the
rats during the ten FR5 ratios run at the start of each PR session.
(A) Data from sessions where BACHD and WT rats were both
deprived to 85% of their respective free-feeding body weights. (B)
Data from sessions where food deprivation was adjusted to match
the food consumption rate of BACHD and WT rats. Results were
obtained from the sessions used for baseline curves in Figure 6A.
Graphs indicate the performance of individual rats and group
mean. Results from t-tests or Mann-Whitney tests are indicated in
the graphs. Significant genotype differences are indicated by (p,
0.05) *, (p,0.01) **, (p,0.001) *** and (p,0.0001) ****.
(TIF)
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  Figure	  S1.	   Food	  debris	   and	  water	   consumption	  during	   the	  ad	  libitum	   food	   consumption	   test.	   (A)	  The	   approximate	   daily	   amount	   of	   food	   debris	   produced	   per	   cage	   (calculated	   from	   a	   three-­‐	   to	   four-­‐day	  average),	  plotted	  against	  the	  age	  of	  the	  rats.	  (B)	  The	  approximate	  amount	  of	  food	  debris	  per	  cage	  relative	  to	  the	  average	  food	  consumption	  per	  cage,	  plotted	  against	  the	  age	  of	  the	  rats.	  (C)	  The	  approximate	  daily	  food	  consumption	  per	   rat	   (calculated	   from	   the	  weekly	   food	  consumption	  per	   cage)	  after	  accounting	   for	  food	   debris	   left	   in	   the	   cages,	   plotted	   against	   the	   age	   of	   the	   rats.	   (D)	   The	   approximate	   daily	   water	  consumption	  per	  rat	  (calculated	  from	  the	  weekly	  water	  consumption	  per	  cage),	  plotted	  against	  the	  age	  of	  the	  rats.	  The	  graphs	   indicate	  group	  mean	  plus	  standard	  error	  of	   the	  mean.	  Two-­‐way	  ANOVA	  results	  are	  displayed	   above	   each	   graph,	   and	   results	   from	   post-­‐hoc	   analysis	   are	   shown	   for	   individual	   data	   points.	  Significant	   genotype	   differences	   are	   indicated	   by	   (p	  <	  0.05)	   *,	   (p	  <	  0.01)	   **,	   (p	  <	  0.001)	   ***	   and	  (p	  <	  0.0001)	   ****.	   For	   (D),	   WT	   and	   BACHD	   rats	   differed	   highly	   significant	   (****)	   for	   all	   data	   points	  between	  11	  and	  26	  weeks	  of	  age.	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  Figure	   S2.	   Body	   length	  measurements.	   (A-­‐D)	  Data	   from	   length	  measurement	   as	   stated	   in	   the	   graph	  titles.	   The	   graphs	   show	   group	   mean	   plus	   standard	   error	   of	   the	   mean.	   Two-­‐way	   ANOVA	   results	   are	  displayed	  above	  each	  graph,	  and	  significant	  results	  from	  post-­‐hoc	  analysis	  are	  displayed	  inside	  each	  graph.	  Significant	   genotype	   differences	   are	   indicated	   by	   (p	  <	  0.05)	   *,	   (p	  <	  0.01)	   **,	   (p	  <	  0.001)	   ***	   and	  (p	  <	  0.0001)	  ****.	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  Figure	  S3.	  Habituation	  to	  the	  operant	  conditioning	  boxes.	  (A)	  The	  total	  number	  of	  head	  entries	  made	  into	  the	  pellet	  receptacle	  during	  habituation	  sessions.	  (B)	  The	  total	  time	  spent	  with	  the	  head	  inside	  of	  the	  pellet	   receptacle	  during	  habituation	   sessions	   as	   a	  measurement	  of	   the	  duration	  of	   receptacle	   visits.	   (C)	  The	  mean	  latency	  to	  enter	  the	  pellet	  receptacle	  after	  the	  delivery	  of	  a	  reward	  pellet.	  The	  graphs	  indicate	  group	  mean	  plus	  standard	  error	  of	   the	  mean.	  Two-­‐way	  ANOVA	  results	  are	  displayed	  above	  each	  graph,	  and	  results	  from	  post-­‐hoc	  analysis	  are	  shown	  for	  individual	  data	  points.	  Significant	  genotype	  differences	  are	  indicated	  by	  (p	  <	  0.05)	  *,	  (p	  <	  0.01)	  **,	  (p	  <	  0.001)	  ***	  and	  (p	  <	  0.0001)	  ****.	  
107
Publication	  I	  Supplementary	  Figures	  	  	  
	  	  	  
108
	   Publication	  I	  Supplementary	  Figures	  	  	  Figure	  S4.	  Performance	  on	  the	  CRF	  protocol.	  Results	  from	  the	  final	  session	  of	  CRF	  training	  are	  shown	  as	  indicated	  by	  graph	  titles.	  Session	  duration	  measured	  the	  time	  the	  rats	  needed	  to	  complete	  100	  ratios.	  Retrieval	   latency	  measured	   the	   time	  between	   the	   release	  of	   the	   reinforced	   lever	   and	   the	   entry	   into	   the	  pellet	   receptacle.	   Lever	   return	   latency	   was	   defined	   as	   the	   interval	   between	   the	   first	   receptacle	   entry	  following	  reward	  delivery	  and	  the	  lever	  push	  that	  followed.	  Graphs	  indicate	  the	  performance	  of	  individual	  rats	  and	  group	  mean.	  Results	  from	  t-­‐tests	  or	  Mann-­‐Whitney	  tests	  are	  indicated	  in	  the	  graphs.	  Significant	  genotype	  differences	  are	  indicated	  by	  (p	  <	  0.05)	  *,	  (p	  <	  0.01)	  **,	  (p	  <	  0.001)	  ***	  and	  (p	  <	  0.0001)	  ****.	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  Figure	  S5.	  Performance	  on	  fixed	  ratio	  protocols.	  Results	  for	  several	  basic	  parameters	  of	  FR3	  and	  FR5	  protocols	  are	  shown	  as	  indicated	  by	  the	  graph	  titles.	  Session	  duration	  measured	  the	  time	  the	  rats	  needed	  to	   complete	  100	  ratios.	  Ratio	  duration	  measured	   the	   time	  between	   the	   first	  and	   last	   lever	  push	  of	  each	  ratio.	  Ratio	   interval	  was	  defined	  as	   the	   time	  between	  the	   last	   lever	  push	  of	  one	  ratio	  and	   the	   first	   lever	  push	  of	  the	  ratio	  that	  followed.	  Retrieval	  latency	  measured	  the	  time	  between	  the	  release	  of	  the	  reinforced	  lever	  and	  the	  entry	  into	  the	  pellet	  receptacle.	  Lever	  return	  was	  defined	  as	  the	  interval	  between	  the	  first	  receptacle	  entry	  following	  reward	  delivery	  and	  the	  first	  lever	  push	  of	  the	  ratio	  that	  followed.	  Scatter	  plots	  of	  FR3	  results	  indicate	  the	  performance	  of	  individual	  rats	  and	  group	  mean.	  Results	  from	  t-­‐tests	  or	  Mann-­‐Whitney	   tests	   are	   indicated	   in	   the	   graphs.	  Only	   results	   from	   the	   final	   session,	  where	   rats	   performed	   at	  criterion,	  are	  displayed.	  Line	  graphs	  of	  FR5	  results	  indicate	  group	  mean	  plus	  standard	  error	  of	  the	  mean,	  plotted	  against	  the	  training	  session.	  Only	  the	  three	  final	  sessions,	  where	  rats	  performed	  at	  criterion,	  are	  included.	  Two-­‐way	  ANOVA	  results	  are	  displayed	  at	  the	  top	  right	  corner	  of	  each	  FR5	  graph,	  and	  significant	  results	   from	  post-­‐hoc	  analysis	  are	  shown	  for	   individual	  data	  points.	  Significant	  genotype	  differences	  are	  indicated	  by	  (p	  <	  0.05)	  *,	  (p	  <	  0.01)	  **,	  (p	  <	  0.001)	  ***	  and	  (p	  <	  0.0001)	  ****.	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  Figure	  S6.	  Performance	  on	  the	  fixed	  ratio	  part	  of	  the	  progressive	  ratio	  protocol.	  Results	  for	  the	  basic	  parameters	  of	  the	  ten	  FR5	  ratios	  run	  at	  the	  start	  of	  each	  PR	  session.	  (A)	  Data	  from	  sessions	  where	  BACHD	  and	  WT	   rats	  were	   both	   deprived	   to	   85%	   of	   their	   respective	   free-­‐feeding	   body	  weights.	   (B)	   Data	   from	  sessions	  where	  food	  deprivation	  was	  adjusted	  to	  match	  the	  food	  consumption	  rate	  of	  BACHD	  and	  WT	  rats.	  Details	   for	  each	  parameter	  are	  described	  in	  the	  figure	   legend	  of	  Figure	  S4	  and	  S5.	  Lever	  push	  frequency	  was	  calculated	  based	  on	  the	  pushes	  made	  on	  the	  reinforced	  lever	  during	  the	  full	  length	  of	  a	  ratio,	  i.e.	  the	  ratio	  duration	  plus	  interval	  to	  subsequent	  ratio.	  Results	  displayed	  were	  obtained	  from	  the	  sessions	  used	  for	  baseline	  curves	  in	  Figure	  6A.	  The	  graphs	  indicate	  group	  mean	  plus	  standard	  error	  of	  the	  mean.	  Two-­‐way	  ANOVA	  results	  are	  displayed	  at	  the	  top	  right	  corner	  of	  each	  graph,	  and	  results	  from	  post-­‐hoc	  analysis	  are	   shown	   for	   individual	   data	   points.	   Significant	   genotype	   differences	   are	   indicated	   by	   (p	  <	  0.05)	   *,	  (p	  <	  0.01)	  **,	  (p	  <	  0.001)	  ***	  and	  (p	  <	  0.0001)	  ****.	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  Figure	  S7.	  Mean	  number	  of	  errors	  for	  the	  fixed	  ratio	  part	  of	  the	  progressive	  ratio	  protocol.	  Errors	  made	  by	   the	   rats	   during	   the	   ten	  FR5	   ratios	   run	   at	   the	   start	   of	   each	  PR	   session.	  (A)	  Data	   from	   sessions	  where	  BACHD	  and	  WT	  rats	  were	  both	  deprived	  to	  85%	  of	  their	  respective	  free-­‐feeding	  body	  weights.	  (B)	  Data	  from	  sessions	  where	  food	  deprivation	  was	  adjusted	  to	  match	  the	  food	  consumption	  rate	  of	  BACHD	  and	   WT	   rats.	   Results	   were	   obtained	   from	   the	   sessions	   used	   for	   baseline	   curves	   in	   Figure	   6A.	   Graphs	  indicate	  the	  performance	  of	   individual	  rats	  and	  group	  mean.	  Results	  from	  t-­‐tests	  or	  Mann-­‐Whitney	  tests	  are	   indicated	   in	   the	   graphs.	   Significant	   genotype	  differences	   are	   indicated	   by	   (p	  <	  0.05)	   *,	   (p	  <	  0.01)	   **,	  (p	  <	  0.001)	  ***	  and	  (p	  <	  0.0001)	  ****.	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Abstract
Huntington disease is an inherited neurodegenerative disorder characterized by motor, cog-
nitive, psychiatric and metabolic symptoms. We recently published a study describing that
the BACHD rat model of HD shows an obesity phenotype, which might affect their motiva-
tion to perform food-based behavioral tests. Further, we argued that using a food restriction
protocol based on matching BACHD and wild type rats’ food consumption rates might
resolve these motivational differences. In the current study, we followed up on these ideas
in a longitudinal study of the rats’ performance in a progressive ratio test. We also investi-
gated the phenotype of reduced food consumption rate, which is typically seen in food-
restricted BACHD rats, in greater detail. In line with our previous study, the BACHD rats
were less motivated to perform the progressive ratio test compared to their wild type litter-
mates, although the phenotype was no longer present when the rats’ food consumption
rates had been matched. However, video analysis of food consumption tests suggested that
the reduced consumption rate found in the BACHD rats was not entirely based on differ-
ences in hunger, but likely involved motoric impairments. Thus, restriction protocols based
on food consumption rates are not appropriate when working with BACHD rats. As an alter-
native, we suggest that studies where BACHD rats are used should investigate how the
readouts of interest are affected by motivational differences, and use appropriate control
tests to avoid misleading results. In addition, we show that BACHD rats display distinct
behavioral changes in their progressive ratio performance, which might be indicative of stria-
tal dysfunction.
Introduction
Huntington disease (HD) is an autosomal dominantly inherited neurodegenerative disorder,
which is caused by a specific mutation in the gene for the huntingtin protein [1,2]. The
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mutation concerns an expansion of the CAG repeat sequence present in the gene’s first exon,
which results in an elongated stretch of glutamine in the translated protein. Patients who carry
an allele with more than 40 CAG repeats invariably develop HD [3,4]. During the disease pro-
cess there is extensive neuronal loss, starting in the caudate nucleus of the striatum, but even-
tually encompassing most brain regions [5–7]. This results in a wide range of clinical signs that
are commonly grouped into motor, psychiatric, cognitive and metabolic symptoms [8]. There
are currently no disease-modifying treatments available for HD, and the disease is invariably
fatal [2,8,9].
Several different transgenic animal models of HD have been generated [2, 10–14]. Thus, a
large amount of work in HD research concerns the characterization of these animal models to
better understand which aspects of the disease are well represented in a given model, which
ones are not present, and which aspects might be unique to the model itself. When considering
behavioral characterization studies, one also has to consider that as the models are likely to
show a range of different phenotypes (disease-related or not), some might confound the read-
outs of others. As an example, metabolic phenotypes have been found to confound tests that
assess motoric function [15,16].
Our group primarily works with the BACHD rat model of HD. These rats carry a trans-
genic construct that contains the full-length disease-causing human gene with 97 CAG/CAA
repeats [17]. We recently published a study where we concluded that male BACHD rats, simi-
lar to other HDmodels that carry the full-length disease-causing gene, show a strong obesity
phenotype [18]. Interestingly, we found that although the rats were obese, their body weight
was still similar to that of their wild type (WT) littermates due to developmental deficits
(reduced body size, disproportionally low muscle weight). In addition, the obesity phenotype
persisted despite the fact that the BACHD rats generally consumed less food compared to WT
rats [18].
One of the reasons for us favoring a rat model over any of the mouse models was the wider
range of cognitive tests that are available for rats. However, the apparent metabolic phenotypes
of the male BACHD rats raised some concerns. Specifically, we were concerned that these phe-
notypes might result in BACHD rats being less motivated thanWT rats when performing vari-
ous tests of cognitive function, as many of these are based on working for food rewards [19].
Motivational differences have been shown to affect both apparent cognitive abilities and choice
of strategy in the Barnes maze [20]. For most cognitive tests, it is not known how a motiva-
tional difference affects the animals’ performance. Thus, interpretations of behavioral pheno-
types found in an animal model that might show reduced motivation should be done carefully.
In our initial study we therefore ran a progressive ratio test to assess male BACHD rats’
motivation to perform lever pushes for a food reward [18]. Specifically, we assessed the perfor-
mance during both a standard and an alternative food restriction protocol. The standard food
restriction protocol was based on common practice, where all animals are food restricted until
they reach a specified body weight, typically 85% of their free-feeding weight [18,19]. Using
this protocol, we found that BACHD rats were less motivated than their WT littermates to per-
form the test. This was an interesting phenotype on its own, as it might be related to apathy
symptoms that are frequently found in HD patients [21,22]. However, as the BACHD rats are
obese without showing an increased body weight it would also mean that they likely carried
more adipose tissue compared toWT rats during this restriction protocol. This would in turn
mean that they likely had an increased serum concentration of leptin, a protein that is secreted
from adipose tissue and regulates energy metabolism [23]. Importantly, changes in leptin sig-
naling within the central nervous system have been shown to affect motivation in the progres-
sive ratio test [24–26]. Specifically, increased leptin levels are able to reduce motivation
[24,25], while knock-down of leptin receptors can increase motivation [26]. Thus, the reduced
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motivation among male BACHD rats might have been a result of their metabolic phenotypes.
The alternative food restriction protocol aimed to elucidate this. Rather than being based on
reaching a specific relative body weight, this protocol was based on adjusting the rats’ food
restriction level so that their apparent hunger and food interest was similar [18]. The rats’
apparent hunger was assessed by measuring their food consumption rates in a test where they
were given free access to food during 15 minutes. When maintained on the standard food
restriction protocol, male BACHD rats consumed food at a lower rate compared to WT rats,
although this could be resolved by giving WT rats an increased daily amount of food. When
BACHD andWT rats showed comparable food consumption rates, there was no longer any
difference in motivation to perform the progressive ratio test. Thus, we suggested that motiva-
tional differences between BACHD andWT rats can be expected when using standard food
restriction protocols, that these phenotypes are likely caused by metabolic phenotypes rather
than psychiatric phenotypes, and that the alternative food restriction protocol might be more
suitable to use during tests of cognitive characterization [18].
The study itself still had certain shortcomings, which we have sought to cover in the follow-
up study presented here. Briefly, our first study only considered rats of relatively young ages
(2–4 months of age) and we here aimed to further investigate to what extent the findings were
reproduced at older ages. Further, we have investigated the rats’ body composition during the
alternative food restriction protocols as well as how the leptin levels among BACHD andWT
rats changed during different parts of our tests (i.e. during the different food restriction proto-
cols). Additional control tests have been performed in order to exclude fatigue and satiation as
confounding factors in the progressive ratio results. Finally, more detailed evaluation of the
food consumption test used for assessing the rats’ apparent hunger, and a separate test allow-
ing assessment of individual animals’ feeding behavior, have been performed in order to better
understand the nature of the reduced food consumption rate seen among male BACHD rats.
Material and methods
Animals
A total of 48 male rats were used for the study. These were acquired from two separate in-
house breeding events, with hemizygous BACHDmales from the TG5 line [17] paired with
WT females (Crl:CD(SD), Charles River, Germany). All animals were on Sprague-Dawley
background. Animals were genotyped according to previously published protocols [17] and
housed in genotype-matched groups of three in type IV cages (38 × 55cm), with high lids
(24.5cm from cage floor). Rats had free access to water through the entire study. During exper-
iments, body weight was measured daily to track the rats’ relative food restriction level and
assess basic health. Between experiments, body weight was measured weekly. During experi-
ments, rats were food restricted according to two protocols described in detail below and in
[18]. During both protocols, each cage was given a specific daily amount of food (SNIFF
V1534-000 standard chow) to maintain appropriate restriction levels. Rats had free access to
food between the experiments.
The animal facility kept 21–23˚C, 55–10% humidity, and was set to a partially inverted
light/dark cycle with lights on/off at 02:00/14:00 during summer, and 01:00/13:00 during
winter.
The 48 rats were split into two groups of 24 rats, both composed of 12 WT and 12 BACHD
rats. The first group was used for a longitudinal progressive ratio test, leptin measurements
and endpoint dissection to investigate body composition. This group will be referred to as
Group I. The second group was used for a longitudinal pasta-handling test, although the
results from this are not considered here (unpublished data) (see [27] for protocol). They were
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also used for the detailed study of BACHD rats’ food consumption phenotypes, which is pre-
sented here. This group will be referred to as Group II. Group I was tested at 2, 7, 12 and 17
months of age in the progressive ratio test, while the leptin measurements were only per-
formed at the last age. The results from the test at 2 months were presented in our previous
publication [18] and will only be referred to in this publication. Group II was assessed in the
pasta-handling test at 2, 7 and 12 months of age. The detailed study of BACHD rats’ food con-
sumption presented here was performed at the end of their 12 months experiment. Fig 1 pres-
ents an overview of the tests performed with the two different animal groups.
All experiments were approved by the local ethics committee (Regierungspraesidium Tue-
bingen) and carried out in accordance with the German Animal Welfare Act and the guide-
lines of the Federation of European Laboratory Animal Science Associations, based on
European Union legislation (Directive 2010/63/EU).
Food restriction protocols
As noted above, two different food restriction protocols were used throughout the study. The
first one focused on restricting the animals to a specific relative body weight. During this, both
BACHD andWT rats were restricted until they reached 85% of their respective free-feeding
body weight. This relative body weight, or food restriction level, was calculated using previ-
ously gathered data from growth curves of BACHD andWT rats. Thus, the calculations could
be made with gender, age and genotype-matched values and took normal growth into account.
This protocol was used as the start point for all tests described below, and will be referred to as
the standard food restriction protocol.
Once data from performance on the standard food restriction protocol had been gathered,
the restriction was changed to the alternative protocol. As noted above, this restriction was
based on the rats’ food consumption rates (assessed in a test described in [18] and below),
rather than their relative body weight. During this, the amount of food given to the WT rats
was increased, while the amount given to BACHD rats was kept more or less constant, until
WT and BACHD rats showed similar food consumption rates. At that point, data for a second
baseline was gathered.
It should be noted that it was rarely possible to give the exact same amount of food during
extended periods of time to either of the genotypes, as both the standard and alternative
restriction still had to take natural growth into account.
Progressive ratio
As mentioned above, Group I was used for a longitudinal experiment using the progressive
ratio test. This was the same group of animals that had been used for our initial study [18], and
only the results from their test runs at 7, 12 and 17 months of age will be presented here. A
detailed description of the protocol and setup is available elsewhere [18], and is only described
briefly in the current publication.
Behavioral assessment started 30 minutes after dark phase onset, in a room separate from
the animals’ housing room, using soft red light. A bank of six operant conditioning chambers
(Coulbourn Instruments, H10-11R-TC) was used to run the test. Each chamber was equipped
with two retractable levers, one on either side of a central pellet receptacle trough equipped
with a yellow light. This light was used to signal the delivery of a reward pellet. The chambers
contained a red house light on the wall opposite from the levers and pellet receptacle trough,
which shone during the full duration of the training sessions. A water bottle was also available
on this wall, to ensure ad libitum access to water during testing. The progressive ratio protocol
was designed and run with Graphic State 4.1.04. Rats were given single daily sessions, meaning
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that a total of four daily runs with all six operant chambers were needed to assess the whole
group. Each run assessed three WT and three BACHD rats in a determined order, so that a
given rat was trained on the same time of day through all tests. Each rat was assigned to a spe-
cific operant chamber, although this was arranged so that each operant chamber was used to
assess equal numbers of WT and BACHD rats. Rats received their daily amount of regular
food four hours after the completion of the last run of the day.
At each test age the rats were first put on food restriction for approximately 14 days. This
aimed at restricting both WT and BACHD rats to 85% of their respective free-feeding body
weights, as described above. At the first test age, all rats were then habituated to the operant
conditioning boxes and subjected to initial lever-training protocols before finally being trained
on the progressive ratio protocol. These steps are described in detail elsewhere [18]. For all
subsequent ages (i.e. the results presented in the current publication), rats were directly trained
on the final progressive ratio protocol, as no other retraining appeared to be necessary.
The main aim of the progressive ratio test is to assess how many lever pushes a rat is willing
to perform in order to get a reward pellet (Bio-serv, Dustless Precision Pellets1 F0021,
Fig 1. Study overview. The study used two groups of rats that were assessed in different behavioral tests, as indicated in the figure.
The horizontal arrows indicate the time frame during which the work was performed, with the different tests ages indicated in text
boxes. Gray-colored boxes and text indicate tests that are presented elsewhere, but constitute important information about the rats’
behavioral testing experience. Group I was used in a longitudinal progressive ratio test with a total of four test ages. Different control
tests were used at different ages, as detailed in the Material and Methods section. The results from the first age are presented
elsewhere [18]. Group II was used for the detailed analysis of the reduced food consumption rate seen among BACHD rats. This
analysis was only performed at a single test age. The group had previous experience in a pasta-handling test, the results of which will
be published elsewhere.
doi:10.1371/journal.pone.0173232.g001
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purchased through Bilaney consultants, Duesseldorf, Germany). At the start of each test ses-
sion, both levers were extended into the conditioning chamber, allowing rats to interact with
them. The levers remained in this position for the full duration of the test session. One lever
was reinforced, while the other one was non-reinforced. The exact position (i.e. left or right
lever) of the reinforced and non-reinforced lever was counter-balanced for the two genotypes
and remained constant for individual rats through all experiments. Pushing the reinforced
lever resulted in reward pellets being delivered. At the start of each session, the rats needed to
push five times in order to receive a reward pellet. After ten completed ratios, i.e. ten pellets
received, the number of required pushes increased after each completed ratio. The increase
was made in an arithmetic fashion within each block of ten ratios, but also changed between
the blocks, to give an overall exponential progression. Thus, during the first, second and third
block of ten ratios, the ratio requirement increased with one, three and five pushes per com-
pleted ratio, respectively. The sessions lasted 80 minutes. The main behavioral parameter of
interest was a set of break points, defined as the first ratio where a rat made no responses on
the reinforced lever during 10, 25, 50, 100, 300 or 600 seconds. Rats were trained until both
genotype groups had reached a stable performance. A baseline was then constructed from the
last few sessions as detailed below.
Once a baseline had been achieved using the standard food restriction protocol, the alterna-
tive food restriction protocol was initiated. During this, the rats were still given daily progres-
sive ratio sessions, but in addition, a food consumption test was run each day at the time when
the rats would normally receive their daily amount of food. As noted above, WT rats were then
given an increased amount of food until they showed a comparable food consumption rate to
BACHD rats. At that point, data for a stable baseline of progressive ratio performance was
once again gathered. When a second baseline had been obtained, the rats were put back on
free feeding and the test ended.
Although the exact number of sessions used for the different progressive ratio baselines pre-
sented in this publication differed, none used fewer than six consecutive sessions. It should
also be noted that the feeding test was run on a weekly basis during training on the standard
food restriction protocol. As mentioned in [18], the training took a substantial amount of time
at each age, and despite the intention of assessing the rats’ behavior at 2, 7, 12 and 17 months
of age, the more exact ages for the baselines presented in [18] and here are 2–4, 7–9, 12–14 and
17–19 months of age.
Several parameters were analyzed in addition to the set of break points described above.
These included the total number of completed ratios (i.e. rewards obtained), the total number
of pushes performed on the reinforced lever, the total number of pushes performed on the
non-reinforced lever and several parameters regarding the latency to retrieve the reward pel-
lets. For this, there was first the full retrieval latency, calculated from the delivery of the pellet
to the point where the rat entered the pellet trough to retrieve it. This parameter was then split.
This produced the latency to leave the reinforced lever, which measured the time from delivery
of the reward pellet to the OFF-signal of the last lever push the rat performed on the reinforced
lever. The latency to move from the lever to the pellet trough was then calculated separately,
measuring the time from the OFF-signal of the last lever push to the point when the rat entered
the pellet trough. Two additional parameters were added to describe the latency to leave the
reinforced lever in greater detail. The first one calculated the number of excessive pushes (i.e.
additional pushes performed after the delivery of the reward pellet) that the rats performed on
the reinforced lever before retrieving the pellet. The result of this parameter was expressed as
the mean number of excessive pushes performed per completed ratio. The other parameter
calculated the latency to leave the lever specifically on ratios where no excessive pushes were
performed, and was called the latency to release the reinforced lever.
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Separate analysis for the first ten FR5 ratios was also performed, including a set of slightly
different parameters. These constituted the latency to perform the first lever push, the time
needed to complete a given ratio, the latency to return to the reinforced lever after retrieving
the reward pellet and the pellet retrieval latency (calculated as the full retrieval latency
explained above).
Progressive ratio control tests
In our initial study [18], a set of prefeeding tests was used to further evaluate the motivational
difference between WT and BACHD rats. On each test occasion, the rats were fed a fixed
amount of either regular food or reward pellets prior to performing the progressive ratio test.
The resulting drop in motivation was then analyzed and discussed. In total, the rats were
assessed in four different test sessions, which were presented on alternating days with normal
progressive ratio tests. These prefeeding tests were repeated at the 7–9 months test age. How-
ever, on that occasion bothWT and BACHD rats failed to return to their baseline performance
during sessions that separated the prefeeding tests. Instead, the rats gradually became less
motivated with each prefeeding test being run. Because of this, the results were excluded from
the current manuscript. In addition, the prefeeding tests were not rerun at the subsequent test
ages.
During the 12–14 and 17–19 months test ages, the rats’ progressive ratio performance was
also assessed at satiety, before food restriction according to the standard protocol was initiated.
We hypothesized that the results would be similar to the ones obtained when using the alterna-
tive food restriction protocol, as WT and BACHD rats should in both cases be equally hungry
and/or satiated. These tests used the same basic progressive ratio protocol, but the sessions
were only 45 minutes long. In addition, the test sessions were started two hours after the dark-
phase onset, to give both WT and BACHD rats ample time to finish their main feeding bout of
the dark phase.
Another control test was added during the 12–14 and 17–19 months test ages. In this proto-
col, there was no progression, and the required number of lever pushes was kept at five pushes
through the entire session (FR5 protocol). Single sessions of this protocol were run after estab-
lishing the satiety baseline at 12–14 months, and all three baselines at 17–19 months of age (i.e.
satiety, standard food restriction and alternative food restriction). The sessions were run on
the same time schedule as the standard progressive ratio protocol, had the same maximum
duration, but sessions also ended once a rat had acquired 200 pellets. This protocol was run in
order to investigate if the motivational differences in progressive ratio performance might
have been caused by BACHD rats becoming fatigued or satiated during the sessions.
Leptin measurements
During the 17–19 months test age of Group I, blood samples were collected after establishing
each progressive ratio baseline (i.e satiety, standard food restriction and alternative food
restriction). At each stage, the blood samples were collected the day after the FR5 control test
had been run. In addition, a fourth set of blood samples was collected at the endpoint of the
experiment, when rats were sacrificed and dissected as described below. Samples were col-
lected during the same time of day on all occasions. The first three sets of samples were col-
lected from the rats’ tail vein. This was done by inserting a needle of 0.6 mm diameter into the
vein and collecting roughly 1 ml of whole blood into a microcentrifuge tube. No anesthesia or
specific fixation method were required for this procedure, as the rats had been extensively han-
dled by the experimenters during the study. After collection, the samples were allowed to clot
while being kept on ice, and were then centrifuged at 5˚C with 1000g, for 30 minutes. The
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resulting blood serum was collected and stored at -80˚C until ELISA analysis was performed
approximately 10 months later.
Leptin concentrations were measured at QPS Austria GmbH (Grambach, Austria) using a
Quantikine ELISA kit (Mouse/Rat leptin Quantikine ELISA kit, R&D systems, Austria,
Vienna). Serum samples from animals at satiety were diluted 1:10 and 1:20 for WT and
BACHD rats, respectively. For all other samples, dilution series of 1:2.5, 1:5 and 1:10 were pre-
pared. The final sample preparation resulted in an additional 1:2 dilution, according to the
kit’s accompanying protocol. Concentration measurement was based on the supplied leptin
standard. Duplicate samples were analyzed for satiety samples. For other samples, a mean con-
centration was calculated based on 1–3 samples, depending on how many samples from the
dilution series were within the range of the standard curve. For most samples, this resulted in
duplicate measurements.
Body composition analysis
After completing the set of tests run at 17–19 months of age, the rats of Group I were sacrificed
while they were still maintained on the alternative food restriction protocol. Briefly, the rats
were sacrificed in a carbon dioxide chamber two to four hours before dark-phase onset. Body
lengths and body weights were then measured on the intact animals, with body length mea-
sured from nose tip to tail tip. Additional measurements of head, trunk and tail length were
taken from nose tip to back of the head, back of the head to anus and anus to tail tip, respec-
tively. Afterwards, blood samples were collected transcardially and processed as described
above. The rats were then subjected to a detailed dissection aimed at investigating their body
composition. First, skin and subcutaneous adipose tissue deposits were removed and weighed.
Then, internal organs and adipose deposits located in the abdomen and chest cavity were
removed and weighed. The remaining carcass was weighed to obtain a measurement of bone
and muscle weight (denoted bone/muscle). The dissection of Group I was performed during
four consecutive days.
Standard food consumption test
The standard food consumption test was used at several points during the study to assess the
rats’ food consumption rates and formed the basis of the alternative food restriction protocol.
The protocol for this test has been described in our initial study of the BACHD rats’ food con-
sumption rates [18], and similar protocols have been described by others [28–33]. The aim of
the test is to acquire a basic measurement of the rats’ apparent interest in food, i.e. hunger lev-
els. For this, a small amount of food was placed in the cage tops of the rats’ homecages (approx-
imately 50 g, the exact weight differed between cages (+/- 5 g), but was carefully noted, down
to two decimals). The food was then left there for 15 minutes. Afterwards, the remaining food
in each cage was measured.
As noted above, the food consumption tests were run in connection to the actual time of
feeding for the rats. After calculating how much food the rats consumed during the test, this
amount was subtracted from the cages’ daily food amount.
For Group I, this test was run weekly during the progressive ratio training when rats were
maintained on the standard food restriction protocol, and daily during the progressive ratio
training when rats were maintained on the alternative food restriction protocol. For Group II,
where characterizing the food consumption rate phenotype was the primary aim, the test was
run daily during both food restriction protocols. Specifically, the rats’ behavior during the
standard food restriction protocol was first assessed during eight consecutive days to establish
a baseline of their performance. Afterwards, they were run in the individual food consumption
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test as described below. Once that had been completed, the rats were run on the standard food
consumption test for an additional three sessions. During these three days, videos of the rats’
performance were recorded. Afterwards, a single session was run where the food was placed
on the cage floors instead of the cage tops. When all of that was done, the rats were put on the
alternative food restriction, and the standard food consumption test was once again run daily,
until BACHD andWT rats showed similar food consumption rates. At that point, the rats
were again run in the individual food consumption test. After this, the rats were assessed in the
standard food consumption test during three consecutive days in order to gather videos of
their performance. The video scoring of the tests is described in detail below.
Individual food consumption test
The fact that the standard food consumption test is run in groups, leads to some drawbacks.
As an example, detailed scoring of the number of bites and duration of chewing episodes can-
not reliably be scored from videos of the test. Because of this, we also sought to evaluate the
consumption rates and feeding behavior of individual animals, in Group II. Through their
pasta-handling test (data not shown), the rats had been extensively habituated to a roughly
cube-shaped glass cage (28.5 × 29 × 29.5 cm, also described in [18]). Because of this, they read-
ily consumed regular food inside the same setup, which made them suitable for the current
study. In addition, the setup allowed for good quality close-up videos of the rats’ behavior.
As noted above, the rats were assessed in this test after stable baselines of their performance
in the standard food consumption test had been established (during both food restriction pro-
tocols). Each animal was given single daily sessions where they were placed inside the glass
cage and given a single food piece. The trial then continued until the rats had consumed the
food piece. The entire trial was video-recorded to allow for subsequent video scoring (see
below). The food pieces had been filed down to approximately 2.4 g (+/- 0.1 g) (the exact
weight of each food piece was noted, down to two decimals) to achieve consistent weight and
blunt edges for all trials. During both the standard and alternative food restriction, several ses-
sions were run in order to establish stable baseline performance. At the end of the test, the rats’
head length, from nose tip to the back of the head, was measured.
Video analysis
As noted, video recordings of both the standard and the individual food consumption tests
were made to better investigate the nature of the phenotypes that had been found. During
scoring, experimenters were blinded to the rats’ genotypes, while this was not the case when
the videos were gathered. All video scoring was performed using the Observer XT software
(v.12.5.927, Noldus, The Netherlands, Wageningen). The following behaviors were scored for
the standard food consumption test:
Food-oriented behaviors. This included all behaviors that could be argued to be food-ori-
ented. In addition to the more specific behaviors noted below, this primarily considered occa-
sions when the rats appeared to be searching through the bedding material for food pieces, but
in general included most behaviors performed at or around the food crib. In contrast, behav-
iors where the rats investigated smells and sounds from outside the cage, or general activity
in the part of the cage that was not situated below the food crib, was not considered food-
oriented.
Food crib attention. Episodes of food-crib attention were scored when the rats clearly
investigated the food inside the food crib. Naturally, this included the time they actively spent
biting on food pieces, but also occasions where they only sniffed the food or clearly angled
their heads towards it while being in its direct vicinity.
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Biting episode. This was specifically scored when the rats where actively biting or trying
to bite the food pieces in the food crib.
Consuming a separate food piece. On occasion, rats would bite off a larger food piece, or
find a food piece in the bedding material below the food crib. They would then frequently take
the piece in their mouth, walk away from the food crib and sit still in another part of the cage.
Although it was rarely directly visible, it was assumed that they were then actively consuming
the food piece, which was scored as a separate behavior. The behavior was clearly distinguish-
able from both grooming and resting, as the rats sat very still in a hunched position, rather
than performing typical grooming movements or lying down.
Through the tests sessions, these behaviors occurred in episodes of different durations. For
each behavior, the total number of episodes, the mean episode duration and the total time
spent doing a specific type of behavior was calculated. From this, the total time spent on two
other behavioral parameters were calculated. General food crib attention was calculated by
subtracting the total time of biting episodes from the total time spent paying attention to the
food crib. The parameter thus described the total time the rats spent on more cursory investi-
gations of the food crib. Other food-oriented behaviors was calculated by subtracting the total
time spent paying attention to the food crib and the total time spent consuming a separate
food piece from the total time spent on arguably food-oriented behaviors. Finally, the latency
to initiate biting was calculated for food crib attention episodes where biting occurred.
For both the standard and alternative food restriction protocols, only one video per cage
was analyzed. The videos were chosen so that the rats’ food consumption rate on the analyzed
session was a good approximation of their baseline performance. For a given cage, scoring was
made on each individual rat, although the tail and ear markings that were used for identifying
them were not visible on the videos. Thus, the rats were given arbitrary names based on their
position inside the cage at the session start, to keep them apart during scoring.
The scoring of the individual food consumption test focused on the detailed behavior of
how the rats consumed single food pieces. In general, the rats spent essentially no time doing
general exploration of the setup, so a separate scoring of this was not necessary. Thus, the fol-
lowing parameters were scored:
Time needed to consume the food piece. Rats were considered to be feeding when clearly
biting and gnawing on the food piece. In addition, making clear chewing motions when either
holding the food piece or standing in its direct vicinity and remaining focused on it was con-
sidered active feeding. Rats were not considered to be actively feeding if they were walking
around investigating the setup or were clearly not focusing on the food pellet, even if these
behaviors often included some chewing motions. In addition, eating food dust from the cage
floor was excluded from the active feeding time. Still, it should be noted that these behaviors
were rare.
Number, duration and frequency distribution of biting episodes. A biting episode was
considered any phase where the rats were actively biting or gnawing pieces off of the main
food piece. The start of these episodes was clearly identifiable with the rat using its forepaws to
lift the food piece upwards, and simultaneously lowering its head, in order to position the food
piece into its open mouth. The specific nature of the biting episode could then be quite vary-
ing, although the rat typically either bit a single piece off or performed several gnawing
motions with its lower jaw. The end of the biting episode, and the start of the chewing episode,
was then scored when the rat lifted its head from the food piece and started chewing. In addi-
tion to calculating the total number and mean duration of biting episodes, the frequency distri-
bution of biting episodes with different durations was analyzed. This analysis used 15 bins of
0.2 seconds, and a final bin containing biting episodes that were longer than three second.
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Number, duration and frequency distribution of chewing episodes. Once the rat had
managed to bite a piece off from the main food piece, it typically spent some time chewing
before returning to bite another piece off. The chewing episodes were considered to end when
the rat initiated another biting episode. Through this, the bouts of active feeding were split
into several alternating biting and chewing episodes. In addition to calculating the total num-
ber and mean duration of chewing episodes, the frequency distribution of chewing episodes of
different durations was analyzed. This analysis used 25 bins of 0.2 seconds, and five bins of
three seconds for longer chewing episodes.
On some occasions the rats bit off pieces that were too large to eat in a single bite. The rats
would then drop the main food piece and hold on to the piece that was bitten off, in order to
bite smaller pieces off from it. These events were scored as a single biting episode, as no chew-
ing was initiated. On other occasions, the rats would bite a piece off and then spend some time
using small mouth movements to get the whole piece into their mouths before actually starting
to chew it. On these occasions, the chewing episode was considered to start from the point that
the rats had bitten the piece off in order to include also the small mouth movements. Thus, the
biting episodes included behaviors that aimed at getting a comfortable food piece off of the
food pellet while the chewing episodes included behaviors that focused on managing to chew
and swallow those food pieces.
In addition to the parameters above, the theoretical bite size for each rat was calculated
based on the number of biting episodes the rats had made and the measured weight of the
food pellet. Further, the food consumption rate was calculated based on the food pellet’s
weight and the time needed to consume it.
Statistical analysis
Analysis of baseline performance during the progressive ratio test comprised of several differ-
ent graphing and analysis methods. Single comparisons of BACHD andWT performance
were subjected to t-test, t-test with Welch correction or Mann-Whitney test depending on the
data’s apparent distribution. Parameters presented in curves were analyzed with two-way
repeated measures ANOVAs using in most cases genotype as between-subject factor and
break point, age, food restriction protocol or behavioral protocol as within-subject factor.
Sidak’s multiple comparison post-hoc test was used to follow up on any significant effects of
genotype, or on interaction effects found in the two-way ANOVAs. Analysis of performance
during the FR5 part of the progressive ratio protocol (i.e. performance during the first ten
ratios) was performed in the same manner, but with ratio being used as within-subject factor.
During the study, some rats became ill and had to be sacrificed. Thus the n of the analyses
changed as follows: 7–9 months data (WT: 12, BACHD: 11), 12–14 months data (WT: 12,
BACHD: 11) and 17–19 months data (WT: 12, BACHD: 9 for data from standard food restric-
tion, WT: 11, BACHD: 9 for data from alternative food restriction). Analysis of age progres-
sion excluded animals for which data was not available at all ages. No other exclusion criteria
were used.
To gain further information of the rats’ progressive ratio performance, data from the final
break point (break point 600) from all baselines established during standard and alternative
food restriction was analyzed in a three-way ANOVA. The analysis used genotype as between-
subject factor and age and food restriction protocol as within-subject factors. Significant two-
way interactions were graphed and pairwise analyses were made using Sidak’s multiple com-
parison post-hoc test. As the analysis included age, data from rats that had been sacrificed
before the end of the study were excluded. This put the n for the analysis at 11 for WT and 9
for BACHD rats.
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Parameters investigated in connection to leptin level analysis were analyzed through a series
of single comparisons between BACHD andWT rats, using t-test, t-test with Welch correction
or Mann-Whitney test depending on the data’s apparent distribution. Curves and ANOVAs
were avoided due to the strong non-normal distribution in WT rats’ leptin levels, which was
found to influence statistical readouts and obscure the findings concerning the alternative
food restriction protocol. The current approach was chosen to avoid excluding experimentally
sound data. Analysis was performed on the 11 WT and 9 BACHD rats for which progressive
ratio data and blood samples were available at all three baselines (satiety, standard food restric-
tion and alternative food restriction). WT rats were, in addition, subjected to paired analysis of
body weight, leptin levels and BP600 for the two different food restriction protocols.
Parameters from dissection results were also analyzed in a series of single comparisons
between BACHD andWT rats, using t-test, t-test with Welch correction or Mann-Whitney
test depending on the data’s apparent distribution.
Curves comparing mean baseline food consumption rates during standard and alternative
food restriction protocols, for both the standard and individual food consumption tests,
were analyzed with two-way repeated measures ANOVA. As above, these used genotype as
between-subject factor and restriction protocol as within-subject factor. Sidak’s multiple com-
parison post-hoc test was used to follow up on any significant effects of genotype, or interaction
effects. In addition, performance of WT rats was subjected to paired analysis, comparing the
performance on both restriction settings. Additional curves showing food consumption rate
on all test sessions are included in the figures for descriptive purpose. The standard food con-
sumption test was based on mean consumption rates for cages, resulting in an n of 4 for both
WT and BACHD rats. The individual food consumption test was based on individual perfor-
mances. Group II consisted of a total of 12 WT and 12 BACHD rats. However, 2 WT rats had
to be excluded from the analysis, as they did not reliably consume the food piece during the
alternative food restriction protocol, leaving an n of 10 WT and 12 BACHD rats.
The video analysis of the standard food consumption test focused on a series of individual
comparisons between WT and BACHD rat performance, using t-test, t-test with Welch cor-
rection or Mann-Whitney test depending on the data’s apparent distribution. No specific
analysis of behavioral changes due to the change of food restriction protocol was performed,
although additional graphs depicting the change, but using the statistics of the individual com-
parisons, were made. This was because the rats’ actual identity was not visible in the videos,
and thus repeated measures analysis could not be performed. Scoring within each baseline per-
formance was done on an individual basis, giving an n of 12 for both WT and BACHD rats.
Video analysis of behavior during the individual food consumption test was only performed
for the alternative food restriction protocol, as the restriction protocol did not appear to have
any effect on food consumption rate in this test. Analysis consisted of a series of individual
comparisons between WT and BACHD rat performance, using t-test, t-test with Welch cor-
rection or Mann-Whitney test depending on the data’s apparent distribution. In addition, the
distribution of biting and chewing episodes of different durations were analyzed with two-way
repeated measures ANOVA using genotype as between-subject factor and episode duration as
within-subject factor. The analysis was performed on both absolute numbers of episodes and
data related to the total number of episodes performed. No post-hoc analysis was performed.
As noted above, the analysis used 10 WT and 12 BACHD rats. An additional distribution anal-
ysis with fewer episode duration bins was also performed. This analysis used a series of indi-
vidual comparisons between BACHD andWT rats, applying tests describe above, rather than
a two-way ANOVA.
Alpha for all analyses was set to 0.05. The three-way ANOVA was performed with SPSS sta-
tistics v.20.0.0 (IBM Corporation, Armonk, New York, USA, http://www.ibm.com). All other
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statistical analyses were conducted using GraphPad Prism v.6.01 (GraphPad Software, San
Diego California USA, http://www.graphpad.com).
Results
Survival
Most rats remained healthy through the entire duration of the study, and only a few rats
(three BACHD and one WT rat from Group I) were sacrificed due to illness. In all cases, the
illnesses concerned tumors. Although the higher incidence of sacrifice among BACHD rats
in this study might suggest that BACHD rats show a generally shorter life span than WT rats,
we have not seen any consistent indications of this when considering all studies performed at
our institute.
Progressive ratio
The results from Group I’s performance on the progressive ratio test at four months of age
[18] were well reproduced when the rats were retested at older ages in the current study (Figs 2
and 3). Specifically, BACHD rats performed fewer pushes on the reinforced lever, completed
fewer ratios and reached lower breakpoints compared to WT rats when the standard food
restriction protocol was used (Fig 2A). Rats of both genotypes appeared to be gradually less
motivated to perform the test as they aged (Fig 2B), although the motivational differences
between the genotypes remained largely unchanged. Still, post-hoc analysis revealed that a sub-
tle progression effect might be present. When using the alternative food restriction protocol,
the genotype differences were no longer present and BACHD andWT rats consistently
showed similar levels of motivation in the progressive ratio test (Fig 3A). This was primarily
due to a clear drop in motivation amongWT rats, although performance also dropped slightly
among BACHD rats. Performance on the alternative food restriction protocol showed no sta-
tistically significant change with age, although weak trends indicated that the motivation
dropped slightly (Fig 3B). Pushes on the non-reinforced lever were rare for both genotypes at
all ages and on both food restriction protocols, with no indication of genotype or interaction
effects (S1 Fig). Rats of both genotypes performed their highest number of non-reinforced
lever pushes during the 7–9 months test period when the standard food restriction protocol
was used. At all following baselines, the number of non-reinforced pushes appeared to remain
stable.
The results from the three-way ANOVA analysis of break point 600 supported the results
described above and added certain analysis elements (Fig 4). The ANOVA did not reveal any
overall effect of genotype, while both the restriction protocol and age had a general impact on
break point 600 (Fig 4A). Further, each of the reported two-way interactions (Genotype x
Restriction protocol, Genotype x Age, and Restriction protocol x Age) were significant,
although the Genotype x Age interaction was considerably weaker than the others (Fig 4A).
The three-way interaction (Restriction protocol x Age x Genotype) was, in contrast, not signif-
icant (Fig 4A). The significant two-way interactions were subjected to further analysis (Fig
4B). From this, it was once again noted that although both WT and BACHD rats dropped in
motivation between the two baselines, the effect was stronger amongWT rats. This effect likely
caused the significant Genotype x Restriction protocol interaction. The analysis further indi-
cated that as rats grew older, their performance appeared to drop at a faster rate among
BACHD rats compared toWT rats. This likely caused the significant Genotype x Age interac-
tion effect. Finally, the performance difference between rats maintained on the standard and
alternative food restriction protocols was particularly strong during the 7–9 months test age.
This likely caused the significant Restriction protocol x Age interaction effect.
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Fig 2. Primary readouts of progressive ratio performance during standard food restriction. The graphs show the
performance of Group I in the progressive ratio test, when rats were maintained on the standard food restriction protocol.
(A) displays the baseline performance at the three older ages. The mean number of pushes performed on the reinforced
lever and mean number of completed ratios are displayed in scatter plots, where each data point represents an individual
animal’s performance. The groups’ mean values are also indicated. The graphs for break point analysis display the ratio
where a given break point was reached, with group mean plus standard error being shown. (B) displays the age
progression of the main readouts. The graphs indicate group mean plus standard error. For the scatter plots, significant
results from t-test or Mann-Whitney test are shown inside the graphs. For (B) as well as for all break point graphs, repeated
two-way ANOVA results are displayed inside the graphs, and results from post-hoc analysis are shown for individual data
points in case significant genotype differences were detected. (P < 0.05) *, (P < 0.01) ** and (P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g002
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Fig 3. Primary readouts of progressive ratio performance during alternative food restriction. The graphs show the
performance of Group I in the progressive ratio test, when animals were food restricted so that their food consumption rates were
matched. (A) displays the baseline performance at the three older ages. The mean number of pushes performed on the reinforced
lever and mean number of completed ratios are displayed in scatter plots, where each data point represents an individual animal’s
performance. The groups’ mean values are also indicated. The graphs for break point analysis display the ratio where a given break
point was reached, with group mean plus standard error being shown. (B) displays the age progression of the main readouts. The
graphs indicate group mean plus standard error. For the scatter plots, significant results from t-test or Mann-Whitney test are shown
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inside the graphs. For (B) as well as for all break point graphs, repeated two-way ANOVA results are displayed inside the graphs, and
results from post-hoc analysis are shown for individual data points in case significant genotype differences were detected. (P < 0.05)
*, (P < 0.01) ** and (P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g003
Fig 4. Three-way ANOVA analysis of break point 600. The graphs show the results from a three-way ANOVA analysis of
break point 600 for the performance baselines displayed in Figs 2 and 3. (A) displays all included data points and a summary
table of the statistics. (B) displays plots for the significant two-way interaction effects. All graphs display group mean plus
standard error. In (B), results from pairwise comparisons with Sidak’s multiple comparison post-hoc test are displayed for data
points that differed significantly from each other. (P < 0.05) *, (P < 0.01) ** and (P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g004
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BACHD rats were consistently found to have longer full pellet retrieval latencies compared
to WT rats, regardless of which food restriction protocol was used (Fig 5A). As described in
the Material and Methods section, the full pellet retrieval latency was composed of the latency
to leave the reinforced lever and the time needed to move from the reinforced lever to the pel-
let receptacle. BACHD rats were slightly slower thanWT rats in terms of leaving the reinforced
lever (Fig 5B), which appeared to be caused by themmaking a higher number of excessive
lever pushes before retrieving the pellet (Fig 5C), rather than having problems with simply
releasing the lever (Fig 5D). In addition, BACHD rats were consistently found to be slower
thanWT rats in moving from the reinforced lever to the pellet trough (Fig 5E), which likely
represented the main cause of their slowed full retrieval latency. Concerning age progression,
WT rats showed stable pellet retrieval latencies, while BACHD rats appeared to become slower
as they were retested (Fig 5A and 5E). The number of excessive lever pushes (Fig 5C), and
other parameters (Fig 5B and 5D), remained arguably stable with increasing age.
There were no striking differences between the BACHD andWT rats’ performance during
the FR5 phase of the progressive ratio test (S2 Fig). Still, there was a trend indicating that
BACHD rats needed longer time thanWT rats to complete the very first ratio of the session
(S2B Fig). In addition, BACHD rats were again found to need significantly longer time than
WT rats to retrieve the reward pellets on both food restriction protocols (S2C Fig).
Progressive ratio control tests
During the test performed at 2–4 months of age, we used a prefeeding control test [18]. The
aim was to control for differences in the BACHD andWT rats’ hunger levels. As mentioned in
the Material and Methods section, this was repeated for the 7–9 months test, but the results
were excluded, as the rats did not reliably return to their baselines between the prefeeding
tests. A separate set of control tests was thus added at 12–14 and 17–19 months of age. On
both occasions, the rats were assessed in the progressive ratio test and in an FR5 test at satiety.
During the 17–19 months test, the FR5 protocol was also run after establishing the progressive
ratio baselines for the standard and alternative food restriction protocols. At satiety, BACHD
rats were less motivated thanWT rats to perform the progressive ratio test (Fig 6A), but were
equally motivated to perform the FR5 test (Fig 6B). This was true for both test ages. Impor-
tantly, both BACHD andWT rats completed more ratios (Fig 6A and 6B) and performed
more pushes on the reinforced lever (Fig 6C) during the FR5 protocol compared to the pro-
gressive ratio protocol. When comparing progressive ratio test performances during satiety
and the standard food restriction protocol, rats of both genotypes showed increased motiva-
tion to lever-push for rewards on the latter. This effect appeared to be somewhat stronger
amongWT rats, particularly at the last test age (S3 Fig).
During the last test age, the FR5 control test was repeated when the rats were maintained
on the standard and alternative food restriction protocols. During this, most of the rats
reached the maximum of 200 reward pellets without making larger breaks, and thus no
detailed analysis of break points could be made. Instead, the primary readouts were the num-
ber of completed ratios and the number of lever pushes performed on the reinforced lever.
Similar to the FR5 test at satiety, there were no differences between BACHD andWT rats in
these parameters, and both completed more ratios (Fig 7A) and performed more lever pushes
(Fig 7B) compared to their progressive ratio performance.
Leptin measurements
BACHD rats showed no significant difference in body weight compared toWT rats at either of
the different baselines (Fig 8A), but along with the poorer progressive ratio performance (Fig 8B),
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Fig 5. Detailed analysis of pellet retrieval latency during the progressive ratio test. The graphs show
age progression of various parameters related to the latency to retrieve the reward pellet during progressive
ratio testing of Group I. Results from both food restriction protocols are shown. (A) shows the full retrieval
latency, while (B)–(E) show its individual components. Detailed information on how the different parameters
were measured is described in the Material and Methods section. The graphs indicate group mean plus
standard error. Repeated two-way ANOVA results are displayed inside each graph, and results from post-hoc
analysis are shown for individual data points in case significant genotype differences were detected.
(P < 0.05) *, (P < 0.01) ** and (P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g005
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they showed significantly higher serum concentrations of leptin (Fig 8C). The difference in leptin
levels was strongest at satiety and during the standard food restriction protocol. Although the dif-
ference was milder during the alternative food restriction protocol, it was still present. Paired
analyses of WT rats further showed that the switch from standard to alternative food restriction
resulted in them becoming heavier (Fig 8D) and being less motivated to perform the progressive
ratio test (Fig 8E), while having increased serum leptin concentrations (Fig 8F).
Body composition analysis
The detailed dissection of Group I at the study’s endpoint indicated that BACHD andWT rats
did not differ in body weight (Fig 9A), but in body composition (Fig 9B). Specifically, BACHD
rats carried a larger amount of adipose tissue thanWT rats (Fig 9C), displayed higher serum
concentrations of leptin (Fig 9D) and had lower absolute and relative bone/muscle tissue mass
(Fig 9E and 9F, respectively). Although BACHD rats have regularly been found to be shorter
than WT rats in our institute, no significant difference in the total body length was found in
this cohort. A trend was, however, present due to the BACHD rats having significantly shorter
tails (data not shown).
Standard food consumption test
When the standard food restriction protocol was used, BACHD rats of Group II consistently
consumed less food thanWT rats in the standard food consumption test (Fig 10A). WhenWT
Fig 6. Progressive ratio and FR5 control test performance during satiety. The graphs show performance of Group I in the
progressive ratio and FR5 control tests when rats were maintained on free-feeding conditions. (A) shows break point analyses for
progressive ratio testing at 12–14 and 17–19 months of age. (B) shows break point analyses for FR5 testing at the same ages. (C)
shows comparisons of the mean number of lever pushes performed on the reinforced lever during the two test protocols. The graphs
display group mean plus standard error. Repeated two-way ANOVA results are displayed above each graph, and results from post-
hoc analysis are shown for individual data points in case significant genotype differences were detected. (P < 0.05) *, (P < 0.01) **
and (P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g006
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rats were given more food on a daily basis they responded with reduced food consumption
rates (Fig 10A). Through careful adjustments of their feeding regimen it was possible to obtain
a setting where they showed comparable food consumption rates to the BACHD rats (i.e. the
alternative food restriction protocol) (Fig 10A). Baseline values of the rats’ performance were
created, using all sessions performed on the standard food restriction protocol and the last ten
sessions performed on the alternative food restriction protocol. Statistical analysis of these
baselines showed a clear change in food consumption rate amongWT rats due to the adjust-
ment (Fig 10B and 10C). Similar results were obtained for Group I and for several other animal
groups that we have assessed (data not shown). Notably, there was no apparent change in the
phenotype when the food was placed on the cage floor instead of in the food crib, although rats
of both genotypes consumed generally more food in the former setting (S4 Fig).
Detailed video scoring of the rats’ behavior during the standard food consumption test did
not indicate any striking differences betweenWT and BACHD rats when they were main-
tained on standard food restriction (Fig 11). WT rats consumed more food during the con-
sumption test compared to BACHD rats (Fig 11A), in line with their behavior during baseline
performance (Fig 10A). Rats of both genotypes spent comparable amounts of time on arguably
food-oriented behaviors, such as paying attention to and biting the food that had been placed
Fig 7. FR5 control test performance during standard and alternative food restriction. The graphs show
comparisons of Group I’s performance on the progressive ratio and FR5 control tests, when rats were
maintained on the standard and alternative food restriction protocols. The number of completed ratios (A) and
number of lever pushes performed on the reinforced lever (B) were analyzed, as detailed break point analysis
could not be performed. The graphs display group mean plus standard error. Repeated two-way ANOVA
results are displayed inside each graph, and results from post-hoc analysis are shown for individual data
points in case significant genotype differences were detected. (P < 0.05) *, (P < 0.01) ** and (P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g007
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Fig 8. The effect of food restriction adjustment on body weight, progressive ratio performance and serum leptin
levels. The graphs show body weight, the number of completed ratios at break point 600 and serum leptin levels of Group I
during different food restriction protocols, at 17–19months of age. (A)–(C) show comparisons betweenWT and BACHD
rats, while (D)–(F) show the specific comparison of WT rats before and after food restriction adjustment. The graphs
indicate values from individual rats and group mean. Significant results from t-test, Mann-Whitney test, Wilcoxon test or
paired t-test are displayed inside each graph. (P < 0.05) *, (P < 0.01) ** and (P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g008
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Fig 9. Body composition analysis of rats maintained on alternative food restriction. Parameters of body
composition obtained from the dissection of Group I at 19 months of age. Rats were at that time maintained on
the alternative food restriction. All graphs except (B) indicate values from individual rats and group mean. (B)
indicates group mean plus standard error. Bone/muscle weight in (E) was related to the animals’ body lengths to
obtain the relative bone/muscle values presented in (F). Significant results from t-test or Mann-Whitney tests are
displayed inside each graph. (P < 0.05) *, (P < 0.01) ** and (P < 0.001) ***. For (B), "a" denotes a significant
difference in adipose tissue (P < 0.05) and "bb" denotes a significant difference in bone/muscle tissue (P < 0.01).
doi:10.1371/journal.pone.0173232.g009
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in the food crib (Fig 11B). However, further analysis revealed that BACHD rats had a higher
number of both food crib attention (Fig 11C) and biting episodes (Fig 11D). These were, how-
ever, shorter compared to WT rats’, resulting in the comparable total time spent on either
behavior (Fig 11B). Furthermore, BACHD rats had a shorter latency to initiate biting, but
there was no difference in how often a food crib attention episode developed into a biting epi-
sode (Fig 11D). There was also no difference between genotypes regarding the number of
times the rats bit off larger food pieces (Fig 11E). There were, however, trends indicating that
BACHD rats took less time to consume such a piece compared to WT rats and that they bit off
a separate piece at a slightly lower frequency (Fig 11E). In line with this, there was a significant
difference in the total time spent consuming separate food pieces, with BACHD rats spending
Fig 10. Food consumption rates in the standard food consumption test. Group II’s performance in the
standard food consumption test at 12 months of age on standard and alternative food restriction is displayed.
(A) shows the performance on individual sessions, while (B) and (C) show comparisons of baseline
performance during the different food restriction protocols. In (A) and (B) the symbols indicate group mean
plus standard error, in (C) the symbols indicate individual WT cages. For (B), repeated two-way ANOVA
results are indicated inside the graph, and results from post-hoc analysis are displayed in caseWT and
BACHD differed significantly. For (C), significant results from paired t-test is indicated. (P < 0.05) *, (P < 0.01)
** and (P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g010
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Fig 11. Video scoring of behavioral parameters from the standard food consumption test during standard food
restriction. Group II’s performance on the standard food consumption test during the standard food restriction protocol
was subjected to detailed video analysis. (A) shows the consumption rate measured for individual cages on the video
scored session. (B)–(E) display the behavior of individual rats during the same session. (B) shows the total amount of time
spent on different behaviors, in relation to the duration of the test session. (C)–(E) show details concerning some of the
behaviors, indicating the number of behavioral episodes, mean episode duration, frequency of behavior and the latency to
initiate the behaviors. Frequency relates to the percentage of food crib attention episodes that turn into biting episodes (D)
and episodes were rats consume a separate food piece (E). Significant results from t-test or Mann-Whitney tests are
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less time on this activity compared to WT rats (although the difference was no longer signifi-
cant when multiple comparison corrections were considered) (Fig 11B).
As noted, WT and BACHD rats consumed comparable amounts of food when they were
maintained on the alternative food restriction protocol (Fig 12A). Interestingly, under these
conditions WT rats spent less time than BACHD rats on food-oriented behaviors (Fig 12B).
This was primarily due to them spending less time than BACHD rats on general food crib
attention, while the time spent actively biting the food, consuming separate food pieces and
performing other food-oriented behaviors did not significantly differ between the genotypes
(Fig 12B). BACHD rats still showed a higher number of food crib attention episodes compared
to WT rats, although there was no longer any difference in the mean duration of individual
episodes (Fig 12C). The rats’ behavior during biting episodes was similar to what was found
during the standard food restriction protocol, with BACHD rats showing a higher number of
episodes, a shorter mean duration of individual episodes, but no difference in biting episode
frequency compared to WT rats. However, in contrast to the previous results, there was no dif-
ference between WT and BACHD rats in the latency to initiate biting (Fig 12D). As noted
above, BACHD rats spent in total less time thanWT rats on consuming separate food pieces
when the standard food restriction protocol was used (Fig 11B). An opposite trend was found
during the alternative food restriction (Fig 12B and 12E). Specifically, WT rats showed fewer
episodes where they consumed separate food pieces compared to BACHD rats (Fig 12E).
Interestingly, there was a trend indicating that WT rats still bit off food pieces at a higher fre-
quency (Fig 12E). As before, there was no difference between WT and BACHD rats concern-
ing the mean duration of episodes spent consuming separate food pieces.
In addition to the analysis shown in Figs 11 and 12, a series of curves were made to better
display how the WT rats’ behavior changed as a result of the change in food restriction proto-
col (S5 and S6 Figs). As expected from the results described above, WT rats showed a specific
drop in the time spent on food-oriented behavior (S5B Fig) due to a drop in the time spent on
general food crib attention (S5E Fig). This in turn appeared to be due to a drop in the mean
duration of individual food crib attention episodes, rather than a drop in the number of such
episodes (S6A Fig). In line with this, the latency to initiate biting amongWT rats was reduced
when the alternative food restriction protocol was used (S6B Fig).
Individual feeding test
Most rats reliably consumed the full food piece without frequent or extensive breaks, regard-
less of which food restriction protocol was used. TwoWT rats, however, did not reliably con-
sume the food pellet during the alternative restriction and had to be excluded from the
analysis. During both restriction protocols, WT and BACHD rats showed a relatively high
consumption rate on initial sessions compared to their stable baseline performance (Fig 13A).
For analyzing mean baseline consumption rates, sessions 5–15 and 5–12 were used for the
standard and alternative food restriction protocols, respectively. BACHD rats showed a gener-
ally lower food consumption rate compared to WT rats during both restriction protocols,
although the phenotype was somewhat stronger when the rats were maintained on the alterna-
tive food restriction (Fig 13B). The change in food restriction protocol did not appear to have
a major impact on the WT rats’ performance (Fig 13C), with the exception of the aforemen-
tioned two rats that generally lost interest in consuming the food pellet.
displayed inside each graph. (P < 0.05) *, (P < 0.01) ** and (P < 0.001) ***. Results in (B) were corrected for multiple
comparisons using the Sidak method. Significance levels that were lost through this approach are indicated with a
parenthesis.
doi:10.1371/journal.pone.0173232.g011
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Fig 12. Video scoring of behavioral parameters from the standard food consumption test during alternative food
restriction. Group II’s performance on the standard food consumption test during the alternative food restriction protocol
was subjected to detailed video analysis. (A) shows the consumption rate measured for individual cages on the video
scored session. (B)–(E) display the behavior of individual rats during the same session. (B) shows the total amount of time
spent on different behaviors, in relation to the duration of the test session. (C)–(E) show details concerning some of the
behaviors, indicating the number of behavioral episodes, mean episode duration, frequency of behavior and the latency to
initiate the behaviors. Frequency relates to the percentage of food crib attention episodes that turn into biting episodes (D)
and episodes were rats consume a separate food piece (E). Significant results from t-test or Mann-Whitney tests are
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Video scoring was performed on videos gathered on the first, fifth, sixth and seventh test
session of the alternative food restriction test. The first session was chosen due to the pheno-
type being particularly strong, while session 5–7 were thought to represent baseline perfor-
mance. Individual biting and chewing episodes were easily identifiable in the videos and made
up>96% of the time scored as active feeding (data not shown). The unaccounted time was
most likely lost due to the manual nature of the scoring method, which resulted in slight breaks
displayed inside each graph. (P < 0.05) *, (P < 0.01) ** and (P < 0.001) ***. Results in (B) were corrected for multiple
comparisons using the Sidak method. Significance levels that were lost through this approach are indicated with a
parenthesis.
doi:10.1371/journal.pone.0173232.g012
Fig 13. Food consumption rates in the individual food consumption test. Group II’s performance in the
individual food consumption test at 12 months of age on standard and alternative food restriction is displayed.
(A) shows the performance on individual sessions, while (B) and (C) show comparisons of baseline
performance during the different food restriction protocols. In (A) and (B) the symbols indicate group mean
plus standard error, in (C) the symbols indicate individual WT rats. For (B), repeated two-way ANOVA results
are indicated inside the graph, and results from post-hoc analysis are displayed in caseWT and BACHD
differed significantly. For (C), significant results from paired t-test is indicated. (P < 0.05) *, (P < 0.01) ** and
(P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g013
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between the scored behaviors whenever a switch between biting and chewing episodes
occurred. Video analysis of the first session indicated that BACHD rats needed more time
thanWT rats to consume the food pellet (Fig 14A). In addition, BACHD rats required more
bites compared to WT rats (Fig 14B) and consequently had a smaller estimated bite size (Fig
14C). Although there was no difference in the mean duration of individual biting episodes (Fig
14D), curves showing the biting episode duration distribution still clearly indicated a behav-
ioral difference between the rats (Fig 14E and 14H). While WT rats had a small range of rela-
tively fast bites, BACHD rats showed a slightly right-shifted and broadened peak, indicating
that they had slightly longer biting episodes compared to WT rats (Fig 14E and 14H). There
was no difference between the genotypes in the mean chewing episode duration (Fig 14F).
Detailed analysis of the chewing episode duration distribution indicated that BACHD rats had
a higher number of short chewing episodes compared to WT rats (Fig 14G), although the rela-
tive distribution of chewing episodes did not indicate any behavioral differences between the
genotypes (Fig 14I).
As noted above, the food consumption rate phenotype was noticeably weaker during base-
line performance. This was also true for the phenotypes found in the video scoring. BACHD
rats still needed more time thanWT rats to consume the food pellet (S7A Fig), but there was
no longer any statistical difference in the number of bites (S7B Fig) or the estimated bite size
(S7C Fig). BACHD rats still showed a shift towards making longer biting episodes compared
to WT rats (S7E Fig), although it was less pronounced than during the first test session (Fig
14E). BACHD rats did again not show any indications of having a changed chewing behavior
during baseline performance (S7F, S7G and S7I Fig). When splitting the total time needed to
consume the food pellet (S8A Fig) into the total time spent biting (S8B Fig) and the total time
spent chewing (S8C Fig), BACHD rats spent specifically more time chewing compared toWT
rats. Additional analysis of chewing episode distribution, using a different set of bins, indicated
that BACHD rats had more chewing episodes of intermediate duration (1.6–5.0 s) compared
to WT rats (S8D Fig). BACHD rats also showed an increased total amount of time chewing
specifically within this range of chewing episodes (S8E Fig), without showing a difference in
mean chewing episode duration (S8E Fig).
Finally, the BACHD rats of Group II were found to have shorter heads compared to their
WT littermates (S9A Fig). However, this did not appear to have any major influence on the
rats’ food consumption rates (S9C and S9D Fig).
Discussion
Progressive ratio performance and motivational phenotype of BACHD
rats
One of the aims of the current study was to evaluate if our initial findings concerning the
BACHD rats’ performance in the progressive ratio test [18] were reproducible at older ages.
This was clearly the case. At all investigated ages, BACHD rats were less motivated thanWT
rats to perform the test when the standard food restriction protocol was used. When the alter-
native food restriction protocol was used, WT and BACHD rats reliably showed comparable
motivation to perform the test. Ultimately, the results are likely to also be reproducible with
other groups of BACHD rats, as they do not appear to be caused by unspecific variations in
performance.
Our initial interpretation regarding the motivational deficit in the BACHD rat was that it
was likely to be caused by metabolic, rather than psychiatric disturbances [18]. We hypothe-
sized that when the rats were maintained on standard food restriction, WT rats were hungrier
than BACHD rats, resulting in them being more motivated to perform lever pushes for a food
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Fig 14. Video scoring of the individual food consumption test during alternative food restriction.
Group II’s performance on the first session of the individual food consumption test during the alternative food
restriction protocol was subjected to detailed video analysis. (A)–(D) and (F) indicate the performance of
individual rats. Significant results from t-test or Mann-Whitney test are shown. (E), (G), (H) and (I) show
frequency distribution curves for biting and chewing episodes of different durations, indicating group mean
plus standard error. The bins used are described in detail in the Material and Methods section. Note that the x-
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reward. The alternative food restriction protocol sought to adjust the food restriction levels of
the rats, so that they became equally hungry. As this reliably resolved the motivational deficit
in the progressive ratio test, we considered it unlikely that the initial phenotype had been
caused by psychiatric deficits. In the current study, we aimed at further evaluating this idea by
performing the progressive ratio test while the rats had free access to food. This constituted a
second feeding condition (on top of the alternative food restriction), where WT and BACHD
rats should be equally hungry (i.e. in this case satiated). However, in contrast to their behavior
during the alternative food restriction, BACHD rats were found to be less motivated than the
WT rats in this setting (i.e. similar to the rats’ behavior during the standard food restriction).
Importantly, this did not appear to be due to BACHD rats becoming satiated or fatigued at an
earlier point than WT rats, as performance on the FR5 control test (where rats of both geno-
types performed more pushes and consumed more pellets compared to the progressive ratio
sessions) did not differ between the genotypes (for the same reason, the BACHD rats’ reduced
motivation during the standard food restriction is likely not caused by fatigue or satiety). Ulti-
mately, a difference in hunger levels is unlikely to fully explain the motivational deficit found
in BACHD rats performing the progressive ratio test. Still, the phenotype might be otherwise
connected to the rats’ metabolic disturbances.
As previously noted, male BACHD rats are obese [18]. Leptin, an endocrine hormone
secreted from white adipose tissue [23], has been shown to affect rats’ motivation to perform
the progressive ratio test. Specifically, increased leptin signaling has been found to reduce
motivation [24,25], while knock-down of leptin receptors has been found to increase motiva-
tion [26]. Interestingly, leptin has been shown to decrease motivation in progressive ratio tests
both at satiety [24,25] and during food restriction [26]. Because of this, we hypothesized that
the motivational deficit seen in BACHD rats during satiety and the standard food restriction
was caused by an obesity-related increase in serum leptin levels. We further hypothesized that
this phenotype would be resolved through the use of the alternative food restriction protocol.
To evaluate this, we measured serum leptin levels in Group I during their different perfor-
mance baselines. The results clearly indicated that BACHD rats had higher leptin levels than
WT rats both at satiety and when the standard food restriction protocol was used. However,
although the difference was less apparent during the alternative food restriction, it was not
fully resolved. In line with this, the dissection results clearly showed that the BACHD rats still
carried more adipose tissue thanWT rats when they were maintained on the alternative food
restriction. Thus, the results appear to argue against the hypothesis that the BACHD rats’ moti-
vational deficit is caused primarily by their obesity. Still, it is not known how large the differ-
ence in leptin levels would have to be in order to result in such a phenotype. In relation to this,
it is also unknown, if the neuronal circuits necessary for leptin signaling are intact in BACHD
rats. To better understand the current results, it would therefore be of interest to investigate
dose-response curves for leptin’s effect on BACHD andWT rats’ progressive ratio perfor-
mance. In addition, it would be important to study the expression of leptin receptors in the
BACHD rats’ mid- and hindbrain, as these regions appear to be involved in progressive ratio
performance [24,26,34] (interestingly, leptin receptors in the hypothalamus appear to be of
less importance [26]).
However, further studies of the integrity of the BACHD rats’ leptin system are unlikely to
offer any final conclusions regarding whether or not their motivational deficit is caused by
their obesity. For this, efforts should be made to elucidate the cause of the rats’ obesity, so that
axis in (G) and (I) only labels every other bin. Results from repeated two-way ANOVA are displayed inside the
graphs. (P < 0.05) *, (P < 0.01) ** and (P < 0.001) ***.
doi:10.1371/journal.pone.0173232.g014
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lean BACHD rats might be obtained and subsequently assessed in the progressive ratio test.
Interestingly, inactivating mutant huntingtin expression in the hypothalamus of BACHDmice
completely resolved their obesity phenotype [35]. Although the cause for the obesity pheno-
types might differ between BACHDmice and BACHD rats (obesity in the mouse model has
been suggested to be due to overeating [35], while this does not appear to be the case in the rat
model [17,18]), both could be due to hypothalamic pathologies, involving different subregions
[36]. Regarding BACHD rats, the arcuate nucleus is particularly interesting, as lesioning this
region has been shown to result in obesity without associated hyperphagia [36–40]. Interest-
ingly, the lesions appear to target neuron populations that are involved in regulating the release
of growth hormone [40–43]. In line with this, down-regulation of growth hormone signaling
has been found to result in growth impairments coupled with obesity [44–46], i.e. specifically
the phenotypes that we have previously noted in male BACHD rats [18]. Moreover, one of the
peripheral functions of growth hormone is to stimulate the release of IGF-1 from the liver
[47], and we have repeatedly found that male BACHD rats have lower serum levels of IGF-1
(unpublished data). Thus, the growth hormone signaling axis and the integrity of the arcuate
nucleus are of great interest for future work with the BACHD rats. In connection to this,
detailed investigation of the similarities and differences in male and female BACHD rats’ phys-
iologies would be of importance.
The phenotype of reduced motivation among BACHD rats remained arguably stable when
the rats were retested at older ages. Still, there were some indications that a subtle progressive
worsening of the phenotype might be present (i.e. the post-hoc analysis shown in Fig 2B and
the results from the three-way ANOVA Genotype x Age interaction effect). However, addi-
tional longitudinal studies of the BACHD rats’ progressive ratio performance would be neces-
sary to conclude if this is truly the case. Based on HD’s clinical presentation, one would expect
disease-related phenotypes in animal models to progressively worsen with age. In line with
this, other phenotypes found in the BACHD rats have shown strong progressive change even
at ages below four months [17,48,49], which is well within the ages investigated in the current
study. Still, it is worth noting that the obesity phenotype did not appear to change with age
during our previous study [18], so if that indeed causes the motivational phenotypes one
would expect the latter to remain reasonably stable as well. Still, not all psychiatric symptoms
in HD patients clearly progress with age either [50]. For example, while apathy appears to pro-
gressively worsen, depression does not [22,50–52]. Performance in the progressive ratio test
at satiety has been suggested to be primarily affected by the rats’ hedonic value of the food
reward, while motivation to perform the test during food restriction is thought to be more gov-
erned by the induced energy imbalance (i.e. hunger) [53, 54]. As the BACHD rats were less
motivated to perform the test at satiety, it is possible that their motivational phenotype is at
least to some extent due to anhedonia, which is an aspect of depression that has been impli-
cated in HD [55]. In the end, the apparent lack of progression seen in the BACHD rats’ moti-
vational deficit does not offer any clear insight into the specific nature of the phenotype.
Although the alternative food restriction protocol only changed the WT rats’ restriction
conditions, BACHD rats also showed drops in motivation between the performance baselines
established on the standard and alternative restriction protocols. During the 7–9 months test,
this was primarily caused by the set of prefeeding tests described in the Material and methods
section. As noted, both WT and BACHD rats failed to return to their initial performance base-
line between the prefeeding tests, and their motivation instead dropped with each session. As
the prefeeding tests were run between the establishment of performance baselines on the stan-
dard and alternative restriction, the BACHD rats show a clear drop in motivation when the
two are compared directly. As the same issue concerned the WT rats, the change in restriction
protocol appeared to have a particularly pronounced effect on performance during the 7–9
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months test (as indicated by the significant Restriction protocol x Age interaction effect
revealed by the three-way ANOVA). The drop in motivation that was seen among BACHD
rats during the later test ages was instead likely related to a specific aspect of the food restric-
tion. As noted, both the standard and alternative food restriction protocols took natural
growth into account, which meant that the amount of food given to the rats was continuously
adjusted. We have in other studies found that the current calculations result in a slight over-
correction of the food restriction (due to the expected growth being overestimated). The error
increases with experiment duration, although we have not found any strong behavioral effects
of this and have reliably been able to establish stable performance baselines. Still, this is likely
the reason for the small drop in motivation seen among BACHD rats when directly comparing
their baselines from the current study.
One final and important aspect to consider in the current progressive ratio results concerns
the readouts that were not directly related to the rats’ motivation, as these indicated that
BACHD rats might suffer from striatal impairments. First, there is the slowed food pellet
retrieval seen among BACHD rats. From the several Skinner box-based tests that we have run
so far at our institute, this phenotype is found in almost all test protocols and animal groups
(largely unpublished, but see [18]). Thus, it offers an interesting and reproducible phenotype
to work with, although it is at this point unclear if the impairment is caused by motoric or psy-
chiatric deficits. Similar phenotypes have been found in the TgHD rat model of HD [56] and
rats with lesions to the dorsolateral striatum [57]. Second, BACHD rats were found to perform
an increased number of excessive (i.e. perseverative) lever pushes. This has also been seen in
rats with lesions to the dorsal striatum [57]. Interestingly, such lesions do not appear to affect
the rats’ overall motivation to perform the progressive ratio test [57]. Thus, the slowed pellet
retrieval latency and the increase in perseverative lever pushes suggest that the BACHD rats
suffer from some kind of striatal dysfunction, which is likely separate from what causes their
motivational impairment. In line with this, the slowed pellet retrieval and perseverative
responding were present on both standard and alternative food restriction.
Food consumption rate phenotypes of BACHD rats
In our initial study [18], we used a food consumption test (the standard food consumption
test) in order to estimate the rats’ apparent hunger and food interest, as similar methods had
been used by others [28–33]. In the current study, we sought to extend our initial work by add-
ing a video-based scoring of the rats’ behavior in the standard food consumption test, and also
assess how they consume individual food pieces (individual food consumption test). When the
standard food restriction protocol was used, BACHD rats were found to have a lower food
consumption rate compared to WT rats in both tests. In contrast, when the alternative food
restriction protocol was used, there was no difference in the rats’ food consumption rate in the
standard food consumption test, while BACHD rats were still slower thanWT rats in the indi-
vidual food consumption test.
BACHD rats were found to require more biting episodes than WT rats in order to con-
sume the food pellets in the individual food consumption test. As all rats were given food
pellets of comparable size, the results suggest that BACHD rats also took smaller bites com-
pared to WT rats. This phenotype could be related to BACHD rats having problems with bit-
ing larger pieces off from the food pellet, with keeping a large amount of food inside their
mouths or with efficiently chewing and swallowing a large food piece. Importantly, the defi-
cit did not appear to be due to the BACHD rats’ smaller heads, and did not seem to be
strongly influenced by hunger. In addition to requiring a higher number of biting episodes
to consume the pellets, the BACHD rats’ biting episodes were slightly longer than the WT
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rats’. It is possible that BACHD and WT rats used similar techniques for biting pieces off
from the food pellet. If so, the BACHD rats’ longer biting episodes might indeed indicate
that they had problems biting pieces off. However, the results might also be due to BACHD
rats preferring more time-consuming techniques (such as gnawing rather than performing
distinct bites) compared to WT rats. More detailed scoring would be required to determine
if that was the case. Further characterization work would also be necessary in order to deter-
mine if this could explain the BACHD rats’ smaller bite size, and whether or not it would be
related to a motoric impairment. The duration of single biting episodes among both WT and
BACHD rats were still short compared to the chewing episodes. Therefore, the latter likely
had a stronger impact and probably contributed more to the BACHD rats’ food consump-
tion rate phenotype. In line with the hypothesis that BACHD rats made smaller bites com-
pared to WT rats, analysis revealed that they showed a higher absolute (but not relative)
number of short chewing episodes. If BACHD rats were as skillful as WT rats at chewing and
swallowing, while managing smaller volumes of food during each chewing episode, one
might have expected them to show a more pronounced shift towards shorter chewing epi-
sodes. The apparently unchanged frequency distribution of chewing episodes could thus
indicate that BACHD rats indeed have problems with chewing and swallowing. In this
regard, it is worth considering that the smaller bite size discussed above might constitute a
compensatory mechanism, allowing BACHD rats to maintain optimal (i.e. seemingly
unchanged) chewing. Impaired chewing and swallowing could be due to motoric impair-
ments, although other possibilities should also be considered. Specifically, we have found
that BACHD rats have disproportionally small salivary glands (unpublished results), which
might impair their ability to form a convenient food bolus. HD patients often suffer from
problems regarding eating, with particularly frequent problems when swallowing [58–61].
We have repeatedly performed tests where WT and BACHD rats are allowed to consume a
large amount of the reward pellets used in the Skinner boxes (see [18] for a published exam-
ple). Typically, BACHD rats are slightly slower than WT rats during initial sessions of this,
but quickly reach a comparable consumption rate. Importantly, consumption of these small
reward pellets appears to involve very limited chewing behavior, suggesting that other
aspects (such as tongue protrusion and swallowing) are more important determinants of the
food consumption rate in this test. Given the BACHD rats’ generally unimpaired perfor-
mance in these tests, their ability to swallow is most likely not strongly impaired. In addition,
we have performed several tests where BACHD rats were allowed to consume spaghetti
pieces (unpublished data). Feeding behavior under these circumstances appears to involve
biting primarily with the incisors, and once again limited chewing. Again, BACHD rats have
generally been found to show comparable consumption rates to WT rats in this test. Thus,
the key factor causing the BACHD rats’ slowed food consumption in the individual food
consumption test might concern the test’s strong dependency on chewing and/or the forma-
tion of a convenient bolus for swallowing. Further efforts should be made to characterize the
noted consumption rate deficit, as it constitutes an interesting and robust phenotype seen
among the BACHD rats.
Our initial interpretation of the slowed consumption rate among BACHD rats in the stan-
dard food consumption test was that they were less hungry compared toWT rats, and that the
alternative restriction protocol resolved this difference. The results from the current study do
not strongly support this idea, but do not necessarily refute them either. When the standard
restriction protocol was used, BACHD andWT rats generally behaved in a comparable way.
They showed similar amounts of food-oriented behaviors and spent the same amount of time
on both paying attention to the food in the food crib and actively trying to bite pieces off from
it. As it is clear that BACHD rats still consumed less food thanWT rats, it is reasonable to
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assume that their biting behavior was less efficient. The analysis also indicated that BACHD
rats performed more but shorter biting episodes compared to WT rats. Based on the results
from the individual food consumption test, it seems fair to assume that this might be due to
them taking a high number of smaller bites, while WT rats made a low number of larger bites.
This is further supported by the fact that episodes where rats consumed a separate food piece
did not differ in length between the genotypes. If BACHD andWT rats had bitten off pieces of
comparable size, one would expect these consumption episodes to be longer among BACHD
rats (according to the results of the individual food consumption test). Thus, the nature of the
reduced food consumption rate among BACHD rats seems at first glance to be comparable
between the standard and individual food consumption tests. Ultimately, this suggests that the
phenotype seen in the standard food consumption tests during standard food restriction is pri-
marily due to them taking smaller bites, which (based on the results from the individual food
consumption test) might not be strongly affected by hunger.
The alternative food restriction protocol sought to match WT and BACHD rats’ food con-
sumption rates (with the assumption that this represented the rats’ hunger level). This pri-
marily focused on giving more food to WT rats, and as a consequence, there was a clear
change in their behavior. Most notably, the amount of time spent on food-oriented behaviors
and paying attention to the food crib dropped below the level of BACHD rats. This appeared
to be largely a result of WT rats making shorter visits to the food crib, rather than fewer.
This, in turn, seemed to be due to the WT rats showing a reduced latency to initiate biting
episodes. In contrast, the time spent biting at the food remained unchanged and comparable
to both their behavior during the standard food restriction protocol and to that of the
BACHD rats. As the WT rats still consumed less food under these circumstances, the results
suggest that their biting behavior had now become less efficient. Due to the limitations of the
video quality, it remains unclear if the unidentified hunger-sensitive behaviors that modu-
lated the WT rats’ biting efficiency were the same as the ones causing the BACHD rats’
reduced food consumption rate during the standard food restriction protocol. As noted, a
reduced bite size might be the cause of the BACHD rats’ reduced consumption rate in the
standard food consumption test. A change in bite size could theoretically also explain the
change in the WT rats’ consumption rate during the alternative food restriction. The latter
is, in contrast to the former, not supported by the results from the individual food consump-
tion test, as bite size appeared to be unaffected by the change in food restriction protocol.
Still, it should be noted that food consumption behavior in these two tests might not be
directly comparable. In the standard food consumption test, the rats remain in their home
cage and are allowed to consume food if they are interested. In contrast, in the individual
food consumption test the rats are more or less forced to consume the food piece before
being allowed to return to their home cage. Thus, the latter test might have conditioned the
rats to eat as fast as possible, rather than based on how hungry they were. This might have
resulted in the evaluated parameters’ (e.g. bite size) apparent resistance to a change in hunger
levels. Importantly, it is clear that hunger was not the only factor that affected the rats’ per-
formance in the individual consumption test, as both WT and BACHD rats showed very
high consumption rates during early sessions and needed several sessions to approach a sta-
ble baseline performance. This was despite the fact that the rats were maintained on a con-
stant feeding regimen. Thus, while bite size appears to be unaffected by hunger in the
individual food consumption test, it might still be sensitive to hunger in the standard food
consumption test. Ultimately, it is therefore still possible that the less efficient biting behav-
ior of BACHD rats in the standard food consumption test during standard food restriction is
caused by them being less hungry compared to WT rats. Additional work is needed before a
final conclusion regarding this matter can be reached.
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The more extensive investigation of WT and BACHD rats’ food consumption behavior in
the current study was in part performed to better understand the progressive ratio phenotype
of the BACHD rats. As noted, the BACHD rats’ motivational deficit cannot be fully explained
by a difference in hunger or leptin levels. Based on the results above, it can be further argued
that the standard food restriction constitutes a suitable protocol, as it seems to induce similar
food interest amongWT and BACHD rats. In addition, one can argue that the lower food con-
sumption rates among BACHD rats could primarily be caused by non-hunger related differ-
ences in feeding behavior. If so, the alternative food restriction protocol would only serve to
mask the underlying phenotype rather than to resolve it. This would also suggest that the
apparent lack of a motivational deficit in the progressive ratio test during the alternative food
restriction is coincidental. Ultimately, the true phenotype of the BACHD rats would be a
reduced motivation to perform the progressive ratio test, likely based on a psychiatric deficit.
However, as noted above, the influence of the BACHD rats’ obesity and increased leptin levels
on their progressive ratio performance is not clear, and conclusive results still have to be
obtained. Likewise, the exact nature of the food consumption rate phenotype in the standard
food consumption test remains unclear, and could still involve more discreet hunger-related
behaviors than the ones scored here.
Connection to previously noted motor impairments of the BACHD rats
Other studies have sought to directly investigate the presence of motor impairments among
the BACHD rats [17,48,49]. These have revealed early (onset at one to two months of age) pro-
gressive deficits in the BACHD rats’ ability to maintain balance on a rotating rod [17,48,49],
and late (onset at twelve to fourteen months) deficits in unhindered gait [17,48]. The results
from the current study suggest that yet another kind of motor function (i.e. orofacial) might be
disturbed in the BACHD rat, and is worth investigating further. From the results we have gath-
ered so far, these impairments appear to show an early onset [18], without any clear progres-
sion with age. All together, the results suggest that BACHD rats might suffer from a range of
different motor impairments, which become apparent and progress differently throughout
their disease development. However, the influence that possible confounding factors (such as
repeated exposure to the stressful rotarod test and the BACHD rats’ changed physiology) have
had on these motor impairments has not been investigated. Thus, additional work is needed
before conclusions on the overall picture of the BACHD rats’ motor impairments can be
drawn.
Assessing BACHD rats’ performance in food-based tests
One of the overarching aims of our research is to investigate the presence of cognitive impair-
ments in the BACHD rat. A large concern when considering this has been the BACHD rats’
metabolic phenotypes and the possibility that these could confound the readouts of a given
behavioral protocol. Although it remains unclear if the obesity phenotype is the main cause of
the BACHD rats’ reduced motivation to perform the progressive ratio test, the consistent dif-
ference in motivation is of importance when considering other behavioral protocols. Notably,
differences in motivation have been found to result in remarkable differences in behavior [20].
In our initial publication [18], we argued that the alternative food restriction protocol consti-
tutes a good approach to achieve an experimental setting where WT and BACHD rats are
comparably motivated to perform a given food-reinforced behavioral test. Although the cur-
rent results also largely argue for that, the use of the alternative food restriction protocol can
no longer be fully supported. This is primarily due to the fact that it is based on matching the
rats’ food consumption rates, with the assumption that this represents a good measurement of
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hunger. As noted, the exact nature of the BACHD rats’ reduced food consumption rates is not
clear, and it might be influenced by non-hunger related feeding impairments. However, the
standard food restriction protocol clearly results inWT and BACHD rats having different met-
abolic characteristics, and would likely result in them being differently interested in perform-
ing a given food-reinforced test. As neither protocol is optimal on its own, we suggest that any
behavioral characterization performed with BACHD rats in food-reinforced tests should
include appropriate control tests. These should aim at investigating how the readouts of the
given test are affected by changes in motivation. If phenotypes are found in parameters that
are sensitive to changes in motivation, interpretations should be made carefully.
Another option is to use cognitive tests that do not rely on food reinforcements. Specifi-
cally, tests that make use of larger maze setups frequently use the possibility of returning to the
home cage as an incentive for rats to perform the given task. Such a protocol has previously
been used for evaluating reversal learning in BACHD rats [62] (the authors specifically argued
that avoiding food restriction would be preferable when considering the difference in ad libi-
tum food consumption first described in [17]). Still, this should also be done with some cau-
tion, as BACHD rats have repeatedly been found to show reduced anxiety in a test of
exploration behavior [17,49]. Such a phenotype might under some circumstances result in
them having a reduced interest in returning to their home cage compared to WT rats. Thus,
further investigation of the use of this kind of reinforcement should also be made before con-
sidering it a better alternative.
Conclusions and final remarks
The current study does not offer any final conclusions regarding the reduced motivation and
food consumption rate found among male BACHD rats. It does, however, support the results
of our initial study [18], indicating that BACHD rats are likely to be less motivated thanWT
rats to perform food-reinforced tasks when standard food restriction protocols are used.
In addition, detailed analysis of progressive ratio performance revealed that BACHD rats
were reliably slower at retrieving the reward pellets, and had an increased tendency to perform
excessive lever pushes. Both phenotypes appeared to be unrelated to their lower motivation,
and might be indicators of striatal dysfunction.
We further found clear indications that male BACHD rats are slower thanWT rats in con-
suming single pieces of standard rodent chow, suggesting a non hunger-related feeding
impairment reminiscent of eating problems in HD patients. Because of this, we no longer con-
sider it advisable to use the standard food consumption test as a test of hunger when working
with BACHD rats.
As the presence of motivational differences betweenWT and BACHD rats is a possible con-
founding factor when working with food-based tests, and as the alternative food restriction
protocol is not necessarily better than the standard restriction protocol, we suggest that any
work with BACHD rats and food-reinforced tests should include appropriate control tests.
Supporting information
S1 Fig. Pushes on the non-reinforced lever during the progressive ratio test. Age progres-
sion of the number of pushes on the non-reinforced lever during the progressive ratio test per-
formed with Group I is shown. (A) shows performance during the standard food restriction
protocol, while (B) shows performance during the alternative food restriction protocol. The
graphs indicate group mean plus standard error. Repeated two-way ANOVA results are dis-
played in each graph, and results from post-hoc analysis are shown for individual data points
in case significant genotype differences were detected. (P< 0.05) , (P< 0.01)  and
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S2 Fig. FR5 phase of the progressive ratio test on standard and alternative food restriction.
Group I’s performance during the FR5 phase of the progressive ratio test, during both food
restriction protocols, is shown. Data was created based on the overall performance on all test
ages, as no consistent change with age was found for the parameters. Detailed information on
how the different parameters were measured is given in the Material and Methods section. (A)
indicates the performance of individual rats and group mean. Significant results fromMann-
Whitney test are shown inside the graphs. (B)–(D) show group mean plus standard error.
Repeated two-way ANOVA results are displayed inside the graphs, and results from post-hoc
analysis are shown for individual data points in case significant genotype differences were
detected. (P< 0.05) , (P< 0.01)  and (P< 0.001) .
(TIFF)
S3 Fig. The effect of food restriction on break point 600. The graphs show comparisons of
the number of ratios completed at break point 600 for Group I during their progressive ratio
baselines at satiety and the standard food restriction protocol. (A) shows data from the tests
performed at 12–14 months of age. (B) shows data from the tests performed at 17–19 months
of age. The curves indicate group mean plus standard error, repeated two-way ANOVA results
are displayed inside the graphs, and results from post-hoc analysis are shown for individual
data points in case significant genotype differences were found. (P< 0.05) , (P< 0.01)  and
(P< 0.001) .
(TIFF)
S4 Fig. Performance in the standard food consumption test using different food place-
ments.When Group II was maintained on the standard food restriction protocol, one session
of the standard food consumption test was run with the food placed inside of the cage (on the
cage floor) instead of in the food crib. Data from this session is compared to the performance
baseline of the standard food consumption test. The curve indicates group mean plus standard
error, repeated two-way ANOVA results are displayed inside the graph. Post-hoc analysis did
not reveal significant genotype differences. (P< 0.05) , (P< 0.01)  and (P< 0.001) .
(TIFF)
S5 Fig. Effect of the change in food restriction protocol on the behavior in the standard
food consumption test (part I). The graphs show the change in Group II’s behavior in the
standard food consumption test, when the food restriction protocol was changed from the
standard to the alternative approach. Graphs indicate group mean plus standard error. (A) dis-
plays results from repeated two-way ANOVA inside the graph and post-hoc analysis at data
points where performance between the genotypes differed significantly. (B)–(G) concern the
total amount of time spent on the different scored behaviors, and show significant results from
t-test or Mann-Whitney test for single comparisons between the genotypes on either restric-
tion protocol (see also Figs 10B and 11B). (P< 0.05) , (P< 0.01)  and (P< 0.001) .
(TIFF)
S6 Fig. Effect of the change in food restriction protocol on the behavior in the standard
food consumption test (part II). The graphs show the change in Group II’s behavior in the
standard food consumption test, when the food restriction protocol was changed from the
standard to the alternative approach. Graphs indicate group mean plus standard error. The
graphs concern details regarding the number of behavioral episodes, their mean duration, fre-
quency and initiation latency of the different scored behaviors. Significant results from t-test
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or Mann-Whitney test for single comparisons between the genotypes on either restriction
protocol are shown (see also Figs 10C–10E and 11C–11E). (P< 0.05) , (P< 0.01)  and
(P< 0.001) .
(TIFF)
S7 Fig. Video scoring of individual food consumption test baseline during alternative food
restriction protocol. Group II’s mean performance on session 5–7 of the individual food con-
sumption test during the alternative food restriction protocol was subjected to detailed video
analysis in order to investigate baseline behavior. (A)–(D) and (F) indicate the performance of
individual rats. Significant results from t-test or Mann-Whitney test are shown in case signifi-
cant genotype differences were found. (E), (G), (H) and (I) show frequency distribution curves
for biting and chewing episodes of different durations, indicating group mean plus standard
error. The bins used are described in detail in the Material and Methods section. Note that the
x-axis in (G) and (I) only labels every other bin. Results from repeated two-way ANOVA are
displayed inside the graphs. (P< 0.05) , (P< 0.01)  and (P< 0.001) .
(TIFF)
S8 Fig. Further analysis of the performance difference found in the individual food con-
sumption test. Group II’s performance on session 5–7 of the individual food consumption
test during the alternative food restriction protocol was subjected to detailed video analysis in
order to investigate baseline behavior. As the initial analysis of these sessions (see S7 Fig) did
not clearly reveal the same phenotypes as found in the first session (see Fig 14), additional
parameters were analyzed. These particularly concerned the total time spent biting (B) and
chewing (C) the food, as well as the frequency distribution of chewing episodes of different
durations, using different bins (E) (compare to Fig 14E, 14I and S7E, S7I Fig). Graphs indicate
the performance of individual rats and group mean. Significant results from t-test or Mann-
Whitney test are shown. (P< 0.05) , (P< 0.01)  and (P< 0.001) .
(TIFF)
S9 Fig. Head size phenotype and its influence on the individual food consumption test.
The head size of the rats in Group II was measured at the endpoint of the study, and a brief
analysis was made to evaluate if this parameter had any strong influence on the rats’ perfor-
mance. For this, the food consumption of a subgroup of rats with comparable head size was
investigated. As noted in previous studies [18], BACHD rats were found to have smaller heads
thanWT rats (A). (B) displays the comparable head sizes in the subgroup used for further anal-
yses. (C) displays the mean food consumption rates of both the full groups and the subgroups
with comparable head sizes (see also Fig 12). (D) shows the mean food consumption rate dur-
ing baseline performance for the subgroup. (A), (B) and (D) indicate data from individual rats.
(C) indicates group mean plus standard error. For (A), (B) and (D), significant results from t-
test or Mann-Whitney test are shown. (P< 0.05) , (P< 0.01)  and (P< 0.001) .
(TIFF)
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   Publication	  II	  Supplementary	  Figures	  	  	  	  	  S1	  Fig.	  Pushes	  on	  the	  non-­‐reinforced	  lever	  during	  the	  progressive	  ratio	  test.	  	  Age	  progression	  of	   the	  number	  of	   pushes	   on	   the	  non-­‐reinforced	   lever	  during	   the	  progressive	   ratio	   test	  performed	  with	  Group	  I	  is	  shown.	  (A)	  shows	  performance	  during	  the	  standard	  food	  restriction	  protocol,	  while	  (B)	  shows	  performance	  during	  the	  alternative	  food	  restriction	  protocol.	  The	  graphs	  indicate	  group	  mean	  plus	  standard	  error.	  Repeated	  two-­‐way	  ANOVA	  results	  are	  displayed	  in	  each	  graph,	  and	  results	  from	  
post-­‐hoc	   analysis	   are	   shown	   for	   individual	   data	   points	   in	   case	   significant	   genotype	   differences	   were	  detected.	  (P	  <	  0.05)	  *,	  (P	  <	  0.01)	  **	  and	  (P	  <	  0.001)	  ***.	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   Publication	  II	  Supplementary	  Figures	  	  	  	  S2	  Fig.	  FR5	  phase	  of	  the	  progressive	  ratio	  test	  on	  standard	  and	  alternative	  food	  restriction	  Group	   I’s	   performance	   during	   the	   FR5	   phase	   of	   the	   progressive	   ratio	   test,	   during	   both	   food	   restriction	  protocols,	  is	  shown.	  Data	  was	  created	  based	  on	  the	  overall	  performance	  on	  all	  test	  ages,	  as	  no	  consistent	  change	  with	   age	  was	   found	   for	   the	   parameters.	   Detailed	   information	   on	   how	   the	   different	   parameters	  were	  measured	  is	  given	  in	  the	  Material	  and	  Methods	  section.	  (A)	  indicates	  the	  performance	  of	  individual	  rats	  and	  group	  mean.	  Significant	  results	  from	  Mann-­‐Whitney	  test	  are	  shown	  inside	  the	  graphs.	  (B)	  –	  (D)	  show	  group	  mean	  plus	  standard	  error.	  Repeated	  two-­‐way	  ANOVA	  results	  are	  displayed	  inside	  the	  graphs,	  and	   results	   from	   post-­‐hoc	   analysis	   are	   shown	   for	   individual	   data	   points	   in	   case	   significant	   genotype	  differences	  were	  detected.	  (P	  <	  0.05)	  *,	  (P	  <	  0.01)	  **	  and	  (P	  <	  0.001)	  ***.	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   Publication	  II	  Supplementary	  Figures	  	  	  	  	  S3	  Fig.	  The	  effect	  of	  food	  restriction	  on	  break	  point	  600	  	  The	  graphs	  show	  comparisons	  of	   the	  number	  of	  ratios	  completed	  at	  break	  point	  600	  for	  Group	  I	  during	  their	  progressive	  ratio	  baselines	  at	  satiety	  and	  the	  standard	  food	  restriction	  protocol.	  (A)	  shows	  data	  from	  the	  tests	  performed	  at	  12–14	  months	  of	  age.	  (B)	  shows	  data	  from	  the	  tests	  performed	  at	  17–19	  months	  of	  age.	  The	  curves	  indicate	  group	  mean	  plus	  standard	  error,	  repeated	  two-­‐way	  ANOVA	  results	  are	  displayed	  inside	   the	   graphs,	   and	   results	   from	   post-­‐hoc	   analysis	   are	   shown	   for	   individual	   data	   points	   in	   case	  significant	  genotype	  differences	  were	  found.	  	  (P	  <	  0.05)	  *,	  (P	  <	  0.01)	  **	  and	  (P	  <	  0.001)	  ***.	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   Publication	  II	  Supplementary	  Figures	  	  	  	  	  S4	  Fig.	  Performance	  in	  the	  standard	  food	  consumption	  test	  using	  different	  food	  placements	  When	  Group	  II	  was	  maintained	  on	  the	  standard	  food	  restriction	  protocol,	  one	  session	  of	  the	  standard	  food	  consumption	  test	  was	  run	  with	  the	  food	  placed	  inside	  of	  the	  cage	  (on	  the	  cage	  floor)	  instead	  of	  in	  the	  food	  crib.	  Data	   from	  this	  session	   is	  compared	  to	   the	  performance	  baseline	  of	   the	  standard	   food	  consumption	  test.	  The	  curve	  indicates	  group	  mean	  plus	  standard	  error,	  repeated	  two-­‐way	  ANOVA	  results	  are	  displayed	  inside	  the	  graph.	  Post-­‐hoc	  analysis	  did	  not	  reveal	  significant	  genotype	  differences.	  (P	  <	  0.05)	  *,	  (P	  <	  0.01)	  **	  and	  (P	  <	  0.001)	  ***.	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Standardrestriction Alternativerestriction020406080100120Total time (% of session duration) Food-oriented behavior***WTBACHD Standardrestriction Alternativerestriction0102030Total time (% of session duration) General food crib attention**WTBACHD
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   Publication	  II	  Supplementary	  Figures	  	  	  	  S5	   Fig.	   Effect	   of	   the	   change	   in	   food	   restriction	   protocol	   on	   the	   behavior	   in	   the	   standard	   food	  consumption	  test	  (part	  I)	  	  The	  graphs	  show	  the	  change	  in	  Group	  II’s	  behavior	  in	  the	  standard	  food	  consumption	  test,	  when	  the	  food	  restriction	  protocol	  was	   changed	   from	   the	   standard	   to	   the	   alternative	   approach.	  Graphs	   indicate	   group	  mean	  plus	  standard	  error.	  (A)	  displays	  results	  from	  repeated	  two-­‐way	  ANOVA	  inside	  the	  graph	  and	  post-­‐
hoc	   analysis	   at	   data	   points	   where	   performance	   between	   the	   genotypes	   differed	   significantly.	   (B)	   –	   (G)	  concern	   the	   total	   amount	   of	   time	   spent	   on	   the	   different	   scored	   behaviors,	   and	   show	   significant	   results	  from	   t-­‐test	   or	   Mann-­‐Whitney	   test	   for	   single	   comparisons	   between	   the	   genotypes	   on	   either	   restriction	  protocol	  (see	  also	  Figs	  10B	  and	  11B).	  (P	  <	  0.05)	  *,	  (P	  <	  0.01)	  **	  and	  (P	  <	  0.001)	  ***.	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   Publication	  II	  Supplementary	  Figures	  	  	  	  S6	   Fig.	   Effect	   of	   the	   change	   in	   food	   restriction	   protocol	   on	   the	   behavior	   in	   the	   standard	   food	  consumption	  test	  (part	  II)	  The	  graphs	  show	  the	  change	  in	  Group	  II’s	  behavior	  in	  the	  standard	  food	  consumption	  test,	  when	  the	  food	  restriction	  protocol	  was	   changed	   from	   the	   standard	   to	   the	   alternative	   approach.	  Graphs	   indicate	   group	  mean	  plus	  standard	  error.	  The	  graphs	  concern	  details	  regarding	  the	  number	  of	  behavioral	  episodes,	  their	  mean	  duration,	  frequency	  and	  initiation	  latency	  of	  the	  different	  scored	  behaviors.	  Significant	  results	  from	  
t-­‐test	  or	  Mann-­‐Whitney	  test	  for	  single	  comparisons	  between	  the	  genotypes	  on	  either	  restriction	  protocol	  are	  shown	  (see	  also	  Figs	  10C-­‐E	  and	  11C-­‐E).	  (P	  <	  0.05)	  *,	  (P	  <	  0.01)	  **	  and	  (P	  <	  0.001)	  ***.	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   WT BACHD0100200300400500(s) Pellet consumption time*WT BACHD0.00.51.01.5(s) Mean biting episode durationWT BACHD0123(s) Mean chewing episode duration
WT BACHD050100150200Bites Number of bites
0.0 - 0.20.2 - 0.40.4 - 0.60.6 - 0.80.8 - 1.01.0 - 1.21.2 - 1.41.4 - 1.61.6 - 1.81.8 - 2.02.0 - 2.22.2 - 2.42.4 - 2.62.6 - 2.82.8 - 3.0 > 3.00510152025 Duration (s)Number of episodes Biting duration distribution Genotype: nsDuration: *** Interaction: **WTBACHD
0.0 - 0.20.4 - 0.60.8 - 1.01.2 - 1.41.6 - 1.82.0 - 2.22.4 - 2.62.8 - 3.03.2 - 3.43.6 - 3.84.0 - 4.24.4 - 4.64.8 - 5.08.0 - 11.014.0 - 17.0051015 Duration (s)Number of episodes Chewing duration distribution Genotype: nsDuration: *** Interaction: nsWTBACHD
WT BACHD020406080100(mg) Estimated bite size
0.0 - 0.20.2 - 0.40.4 - 0.60.6 - 0.80.8 - 1.01.0 - 1.21.2 - 1.41.4 - 1.61.6 - 1.81.8 - 2.02.0 - 2.22.2 - 2.42.4 - 2.62.6 - 2.82.8 - 3.0> 3.0010203040 Duration (s)Percentage of episodes Relative biting duration distributionGenotype: ** Duration: ***Interaction: ***WTBACHD 0.0 - 0.20.4 - 0.60.8 - 1.01.2 - 1.41.6 - 1.82.0 - 2.22.4 - 2.62.8 - 3.03.2 - 3.43.6 - 3.84.0 - 4.24.4 - 4.64.8 - 5.08.0 - 11.014.0 - 17.0051015 Duration (s)Percentage of episodes Relative chewing duration distributionGenotype: ns Duration: *** Interaction: nsWTBACHD
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   Publication	  II	  Supplementary	  Figures	  	  	  	  	  S7	   Fig.	   Video	   scoring	   of	   individual	   food	   consumption	   test	   baseline	   during	   alternative	   food	  restriction	  protocol.	  	  Group	   II’s	   mean	   performance	   on	   session	   5–7	   of	   the	   individual	   food	   consumption	   test	   during	   the	  alternative	   food	   restriction	   protocol	   was	   subjected	   to	   detailed	   video	   analysis	   in	   order	   to	   investigate	  baseline	  behavior.	  (A)	  –	  (D)	  and	  (F)	  indicate	  the	  performance	  of	  individual	  rats.	  Significant	  results	  from	  t-­‐test	  or	  Mann-­‐Whitney	  test	  are	  shown	  in	  case	  significant	  genotype	  differences	  were	  found.	  (E),	  (G),	  (H)	  and	  (I)	  show	  frequency	  distribution	  curves	  for	  biting	  and	  chewing	  episodes	  of	  different	  durations,	   indicating	  group	   mean	   plus	   standard	   error.	   The	   bins	   used	   are	   described	   in	   detail	   in	   the	   Material	   and	   Methods	  section.	  Note	   that	   the	   x-­‐axis	   in	   (G)	   and	   (I)	   only	   labels	   every	   other	   bin.	   Results	   from	   repeated	   two-­‐way	  ANOVA	  are	  displayed	  inside	  the	  graphs.	  (P	  <	  0.05)	  *,	  (P	  <	  0.01)	  **	  and	  (P	  <	  0.001)	  ***.	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   Publication	  II	  Supplementary	  Figures	  	  	  	  S8	  Fig.	  Further	  analysis	  of	   the	  performance	  difference	   found	   in	   the	   individual	   food	  consumption	  test	  	  	  Group	  II’s	  performance	  on	  session	  5–7	  of	  the	  individual	  food	  consumption	  test	  during	  the	  alternative	  food	  restriction	  protocol	  was	  subjected	  to	  detailed	  video	  analysis	  in	  order	  to	  investigate	  baseline	  behavior.	  As	  the	  initial	  analysis	  of	  these	  sessions	  (see	  S7	  Fig)	  did	  not	  clearly	  reveal	  the	  same	  phenotypes	  as	  found	  in	  the	  first	   session	   (see	   Fig	   14),	   additional	   parameters	  were	   analyzed.	   These	   particularly	   concerned	   the	   total	  time	  spent	  biting	  (B)	  and	  chewing	  (C)	  the	  food,	  as	  well	  as	  the	  frequency	  distribution	  of	  chewing	  episodes	  of	  different	  durations,	  using	  different	  bins	   (E)	   (compare	   to	  Fig	  14E,I	  and	  S7E,I	  Fig).	  Graphs	   indicate	   the	  performance	  of	  individual	  rats	  and	  group	  mean.	  Significant	  results	  from	  t-­‐test	  or	  Mann-­‐Whitney	  test	  are	  shown.	  (P	  <	  0.05)	  *,	  (P	  <	  0.01)	  **	  and	  (P	  <	  0.001)	  ***.	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  II	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  Figures	  	  	  	  	  S9	  Fig.	  Head	  size	  phenotype	  and	  its	  influence	  on	  the	  individual	  food	  consumption	  test	  The	  head	  size	  of	  the	  rats	  in	  Group	  II	  was	  measured	  at	  the	  endpoint	  of	  the	  study,	  and	  a	  brief	  analysis	  was	  made	  to	  evaluate	   if	   this	  parameter	  had	  any	  strong	  influence	  on	  the	  rats'	  performance.	  For	  this,	   the	  food	  consumption	   of	   a	   subgroup	   of	   rats	   with	   comparable	   head	   size	   was	   investigated.	   As	   noted	   in	   previous	  studies	  [18],	  BACHD	  rats	  were	  found	  to	  have	  smaller	  heads	  than	  WT	  rats	  (A).	  (B)	  displays	  the	  comparable	  head	   sizes	   in	   the	   subgroup	  used	   for	   further	   analyses.	   (C)	   displays	   the	  mean	   food	   consumption	   rates	   of	  both	  the	  full	  groups	  and	  the	  subgroups	  with	  comparable	  head	  sizes	  (see	  also	  Fig	  12).	  (D)	  shows	  the	  mean	  food	  consumption	  rate	  during	  baseline	  performance	  for	  the	  subgroup.	  (A),	  (B)	  and	  (D)	  indicate	  data	  from	  individual	  rats.	  (C)	  indicates	  group	  mean	  plus	  standard	  error.	  For	  (A),	  (B)	  and	  (D),	  significant	  results	  from	  
t-­‐test	  or	  Mann-­‐Whitney	  test	  are	  shown.	  (P	  <	  0.05)	  *,	  (P	  <	  0.01)	  **	  and	  (P	  <	  0.001)	  ***.	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Abstract
The BACHD rat is a recently developed transgenic animal model of Huntington disease, a
progressive neurodegenerative disorder characterized by extensive loss of striatal neurons.
Cognitive impairments are common among patients, and characterization of similar deficits
in animal models of the disease is therefore of interest. The present study assessed the
BACHD rats’ performance in the delayed alternation and the delayed non-matching to posi-
tion test, two Skinner box-based tests of short-term memory function. The transgenic rats
showed impaired performance in both tests, indicating general problems with handling basic
aspects of the tests, while short-term memory appeared to be intact. Similar phenotypes
have been found in rats with fronto-striatal lesions, suggesting that Huntington disease-
related neuropathology might be present in the BACHD rats. Further analyses indicated that
the performance deficit in the delayed alternation test might be due to impaired inhibitory
control, which has also been implicated in Huntington disease patients. The study ultimately
suggests that the BACHD rats might suffer from neuropathology and cognitive impairments
reminiscent of those of Huntington disease patients.
Introduction
Huntington disease (HD) is an autosomal hereditary neurodegenerative disease, which is
caused by a specific mutation in the gene for the huntingtin protein [1,2]. The gene contains a
CAG repeat sequence in its first exon, which codes for a stretch of glutamines that is present in
the translated protein. Patients who carry an allele with a CAG repeat sequence that is 40
repeats or longer invariably develop HD. As the disease manifests and progresses there is
extensive neuronal loss throughout the brain. This is first evident in the caudate nucleus of the
striatum, although it eventually affects most brain regions. This result in a wide range of
clinical signs that are commonly grouped into motor, psychiatric, cognitive and metabolic
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symptoms. There are currently no disease-modifying treatments available for HD, and the dis-
ease is invariably fatal.
HD patients have been found to suffer from a range of different cognitive impairments [3–
14]. Among these there are frequent findings indicating impaired executive function [10–14],
which is commonly considered to be dependent on specific regions of the prefrontal cortex
and their connections to various subcortical nuclei [15–18]. In line with this, some of the exec-
utive function impairments seen in HD appear to be related to fronto-striatal pathology [19–
22]. Due to the single disease-causing gene of HD, there are several relevant transgenic animal
models of the disease. Our group works primarily with the BACHD rat, a recently developed
model that is currently being characterized in order to understand its advantages and disad-
vantages concerning modeling of HD. In the current study, we investigated the rats’ perfor-
mance in two operant conditioning protocols called the delayed alternation and the delayed
non-matching to position tests. Both are frequently used for assessing short-term memory in
rodents, and commonly utilize operant conditioning chambers equipped with two retractable
levers [23–29]. In the alternation test, the rats have to learn to alternate their responses
between the two levers, when these are presented on discrete trials. In the non-matching test,
trials are divided into two parts. During the first part, the rats are presented with one randomly
chosen sample lever. During the second part, the rats are presented with both levers and
should respond to the lever that was not presented as a sample. Successful performance in
either protocol is rewarded with small food pellets. In order to evaluate the rats’ short-term
memory, delays are introduced in the protocols to evaluate how long the rats remember which
lever to respond to. As successful performance in both the delayed alternation and the delayed
non-matching to position test is sensitive to various lesions of prefrontal and striatal brain
regions [23–29], they offer a good set of tests to evaluate the presence of HD-related pathology
in the BACHD rats.
Materials and Methods
Animals
A total of 48 male rats were used for the study. These were acquired from two separate in-
house breeding events with hemizygous BACHDmales from the TG5 line [30] paired with
WT females (Charles River, Germany). All animals were on Sprague-Dawley background.
Animals were genotyped according to previously published protocols [30] and housed in
genotype-matched groups of three in type IV cages (38×55 cm), with high lids (24.5 cm from
cage floor). During tests, rats were food restricted according to the two protocols described
below. During both protocols, each cage was given a specific daily amount of food (SNIFF
V1534-000 standard chow) to maintain appropriate restriction levels. Rats had free access to
food between the tests. Rats had free access to water through the entire study. During tests,
body weight was measured daily to track the rats’ relative food restriction level and assess basic
health. Between tests, body weight was measured weekly.
The animal facility kept 21–23˚C, 55–10% humidity, and was set to a partially inverted
light/dark cycle with lights on/off at 02:00/14:00 during summer, and 01:00/13:00 during
winter.
Two groups of 24 rats were formed from the total of 48. The birth dates of the rats in these
two groups were spaced roughly two months apart. Each group was composed of 12 WT and
12 BACHD rats. One group was used for a longitudinal study of performance on the delayed
alternation protocol, while the other one was used for a longitudinal study of performance
on the delayed non-matching to position protocol. The groups were run in an alternating fash-
ion so that the testing ages were the same for both groups. Behavioral evaluation was thus
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performed at 4, 9, 14 and 19 months of age. It should, however, be noted that training was ini-
tiated approximately two months before the set ages, as the rats had to progress through several
steps before reaching the final test protocols. Thus, the actual test ages were 2–4, 7–9, 12–14
and 17–19 months of age.
During the late test ages, several rats had to be sacrificed due to illnesses (the exact number
of rats is specified in the Results section). Decision to sacrifice was always made together with
the local veterinarians, after careful examination of the rat. End points considered unidentified
illnesses causing weight loss past 80% of free-feeding body weight, or critically reduced welfare
according to commonly used indicators (i.e. tumorous swellings that clearly impaired the rats’
ability to eat, move and clean themselves, labored breathing, poor grooming, lethargy, dis-
turbed gait, sensitivity to handling or reduced appetite). In such cases, these rats were eutha-
nized in a CO2 inhalation chamber. No other methods were used to alleviate suffering.
All tests were approved by the local ethics committee (Regierungspraesidium Tuebingen)
and carried out in accordance with the German Animal Welfare Act and the guidelines of the
Federation of European Laboratory Animal Science Associations, based on European Union
legislation (Directive 2010/63/EU).
Food restriction protocols
Two different food restriction protocols were used during the study. The first one focused on
restricting the animals to a specific relative body weight. During this, both BACHD andWT
rats were restricted until they reached 85% of their respective free-feeding body weight. This
relative body weight, or food restriction level, was calculated using previously gathered data
from growth curves of free-feeding BACHD andWT rats. Thus, the calculations of restriction
levels were made with gender, age and genotype-matched values and took normal growth into
account. This protocol was used as the start point at all test ages and will be referred to as the
standard food restriction protocol.
We have previously found that male BACHD rats are obese, but have comparable body
weights to WT rats [31]. Interestingly, the transgenic rats still reliably consume less food than
their WT littermates [30,31]. It is currently unclear to what extent these phenotypes affect the
BACHD rats’ motivation to perform food-oriented tasks in general, although it has been
shown that they are less motivated thanWT rats to perform a progressive ratio task (a classical
test of motivation) when standard food restriction protocols are used [31]. Because of this, we
sought to evaluate the impact of motivation on the readouts from the protocols used in the
current study. Thus, once data from performance during the standard food restriction proto-
col had been gathered, the restriction protocol was changed to an alternative protocol. During
this, the amount of food given to WT rats was increased so that they reached 95% of their free-
feeding weight rather than the previous 85%. When they had reached the new restriction level,
data for a second baseline was gathered. BACHD rats were during this given continuous train-
ing (but were kept at 85% of their free-feeding body weights) to validate that any effects seen in
the WT rats were indeed due to the change in food restriction level.
It should be noted that it was rarely possible to give the exact same amount of food to either
of the genotypes during extended periods of time, as both the standard and alternative restric-
tion protocol had to take natural growth into account. We have, however, found that these
smaller adjustments have little impact on the rats’ performance.
Operant conditioning setup
A bank of six operant conditioning boxes (Coulbourn Instruments, H10-11R-TC) was used to
run the test. Each chamber was equipped with two retractable levers, one on either side of a
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central pellet delivery trough that was equipped with a yellow light. This light was used to sig-
nal the delivery of a reward pellet during the protocols. Above each lever was a single white
cue light. The boxes further contained a red house light on the wall opposite from the levers
and pellet delivery trough, which shone during the full duration of the training sessions. A
water bottle was also available on this wall to ensure ad libitum access to water during testing.
The protocols were designed and run with Graphic State 4.1.04. Rats were given single daily
sessions, meaning that a total of four daily runs with all six operant chambers were needed to
assess a full group. Each run assessed three WT and three BACHD rats in a determined order
so that a given rat was trained on the same time of day through all tests. Each rat was assigned
to a specific operant chamber, although this was arranged so that each operant chamber was
used to assess equal numbers of WT and BACHD rats.
Behavioral assessment started approximately six hours after dark phase onset, in a room
separate from the animals’ housing room, using soft red light. Rats received their daily amount
of regular food one hour after the completion of the last run of the day.
Operant conditioning protocols
At each test age, the rats were first put on food restriction for approximately 14 days before
any training occurred. This aimed at restricting both WT and BACHD rats to 85% of their
respective free-feeding body weights, as described above. During the first test age, this step was
also used to familiarize the rats with the reward pellets that were used in the operant condition-
ing boxes. This was done by adding a spoonful of reward pellets (Bio-serv, Dustless Precision
Pellets1 F0021, purchased through Bilaney Consultants, Duesseldorf, Germany) to the daily
amount of food given to each cage. It was not necessary to repeat this when the rats were reas-
sessed at older ages.
Before reaching the final operant conditioning protocols of interest, the rats had to be
trained in a series of separate protocols. The first protocols aimed at habituating the rats to the
operant conditioning boxes, and at training them to reliably respond to the levers. These first
steps were similar for the two rat groups and were only run during the first test age. The spe-
cific protocols are described below.
Habituation. All rats were given two habituation sessions in order for them to familiarize
themselves to the operant conditioning boxes and the pellet trough where food rewards could
be retrieved. During these sessions, both levers were retracted and a single reward pellet was
delivered to the pellet trough at 10-, 15-, 20-, 25-, or 30-second intervals. The pellet delivery
interval varied in a pseudo-randomized fashion so that each set of five deliveries used each
interval once. Pellet retrieval, or failure to retrieve the pellet within five seconds after delivery,
lead to the start of the next pellet delivery interval. Pellet deliveries were signaled by the light in
the pellet trough being switched on. The light was switched off when the pellet was retrieved,
or when five seconds had passed and the next interval started. Sessions lasted until 100 pellets
had been delivered, which took roughly 30 minutes.
Continuous reinforcement (CRF) with help. The aim of these sessions was to train the
rats to reliably perform lever pushes to obtain reward pellets. During the sessions one of the
two levers was inserted into the box and remained inserted until the end of the session. Each
lever push resulted in the delivery of a single reward pellet. At the start of the session, the lever
was baited with a paste made by mashing some reward pellets in water. The experimenter then
manually delivered rewards when the rats approached, sniffed and touched the inserted lever.
Through this, the rats eventually performed a few accidental responses and soon developed a
reliable lever-pushing behavior. Sessions ended either after 30 minutes had passed or after 100
pellets had been delivered. Training continued until the rats had managed to perform 100
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pushes within one session without any help from the experimenter. Training was organized so
that half of the rats from each genotype group were trained on the right lever, while the other
half was trained on the left lever.
CRF on the second lever. Once the rats had passed the criterion for CRF performance on
the first lever, the same training was done for the second lever. Thus, the lever the rats were ini-
tially trained on was retracted, while the other lever was inserted. The new lever was also baited
at the start of the trial, but the experimenter only manually delivered reward pellets if rats had
clear problems understanding what to do. Session durations and criteria were the same as dur-
ing the initial CRF training.
Forced alternation and non-matching to position sequence training. At this point, the
rats of the two groups were trained on slightly different protocols. Both protocols aimed at
training the rats to reliably start the individual trials that made up the delayed alternation and
delayed non-matching to position sessions. In addition, the protocols sought to familiarize the
rats with the main concept of the tasks they were going to perform (i.e. alternation and non-
matching to position).
The rats in the delayed alternation group were trained on a forced alternation protocol. For
this protocol, each session was split into a series of trials, separated by brief (2 s) inter-trial
intervals (ITIs). The sessions started with an ITI step, with both levers retracted, the house
light switched on and all cue lights off. At the end of the ITI the light in the pellet trough would
start to shine. When the rats entered the pellet trough with their head, the light was switched
off and either the left or right lever was inserted. The lever remained inserted until the rats per-
formed a response. The lever retracted and a reward pellet was delivered at the off signal of a
lever response. Delivery of a reward pellet was signaled with the light in the pellet trough shin-
ing once again. The trial ended either when the rats collected the reward pellet or when five
seconds had passed since the reward pellet had been delivered. Either event triggered the start
of a new ITI. On the first trial of the session, the protocol was set to randomly insert either the
left or the right lever. On all subsequent trials, the inserted lever would be on the opposite side
of the lever used during the previous trial. Through this, the rats were forced to alternate their
responses between the left and right lever. The sessions lasted either until the rats had com-
pleted 100 trials or until 45 minutes had passed. Rats were trained until they completed 100 tri-
als within the session duration limit without any help from the experimenter.
The rats in the delayed non-matching to position group were trained on a non-matching to
position sequence training protocol. The sessions of this protocol were also split into a series of
trials separated by ITIs. The duration of these ITIs varied in a pseudo-randomized fashion
between 5, 7, 9 and 11 seconds so that each block of four ITIs used each duration once. The
sessions started with an ITI step, with both levers retracted, the house light switched on and all
cue lights off. At the end of the ITI the light in the pellet trough started to shine. When the rats
entered the pellet trough with their head, the light was switched off and either the left or right
lever was inserted. The protocol followed a pseudo-randomized structure so that each block of
six trials used three trials with the left lever and three trials with the right lever. This also meant
that a given trial type (i.e. left or right lever) could maximally appear six times in a row. The
lever remained inserted until the rats performed a lever response. The lever retracted and the
food trough light started to shine again at the off signal of a lever response. Notably, no reward
pellet was given for this response. When the rats entered the pellet trough again, the pellet
trough light went out, both lever cue lights shone and the lever on the opposite side from the
first one was inserted. The lever once again stayed inserted until the rats made a response. The
lever retracted, the lever cue lights stopped shining and a reward pellet was delivered at the off
signal of a lever response. As in previous steps, the delivery of a reward pellet was signaled by
the light in the pellet trough starting to shine. The trial ended either when the rats collected the
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reward pellet, or when five seconds had passed since the reward pellet was delivered. Either
event triggered the next ITI. The sessions lasted either until rats had completed 100 trials or
until 45 minutes had passed. Rats were trained until they completed 100 trials within the ses-
sion duration limit without any help from the experimenter.
Once rats had reached the performance criterion on their respective protocols, omission
limits were added in the protocols to make sure that the rats performed the desired responses
at a proper pace. For the forced alternation protocols, these limits were set for starting a trial
and responding to the inserted levers. For the non-matching to position sequence learning, the
limits were set for the trial start, responding to the first lever, returning to the pellet trough and
responding to the second lever. On those steps, if a rat failed to perform the required response
within ten seconds, the protocol went into an omission state, in which all lights were switched
off and all levers retracted. After ten seconds the protocols went into ITIs that ensured that the
rats would be given an identical trial to the one they had just failed to complete. These proto-
cols were run until the rats performed less than 5 omissions in total, while completing 100 tri-
als within the session duration. Importantly, omitted trials were not counted towards the
100-trial limits of the sessions, as they were not considered to be completed trials.
Free alternation and non-matching to position. The next set of protocols were the first
ones where rats were able to make mistakes, and also served as the starting point when rats
were retrained at older ages. The basic structure of the protocols were similar to the forced
alternation and the non-matching to position sequence learning protocols. Thus, they used the
same basic structure concerning the start and stop of the individual trials as well as the ITI
setup described above. In addition, both protocols still ended either after 100 completed trials
or 45 minutes. As above, omitted trials did not count towards this 100-trial limit, while both
successful and failed trials did. The outlines of the two tests are shown in Figs 1 and 2.
The main difference between the forced and free alternation protocols was that both levers
were inserted during each trial of the latter protocol. On the first trial of each session, the rats
were rewarded for pushing either the left or right lever. On all subsequent trials, however, the
rats were only rewarded for pushing the lever they did not respond to on the previous trial.
Importantly, this was independent of whether the previous trial was successful or not. Thus, in
order to continuously receive rewards, the rats had to alternate their responses between the left
and right levers and avoid making repeated responses on one of the levers. A mistake resulted
in a brief timeout (3 s) during which the house light was switched off. At the end of the time-
out, the protocol returned to an ITI state, which was followed by a new trial. On occasions
where the rats performed an omission, the protocol reset to a starting position. Thus, on the
next trial the rats were rewarded for pushing either lever, and this trial set the start point for
the next series of alternations. Importantly, the first trial of the session, and trials that directly
followed omissions, were not counted towards the 100-trial limit of the session and were also
not included in the success rate calculations. Training continued until the rats showed an 85%
or higher success rate during three consecutive sessions.
The free non-matching to position test used the same two-part structure as the non-match-
ing to position sequence learning protocol. Thus, after the trial start, the rats were prompted to
push a single non-reinforced lever, which will be referred to as the sample lever. After respond-
ing to the sample lever and returning to the pellet trough, both levers were now inserted into
the box. This second part of the non-matching trials will be referred to as the choice step. Simi-
lar to the previous training step, the rats were rewarded for pushing the lever that was not pre-
sented during the sample step. Pushing the same lever as the sample lever resulted in a ten-
second timeout similar to the one described for the free alternation protocol. During the first
testing age, the rats were trained until they showed an 85% success rate or higher during three
consecutive sessions. This was, however, reduced to two consecutive sessions when the rats
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Fig 1. Delayed alternation protocol. The figure describes the steps that make up individual trials in the delayed
alternation test.
doi:10.1371/journal.pone.0169051.g001
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Fig 2. Delayed non-matching to position protocol. The figure describes the steps that make up individual trials in the delayed
non-matching to position protocol.
doi:10.1371/journal.pone.0169051.g002
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were retested, as the rats showed little problem with handling the test. Trials using the left and
right sample lever were pseudo-randomized as described above. Omissions resulted in the rats
being presented with a trial using the same sample lever again.
Delayed alternation and non-matching to position. When the rats had learned to handle
their respective basic task, delays were introduced into the protocols. The aim of this was to
assess the rats’ short-term memory function. In the alternation protocol, the delays were intro-
duced at the start of the trials, at the point when the pellet trough light started to shine. As
explained above, a head entry at that point usually triggered the continuation of the trial (i.e.
lever insertion). During the delayed alternation, however, head entries had no effect until the
end of the set delay. Once the delay was over, the first head entry resulted in the levers being
inserted. Delays were introduced in a similar manner in the non-matching to position proto-
col. Specifically, they were used during the step where the rats returned to the pellet trough
after responding to the sample lever. As described above, making the second entry into the pel-
let trough would usually result in triggering the choice step of the protocol. But during the
delayed non-matching to position protocol, head entries had no effect until the delay was over.
Similarly to the delayed alternation protocol, the first head entry performed after the end of
the delay would trigger the choice step. Through these delays, rats were thus forced to perform
responses in the two protocols with certain specific spacing in relation to either the previous
trial or their sample lever response. The omission limits that were set for trial start and initia-
tion of the choice step were applied at the end of the delays. Thus, if a rat had not performed a
head entry response within ten seconds after the end of the delay on either protocol, the trial
was aborted.
The sessions were initially made up of 100 trials and used a set of five different delays, lead-
ing to five different trial types. These were presented in a pseudo-randomized fashion so that
each block of 20 trials used each delay four times. This also meant that a given delay could be
presented a maximum of eight times in a row. If rats had performed an omission the protocols
were designed so that the rat had to rerun a trial with the same delay. The pseudo-randomiza-
tion of sample levers in the delayed non-matching to position protocol was also changed com-
pared to before. Specifically, each block of four trials used each sample lever twice. The rats
were trained on several protocols with gradually increasing delay durations. The aim of this
was to find a delay set where a clear drop in the rats’ success rate could be seen between trials
with the shortest and longest delay. For the delayed alternation protocol, the delay sets were as
follows: 0, 1, 2, 3, 4 seconds / 0, 1, 3, 6, 9 seconds / 0, 1, 4, 8, 12 seconds / 0, 2, 5, 10, 15 seconds
/ 0, 4, 8, 12, 16, 20 seconds. During the first test, the age rats progressed from one protocol to
another when they had shown above 80% success on three consecutive sessions. During retest-
ing at older ages, this criterion was reduced to rats performing above 80% success on two con-
secutive sessions. Exceptions to this performance-based criterion were the two last delay sets.
Specifically, rats were given three training sessions on the second last delay set, regardless of
their success rate. Training on the last delay set continued until rats showed a stable perfor-
mance, as defined below. The delay sets used for the delayed non-matching to position test
were: 0, 1, 2, 3, 4 seconds / 0, 1, 3, 6, 9 seconds / 0, 1, 4, 8, 12 seconds / 0, 2, 5, 10, 15 seconds /
0, 5, 10, 15, 20 seconds / 0, 5, 10, 15, 20, 25 seconds. The same criterions as described above
were used for progressing through these delay sets. Notably, the last delay set for both the
delayed alternation and the delayed non-matching to position protocol used six delays rather
than five. To accommodate this, the number of trials per session and the pseudo-randomiza-
tion were adjusted. The delayed alternation sessions were set to last 120 trials or 60 minutes.
The trials were organized so that each block of 12 trials used each delay twice. For the delayed
non-matching to position protocol, the number of trials was initially set to 96, but was reduced
to 48 for a large part of the study (all baselines except the ones for the 4 months performance
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at standard food restriction and both baselines from the 19 months test). The reason for this
was that many rats were not motivated enough to perform 96 trials and we sought to minimize
differences in possible within-session training effects. The protocol was still set so that each
block of four trials used each sample lever twice, while the delays were organized in the same
way as the delayed alternation trials. It should be noted that the pseudo-randomization limits
described above were not completely reliable. However, they functioned well enough to ensure
that rats experienced comparable numbers of each trial type on any given session (+/- 3 trials).
In addition, the baselines were constructed from performance over several consecutive ses-
sions, thus minimizing the effect that slight differences in the frequency of a given trial type
would have had on the overall performance.
As noted, the rats were trained on the final delay sets until they showed a stable perfor-
mance. When this was achieved, data from a number of consecutive sessions were used to cre-
ate the baseline data that was used for detailed analysis. At each test age this baseline data was
first gathered while the rats were maintained on the standard food restriction protocol. After-
wards, the food restriction protocol was changed. Rats of both genotypes were continuously
given daily sessions through the restriction adjustment. When the alternative food restriction
levels had been established and rats were once again performing stably, data for a second per-
formance baseline was gathered. Once the data had been gathered, the rats were once again
given free access to food and the test ended.
Both the delayed alternation and the delayed non-matching to position tests are well
described in literature [23–29,32]. Our protocols were based on the general consensus and
small optimizations of these references.
Operant conditioning protocol parameters
The operant conditioning system created individual log files for each training session and rat.
These log files were run through a series of in-house designed analysis scripts written in R, to
obtain a large set of parameters that were used for subsequent analysis.
The number of sessions required to reach the various performance criteria served as a
major parameter for evaluating how animals learned the given tasks and progressed through
the series of protocols. Success rate (i.e. the percent of trials with successful responses) was cal-
culated differently depending on the protocols used. During the free alternation and the non-
matching to position sequence learning protocols, the calculation included all completed trials
to give a single success rate value for each session. For protocols where delays were present,
separate success rates were calculated for each trial type (i.e. trials with different delays) so that
curves plotting success rate against delay durations could be created for each session. These
curves served as the main readout of the tests and were used to determine when the rats had
reached stable performance on the final delay sets. During testing, the rats’ mean performance
on each block of three consecutive sessions was calculated. When statistical analysis showed
no significant change between several consecutive session blocks, the rats were considered to
have reached stable performance. As noted, the sessions within the blocks where stable perfor-
mance was found were used for detailed analysis of baseline performance. Although the exact
number of sessions included in these analyses varied between baselines, it stayed between 9
and 12 sessions. As noted above, only completed trials (i.e. trials where the rats performed
either a correct or incorrect response) were included in success rate calculations. The number
and frequency of omission trials (trials where rats failed to perform a head entry or lever push
within the set time limit) constituted their own analysis.
The protocols offered several parameters regarding the rats’ latency to perform specific
responses. For the free alternation protocol, this primarily included the latency to start trials
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(measured from the pellet trough light being switched on to the rat entering the pellet trough,
triggering lever insertion) and the latency to respond to the inserted levers (measured from
lever insertion to lever push). The free non-matching to position protocol included similar
parameters, with trial start latency (measured from the pellet trough light being switched on,
to the rat entering the pellet trough, triggering insertion of the sample lever), latency to
respond to the sample lever (measured from lever insertion to lever push), latency to return to
the pellet trough (measured from release of sample lever to the rat entering the pellet trough,
triggering the choice step) and the latency to perform a lever response during the choice step
(as above, measured from lever insertion to lever push). When delays were added to the proto-
cols, the exact measurement made by some of these parameters were slightly modified and
additional parameters were added to ensure a comprehensive analysis of the rats’ behavior.
For the delayed non-matching to position protocol the latencies to start trials and respond to
levers were measured in the same way as during the free non-matching to position protocol.
The latency to return to the pellet trough after responding to the sample lever was, however,
replaced by the parameters for the latency to perform the first head entry of the delay (mea-
sured from release of sample lever to first entry) and the latency to trigger the choice step
(measured from the end of the delay, to the point when rats performed the entry that triggered
insertion of both levers). It is important to note that trials with 0 second delays were only
included in the latter analysis. For the delayed alternation, the lever response latency was mea-
sured in the same way as during the free alternation protocol. However, the trial start latency
was now measured from the end of the delay to the point when rats performed the entry that
triggered lever insertion. Similarly to the delayed non-matching to position protocol, a mea-
surement for the latency to perform the first head entry of the delay (measured from the pellet
trough light being switched on to the point when rats performed the first entry) was added.
The distinction of these various parameters is important to consider when comparing the per-
formance between the various protocols. Thus, the trial start latency in the free alternation,
free non-matching to position and delayed non-matching to position can be considered a mea-
surement of how fast the rats respond to the light in the pellet trough being switched on. How-
ever, in the delayed alternation protocol, this behavior is best described by the latency to
perform the first head entry of the delay rather than the trial start latency. Further, the trial
start latency of the delayed alternation protocol is closely connected to the rats’ interest in the
pellet trough during the delays, and is comparable to the latency to trigger the choice step in
the delayed non-matching to position protocol. The lever response latency in the alternation
protocols is comparable to the choice lever response latency in the non-matching to position
protocols. Finally, the latency to respond to the sample lever and perform the first entry of the
delay during the delayed non-matching to position protocol lack direct counterparts in the
delayed alternation protocols. Additional parameters were used to investigate the rats’ behav-
ior during delay steps. These measured the mean number of entries and the total time spent
inside the pellet trough during delay steps, as well as the mean duration of individual entries.
Trials with the longest delays were subjected to further analysis. Specifically, the mean number
of head entries performed during discrete segments of these delays was evaluated in order to
investigate if the rats’ interest in the pellet trough changed with time. The latency to retrieve
reward pellets was investigated for all tests. This was measured from the point of releasing the
reinforced lever to entering the pellet trough.
As with the success rate analysis, the parameters described above were only evaluated for
completed trials. For alternation protocols, the first trial of the session and the first trial follow-
ing omissions (i.e. trials where any lever response would be reinforced) were also excluded.
Analysis of free alternation and free non-matching to position performance was made over all
completed trials. In contrast, separate analysis of trials with different delay durations was
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performed for most of the parameters in the delayed alternation and delayed non-matching
protocols. Analysis was primarily made over all trials regardless of outcome, although separate
analyses for successful and failed trials were also performed.
Video scoring
As noted above, several parameters were used to evaluate the rats’ behavior during delay steps.
All these parameters used readouts from the entry sensor in the pellet trough. Interpretations
of these parameters can occasionally be difficult, as the signaled number of entries does not
always correspond to the actual number of entries. Thus, several videos were recorded during
the last test age in order to manually score their behaviors during delays. Video scoring was
performed with the Observer XT software (v.12.5.927, Noldus, The Netherlands, Wagenin-
gen). The following behaviors were scored during delays:
Time spent in pellet trough. This considered all occasions where a rat had anything from
its nose to its entire head inside the pellet trough.
Time spent in a central position. This considered all occasions where a rat had its head
inside the pellet trough. It also included all occasions where a rat was sitting in front of the pel-
let trough, keeping its head outside, while still appearing to focus on it. In addition, it included
occasions where a rat investigated the wall portion that was positioned directly above the pellet
trough.
Body shifts towards the left or right side. With quite high frequency, the rats would exit
the pellet trough to briefly investigate the wall portions to the right or left of the pellet trough,
and then return. These body shifts occurred in several different forms. Some were short, and
the rat only quickly indicated an interest to either the right or left side. Others were longer and
could include both direct investigation of the lever slots or more general investigation of the
surrounding wall area. All body shifts, regardless of duration or specific nature, were included
in the analysis. During analysis, separate scores were given for shifts to the left and right side.
All scoring focused on noting start and stop point of each occasion where a rat displayed
the above mentioned behaviors. The logs from the Observer XT software were later combined
with the log files from the operant conditioning system. These were run through in-house
designed R scripts to obtain detailed analysis. Through this, the number of behavioral episodes,
their mean duration and the total time spent on the different behaviors could be evaluated for
individual delay steps. The estimated amount of time spent investigating other parts of the
operant conditioning boxes during delays was also calculated. These calculations primarily
considered time spent investigating the back wall as well as the back halves of the left and right
wall of the operant conditioning box. The calculations were based on the total time for all
behaviors noted above and the known delay durations. The body shifts were initially scored as
being made either to the left or right side of the pellet trough, although they were later rela-
beled depending on if they were made towards the correct or incorrect lever, or if they were
made towards the lever that the rats eventually responded to. The latter was initially used to
assess whether the body shifts at all constituted a form of strategy. It was further used to evalu-
ate how rats established, maintained and shifted focus during delays. For this, the rats were
considered to have established a focus for one particular lever based on their first body shift
during a given delay step. The rats were then considered to have maintained or changed it, if
the last body shift during the delay step was made towards the same or the opposite side,
respectively. Thus, the focus behavior during each delay step was classified as having no focus
(no body shifts occurred), established focus (only one body shift occurred), maintained focus
(first and last body shifts of delay were made towards the same side) or changed focus (first
and last body shifts of delay were made towards different sides). Further scores were made to
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evaluate if the initial focus had been made towards the correct or incorrect lever. Finally, spe-
cific analysis was made for trials with the longest delay steps. For this, the relative amount of
time spent around the correct lever during segments of the delay was analyzed separately for
successful and non-successful trials. In addition to the behaviors that were scored during
delays, the rats’ behavior during lever responses was also investigated. Specifically, it was noted
if rats had responded to the chosen lever without showing any interest in the other lever (direct
responses), if the rats first headed for one lever but changed their mind and ultimately
responded to the other lever (corrections) or if the rats went back and forth between the two
levers a few times before finally deciding on one (uncertain responses). In addition to investi-
gating the frequency of the different behaviors, theoretical success rate curves were created to
assess the importance of the corrections. For this, the hypothetical results of rats responding
according to the lever they first showed interest in during correction trials was considered.
Statistical analysis
All statistical analyses were conducted using GraphPad Prism v.6.01 (GraphPad Software, San
Diego California USA, http://www.graphpad.com).
The results from most parameters were investigated with different types of two-way
repeated measures ANOVAs. Most of these were aimed at investigating genotype differences,
and thus focused on data where genotype was used as the non-repeated factor, while either
age, delay duration, type of baseline or specific protocol step served as the repeated factor. Cer-
tain analyses, however, were performed within genotype groups, and aimed at investigating
performance differences between baselines at different ages, baselines at different food restric-
tion protocols or performance on successful or failed trials. All these analyses used two-way
repeated measures ANOVAs where both delay and the other given factor were considered to
be repeated factors. This kind of ANOVA was also used when evaluating if rats had reached a
stable performance baseline. The results from video scoring the frequency of different behav-
iors during delay and lever steps of the delayed alternation and delayed non-matching tests
were analyzed with separate two-way ANOVAs for the different behaviors. As above, these
used genotype as the non-repeated factor and delay as the repeated factor. Sidak’s multiple
comparison post-hoc test was used to follow up any significant effects found in the two-way
ANOVAs. The number of sessions required to progress through the set of delayed alternation
and delayed non-matching to position protocols with gradually increasing delay durations was
analyzed in several single comparisons betweenWT and BACHD rats. For these, t-test, t-test
with Welch’s correction or Mann-Whitney test were used, depending on the data’s apparent
distribution.
During testing there were occasionally rats that fell ill and had to be sacrificed. Thus, the n
of the analyses changed as follows. For the delayed alternation group, 2–4 months (WT:12,
BACHD: 12), 4–9 months (WT: 12, BACHD: 12), 12–14 months (WT: 11, BACHD: 11) and
17–19 months (WT: 9, BACHD: 8 during standard food restriction protocol, 7 during alterna-
tive food restriction protocol). For the delayed non-matching to position group, 2–4 months
(WT:12, BACHD: 12), 4–9 months (WT: 12, BACHD: 12), 12–14 months (WT: 12, BACHD:
12) and 17–19 months (WT: 12 during standard food restriction protocol, 11 during alterna-
tive food restriction protocol, BACHD: 11). Video scored behavior concerned (WT: 9,
BACHD: 7) and (WT: 11, BACHD: 11) for the alternation and non-matching tests, respec-
tively. Age development analyses excluded data from animals that were not assessed at all ages.
No other exclusion criteria were used. As described in the Results section, there was very rarely
any clear effect of age found on the various parameters. Thus, for most baseline parameters the
analysis was performed on the mean performance of all evaluated ages to maintain an n of 12.
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Alpha for all analyses was set to 0.05.
Results
Survival
Most rats remained healthy through the entire duration of the tests, although some rats had to
be sacrificed due to illness. All in all, three WT and five BACHD rats were sacrificed from the
delayed alternation group, and one rat of each genotype was sacrificed from the delayed non-
matching to position group. In most cases, the illnesses concerned tumors. The change in n for
the different groups is described in detail in the Material and Methods section.
Basic operant conditioning protocols
There were no consistent or overt performance differences between BACHD andWT rats dur-
ing habituation, CRF training, forced alternation training or non-matching to position
sequence training (data not shown). All rats quickly progressed through their specific set of
protocols, and rarely required more than a single session per step. BACHD rats were during
CRF training occasionally found to be slower thanWT rats when returning to the reinforced
lever after retrieving a pellet reward (data not shown).
Free and delayed alternation performance
During the first three test ages, BACHD andWT rats completed comparable numbers of trials
on all of the investigated protocols described below. During the 19-month test age, BACHD
rats tended to complete fewer trials thanWT rats on the protocol with the final delay set,
although the difference did not reach statistical significance (data not shown). There were at
no point any differences concerning the ratio of completed Left-Right and Right-Left alterna-
tions between WT and BACHD rats (data not shown).
The number of sessions needed to reach criterion on the free alternation protocol decreased
with repeated testing for rats of both genotypes (Fig 3A) (age effect: F(3,45) = 253.8, P< 0.001).
BACHD rats required more sessions compared to WT rats during the first two test ages, as
indicated by a significant genotype effect (F(1,15) = 19.15, P< 0.001), genotype x age interaction
effect (F(3,45) = 10.96, P< 0.001) and post-test results (4 months: P< 0.001; 9 months: P<
0.05) (Fig 3A). During criterion-level performance, there were no consistent differences
betweenWT and BACHD rats in terms of success rate (Fig 3B), trial start latency (Fig 3C),
lever response latency (Fig 3D) or number of omissions (Fig 3E). BACHD rats did, however,
become progressively slower at retrieving the reward pellets, resulting in them showing signifi-
cantly longer latencies compared to WT rats at the last test age (Fig 3F) (post-test result at 19
months: P< 0.05).
Most rats reliably reached the performance criterion on each delayed alternation protocol,
and thus progressed properly through the series of delay sets. A total of four BACHD rats did
not consistently reach each performance criterion and would occasionally get stuck on a par-
ticular delay set (two to three out of the four rats at each test age). The rats would in these cases
show no clear indication of improving their performance, despite being given extensive
training (up to ten sessions with arguably stable performance). Their performance typically
remained close to criterion, being just above or below it on more or less alternating sessions.
These rats were still allowed to continue through the series of delayed alternation protocols, as
they were deemed to simply have reached their maximum performance. The rats were, how-
ever, excluded from the analysis of the number of sessions required to progress through all the
protocols. This analysis showed that rats of both genotypes required a high number of sessions
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Fig 3. Age development of free alternation performance. The graphs show the main readouts of the free alternation protocol
over the four test ages. (A) shows the number of training sessions required for reaching criterion. (B)–(F) show the mean
performance of rats during sessions where their success rate was at criterion level. Curves show group mean plus standard error.
Results from two-way repeated measures ANOVA are shown inside the graphs. Results from post-hoc analysis are indicated in
case significant genotype differences were found. * (P < 0.05) ** (P < 0.01) *** (P < 0.001).
doi:10.1371/journal.pone.0169051.g003
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during the first test age, but then dropped to a relatively stable level during retesting (S1 Fig).
BACHD rats needed significantly more sessions thanWT rats to progress through the series of
delayed alternation protocols during the first three test ages, although the phenotype was
strongest during the first test age (S1 Fig) (single comparisons: 4 months: P< 0.001; 9 months:
P< 0.05; 14 months: P< 0.05).
The main parameter of interest for the delayed alternation test concerned the success rate
on the different trial types. Analysis of this parameter showed that rats of both genotypes main-
tained a high success rate when trials were preceded by a delay of zero seconds, but dropped as
the delay duration increased (Fig 4A for 4-month data, S2 Fig for 9-, 14- and 19-month data)
(delay effect at 4 months: F(5,110) = 66.14, P< 0.001; 9 months: F(5,110) = 81.59, P< 0.001; 14
months: F(5,100) = 103.4, P< 0.001; 19 months: F(5,75) = 70.50, P< 0.001). BACHD rats per-
formed generally worse thanWT rats at all investigated ages, as indicated by significant
genotype effects for all baseline comparisons (genotype effect at 4 months: F(1,22) = 19.99,
Fig 4. Success rate per delay in the delayed alternation test. The graphs show the success rate on trials preceded by delays of
different durations in the delayed alternation test. (A) shows the stable baseline performance of rats maintained on the standard
food restriction protocol at four months of age. (B) and (C) show the age progression of performance for WT and BACHD rats.
Curves display group mean plus standard error. Results from two-way repeated measures ANOVA are shown inside the graphs.
For (A), results from post-hoc analysis are indicated in case significant genotype differences were found. * (P < 0.05) ** (P < 0.01)
*** (P < 0.001).
doi:10.1371/journal.pone.0169051.g004
Fronto-Striatal Dysfunction in BACHDRats
PLOSONE | DOI:10.1371/journal.pone.0169051 January 3, 2017 16 / 45195
P< 0.001; 9 months: F(5,110) = 13.66, P< 0.01; 14 months: F(5,20) = 11.20, P< 0.01; 19 months:
F(5,15) = 8.79, P< 0.01) without statistically significant genotype x delay interaction. Still,
trends and post-hoc analysis indicated that the reduced success rate among BACHD rats was
more pronounced on trials preceded by longer delays. Performance and phenotypes did not
notably change with age when rats were retested (Fig 4B and 4C, S2 Fig).
Several additional parameters concerning delayed alternation performance were investi-
gated. One set of parameters concerned the entries made into the pellet trough during delays
(Fig 5). These parameters did not appear to change with age and therefore, although initial
analyses were made for individual test ages, only mean performance over all test ages is dis-
played and discussed here. The latency to perform the first head entry during the delay
increased with delay duration (Fig 5A) (delay effect: F(4,88) = 13.41, P< 0.001). The ANOVA
did not reveal an overall genotype difference. However, BACHD rats were slower thanWT
rats during the longest delay step, as indicated by a significant genotype x delay interaction
(F(4,88) = 2.763, P< 0.05) as well as a significant genotype difference in post-hoc analysis of that
data point (head entry latency at 20 months: P< 0.05). The number of entries made during
delays increased with delay duration (Fig 5B) (delay effect: F(4,88) = 152.4, P< 0.001). BACHD
rats made generally fewer entries compared to WT rats (genotype effect: F(1,22) = 6.715,
P< 0.05), although the phenotype was more pronounced during longer delays, as indicated by
a significant genotype x delay interaction effect (F(4,88) = 7.554, P< 0.001) and significant
genotype differences in post-hoc analyses (16-second delay: P< 0.01, 20-second delay:
P< 0.001). To gain further insight into the behavior, the number of entries made during seg-
ments of the 20-second delay was analyzed (Fig 5C). This indicated that BACHD rats made
fewer entries than WT rats on all segments of the delay (genotype effect: F(1,22) = 7.852,
P< 0.05, post-test result: P< 0.05 for the 5–8, 9–12, and 13–16 seconds delay segments).
However, WT and BACHD rats still spent comparable amounts of time inside the pellet
trough (Fig 5D), as BACHD rats made generally longer entries compared to WT rats (Fig 5E)
(genotype effect: F(1,22) = 33.34, P< 0.001, post-test result: P< 0.001 for all delays).
During the 4-month test age, there was no difference betweenWT and BACHD rats regard-
ing their trial start latencies (S3A Fig) or number of trial start omissions (S3B Fig). However, a
peculiar performance difference developed during retesting. Specifically, BACHD rats showed
longer trial start latencies compared to WT rats on trials that were preceded by intermediate
delays, but not on trials preceded by 0- or 20-second delays (S3C Fig) (genotype difference in
post-hoc analysis 4-second delay: P< 0.05, 8-second delay: P< 0.001, 12-second delay:
P< 0.01). The behavioral basis for this phenotype was discovered during video scoring and is
discussed further below. Specifically, it was found that BACHD rats frequently turned away
from interactive wall in order to drink. The same behavior also caused BACHD rats to perform
a higher number of trial start omissions thanWT rats on trials preceded by short delays (S3D
Fig) (genotype difference in post-hoc analysis 0-second delay: P< 0.01, 4-second delay:
P< 0.001, 8-second delay: P< 0.05).
There were no overt differences in lever response latencies between the genotypes, although
BACHD rats appeared to be a bit slower thanWT rats at responding during trials preceded by
a 0-second delay (S4A Fig). Finally, BACHD rats were slower thanWT rats at retrieving the
reward pellets (S4B Fig). The phenotype became more apparent with age, and the age progres-
sion analysis shown in S4 Fig only found a significant phenotype during the last test age (geno-
type difference in post-hoc analysis 19 months: P< 0.05). It should, however, be noted that
single comparisons at each test age reliably revealed a significant genotype difference (data not
shown).
The results described above were from analyses that included all completed trials, i.e. both
successful and failed trials (although excluding omitted ones). Analysis of each parameter was,
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Fig 5. Head entry behavior during delays of the delayed alternation protocol. The graphs show several aspects of head
entries made into the pellet trough during delay steps of the delayed alternation test. Curves were created based on the overall
performance at all test ages, as no significant change with age was found for the parameters. (C) concerns the 20-second delay
step. Graphs indicate groupmean plus standard error. Results from two-way repeated measures ANOVA are shown inside the
graphs. Results from post-hoc analysis are indicated in case significant genotype differences were found. * (P < 0.05) ** (P < 0.01)
*** (P < 0.001).
doi:10.1371/journal.pone.0169051.g005
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however, also performed based on trial outcome (S5 Fig). This was done to evaluate, if the
BACHD rats’ lower success rate is connected to the other noted behavioral differences.
Among BACHD rats, failed trials were preceded by delays with slightly fewer entries (S5A Fig)
(trial type difference in post-hoc analysis 8-second delay: P< 0.05, 12-second delay: P< 0.05,
16-second delay: P< 0.01, 20-second delay: P< 0.01) and slightly less time spent in the pellet
trough (S5B Fig) (trial type difference in post-hoc analysis 8-second delay: P< 0.05, 16-second
delay: P< 0.05, 20-second delay: P< 0.05). However, these differences were small and not
consistently present at all individual test ages, and thus unlikely to be of major importance.
Trial start latencies (S5C Fig) and lever response latencies (S5D Fig) instead appeared to have
stronger impact on the trial outcome. On trials preceded by short delays, failing appeared to be
related to long trial start latencies for BACHD rats (trial type difference in post-hoc analysis
0-second delay: P< 0.001, 4-second delay: P< 0.001, 8-second delay: P< 0.05), while being
related to long lever response latencies for WT rats (trial type difference in post-hoc analysis
0-second delay: P< 0.001, 4-second delay: P< 0.001).
Changing the food restriction protocol so that the WT rats’ food restriction level increased
from 85% (standard food restriction) to 95% (alternative food restriction) did not markedly
change the rats’ behavior. They still completed all trials of the sessions and performed compa-
rable number of Left-Right and Right-Left alternations (data not shown). The success rate
per delay remained completely unchanged by the adjustment of food restriction at all ages
(S6 Fig). The shift also did not have any overt effects on the other parameters of the delayed
alternation protocol (S7 Fig). Still, trial start latencies (S7C Fig) and lever response latencies
(S7D Fig) appeared to become longer after adjustment (specific effect among WT rats being
changed to a lower restriction level, not seen for BACHD rats during the extended training)
(food restriction effect on trial start latency in WT rats: F(1,11) = 11.91, P< 0.01; food restric-
tion effect on lever response latency in WT rats: F(1,11) = 9.55, P< 0.05). For the trial start
latencies, the change primarily concerned the intermediate delays (food restriction difference
in post-hoc analysis 4-second delay: P< 0.001, 8-second delay: P< 0.001, 12-second delay:
P< 0.001; 16-second delay: P< 0.01). Despite this, the aforementioned genotype difference
in trial start latency largely remained the same (data not shown). The number of omissions
was affected both by the motivational shift due to food restriction adjustment and by
extended training (S8A Fig). Specifically, WT rats performed more omissions, while BACHD
rats performed fewer ones, resulting in a significant genotype x baseline interaction effect
(F(1,22) = 15.42, P< 0.001). The change among BACHD rats appeared to be connected to a
slightly lower omission rate on trials preceded by no delay (S8B Fig) (baseline difference in
post-hoc analysis 0-second delay: P< 0.01), while the change among WT rats concerned an
increase in their omission rates on all other trial types (baseline difference in post-hoc analy-
sis: P< 0.001 for 4-, 8-, 12-, 16-, and 20-second delays). Despite these changes, the initial
phenotype of BACHD rats performing more omissions than WT rats was not resolved (data
not shown).
Free and delayed non-matching to position performance
BACHD rats tended to complete fewer trials thanWT rats (data not shown), although this
could not be investigated in detail, as the session duration was adjusted so that rats of both
genotypes would complete comparable numbers of trials. Despite these efforts, BACHD rats
were found to complete significantly fewer trials than WT rats during the 19-month test age
(data not shown). At that point, BACHD rats completed on average 84 trials, while WT rats
completed 96 trials. There was at no point any difference concerning the ratio of completed
Left-Right and Right-Left trials betweenWT and BACHD rats (data not shown).
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The free non-matching to position protocol was, in contrast to the free alternation, very
easy for the rats to learn. Thus, after the initial response sequence training and upon retesting
at older ages, most rats performed at criterion level from the first session onwards. This
resulted in rats needing very few sessions to reach the performance criterion, and no difference
was found between the genotypes concerning this parameter at any age (Fig 6A). During per-
formance at criterion level, there were no differences regarding success rate (Fig 6B), trial start
latency (Fig 6C), sample lever response latency (Fig 6D), pellet trough return latency (Fig 6E),
choice lever response latency (Fig 6F) or number of omissions (Fig 6G). BACHD rats were,
however, found to be slower thanWT rats at retrieving the reward pellets (Fig 6H). This phe-
notype was most pronounced during the last two ages and not present during the first test age,
as indicated by a significant genotype effect (F(1,21) = 5.265, P< 0.05), significant genotype x
age interaction effect (F(3,63) = 6.338, P< 0.001) and results from post-hoc analysis (significant
genotype differences at 14 and 19 months: P< 0.05).
Most rats progressed properly through the delayed non-matching to position protocols
with increasing delay durations by reaching the performance criterion of each protocol. There
were, however, a total of three BACHD rats that did not reliably manage to reach each crite-
rion and thus would occasionally get stuck at a particular delay set despite extensive training.
The rats did not consistently show the problems, meaning that at each given test age there
were between zero and three out of those three BACHD rats that did not manage all perfor-
mance criteria. The rats were handled like the ones in the delayed alternation. Thus, they were
allowed to continue through the series of protocols, were part of the main performance analy-
sis, but not the specific analysis concerning the number of sessions required to progress
through the series of delay sets. This sessions to criterion analysis indicated that rats needed a
relatively stable number of sessions to reach the final delay step, and the two genotypes
required similar numbers of sessions at all test ages (S9 Fig).
The main parameter of interest was once again the success rate on trials with different delay
durations. Analysis of this parameter showed that rats of both genotypes maintained a high,
close to 100%, success rate on trials with a 0-second delay, but dropped as the delay duration
increased (Fig 7A for 4-month data, S10 Fig for 9-, 14- and 19-month data) (delay effect at 4
months: F(5,110) = 40.10, P< 0.001; 9 months: F(5,110) = 32.51, P< 0.001; 14 months: F(5,110) =
35.76, P< 0.001; 19 months: F(5,105) = 48.53, P< 0.001).
While there was no difference between the genotypes’ performance on trials with 0-second
delays, the BACHD rats’ success rate dropped more thanWT rats’ on trials with 5- and 10-sec-
ond long delays. Interestingly, the two genotypes appeared to show a comparable decline in
success rate for trials with longer delays. Ultimately, while WT rats showed reasonably linear
drops in success rate with increasing delays, BACHD rats appeared to show a biphasic curve.
Still, statistical analysis failed to reliably detect significant differences in the rats’ performance.
No differences were found during the first two test ages, while the last two presented both sig-
nificant genotype effects (14 months: F(1,22) = 11.01, P< 0.01; 19 months: F(1,21) = 4.95,
P< 0.05) and genotype x delay interaction effects (14 months: F(5,110) = 4.49, P< 0.001; 19
months: F(5,105) = 4.23, P< 0.01). As this did not appear to be due to either of the genotypes
changing their behavior with repeated testing (Fig 7B and 7C), and as the performance during
the first test age still showed a quite strong genotype effect trend (F(1,22) = 3.44, P = 0.08), this
ultimately indicated a stable but discrete phenotype sensitive to small variations in the
recorded data. The notion of a biphasic success rate curve for BACHD rats was supported by
the fact that the genotype x delay interaction effect was also found when the analysis was lim-
ited to trials with 0- to 10-second delays (data not shown), while analysis of trials with 10- to
25-second delays did not reveal a significant genotype x delay but only an overall genotype
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Fig 6. Age development of free non-matching to position performance. The graphs show the main
readouts of the free non-matching to position protocol over the four test ages. (A) shows the number of
training sessions required for reaching criterion. (B)–(H) show the mean performance of rats during sessions
where their success rate was at criterion level. Session to criterion data was corrected for the change in
criterion between the first test age and retesting. Curves show group mean plus standard error. Results from
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effect (data not shown). Thus, the phenotype was dependent on the presence of delays,
although the extent of impairment was not directly related to their duration.
As with the delayed alternation protocol, several additional parameters concerning delayed
non-matching to position performance were investigated. Once again, one set of parameters
concerned the entries made into the pellet trough during delay periods (Fig 8). Performance
on these parameters did not appear to change with age and therefore, although initial analyses
were made for individual test ages, only the mean performance over all test ages is displayed
and discussed here. The latency to perform the first head entry of the delay remained stable
with delay duration and did not differ betweenWT and BACHD rats (Fig 8A). The number of
two-way repeated measures ANOVA are shown inside the graphs. Results from post-hoc analysis are
indicated in case significant genotype differences were found. * (P < 0.05) ** (P < 0.01) *** (P < 0.001).
doi:10.1371/journal.pone.0169051.g006
Fig 7. Success rate per delay in the delayed non-matching to position test. The graphs show the success rate on trials with
delays of different durations in the delayed non-matching test. (A) shows the stable baseline performance of rats maintained on the
standard food restriction protocol at four months of age. (B) and (C) show the age progression of performance for WT and BACHD
rats, respectively. Curves display group mean plus standard error. Results from two-way repeated measures ANOVA are shown
inside the graphs. For (A), results from post-hoc analysis are indicated in case significant genotype differences were found.
* (P < 0.05) ** (P < 0.01) *** (P < 0.001).
doi:10.1371/journal.pone.0169051.g007
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Fig 8. Head entry behavior during delays on the delayed non-matching to position protocol. The graphs show several
aspects of head entries made into the pellet trough during delay steps of the delayed non-matching to position test. Curves were
created based on the overall performance on all test ages, as no consistent change with age was found for the parameters. (C)
concerns the 25-second delay step. Graphs indicate group mean plus standard error. Results from two-way repeated measures
ANOVA are shown inside the graphs. Results from post-hoc analysis are indicated in case significant genotype differences were
found. * (P < 0.05) ** (P < 0.01) *** (P < 0.001).
doi:10.1371/journal.pone.0169051.g008
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entries made during delays increased with delay duration (Fig 8B) (delay effect: F(4,88) = 613.5,
P< 0.001). BACHD rats made generally fewer entries compared to WT rats (genotype effect:
F(1,22) = 17.57, P< 0.001), although the phenotype was more pronounced during longer
delays, resulting in a significant genotype x delay interaction effect (F(4,88) = 14.62, P< 0.001)
and significant genotype differences in post-hoc analyses (15-second delay: P< 0.01, 20-second
delay: P< 0.001, 25-second delay: P< 0.001). To gain further insight, the number of entries
made during segments of the 25-second delay was analyzed (Fig 8C). This once again indicated
that BACHD rats made fewer entries than WT rats throughout the delay, rather than during
specific parts of it (genotype effect: F(1,22) = 17.00, P< 0.001; genotype difference in post-hoc
analyses: P< 0.001 for all delay segments). Through this, BACHD rats ended up spending
slightly less time inside the pellet trough during the delays compared to WT rats (Fig 8D). Still,
this phenotype was weak and only resulted in a significant genotype x delay interaction effect
(F(4,88) = 2.58, P< 0.05), but not in an overall genotype effect or significant differences in
post-hoc analyses. This was likely due to the strong trend indicating that BACHD rats made
generally longer head entries compared to WT rats (Fig 8E) (genotype effect: F(1,22) = 4.29,
P = 0.0504).
In contrast to the trial start latency during the delayed alternation protocol, the latency to
trigger the choice step in the delayed non-matching to position test did not noticeably change
with delay duration (S11A Fig). Both genotypes showed similar, and very short, latencies to
trigger the choice step. In connection, neither genotype performed frequent omissions at this
point of the protocol (S11B Fig). Rather, the main omission type in the delayed non-matching
to position test concerned the trial starts, where BACHD rats performed slightly more omis-
sions compared to WT rats (S11C Fig) (post-test result: P< 0.05). The latency to start individ-
ual trials was not different betweenWT and BACHD rats at any of the investigated ages (S12
Fig). Response latency to sample levers did not notably change with delay duration or differ
between the genotypes (S13A Fig). Response latencies during choice steps were affected by
delay duration, with rats of both genotypes being slightly slower at responding during trials
with 0-second delays compared to all other delay durations (S13B Fig) (delay effect: F(5,110) =
11.88, P< 0.001). Regardless of this effect, BACHD andWT rats showed identical choice
response latencies. For both genotypes, response latencies during the choice step were gener-
ally shorter than response latencies to sample levers (S13C and S13D Fig) (trial step effect WT:
F(1,11) = 8.501, P< 0.05; trial step effect BACHD: F(1,11) = 9.547, P< 0.05). Finally, BACHD
rats were generally slower at retrieving the reward pellets during the delayed non-matching to
position test (S14A Fig) (genotype effect: F(1,21) = 6.638, P< 0.05). Although the exact retrieval
latency differed with age (age effect: F(3,63) = 5.845, P< 0.01), there was no significant genotype
x age effect, suggesting that the phenotype was similarly apparent at all ages. Pellet retrieval
and pellet trough return are two behaviors that depend on comparable motoric aspects. As
noted, WT and BACHD rats performed similarly on the former parameter, but differed on the
latter. A direct comparison of these two parameters suggested that BACHD rats showed simi-
lar latencies for both behaviors (S14B Fig). In contrast, WT rats were faster when they retrieved
reward pellets, compared to when they were returning to the pellet trough after responding to
the sample lever. This discrepancy resulted in a significant genotype x protocol step interaction
effect (F(1,22) = 5.205, P< 0.05).
The results described above were from analyses that included all completed trials, i.e. both
successful and failed trials (although excluding omitted ones). Analysis of each parameter was,
however, also performed based on trial outcome. This was used to evaluate if the noted behav-
ioral differences were connected to the BACHD rats’ lower success rate (S15 and S16 Figs).
For WT rats (S15 Fig), failure on trials without delays was related to longer trial start latencies
(S15A Fig) (trial type difference in post-hoc analysis of 0-second trials: P< 0.001), pellet trough
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return latencies (S15C Fig) (trial type difference in post-hoc analysis of 0-second trials:
P< 0.001), triggering of choice steps (S15F Fig) (trial type difference in post-hoc analysis of
0-second trials: P< 0.01) and choice lever responses (S15G Fig) (trial type difference in post-
hoc analysis of 0-second trials: P< 0.001). Similar results were seen when analyzing BACHD
rats (S16 Fig) (trial type difference in post-hoc analysis of 0-second trials: Trial start latency:
P< 0.05; Pellet trough return latency: P< 0.001; Latency to trigger choice step: P< 0.01;
Choice lever response latency: P< 0.001), although the effects appeared to be less pronounced
for all parameters except for the choice lever response latency. Importantly, the number of
entries and total time spent in the pellet trough during delays were not clearly connected to
trial outcome for either genotype (S15D and S15E, S16D and S16E Figs).
Changing the food restriction protocol so that WT rats increased from 85% (standard
restriction) to 95% (alternative restriction) of their free-feeding body weight did not markedly
change the behavior of the rats. The aforementioned slight difference in the number of com-
pleted trials was resolved due to WT rats performing fewer trials after changing the food
restriction protocol (data not shown). Rats still completed comparable numbers of Left-Right
and Right-Left trials (data not shown). Success rate per delay remained completely unaffected
by the change of food restriction protocol at all ages (S17 Fig). The shift did also not have any
overt effects on the other parameters of the delayed non-matching to position protocol (S18
Fig). Small increases in the sample lever response latency (S18B Fig), the time spent in the pel-
let trough (S18E Fig) and the choice lever response latency (S18G Fig) were found. However,
similar changes were seen among BACHD rats that were given extended training on the proto-
col (S19 Fig), suggesting that the changes were not necessarily related to a shift in motivation
due to the change in food restriction protocol. The number of trial start omissions made dur-
ing the test sessions was, however, specifically affected. While BACHD rats typically performed
more omissions thanWT rats during the initial baselines, this phenotype was resolved when
WT rat were maintained on the alternative restriction protocol (S20 Fig). This was due to WT
rats performing more trial start omissions than during the initial baselines, while BACHD rats
remained unchanged (baseline effect: F(1,22) = 7.29, P< 0.05; interaction effect: F(1,22) = 5.90,
P< 0.05). Other omission types were not notably affected, neither by the motivational change
nor the extended training (data not shown).
Video scoring
As noted, video recordings were made during baseline performance of both the delayed alter-
nation and delayed non-matching test, at the 17–19-month test age. During this, several videos
of full training sessions were gathered for each animal. For the delayed non-matching to posi-
tion test, a single video from each rat was selected for video scoring. Video selection was made
so that the performance on the selected sessions (with regard to the parameters presented
above) was comparable to the overall baseline. Video analysis of delayed alternation perfor-
mance was more elaborate. Initial investigation of the rats’ behavior during the test revealed
that the BACHD rats frequently turned away from the interactive wall of the conditioning
chamber to drink water. In order to focus the analysis on other types of behavior, trials where
the rats had been drinking were excluded. To still get a comprehensive analysis that covered a
full test session (i.e. 120 trials), data from several separate sessions were combined. Importantly,
the gathered data set still recapitulated most of the phenotypes mentioned in the previous sec-
tions, including the lower success rate and lower number of head entries during delays seen
among BACHD rats (data not shown). The increased number of omissions and longer trial
start latencies seen for BACHD rats on trials with intermediate delays were, however, no longer
present (data not shown), concluding that the drinking behavior was the underlying cause.
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Video scoring of both tests indicated that the mean amount of time spent inside the pellet
trough, in a central position, around the lever slots and in other parts of the operant condition-
ing chambers increased with delay duration (Fig 9). In the delayed alternation test, BACHD
rats appeared to spend slightly less time thanWT rats inside the pellet trough (Fig 9A) and in a
central position (Fig 9C), while spending more time thanWT rats around the levers (Fig 9E).
These trends were, however, not strong and with the exception of a significant genotype x
delay interaction regarding the time spent around the lever slots (F(4,56) = 2.54, P< 0.05), there
were no significant effects. The results from the delayed non-matching test showed similar
behavioral differences between the genotypes, although much more pronounced. There,
BACHD rats spent significantly less time thanWT rats both inside the pellet trough (Fig 9B)
(genotype effect: F(1,20) = 13.63, P< 0.01) and in a central position (Fig 9D) (genotype effect:
F(1,20) = 7.58, P< 0.05) during delays. Both post-tests and genotype x delay interaction effects
indicated that the phenotype was more apparent in trials with longer delays (interaction effect
pellet trough: F(1,20) = 7.80, P< 0.001; interaction effect central position: F(4,80) = 4.01, P<
0.01). BACHD rats also spent significantly more time thanWT rats investigating the wall por-
tions around the lever slots during the delayed non-matching protocol (genotype effect:
F(1,20) = 6.83, P< 0.05). The phenotype was once again more pronounced for trials with longer
delays, as indicated by post-tests and a genotype x delay interaction effect (interaction effect:
F(4,80) = 2.57, P< 0.05). The phenotype was primarily due to the BACHD rats performing a
higher number of body shifts towards the different lever slots, while the duration of these body
shifts were comparable between the genotypes (data not shown). There were no differences
between the genotypes concerning the amount of time they spent in other compartments of
the conditioning boxes in either test (Fig 9G and 9H). In the alternation test, there was no dif-
ference between genotypes regarding the mean duration of head entries, while BACHD rats
were found to make shorter entries compared to WT rats during the delayed non-matching
test (data not shown).
To further evaluate if WT and BACHD rats appeared to use different strategies when per-
forming the tests, their body shifts and apparent focus towards a given side of the interactive
wall were investigated in terms of their eventual lever choice. Rats in the delayed alternation
test (Fig 10) showed a slight preference for making body shifts towards the lever they eventu-
ally responded to (Fig 10A). The preference remained stable with increasing delay, and
although it appeared to be slightly stronger among BACHD rats, there were no significant
genotype or genotype x delay interaction effects. In contrast, both WT and BACHD rats
showed a strong preference for making body shifts towards the lever they eventually responded
to during the non-matching to position test (Fig 11A). This preference dropped slightly with
increasing delay duration (delay effect: F(4,80) = 3.89, P< 0.01). Once again, there was no sig-
nificant genotype or genotype x delay interaction effect. Additional analysis of the longest
delay in each protocol was performed to evaluate the influence of the rats’ apparent lever focus
on trial outcome. For both tests and both genotypes, correct lever choices were associated with
maintaining a preference for the correct lever throughout the entire delay (Figs 10B and 11B).
As above, this preference was notably stronger during the non-matching protocol compared
to the alternation protocol. During trials with incorrect lever choices, the rats initially showed
proper interest in the correct lever, but switched towards focusing on the incorrect lever dur-
ing later phases of the delay. Once again, this behavior was apparent for rats of both genotypes
and during both tests. It should be pointed out that proper statistics could not be performed
for this analysis due to the limited amount of data available. As the noted behaviors appeared
to constitute clear strategies for achieving high success rates on the two tests, further parame-
ters were investigated to evaluate if the reduced success rate seen among BACHD rats might
be explained by impaired strategy development and/or use. As noted, the rats’ initial focus
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Fig 9. Time spent in different parts of the Skinner boxes during delay steps. The graphs show the time
spent in different parts of the Skinner boxes during delays in the delayed alternation and delayed non-matching
to position tests, as measured by video scoring. Specific details regarding the data and scoring method is
available in the Material and Methods section. Graphs indicate group mean plus standard error. Results from
two-way repeated measures ANOVA are shown inside the graphs. Results from post-hoc analysis are indicated
in case significant genotype differences were found. * (P < 0.05) ** (P < 0.01) *** (P < 0.001).
doi:10.1371/journal.pone.0169051.g009
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Fig 10. Video-scored behavior in relation to performance on delayed alternation. The graphs show
various aspects of the behaviors scored from video recordings in relation to the rats’ performance in the delayed
alternation test. Graphs indicate group mean plus standard error. (B) concerns the 20-second delay step. In (F),
the data that is labeled "theoretical" displays the theoretical success rates, as if the rats had responded
according to their initial lever interest and not performed a correction behavior. Further details regarding the
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during delays was frequently directed towards the correct lever. The frequency of trials with
correct initial focus did not differ with delay duration or genotype for either test (Figs 10C and
11C) (data from trials with 0-second delays were excluded from the analysis due to the low
number of trials with established focus). The frequencies of other focus-related behaviors were
quantified as described in the Material and Methods section. During trials with 0-second
delays, most rats did not establish a clear focus (Figs 10D and 11D). However, the frequency of
this behavior dropped dramatically with delay duration (delay effect delayed alternation:
F(5,70) = 127.10, P< 0.001; delayed non-matching to position: F(5,100) = 264.30, P< 0.001). The
frequency of trials where a lever focus was only established (i.e. only one body shift motion
was performed), was highest during trials with 4- and 5-second delays for the alternation and
non-matching test, respectively. Like trials with no focus, their frequency clearly dropped with
increasing delay duration (delay effect delayed alternation: F(5,70) = 26.71, P< 0.001; delayed
non-matching to position: F(5,100) = 66.66, P< 0.001). In contrast, the frequency of trials with
maintained or switched focus clearly increased with delay durations (delay effect of main-
tained focus delayed alternation: F(5,70) = 43.96, P< 0.001; delay effect of maintained focus
delayed non-matching to position: F(5,100) = 66.15, P< 0.001; delay effect of switched focus
delayed alternation: F(5,70) = 32.70, P< 0.001; delay effect of switched focus delayed non-
matching to position: F(5,100) = 30.40, P< 0.001). There were trends indicating that WT rats
showed a higher frequency of trials without focus compared to BACHD rats. This notion was
supported by a significant genotype x interaction effect (F(5,100) = 3.21, P< 0.01) for this
parameter during the delayed non-matching test. Further, WT rats showed a lower frequency
of trials with only established focus compared to BACHD rats, as indicated by significant
genotype effects (delayed non-matching to position: F(1,20) = 9.79, P< 0.01), genotype x delay
interaction effects (delayed alternation: F(5,70) = 2.93, P< 0.05), and post-test results (P<
0.05/0.01 on trials with 4- and 10-second delays for alternation and non-matching test, respec-
tively). WT rats also showed a lower frequency of trials with maintained focus compared to
BACHD rats, as indicated by significant genotype x delay interaction effects (delayed alterna-
tion: F(5,70) = 3.84, P< 0.01; delayed non-matching to position: F(5,100) = 2.78, P< 0.05) and
significant post-hoc analysis results for trials with 5-second delays in the non-matching test
(P< 0.05). There were no significant differences between genotypes in the frequency of trials
with switched focus. It should be noted that althoughWT rats tended to show less trials with
maintained focus, the ratio of maintained focus to switched focus trials did not differ between
the genotypes (data not shown). Thus, the lower frequency of trials with maintained focus seen
amongWT rats in the analysis described above was likely a result of their lower tendency to
perform body shifts (as indicated by the increased frequency of trials without focus).
The final behavioral aspect that was investigated concerned the rats’ behavior while per-
forming the final lever response. In both tests, the most common behavior for both genotypes
and all delays were direct responses (Figs 10E and 11E). Thus, rats rarely showed any interest
in the non-chosen lever. However, during the delayed alternation test, there were still a consid-
erable amount of corrections (Fig 10E). Notably, BACHD rats showed a higher frequency of
direct responses compared to WT rats (genotype effect: F(1,14) = 6.43, P< 0.05), while WT rats
showed a higher frequency of corrections (genotype effect: F(1,14) = 5.00, P< 0.05). The fre-
quency of uncertain choices was marginally higher amongWT rats, although it failed to reach
scored behaviors are described in the Material and Methods section. Results from two-way repeated measures
ANOVA are shown inside the graphs. For (C)–(E), separate two-way ANOVAs were performed for each kind of
behavior, and the respective results are indicated in small tables. Results from post-hoc analysis are indicated
in case significant genotype differences were found. * (P < 0.05) ** (P < 0.01) *** (P < 0.001). In (D), ‘e’ notes
a genotype difference (P < 0.05) for trials with established focus.
doi:10.1371/journal.pone.0169051.g010
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Fig 11. Video-scored behavior in relation to performance on delayed non-matching to position. The
graphs show various aspects of the behaviors scored from video recordings in relation to the rats’ performance
in the delayed non-matching to position test. Graphs indicate group mean plus standard error. (B) concerns the
25-second delay step. In (F), the data that is labeled "theoretical" displays the theoretical success rates, as if
the rats had responded according to their initial lever interest and not performed a correction behavior. Further
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statistical significance. As noted, the behaviors did not notably change with delay duration,
although 0-second delay trials were the only ones where the aforementioned difference was
not clearly present. The correction behavior still appeared to be important for the overall suc-
cess rate of both WT and BACHD rats. Notably, the theoretical success rate of both genotypes
(where the outcome of all correction trials had been adjusted to the hypothetical outcome of
the response they initially intended to do) was markedly lower compared to their actual base-
line (Fig 10F). While the actual baseline showed a similar performance deficit among BACHD
rats as the one described above (genotype effect: F(1,14) = 8.88, P< 0.01), there was no signifi-
cant genotype difference in the theoretical data. Overall, these results were in clear contrast to
the rats’ behavior during the delayed non-matching to position test (Fig 11E). During that test,
rats of both genotypes rarely displayed corrections and uncertain responses, and no genotype
differences were found for these behaviors. In line with this, the rats’ theoretical success rate
did not clearly differ from their original baseline (Fig 11F). Thus, the BACHD rats’ perfor-
mance deficit was apparent in both data sets (genotype effect, recorded data: F(1,20) = 6.04,
P< 0.05; genotype effect, theoretical data: F(1,20) = 5.13, P< 0.05).
An overview of the main results found in the delayed alternation and delayed non-match-
ing to position tests are show in Tables 1 and 2.
Discussion
BACHD rats show no impairment when learning to perform simple
instrumental response tasks
Our study did not reveal any overt differences between BACHD andWT rats during the initial
habituation and lever training steps, with the exception of occasional indications that BACHD
rats were slower at returning to the lever during CRF training. These findings are largely simi-
lar to what we have presented in previous publications [31], and what we have found in several
studies that remain unpublished at this time. It should, however, be noted that in most of these
studies the initial training steps were performed when the rats were 2–5 months old, and learn-
ing deficits might still be present in older animals. In line with this, it has been found that 18
months old BACHD rats (but not 2 and 8 months old rats) required more sessions thanWT
rats to reach criterion when learning to perform single nose pokes for food rewards [33]. How-
ever, no detailed analysis was performed to investigate if this phenotype was based on the rats
having actual difficulties to associate the instrumental response with the delivery of a food pel-
let, or rather them being less interested in exploring the test chamber. Thus, while the BACHD
rats’ ability to learn simple instrumental response tasks appears to be reliably intact at young
ages, it is still unclear if it deteriorates with age.
BACHD rats show slowed learning during alternation training, but not
during non-matching to position training
Later training steps revealed clear differences between the alternation and the non-matching
test. Specifically, while rats of both genotypes needed several training sessions before reaching
criterion on the free alternation protocol, they required very little training to reach criterion
details regarding the scored behaviors are described in the Material and Methods section. Results from two-
way repeated measures ANOVA are shown inside the graphs. For (C)–(E), separate two-way ANOVAs were
performed for each kind of behavior, and the respective results are indicated in small tables. Results from post-
hoc analysis are indicated in case significant genotype differences were found. * (P < 0.05) ** (P < 0.01)
*** (P < 0.001). In (D), ‘ee’ indicates a genotype difference (P < 0.01) for trials with established focus, and ‘m’
indicates a genotype difference (P < 0.05) for trials with maintained focus.
doi:10.1371/journal.pone.0169051.g011
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on the free non-matching test. It is possible that this was due to the alternation protocol put-
ting more strain on the rats’ inhibitory control. Essentially, it is reasonable to assume that rats
have a strong tendency to return to a previously reinforced lever. During alternation protocols,
this would cause them to have a high tendency to perform erroneous responses, and appropri-
ate response inhibition would be required to achieve a high success rate. In contrast, the ten-
dency to respond to the sample lever position during the non-matching protocols is likely low,
as that response is never reinforced. Interestingly, BACHD rats showed a slowed learning
compared to WT rats during the free alternation but not the free non-matching. This could
have been due to them having specific problems with certain aspects of the alternation proto-
col (such as the suggested inhibitory control aspect), although it is also possible that the slowed
learning represented a general learning deficit, which was not apparent during the non-match-
ing test due to its relative simplicity. However, the latter hypothesis is unlikely to be true, as we
have performed other complex cognitive tests without finding slowed learning among
BACHD rats (unpublished results). In addition, the former hypothesis is to some extent sup-
ported by the BACHD rats’ generally impaired performance in the delayed alternation test
(further discussed below). It should also be noted that the slowed learning among BACHD rats
was likely not related to any underlying motivational deficits, as there were no differences in
the number completed trials.
Table 1. Overview of results from the delayed alternation test.
Parameter Results Figure reference
Training needed to handle basic
alternation task
BACHD rats required more training than WT rats during the ﬁrst test age. The phenotype was less
apparent but still present during the second test age and was fully resolved after further retesting.
Fig 3A
Training needed to progress
through delay sets
BACHD rats required more training than WT rats during the ﬁrst test age. The phenotype was less
apparent but still present during the second and third test age and was fully resolved at the last test
age.
S1 Fig
Overall success rate BACHD rats showed a generally impaired performance with lower success rates compared to WT
rats on all trial types.
Fig 4A, S2 Fig
Entries into pellet trough during
delays
BACHD rats made fewer entries compared to WT rats. The phenotype was more pronounced on
trials with long delays, although it did not appear to be due to BACHD rats gradually losing interest
in the pellet trough with time.
Fig 5B and 5C
Time in pellet trough during
delays
No overt difference was found between the genotypes in data recorded by the operant conditioning
system, although a trend indicating that BACHD rats spent less time in the pellet trough compared
to WT rats was found when manually scoring video recorded behaviors of the rats.
Figs 5D and 9A
Trial start latency No difference was found between the genotypes during the ﬁrst test age. During retesting, BACHD
rats showed signiﬁcantly longer trial start latencies compared to WT rats on trials with intermediate
delay durations, which was found to be due to BACHD rats making frequent breaks for drinking.
S3A and S3C Fig
Lever response latency No overt difference was found between the genotypes, although BACHD rats appeared to be
slightly slower than WT rats during trials with 0-second delays.
S4A Fig
Pellet retrieval latency No difference was found between the genotypes during the ﬁrst two test ages. BACHD rats then
appeared to become gradually slower with age, resulting in them being signiﬁcantly slower than WT
rats at the last test age.
S4B Fig
Omissions No difference was found between the genotypes during the ﬁrst test age. During retesting, BACHD
rats showed signiﬁcantly increased omission rates on trials with 0-, 4- and 8-second delays, which
was found to be due to BACHD rats making frequent breaks for drinking.
S3B and S3D Fig
Video-scored behavior During delays, rats of both genotypes were found to frequently exit the pellet trough and investigate
the area around the retracted levers. There were discreet indications that this behavior functioned
as a strategy for remembering which lever to respond to. There was no signiﬁcant difference
between the genotypes regarding this behavior, although BACHD rats tended to do it more
frequently than WT rats. During lever responses, BACHD rats showed a reduced frequency of a
type of correction behavior, and a corresponding increase in performing lever responses without
hesitation, compared to WT rats. The correction behavior appeared to be important for maintaining
a high success rate in the test.
Figs 9 and 10
doi:10.1371/journal.pone.0169051.t001
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Despite the slowed learning among BACHD rats, the performance during criterion sessions
was comparable between the genotypes during both the free alternation and free non-match-
ing. The only exception was the longer pellet retrieval latencies seen among BACHD rats,
which was present in both protocols. This phenotype has been found in almost all operant con-
ditioning tests that have been run with the BACHD rats at our institute (seven longitudinal
studies) and is described in previous publications [31]. Interestingly, similar phenotypes have
been found in transgenic rats that carry a fragment of the HD-causing gene (TgHD rats) [34].
In the current study, the non-matching to position protocol offered additional information
regarding this phenotype. Specifically, it allowed direct comparison between the pellet retrieval
latency and the pellet trough return latency. These two parameters measured the latency to
perform comparable motor behaviors, but aimed towards a pellet trough that either contained
a reward pellet or was empty. While WT rats were clearly faster at moving to the pellet trough
when there was a reward pellet present, BACHD rats showed comparable latencies in both sit-
uations. This could indicate a form of emotional blunting among BACHD rats. However, it is
also possible that the BACHD rats were already moving at their maximum speed. More
focused investigation of this phenotype is needed to better understand if its nature is motoric
or psychological. Interestingly, TgHD rats have shown indications of emotional blunting in a
sucrose solution consumption test [35].
BACHD rats show reduced success rates in both the delayed alternation
and delayed non-matching to position tests
The study’s main finding of interest was the consistently lower success rates found among
BACHD rats in both the delayed alternation and non-matching to position test. The
Table 2. Overview of results from the delayed non-matching test.
Parameter Brief description of phenotype Figure reference
Training needed to handle basic
non-matching task
No difference was found between the genotypes. Fig 6A
Training needed to progress
through delay sets
No difference was found between the genotypes. S9 Fig
Overall success rate BACHD rats showed unchanged success rate on trials without delays, while performance on trials
with delays appeared to be generally impaired.
Fig 7A, S10 Fig
Trial start latency No difference was found between the genotypes. S12 Fig
Sample lever response latency No difference was found between the genotypes. S13A Fig
Food crib return latency No difference was found between the genotypes. Fig 8A
Entries into pellet trough during
delays
BACHD rats made fewer entries compared to WT rats. The phenotype was more pronounced on
trials with long delays, although it did not appear to be due to BACHD rats gradually losing interest
in the pellet trough with time.
Fig 8B and 8C
Time in pellet trough during delays No overt difference was found between the genotypes in data recorded by the operant
conditioning system, although a trend indicated that BACHD rats spent less time in the pellet
trough compared to WT rats. Manual video scoring of the behavior revealed a more pronounced
phenotype of this nature.
Figs 8D and 9B
Latency to trigger choice step No difference was found between the genotypes, although a trend indicated that BACHD rats
were slightly slower than WT rats.
S11A Fig
Choice lever response latency No difference was found between the genotypes. S13B Fig
Pellet retrieval latency BACHD rats were consistently slower than WT rats when retrieving the reward pellets. S14A Fig
Omissions BACHD rats showed a signiﬁcantly higher number of trial start omissions, compared to WT rats S11C Fig
Video-scored behavior During delays, rats of both genotypes were found to frequently exit the pellet trough and
investigate the area around the retracted levers. There were strong indications that this behavior
functioned as a strategy for remembering which lever to respond to. BACHD rats performed this
more frequently than WT rats. However, the video scoring did not reveal any behavioral
differences that might explain the BACHD rats’ reduced success rate in the test.
Figs 9 and 11
doi:10.1371/journal.pone.0169051.t002
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impairment seen in the delayed alternation test was not clearly affected by delay duration, sug-
gesting that the rats had a general problem performing the basic task (i.e. alternation) rather
than a short-term memory deficit. Similar phenotypes have been found in a knock-in HD
mouse model [36] and rats with either striatal or prefrontal lesions [23–25]. The BACHD rats’
slowed learning during the free alternation training also supports the idea that they have prob-
lems handling the basic alternation task. It should, however, be noted that there were occa-
sional tendencies indicating that the BACHD rats’ impairment became stronger with longer
delay durations. Interestingly, such phenotypes have been found when lesioning specific
fronto-striatal circuits [26], but also when lesioning the hippocampus [37]. Both pathologies
could theoretically be present in the BACHD rats, as extensive protein aggregate formation
has previously been found in the rats in these brain regions [30,38]. It should, however, also be
noted that the apparent delay-dependent worsening of the phenotype might have been influ-
enced by other aspects of the rats’ behavior (further discussed below). The impairment seen in
the delayed non-matching to position test was similar to that of the delayed alternation test,
although not identical. Longer delays did once again not appear to result in a stronger deficit,
while the general presence of delays seemed to be crucial. Thus, the phenotype once again
appeared to be due to the BACHD rats having general problems with the basic task, although
it specifically concerned the delayed task. To our knowledge, similar phenotypes have not been
reported elsewhere. Striatal lesions have been found to result in slight learning impairments in
the delayed non-matching test [27], which were not seen in the current study. Further, fornix
lesions have been found to result in delay-dependent impairments [39,40], while lesions to the
prefrontal cortex and hippocampus have been found to produce a general drop in success rate
[28,29]. The latter kind of phenotype was also found in a recent study of the performance of an
HD knock-in mouse in a slightly different version of the test [41]. As noted though, these phe-
notypes do not appear to be directly comparable to the apparent biphasic curves found in the
current study. As a final note, it is interesting that HD patients have shown general problems
to perform accurately in a delayed pattern matching to sample test, although the impairment
did not become more pronounced with increased delays [42].
BACHD rats show other behavioral changes, although their influence on
success rate is likely limited
Additional parameters were evaluated, as non-cognition based behavioral differences between
BACHD andWT rats could have influenced the success rate in the two tests, and needed to be
considered. The results revealed that there were indeed several behavioral differences between
BACHD andWT rats, although few appeared to be directly related to the rats’ success rates.
During the delayed alternation test, BACHD rats were found to be slower at performing the
first head entry of the delay, performed fewer head entries during the delays and showed lon-
ger trial start latencies for trials with intermediate delay durations. Out of these parameters,
the difference in trial start latencies was the only factor that appeared to be related to failed tri-
als. Still, BACHD andWT rats showed comparable trial start latencies during the first test age,
while BACHD rats already presented an overall lower success rate. Similarly, when only trials
without water consumption were considered, there was no difference between genotypes in
terms of trial start latencies, while the reduced success rate among BACHD rats was still pres-
ent. Thus, although the slowed trial start latency among BACHD rats most likely affected their
performance to some extent, it was unlikely the main cause of their reduced success rate.
There were fewer differences between the BACHD andWT rats’ behavior during the delayed
non-matching test. Most notably, BACHD rats again performed fewer head entries thanWT
rats during delays. However, detailed analysis suggested once again that this difference was
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unlikely to explain the difference in success rate. As the reduced number of head entries was
still consistently found in the two tests, it is worth noting that similar phenotypes have been
found in rats with striatal lesions [24], although not consistently [23]. Ultimately, despite the
various noted behavioral differences found between BACHD andWT rats it is likely that
underlying cognitive changes were the main cause of their reduced success rates. However,
additional non cognition-related behavioral differences likely still influenced the overall
appearance of the phenotype to some extent. When considering this, it is also noteworthy that
some parameters appeared to only affect certain trial types. Specifically, the relationship
between trial start latencies and trial outcome in the delayed alternation test appeared to pri-
marily concern trials with short delays, and was restricted to BACHD rats. In contrast, the WT
rats’ success on trials with short delays appeared to be more related to their lever response
latencies. Specific parameters also appeared to be related to failure on trials with short delays
during the delayed non-matching test (i.e. trial start latency, pellet trough return latency,
latency to trigger choice step and choice lever response latency). These aspects complicate the
task of assessing the appearance of the rats’ actual cognitive impairment, making it possible
that the current interpretations (i.e. cognitive impairments resulting in BACHD rats showing
an overall impaired performance in the delayed alternation test, and a biphasic impairment in
the delayed non-matching to position test) are not entirely true. Specifically, the BACHD rats’
lower success rate on trials with 0-second delays during the delayed alternation test might have
been related to non-cognitive behaviors influencing their trial start latencies. Thus, their true
cognitive impairment might have been more comparable to the one seen in the delayed non-
matching to position test, which would also be more in line with their unchanged success rate
during the free alternation protocols.
Although the difference in the number of head entries performed during delays did not
appear to be connected to the reduced success rate among BACHD rats, a difference in delay
behavior might still indicate altered motivation, attention or strategy. Thus, additional analysis
of this phenotype was of interest. The phenotypes were first validated with video scoring that
indicated that BACHD rats indeed spent less time thanWT rats being in an arguably central
position during delays (although the phenotype was quite discreet during the delayed alterna-
tion test). Certain aspects argued against the phenotype being caused by motivational differ-
ences. First, the reduced number of entries was present on each segment of the longer delay
steps, suggesting that the phenotype was not due to the BACHD rats simply losing interest as
time passed. In addition, the number of entries was not strongly affected by changing the food
restriction protocol of WT rats. BACHD rats were, however, found to frequently turn around
to drink water during delays in the delayed alternation test, suggesting a change in their rela-
tive interest in food and water. It is worth noting that this behavior appeared to be the main
cause of the BACHD rats’ peculiar pattern of trial start latencies and omissions during the test.
Further, although the trial start latencies themselves appeared to have only limited influence
on the success rate (see above), it is still possible that the drinking behavior had caused the
trends indicating that the BACHD rats’ performance deficit worsened with longer delays.
Regardless, although the drinking behavior might have affected the BACHD rats’ success rate,
and definitely contributed to their lower number of head entries performed during delays,
both phenotypes were still present when trials with drinking were excluded.
BACHD andWT rats develop comparable strategies to maintain high
success rates on the two tests
As noted, it was subsequently found that BACHD rats had a higher frequency of leaving the
pellet trough to investigate the area around it. This could indicate a change in attention and
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strategy, although there were no indications of either one in the current study. Both BACHD
andWT rats preferentially made body shifts towards the lever they would eventually respond
to, and appeared to focus on the lever that would give a correct response. Thus, although
BACHD rats made these movements at a higher frequency thanWT rats, their use and rele-
vance to lever choices did not notably differ between the genotypes on either test. The
increased use of body shifts seen among BACHD rats might, however, indicate that they were
more dependent on the strategy thanWT rats. This would be in line with the trend suggesting
that BACHD rats had a slightly stronger preference for making body shifts towards the chosen
lever during the delayed alternation test. This idea should be further evaluated by comparing
performance in setups or protocols that make the use of this strategy more difficult, such as
placing the levers and pellet trough on opposite walls, placing walls between the wall sections
containing the lever slots and the pellet trough, or adding limits so that trials are cancelled if
the rats exit the pellet trough. Still, the importance of the body shifts for accurate performance
during the delayed alternation test is somewhat uncertain, as the rats did not show a particu-
larly strong focus for the selected lever. Thus, although the rats clearly used the body shifts as
part of a strategy during the delayed non-matching test, thee reason for at all performing them
(and the consistent finding of BACHD rats performing them more frequently than WT rats)
might be due to more general and not strategy-related behaviors. Interestingly, transgenic rats
carrying a fragment of the HD-causing gene have been found to show a high frequency of
early withdrawals from nose poke modules during a choice reaction time test, which was sug-
gested to be due to impaired response inhibition [43]. This phenotype is arguably similar to
the one found in the current study.
Strategies similar to the body shifts described here have been found in other studies of rats
performing the delayed non-matching to position test [40]. That particular study also indi-
cated that fronto-striatal lesions, which resulted in reduced success rate, also affected these
mediating behaviors. Among other things, lesioned rats showed an increased frequency of
changing focus from one lever to another during delays. Due to this, we investigated similar
parameters in the current study. In both tests and genotypes, there were indications that
maintaining focus on the correct lever throughout the delay was related to a successful out-
come, while switching focus to the wrong lever was related to failed trials. However, there
were no clear indications that BACHD rats switched focus more frequently than WT rats. In
addition, there were no differences regarding how often the rats’ initial focus was on the cor-
rect lever. It should, however, be noted that the scoring method used here (i.e. a rats’ apparent
focus being based on the first and last body shift) was limited. However, more elaborate scor-
ing (such as judging the rat’s apparent focus based on the percentage of time spent around a
given lever) would have suffered from similar limitations due to the low number of body
shifts that were performed (roughly four for WT and six for BACHD rats during the longest
delay). Further insight into the rats’ focus-shifting behavior might still be gained through the
analysis of more data, using a more elaborate scoring protocol, but it is beyond the scope of
the current study.
BACHD rats show a reduced frequency of correction behaviors during
delayed alternation performance
The rats’ behavior while performing lever pushes was also investigated. This scoring indicated
that most rats responded without hesitation during the choice step of the delayed non-match-
ing test. This was most likely due to a strong association between their body shift and the
planned lever response. Thus, the main decision regarding which lever to push was likely
made already during the delay step. This might also explain why both WT and BACHD rats
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were faster at responding to choice levers than to sample levers. All in all, these aspects ques-
tion to what extent the test really evaluated short-term memory rather than the rats’ ability to
establish and maintain focus on the correct lever. Direct responses also constituted the major-
ity of responses made in the delayed alternation test. However, there was a considerable fre-
quency of correction behaviors, where the rats would first start moving towards one lever but
change their mind and respond to the other one. The importance of this behavior was indi-
cated by the dramatically lower success rate found when the rats’ theoretical performance was
considered (i.e. success rate as if they had responded according to their initial lever choice).
Importantly, the frequency of correction behaviors was higher amongWT rats than BACHD
rats. Further, there was no difference betweenWT and BACHD rats in their theoretical success
rates. Thus, it is likely that the reduced frequency of correction behaviors among BACHD rats
was connected to their lower success rate in the delayed alternation test. Still, in connection to
the discussions above, it is noteworthy that there was no clear difference in the frequency of
corrections during trials with 0-second delays. Regardless, the reduced frequency of correction
behavior might be an indication that BACHD rats have difficulties inhibiting already initiated
responses. This would suggest an impairment regarding a quite specific aspect of response
inhibition, which should be further investigated in tests that probe this [44–46]. Evaluating the
BACHD rats’ performance in such tests might also help to determine if the impairment in the
delayed alternation test truly concerned a failure to inhibit erroneous responses, as opposed to
a failure to realize that the initiated responses would be erroneous. Interestingly, changes in
neuronal signaling have been found in HD patients during performance of tests where they
had to inhibit ongoing motor responses [47]. In addition, HD patients [48], HDmouse models
[49] and BACHD rats [50] have all been found to show impaired performance in other tests of
response inhibition. It should, however, be noted that the study performed on BACHD rats
did not conclusively show that the response inhibition impairment concerned a baseline deficit
rather than a response to a change in protocol.
The noted phenotypes generally remained stable with increasing age
As noted, the phenotypes found in the two tests did not appear to change with age. Due to
the progressive nature of HD, one would typically expect that disease-related phenotypes in
animal models would worsen when they grow older. Indeed, other phenotypes found in the
BACHD rats have been shown to progressively worsen, already while the rats were a few
months old [30]. However, the neuropathology of the BACHD rats has not been fully eluci-
dated yet. Although loss of dopamine 2 receptors has been implicated in old animals, and
although there is a gradual accumulation of huntingtin aggregates with age [30], it is not
clear if this results in progressive loss of function in fronto-striatal circuits. The current
results would suggest that it does not. Thus, the impairments found here might be due to
neuropathology caused by the general presence of mutant huntingtin, rather than its pro-
gressive accumulation. Alternatively, the impairments might be due to neuropathology
caused by developmental deficits. Specifically, male BACHD rats have been found to be
smaller than their WT littermates [31] and consistently have smaller brains (unpublished
results). At this point, it is unclear if this developmental deficit only regards size or also func-
tionality. Finally, it should be considered that the rats in the current study spent roughly half
of their life actively being assessed in the respective tests. This frequent behavioral evaluation
might have acted as environmental enrichment, and might have counteracted any progres-
sion that would have occurred if less frequent training were used. To evaluate this further,
additional tests should be run where test ages are spaced further apart or performed with
separate test groups.
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Conclusions and final remarks
BACHD rats showed impaired performance in both the delayed alternation and delayed non-
matching test in the current study. The phenotypes were already present at 2–4 months of age
and did not appear to progressively worsen with age. In both tests, the rats appeared to primar-
ily have problems handling the basic task, while short-term memory remained intact. The
impairment found in the delayed alternation test seemed to in part be caused by a failure to
correct ongoing erroneous responses, which in turn could be due to deficits in attention and/
or inhibitory control. It is currently unclear what specific behavioral differences caused the
impaired performance in the delayed non-matching to position test, although it is likely related
to the distinct mediating behaviors that both WT and BACHD rats used. Importantly, argu-
ably similar performance deficits have been found in other HDmodels and rats with fronto-
striatal lesions, suggesting that the BACHD rats’ phenotypes are caused by HD-related neuro-
pathology. In addition, the phenotypes were not affected by a change in motivation and hun-
ger, suggesting that the impairments likely reflect true cognitive deficits rather than artifacts
due to motivational differences betweenWT and BACHD rats.
As a side note, using water bottles during operant conditioning tests might not be optimal
when working with BACHD rats. During delayed alternation training, the BACHD rats took
frequent breaks to consume water, which dramatically affected their trial start latencies and
omission rates. It is currently not clear why the rats developed this behavior, as it has not been
found in other operant condition tasks performed at our institute. In addition, extensive con-
trol tests were run with the delayed alternation rats to investigate their thirst response to being
fed reward pellets in various conditions. However, there were no indications that BACHD rats
became thirstier than WT rats when consuming reward pellets.
Supporting Information
S1 Fig. Sessions required to progress through delayed alternation training. The graphs
show the total number of sessions required for progressing through the series of delayed alter-
nation protocols at the different test ages, with gradually increasing delay durations that were
implemented before the training on the final delay set had started. The values were adjusted
for the change in criterion that was made after the first test age. Rats, which did not reach crite-
rion on each protocol, were excluded from the analysis. Plots indicate single values for individ-
ual rats. Note that the scale on the y-axis differs between the graphs. Results from t-test or
Mann-Whitney U test are indicated in case significant genotype differences were present.
 (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S2 Fig. Success rate per delay in the delayed alternation test during retesting. The graphs
show the success rate on trial types with delays of different durations in the delayed alternation
test. Each graph shows the stable baseline performance of rats maintained on the standard
food restriction protocol. Curves display group mean plus standard error. Results from two-
way repeated measures ANOVA are shown inside the graphs. For (A), results from post-hoc
analysis are indicated in case significant genotype differences were found.  (P< 0.05)  (P<
0.01)  (P< 0.001).
(TIFF)
S3 Fig. Trial start latency and omissions during delayed alternation. The graphs show trial
start latency and omissions during the delayed alternation protocol. (A) and (B) show the
behavior at the four-month test age, while (C) and (D) show the mean performance at the three
older ages. Graphs indicate group mean plus standard error. Results from two-way repeated
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measures ANOVA are shown inside the graphs. Results from post-hoc analysis are indicated in
case significant genotype differences were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S4 Fig. Additional parameters of delayed alternation performance. The graphs show the
last two parameters investigated for delayed alternation performance. (A) is based on the over-
all performance on all test ages, as no significant change with age was found for the parameter.
Graphs indicate group mean plus standard error. Results from two-way repeated measures
ANOVA are shown inside the graphs. Results from post-hoc analysis are indicated in case sig-
nificant genotype differences were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S5 Fig. Parameters indicating success or failure on delayed alternation. The graphs show
some of the parameters of the delayed alternation protocol with performance of WT and
BACHD rats separated for successful and failed trials. All graphs were constructed based on the
mean performance over all test ages, as the relation to trial outcome did not noticeably change
with age. Graphs indicate group mean plus standard error. Results from two-way repeated
measures ANOVA are shown inside the graphs. Results from post-hoc analysis are indicated in
case significant genotype differences were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S6 Fig. Effect of food restriction adjustment on success rate in delayed alternation test.
The graphs show the WT rats’ performance in the delayed alternation test during two different
food restriction settings at the four investigated ages. Graphs indicate group mean plus stan-
dard error. Results from two-way repeated measures ANOVA are shown inside the graphs.
Results from post-hoc analysis are indicated in case significant genotype differences were
found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S7 Fig. Effect of food restriction adjustment and extended training on delayed alternation
parameters. The graphs show some of the parameters of the delayed alternation protocol,
comparing performance of WT and BACHD rats during their initial baseline with perfor-
mance after changing food restriction protocol or given extended training, respectively. All
graphs were constructed based on the mean performance over all test ages, as the effect of
changing food restriction protocol or giving extended training did not noticeably change with
age. Graphs indicate group mean plus standard error. Results from two-way repeated measures
ANOVA are shown inside the graphs. Results from post-hoc analysis are indicated in case sig-
nificant differences between baselines were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S8 Fig. Effect of food restriction adjustment on omissions during delayed alternation. The
graphs show the effect of food restriction adjustment and extended training on the number of
trial start omissions performed during the delayed alternation test. All graphs were constructed
based on the mean performance over all test ages, as the effect of changing food restriction
protocol or giving extended training did not noticeably change with age. Graphs indicate
group mean plus standard error. Results from two-way repeated measures ANOVA are shown
inside the graphs. Results from post-hoc analysis are indicated in case significant differences
between baselines were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S9 Fig. Sessions required to progress through delayed non-matching to position training.
The graphs show the total number of sessions required for progressing through the series of
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delayed non-matching to position protocols with gradually increasing delay durations, which
were implemented before the training on the final delay set had started. The values were
adjusted for the change in criterion that was made after the first test age. Rats that did not
reach criterion on each protocol were excluded from the analysis. Plots indicate single values
for individual rats. Note that the scale on the y-axis differs between (A) and the remaining
graphs. Results from t-test or Mann-Whitney U test are indicated in case significant genotype
differences were present.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S10 Fig. Success rate per delay in the delayed non-matching to position test during retest-
ing. The graphs show the age development of success rate on trial types with delays of different
durations in the delayed non-matching test. Each graph shows the stable performance found
when rats were maintained on the standard food restriction protocol. Curves display group
mean plus standard error. Results from two-way repeated measures ANOVA are shown inside
the graphs. Results from post-hoc analysis are indicated in case significant genotype differences
were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S11 Fig. Latency to trigger choice step and omissions for delayed non-matching to posi-
tion. The graphs show the latency to initiate the choice step, related omissions and omissions
overview during the delayed non-matching to position protocol. Graphs display the mean per-
formance over all ages, as no significant differences in the rats’ behavior at different ages was
found. (A) and (B) indicate group mean plus standard error. (C) indicates the performance of
individual rats. For (A) and (B), results from two-way repeated measures ANOVA are shown
inside the graphs, and results from post-hoc analysis are indicated in case significant genotype
differences were found. For (C), results from t-test or Mann-Whitney U test are indicated in
case the genotypes differed significantly.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S12 Fig. Trial start latency in the delayed non-matching to position test. The graph shows
the latency to initiate trials on the different test ages of the delayed non-matching to position
protocol. The curve indicates group mean plus standard error. Results from two-way repeated
measures ANOVA are shown inside the graph, and results from post-hoc analysis are indicated
in case significant genotype differences were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S13 Fig. Lever response latencies during delayed non-matching to position. The graphs
show the latencies to respond to a lever during either the sample step or the choice step of the
delayed non-matching to position protocol. (A) and (B) display the comparison betweenWT
and BACHD for both response latencies, while (C) and (D) display comparisons between the
type of response latencies for both genotypes. Graphs display mean performance over all ages,
as no significant differences in the rats’ behavior at different ages was found. Curves indicate
group mean plus standard error. Results from two-way repeated measures ANOVA are shown
inside the graphs, and results from post-hoc analysis are indicated for data points where signifi-
cant genotype differences were found.  (p< 0.05)  (p< 0.01)  (p< 0.001).
(TIFF)
S14 Fig. Reward pellet retrieval latency during delayed non-matching to position. (A)
shows the mean pellet retrieval latency of WT and BACHD rats during the delayed non-
matching to position protocol at all investigated ages. (B) shows a comparison of the mean pel-
let retrieval latency with the mean latency to return to the pellet trough after pushing the
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sample lever. For this, the mean of all investigated ages and trial types were used, as the pheno-
types or differences between latencies did not clearly change with age. Curves indicate group
mean plus standard error. Results from two-way repeated measures ANOVA are shown inside
the graphs, and results from post-hoc analysis are indicated in case significant genotype differ-
ences were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S15 Fig. Parameters indicating success or failure for WT rats in the delayed non-matching
to position test. The graphs show some of the parameters of the delayed non-matching to
position protocol performance of WT rats separated for successful and failed trials. All graphs
were constructed using the mean performance over all ages, as the parameters’ relation to trial
outcome did not noticeably change between test ages. In addition, this was necessary to obtain
data for failed 0-second delay trials for all rats. Curves indicate group mean plus standard
error. Results from two-way repeated measures ANOVA are shown inside the graphs, and
results from post-hoc analysis are indicated in case significant genotype differences were
found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S16 Fig. Parameters indicating success or failure for BACHD rats in the delayed non-
matching to position test. The graphs show some of the parameters of the delayed non-
matching to position protocol performance of BACHD rats separated for successful and failed
trials. All graphs were constructed using the mean performance over all ages, as the parame-
ters’ relation to trial outcome did not noticeably change between test ages. In addition, this
was necessary to obtain data for failed 0-second delay trials for all rats. Curves indicate group
mean plus standard error. Results from two-way repeated measures ANOVA are shown inside
the graphs, and results from post-hoc analysis are indicated in case significant genotype differ-
ences were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S17 Fig. Effect of food restriction adjustment on success rate in delayed non-matching to
position. The graphs show the WT rats’ performance in the delayed non-matching to position
test during two different food restriction settings at the four investigated age. Graphs indicate
group mean plus standard error. Results from two-way repeated measures ANOVA are shown
inside the graphs. Results from post-hoc analysis are indicated in case significant genotype dif-
ferences were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S18 Fig. Effect of food restriction adjustment of WT rats in the delayed non-matching to
position test. The graphs show some of the parameters of the delayed non-matching to posi-
tion protocol performance of WT rats separated for standard and alternative food restriction
protocols. All graphs were constructed using the mean performance over all ages, as the
parameters’ relation to motivational state did not noticeably change between test ages. Curves
indicate group mean plus standard error. Results from two-way repeated measures ANOVA
are shown inside the graphs, and results from post-hoc analysis are indicated in case significant
genotype differences were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S19 Fig. Effect of extended training of BACHD rats in the delayed non-matching to posi-
tion test. The graphs show some of the parameters of the delayed non-matching to position
protocol performance of BACHD rats separated for the baselines after initial and extended
training. All graphs were constructed using the mean performance over all ages, as the
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parameters’ relation to the amount of training did not noticeably change between test ages.
Curves indicate group mean plus standard error. Results from two-way repeated measures
ANOVA are shown inside the graphs, and results from post-hoc analysis are indicated in case
significant genotype differences were found.  (P< 0.05)  (P< 0.01)  (P< 0.001).
(TIFF)
S20 Fig. Trial start omissions during different baselines of delayed non-matching to posi-
tion. The graph shows the number of omissions during the initial baselines and after either a
change in food restriction protocol or extended training on the delayed non-matching to
position protocol. The graph was constructed using the mean performance over all ages, as
the parameters’ relation to food restriction or extended training did not noticeably change
between test ages. The curve indicates group mean plus standard error. Results from two-way
repeated measures ANOVA are shown inside the graph, and results from post-hoc analysis
are indicated in case significant genotype differences were found.  (P< 0.05)  (P< 0.01)
 (P< 0.001).
(TIFF)
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Publication	  III	  Supplementary	  Figures	  	  	  	  S1	  Fig.	  Sessions	  required	  to	  progress	  through	  delayed	  alternation	  training	  The	   graphs	   show	   the	   total	   number	   of	   sessions	   required	   for	   progressing	   through	   the	   series	   of	   delayed	  alternation	   protocols	   at	   the	   different	   test	   ages,	   with	   gradually	   increasing	   delay	   durations	   that	   were	  implemented	   before	   the	   training	   on	   the	   final	   delay	   set	   had	   started.	   The	   values	   were	   adjusted	   for	   the	  change	   in	   criterion	   that	   was	  made	   after	   the	   first	   test	   age.	   Rats,	   which	   did	   not	   reach	   criterion	   on	   each	  protocol,	  were	  excluded	   from	   the	  analysis.	  Plots	   indicate	   single	  values	   for	   individual	   rats.	  Note	   that	   the	  scale	  on	  the	  y-­‐axis	  differs	  between	  the	  graphs.	  Results	  from	  t-­‐test	  or	  Mann-­‐Whitney	  U	  test	  are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  present.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S2	  Fig.	  Success	  rate	  per	  delay	  in	  the	  delayed	  alternation	  test	  during	  retesting	  The	   graphs	   show	   the	   success	   rate	   on	   trial	   types	   with	   delays	   of	   different	   durations	   in	   the	   delayed	  alternation	   test.	   Each	   graph	   shows	   the	   stable	   baseline	  performance	  of	   rats	  maintained	  on	   the	   standard	  food	  restriction	  protocol.	  Curves	  display	  group	  mean	  plus	  standard	  error.	  Results	  from	  two-­‐way	  repeated	  measures	  ANOVA	  are	  shown	  inside	  the	  graphs.	  For	  (A),	  results	  from	  post-­‐hoc	  analysis	  are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S3	  Fig.	  Trial	  start	  latency	  and	  omissions	  during	  delayed	  alternation	  The	   graphs	   show	   trial	   start	   latency	   and	  omissions	  during	   the	  delayed	   alternation	  protocol.	   (A)	   and	   (B)	  show	  the	  behavior	  at	  the	  four-­‐month	  test	  age,	  while	  (C)	  and	  (D)	  show	  the	  mean	  performance	  at	  the	  three	  older	   ages.	   Graphs	   indicate	   group	  mean	  plus	   standard	   error.	   Results	   from	   two-­‐way	   repeated	  measures	  ANOVA	   are	   shown	   inside	   the	   graphs.	   Results	   from	   post-­‐hoc	   analysis	   are	   indicated	   in	   case	   significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S4	  Fig.	  Additional	  parameters	  of	  delayed	  alternation	  performance	  The	  graphs	  show	  the	  last	  two	  parameters	  investigated	  for	  delayed	  alternation	  performance.	  (A)	  is	  based	  on	  the	  overall	  performance	  on	  all	  test	  ages,	  as	  no	  significant	  change	  with	  age	  was	  found	  for	  the	  parameter.	  Graphs	   indicate	  group	  mean	  plus	   standard	  error.	  Results	   from	   two-­‐way	   repeated	  measures	  ANOVA	  are	  shown	   inside	   the	   graphs.	   Results	   from	   post-­‐hoc	   analysis	   are	   indicated	   in	   case	   significant	   genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S5	  Fig.	  Parameters	  indicating	  success	  or	  failure	  on	  delayed	  alternation	  The	  graphs	  show	  some	  of	  the	  parameters	  of	  the	  delayed	  alternation	  protocol	  with	  performance	  of	  WT	  and	  BACHD	   rats	   separated	   for	   successful	   and	   failed	   trials.	   All	   graphs	  were	   constructed	   based	   on	   the	  mean	  performance	  over	  all	  test	  ages,	  as	  the	  relation	  to	  trial	  outcome	  did	  not	  noticeably	  change	  with	  age.	  Graphs	  indicate	   group	  mean	  plus	   standard	   error.	   Results	   from	   two-­‐way	   repeated	  measures	  ANOVA	   are	   shown	  inside	   the	   graphs.	   Results	   from	   post-­‐hoc	   analysis	   are	   indicated	   in	   case	   significant	   genotype	   differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S6	  Fig.	  Effect	  of	  food	  restriction	  adjustment	  on	  success	  rate	  in	  delayed	  alternation	  test	  The	   graphs	   show	   the	   WT	   rats'	   performance	   in	   the	   delayed	   alternation	   test	   during	   two	   different	   food	  restriction	  settings	  at	  the	  four	  investigated	  ages.	  Graphs	  indicate	  group	  mean	  plus	  standard	  error.	  Results	  from	  two-­‐way	  repeated	  measures	  ANOVA	  are	  shown	  inside	  the	  graphs.	  Results	  from	  post-­‐hoc	  analysis	  are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S7	   Fig.	   Effect	   of	   food	   restriction	   adjustment	   and	   extended	   training	   on	   delayed	   alternation	  parameters	  The	  graphs	  show	  some	  of	  the	  parameters	  of	  the	  delayed	  alternation	  protocol,	  comparing	  performance	  of	  WT	   and	   BACHD	   rats	   during	   their	   initial	   baseline	   with	   performance	   after	   changing	   food	   restriction	  protocol	   or	   given	   extended	   training,	   respectively.	   All	   graphs	   were	   constructed	   based	   on	   the	   mean	  performance	   over	   all	   test	   ages,	   as	   the	   effect	   of	   changing	   food	   restriction	   protocol	   or	   giving	   extended	  training	  did	  not	  noticeably	  change	  with	  age.	  Graphs	  indicate	  group	  mean	  plus	  standard	  error.	  Results	  from	  two-­‐way	   repeated	   measures	   ANOVA	   are	   shown	   inside	   the	   graphs.	   Results	   from	   post-­‐hoc	   analysis	   are	  indicated	  in	  case	  significant	  differences	  between	  baselines	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S8	  Fig.	  Effect	  of	  food	  restriction	  adjustment	  on	  omissions	  during	  delayed	  alternation	  The	  graphs	  show	  the	  effect	  of	   food	  restriction	  adjustment	  and	  extended	   training	  on	   the	  number	  of	   trial	  start	  omissions	  performed	  during	  the	  delayed	  alternation	  test.	  All	  graphs	  were	  constructed	  based	  on	  the	  mean	  performance	  over	  all	  test	  ages,	  as	  the	  effect	  of	  changing	  food	  restriction	  protocol	  or	  giving	  extended	  training	  did	  not	  noticeably	  change	  with	  age.	  Graphs	  indicate	  group	  mean	  plus	  standard	  error.	  Results	  from	  two-­‐way	   repeated	   measures	   ANOVA	   are	   shown	   inside	   the	   graphs.	   Results	   from	   post-­‐hoc	   analysis	   are	  indicated	  in	  case	  significant	  differences	  between	  baselines	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	  
241
Publication	  III	  Supplementary	  Figures	  	  	  
WT BACHD
0102030Number of sessions 4 months
WT BACHD
0510152030Number of sessions 14 months WT BACHD0510152030Number of sessions
9 months
WT BACHD
0510152030Number of sessions 19 months
Sessions needed to progress through delayed non-matching to position trainingA BC D 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
242
Publication	  III	  Supplementary	  Figures	  	  	  	  S9	  Fig.	  Sessions	  required	  to	  progress	  through	  delayed	  non-­‐matching	  to	  position	  training	  The	  graphs	  show	  the	  total	  number	  of	  sessions	  required	  for	  progressing	  through	  the	  series	  of	  delayed	  non-­‐matching	  to	  position	  protocols	  with	  gradually	  increasing	  delay	  durations,	  which	  were	  implemented	  before	  the	  training	  on	  the	   final	  delay	  set	  had	  started.	  The	  values	  were	  adjusted	  for	  the	  change	   in	  criterion	  that	  was	  made	  after	  the	  first	  test	  age.	  Rats	  that	  did	  not	  reach	  criterion	  on	  each	  protocol	  were	  excluded	  from	  the	   analysis.	   Plots	   indicate	   single	   values	   for	   individual	   rats.	   Note	   that	   the	   scale	   on	   the	   y-­‐axis	   differs	  between	  (A)	  and	  the	  remaining	  graphs.	  Results	  from	  t-­‐test	  or	  Mann-­‐Whitney	  U	  test	  are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  present.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S10	  Fig.	  Success	  rate	  per	  delay	  in	  the	  delayed	  non-­‐matching	  to	  position	  test	  during	  retesting	  The	  graphs	  show	  the	  age	  development	  of	  success	  rate	  on	  trial	  types	  with	  delays	  of	  different	  durations	  in	  the	   delayed	   non-­‐matching	   test.	   Each	   graph	   shows	   the	   stable	   performance	   found	   when	   rats	   were	  maintained	   on	   the	   standard	   food	   restriction	   protocol.	   Curves	   display	   group	  mean	   plus	   standard	   error.	  Results	   from	   two-­‐way	   repeated	   measures	   ANOVA	   are	   shown	   inside	   the	   graphs.	   Results	   from	   post-­‐hoc	  analysis	  are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S11	  Fig.	  Latency	  to	  trigger	  choice	  step	  and	  omissions	  for	  delayed	  non-­‐matching	  to	  position	  The	  graphs	  show	  the	  latency	  to	  initiate	  the	  choice	  step,	  related	  omissions	  and	  omissions	  overview	  during	  the	  delayed	  non-­‐matching	  to	  position	  protocol.	  Graphs	  display	  the	  mean	  performance	  over	  all	  ages,	  as	  no	  significant	  differences	  in	  the	  rats’	  behavior	  at	  different	  ages	  was	  found.	  (A)	  and	  (B)	  indicate	  group	  mean	  plus	  standard	  error.	   (C)	   indicates	   the	  performance	  of	   individual	  rats.	  For	  (A)	  and	  (B),	   results	   from	  two-­‐way	   repeated	   measures	   ANOVA	   are	   shown	   inside	   the	   graphs,	   and	   results	   from	   post-­‐hoc	   analysis	   are	  indicated	   in	   case	   significant	   genotype	   differences	   were	   found.	   For	   (C),	   results	   from	   t-­‐test	   or	   Mann-­‐Whitney	  U	  test	  are	  indicated	  in	  case	  the	  genotypes	  differed	  significantly.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S12	  Fig.	  Trial	  start	  latency	  in	  the	  delayed	  non-­‐matching	  to	  position	  test	  The	  graph	   shows	   the	   latency	   to	   initiate	   trials	   on	   the	  different	   test	   ages	  of	   the	  delayed	  non-­‐matching	   to	  position	  protocol.	  The	   curve	   indicates	  group	  mean	  plus	   standard	  error.	  Results	   from	   two-­‐way	   repeated	  measures	   ANOVA	   are	   shown	   inside	   the	   graph,	   and	   results	   from	  post-­‐hoc	   analysis	   are	   indicated	   in	   case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S13	  Fig.	  Lever	  response	  latencies	  during	  delayed	  non-­‐matching	  to	  position	  The	  graphs	  show	  the	  latencies	  to	  respond	  to	  a	  lever	  during	  either	  the	  sample	  step	  or	  the	  choice	  step	  of	  the	  delayed	  non-­‐matching	  to	  position	  protocol.	  (A)	  and	  (B)	  display	  the	  comparison	  between	  WT	  and	  BACHD	  for	  both	  response	  latencies,	  while	  (C)	  and	  (D)	  display	  comparisons	  between	  the	  type	  of	  response	  latencies	  for	  both	  genotypes.	  Graphs	  display	  mean	  performance	  over	  all	   ages,	   as	  no	   significant	  differences	   in	   the	  rats’	  behavior	  at	  different	  ages	  was	  found.	  Curves	  indicate	  group	  mean	  plus	  standard	  error.	  Results	  from	  two-­‐way	  repeated	  measures	  ANOVA	  are	  shown	  inside	  the	  graphs,	  and	  results	  from	  post-­‐hoc	  analysis	  are	  indicated	  for	  data	  points	  where	  significant	  genotype	  differences	  were	  found.	  *	  (p	  <	  0.05)	  **	  (p	  <	  0.01)	  ***	  (p	  <	  0.001).	  
251
Publication	  III	  Supplementary	  Figures	  	  	   4 9 14 190.00.51.0 Age (months)Latency (s) Pellet retrieval latency Age development WTBACHDGenotype: * Age: **Interaction: NS * Pellet trough return Pellet retrieval0.00.51.0Latency (s) Pellet trough return vs. pellet retrieval WTBACHDGenotype: NSProtocol step: *Interaction: *A B 	  
252
Publication	  III	  Supplementary	  Figures	  	  	  	  S14	  Fig.	  Reward	  pellet	  retrieval	  latency	  during	  delayed	  non-­‐matching	  to	  position	  (A)	  shows	  the	  mean	  pellet	  retrieval	   latency	  of	  WT	  and	  BACHD	  rats	  during	   the	  delayed	  non-­‐matching	   to	  position	  protocol	  at	  all	  investigated	  ages.	  (B)	  shows	  a	  comparison	  of	  the	  mean	  pellet	  retrieval	  latency	  with	  the	  mean	   latency	   to	  return	   to	   the	  pellet	   trough	  after	  pushing	   the	  sample	   lever.	  For	   this,	   the	  mean	  of	  all	  investigated	  ages	  and	   trial	   types	  were	  used,	  as	   the	  phenotypes	  or	  differences	  between	   latencies	  did	  not	  clearly	  change	  with	  age.	  Curves	  indicate	  group	  mean	  plus	  standard	  error.	  Results	  from	  two-­‐way	  repeated	  measures	  ANOVA	  are	   shown	   inside	   the	  graphs,	   and	   results	   from	  post-­‐hoc	   analysis	   are	   indicated	   in	   case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S15	   Fig.	   Parameters	   indicating	   success	   or	   failure	   for	   WT	   rats	   in	   the	   delayed	   non-­‐matching	   to	  position	  test	  The	  graphs	  show	  some	  of	  the	  parameters	  of	  the	  delayed	  non-­‐matching	  to	  position	  protocol	  performance	  of	   WT	   rats	   separated	   for	   successful	   and	   failed	   trials.	   All	   graphs	   were	   constructed	   using	   the	   mean	  performance	  over	  all	  ages,	  as	  the	  parameters’	  relation	  to	  trial	  outcome	  did	  not	  noticeably	  change	  between	  test	  ages.	  In	  addition,	  this	  was	  necessary	  to	  obtain	  data	  for	  failed	  0-­‐second	  delay	  trials	  for	  all	  rats.	  Curves	  indicate	   group	  mean	  plus	   standard	   error.	   Results	   from	   two-­‐way	   repeated	  measures	  ANOVA	   are	   shown	  inside	  the	  graphs,	  and	  results	  from	  post-­‐hoc	  analysis	  are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S16	  Fig.	  Parameters	   indicating	  success	  or	   failure	   for	  BACHD	  rats	   in	   the	  delayed	  non-­‐matching	   to	  position	  test	  The	  graphs	  show	  some	  of	  the	  parameters	  of	  the	  delayed	  non-­‐matching	  to	  position	  protocol	  performance	  of	   BACHD	   rats	   separated	   for	   successful	   and	   failed	   trials.	   All	   graphs	   were	   constructed	   using	   the	   mean	  performance	  over	  all	  ages,	  as	  the	  parameters’	  relation	  to	  trial	  outcome	  did	  not	  noticeably	  change	  between	  test	  ages.	  In	  addition,	  this	  was	  necessary	  to	  obtain	  data	  for	  failed	  0-­‐second	  delay	  trials	  for	  all	  rats.	  Curves	  indicate	   group	  mean	  plus	   standard	   error.	   Results	   from	   two-­‐way	   repeated	  measures	  ANOVA	   are	   shown	  inside	  the	  graphs,	  and	  results	  from	  post-­‐hoc	  analysis	  are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S17	  Fig.	  Effect	  of	  food	  restriction	  adjustment	  on	  success	  rate	  in	  delayed	  non-­‐matching	  to	  position	  The	   graphs	   show	   the	   WT	   rats'	   performance	   in	   the	   delayed	   non-­‐matching	   to	   position	   test	   during	   two	  different	  food	  restriction	  settings	  at	  the	  four	  investigated	  age.	  Graphs	  indicate	  group	  mean	  plus	  standard	  error.	  Results	  from	  two-­‐way	  repeated	  measures	  ANOVA	  are	  shown	  inside	  the	  graphs.	  Results	  from	  post-­‐hoc	  analysis	  are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S18	  Fig.	  Effect	  of	   food	  restriction	  adjustment	  of	  WT	  rats	   in	   the	  delayed	  non-­‐matching	  to	  position	  test	  The	  graphs	  show	  some	  of	  the	  parameters	  of	  the	  delayed	  non-­‐matching	  to	  position	  protocol	  performance	  of	  WT	  rats	  separated	  for	  standard	  and	  alternative	  food	  restriction	  protocols.	  All	  graphs	  were	  constructed	  using	   the	   mean	   performance	   over	   all	   ages,	   as	   the	   parameters’	   relation	   to	   motivational	   state	   did	   not	  noticeably	  change	  between	  test	  ages.	  Curves	  indicate	  group	  mean	  plus	  standard	  error.	  Results	  from	  two-­‐way	   repeated	   measures	   ANOVA	   are	   shown	   inside	   the	   graphs,	   and	   results	   from	   post-­‐hoc	   analysis	   are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S19	  Fig.	  Effect	  of	  extended	  training	  of	  BACHD	  rats	  in	  the	  delayed	  non-­‐matching	  to	  position	  test	  The	  graphs	  show	  some	  of	  the	  parameters	  of	  the	  delayed	  non-­‐matching	  to	  position	  protocol	  performance	  of	  BACHD	  rats	  separated	  for	  the	  baselines	  after	  initial	  and	  extended	  training.	  All	  graphs	  were	  constructed	  using	  the	  mean	  performance	  over	  all	  ages,	  as	  the	  parameters’	  relation	  to	  the	  amount	  of	  training	  did	  not	  noticeably	  change	  between	  test	  ages.	  Curves	  indicate	  group	  mean	  plus	  standard	  error.	  Results	  from	  two-­‐way	   repeated	   measures	   ANOVA	   are	   shown	   inside	   the	   graphs,	   and	   results	   from	   post-­‐hoc	   analysis	   are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  S20	  Fig.	  Trial	  start	  omissions	  during	  different	  baselines	  of	  delayed	  non-­‐matching	  to	  position	  The	  graph	  shows	  the	  number	  of	  omissions	  during	   the	   initial	  baselines	  and	  after	  either	  a	  change	   in	   food	  restriction	  protocol	  or	  extended	  training	  on	  the	  delayed	  non-­‐matching	  to	  position	  protocol.	  The	  graph	  was	  constructed	  using	  the	  mean	  performance	  over	  all	  ages,	  as	  the	  parameters’	  relation	  to	  food	  restriction	  or	  extended	   training	   did	   not	   noticeably	   change	   between	   test	   ages.	   The	   curve	   indicates	   group	   mean	   plus	  standard	  error.	  Results	  from	  two-­‐way	  repeated	  measures	  ANOVA	  are	  shown	  inside	  the	  graph,	  and	  results	  from	  post-­‐hoc	  analysis	  are	  indicated	  in	  case	  significant	  genotype	  differences	  were	  found.	  *	  (P	  <	  0.05)	  **	  (P	  <	  0.01)	  ***	  (P	  <	  0.001).	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  Appendix	  I	  Organ	  weights	  from	  Publication	  I	  E	  K	  H	  Jansson,	  L	  E	  Clemens,	  O	  Riess,	  H	  P	  Nguyen	  	  Introduction	  Organ	   weights	   of	   male	   BACHD	   and	   WT	   rats	   were	   investigated	   as	   part	   of	   the	   body	  composition	  study	  presented	  in	  Publication	  I.	  The	  data	  was,	  however,	  not	  included	  in	  the	  publication	  in	  order	  to	  maintain	  focus	  on	  the	  overall	  body	  composition	  and	  motivational	  aspects	  of	  the	  animal	  model.	  An	  overview	  of	  the	  organ	  weights	  is	  thus	  presented	  in	  the	  current	  appendix.	  	  	  Material	  and	  methods	  A	  total	  of	  five	  animal	  groups	  were	  at	  different	  ages	  subjected	  to	  detailed	  dissection.	  The	  experimental	  details	   concerning	  breeding,	  housing	  and	  group	  selection	  are	   thoroughly	  explained	  in	  Publication	  I.	  	  	  The	   dissection	   protocol	   included	   the	   following	   parameters:	   body	  weight,	   body	   length,	  head	  length,	  trunk	  length,	  tail	  length,	  weight	  of	  skin,	  weight	  of	  adipose	  tissue	  deposists,	  weight	  of	  internal	  organs	  and	  weight	  of	  remaining	  bone	  and	  muscle	  tissue.	  The	  weights	  of	   the	   following	   internal	   organs	   were	   investigated	   at	   all	   ages:	   brain,	   heart,	   lungs	  (combined	  weight),	   liver,	   kidneys	   (combined	  weight),	   gastrointestinal	   tract	   (including	  pancreas	   and	   omentum	   majus	   with	   attached	   adipose	   tissues)	   (GI	   tract),	   spleen	   and	  testicles.	  Thymus	  weights	  were	  investigated	  at	  one	  and	  three	  months	  of	  age.	  A	  detailed	  dissection	   of	   the	   GI	   tract	  was	   performed	   at	   12	  months	   of	   age.	   Through	   this,	   separate	  weights	  of	  the	  omentum	  majus	  with	  attached	  adipose	  tissue,	  GI	  tract	  content,	  actual	  GI	  tract	  tissues	  and	  pancreas	  were	  obtained.	  In	  addition,	  the	  weight	  and	  length	  of	  the	  rats’	  femur	  was	  investigated	  at	  12	  months.	  	  	  Results	  As	   noted,	   the	   results	   concerning	   the	   overall	   body	   composition	   phenotypes	   have	   been	  described	  and	  discussed	  in	  Publication	  I.	  The	  current	  appendix	  will	  focus	  on	  the	  weights	  of	  internal	  organs.	  	  	  Most	   internal	   organs	   showed	   some	   indication	   of	   being	   lighter	   among	   BACHD	   rats,	  compared	  to	  WT	  rats	  (Figure	  I).	  This	  phenotype	  was	  strong	  for	  brain	  and	  kidneys,	  while	  being	   less	   pronounced	   for	   heart	   and	   lungs,	   and	   finally	   weak	   for	   liver,	   spleen	   and	  testicles.	   Thymus	   weight	   was	   unchanged	   on	   the	   investigated	   ages.	   In	   contrast	   to	   the	  other	   organs,	   the	   weight	   of	   the	   GI	   tract	   was	   generally	   increased	   among	   BACHD	   rats,	  compared	  to	  WT	  rats.	  Detailed	  investigation	  of	  the	  GI	  tract	  indicated	  that	  the	  omentum	  majus	  and	  attached	  adipose	  tissue	  was	  heavier	  in	  the	  BACHD	  rats,	  while	  the	  weights	  of	  GI	   tract	   content	   and	   tissues	   were	   unchanged	   (Figure	   2).	   In	   addition,	   BACHD	   rats’	  pancreas	   was	   lighter	   than	   that	   of	   WT	   rats.	   Finally,	   the	   BACHD	   rats’	   femur	   was	   both	  shorter	  and	  lighter	  than	  that	  of	  the	  WT	  rats,	  although	  the	  weight	  per	  length	  quotient	  did	  not	  appear	  to	  be	  changed	  (Figure	  3).	  	  	  Additional	  analyses	  were	  performed	  to	   investigate	   if	   the	  apparent	  organ	  weights	  were	  proportionate	  to	  the	  BACHD	  rats’	  smaller	  body	  size.	  Thus,	  the	  weight	  of	  each	  organ	  was	  related	   to	   the	   body	   compartment	   it	   resided	   in	   (i.e.	   head	   length	   for	   brain	  weights	   and	  trunk	  length	  for	  all	  other	  organs).	  Results	  from	  this	  analysis	  indicated	  that	  the	  BACHD	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  rats’	   brain,	   heart,	   kidneys	   and	   testicles	   were	   disproportionally	   light	   relative	   to	   their	  body	  size	  (Figure	  4).	  	  	  Finally,	   it	   should	  be	  noted	   that	   the	  various	  differences	   found	   in	  organ	  weights	  did	  not	  appear	  to	  be	  caused	  by	  a	  gradual	  degeneration,	  but	  rather	  impaired	  growth.	  	  	  Discussion	  As	   discussed	   in	   Publication	   I,	   BACHD	   rats	   are	   generally	   smaller	   than	   WT	   rats.	   This	  overarching	  phenotype	  likely	  also	  explains	  the	  quite	  general	  phenotype	  of	  BACHD	  rats	  having	  lighter	  organs	  than	  WT	  rats.	  Still,	  specific	  growth	  deficits	  appear	  to	  be	  present	  for	  brain,	   heart,	   kidneys,	   pancreas	   and	   testicles,	   as	   their	   weights	   were	   disproportionally	  small	  compared	  to	  the	  BACHD	  rats’	  body	  size.	  Details	  concerning	  these	  phenotypes	  are	  further	   discussed	   in	   the	  main	   Results	   and	   discussion	   section	   of	   the	   current	   thesis.	   It	  should,	   however,	   be	   noted	   that	   specific	   functional	   analyses	   would	   be	   necessary	   to	  conclude	  whether	   the	  noted	   size	  differences	   are	   related	   to	   any	  organ	  dysfunctions.	   In	  addition,	  the	  relative	  weights	  calculated	  here	  are	  rather	  simplistic,	  and	  might	  not	  give	  a	  fair	   picture	   of	   the	   rats’	   physiology.	   More	   advanced	   calculations	   would	   be	   needed	   to	  better	  take	  the	  allometric	  growth	  of	  organs	  and	  tissues	  into	  account	  (see	  Shea	  BT,	  Hammer	  RE,	   Brinster	   RL.	   Growth	   allometry	   of	   the	   organs	   in	   giant	   transgenic	   mice.	   1987.	   Endocrinology.	  121:6:1924-­‐1930	   and	   Lindstedt	   SL,	   Schaeffer	   PJ.	   Use	   of	   allometry	   in	   predicting	   anatomical	   and	  physiological	   parameters	   of	  mammals.	  Lab	  Anim.	  2002;	   31:1:1-­‐19	   for	   further	   information	  on	   this	  topic).	  	  	  As	  noted,	   the	  GI	   tract	  was	   the	  only	   organ	   that	   appeared	   to	  be	  heavier	   in	  BACHD	   rats,	  compared	  to	  WT	  rats.	  However,	  this	  phenotype	  appeared	  to	  be	  caused	  by	  an	  increased	  weight	  of	  the	  omentum	  majus,	  which	  contained	  a	  large	  amount	  of	  adipose	  tissue.	  Thus,	  the	  phenotype	  is	  in	  line	  with	  the	  overall	  obesity	  found	  in	  BACHD	  rats	  (see	  Publication	  I).	  	  	  Finally,	  the	  results	  indicated	  that	  the	  BACHD	  rats’	  femurs	  were	  shorter	  and	  lighter	  than	  those	  of	  the	  WT	  rats.	   Importantly,	   the	  overall	  bone	  density	  was	  unchanged,	  suggesting	  that	   the	   disproportionately	   lower	   weight	   of	   bone/muscle	   tissues	   described	   in	  Publication	   I	   was	   primarily	   caused	   by	   a	   deficit	   in	   muscle	   growth.	   A	   general	   growth	  deficit	  of	  muscle	  tissues	  could	  also	  explain	  the	  disproportionately	  lower	  heart	  weights	  of	  the	  BACHD	  rats.	  	  	  Conclusion	  The	  BACHD	  rats	  show	  a	  general	  phenotype	  of	  having	  lighter	  organ	  weights	  compared	  to	  WT	  rats.	  This	  phenotype	   is	   likely	  connected	   to	   the	  BACHD	  rats’	  overall	  growth	  deficit,	  although	   additional	   investigations	   should	   be	   made	   regarding	   the	   rats’	   brain,	   muscle,	  kidney,	   pancreatic	   and	   testicular	   tissues,	   to	   evaluate	   the	   presence	   of	   organ	   specific	  dysfunctions.	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    Figure	   1.	   Organ	   weights	   in	   grams	   from	   animal	   groups	   described	   and	   discussed	   in	  Publication	  I.	  Group	  mean	  plus	  standard	  error	   is	  shown.	  Significant	  results	   from	  two-­‐way	  ANOVA	   are	   indicated	   inside	   graphs.	   Data	   points	   where	   post-­‐tests	   indicated	   a	   significant	  genotype	  effect	  are	  also	  noted	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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  Figure	   2.	   Detailed	   investigation	   of	   gastrointestinal	   tract	   components.	   Data	  was	   obtained	  from	  the	  12	  months	  old	  rats	  described	  and	  discussed	  in	  Publication	  I.	  Scatter	  plots	  indicate	  values	  from	  individual	  animals	  and	  group	  mean.	  Significant	  genotype	  differences	  obtained	  through	  Student	  t-­‐test	  or	  Mann-­‐Whitney	  U	  test	  are	  indicated	  in	  the	  figures	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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     Figure	   3.	   Specific	   investigation	   of	   femur	   parameters.	   Data	   was	   obtained	   from	   the	   12	  months	  old	  rats	  described	  and	  discussed	  in	  Publication	  I.	  Scatter	  plots	  indicate	  values	  from	  individual	   animals	   and	   group	   mean.	   Significant	   genotype	   differences	   obtained	   through	  Student	  t-­‐test	  are	  indicated	  in	  the	  figures	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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  Figure	  4.	  Organ	  weights	   in	   relation	   to	   size	  of	   the	   respective,	   related	  body	   compartment.	  Data	  was	  obtained	   from	  animal	   groups	  described	  and	  discussed	   in	  Publication	   I.	   For	  bar	  graphs,	  group	  mean	  plus	  standard	  error	  is	  shown.	  Significant	  results	  from	  two-­‐way	  ANOVA	  are	   indicated	   inside	  graphs.	  Data	  points	  where	  post-­‐tests	   indicated	  a	  significant	  genotype	  effect	  are	  also	  noted.	  For	  scatter	  plot,	  values	  from	  individual	  rats	  are	  indicated	  together	  with	  group	  mean.	  A	  significant	  genotype	  difference	  from	  Mann-­‐Whitney	  U	  test	  is	  indicated	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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  Appendix	  II	  BACHD	  rats	  performance	  in	  a	  symmetrically	  reinforced	  Go/No-­‐Go	  test	  E	  K	  H	  Jansson,	  A	  Novati,	  L	  E	  Clemens,	  O	  Riess,	  H	  P	  Nguyen	  	  Introduction	  As	   part	   of	   a	   larger	   project	   to	   characterize	   the	   BACHD	   rats’	   performance	   in	   several	  inhibitory	  control	  tests	  they	  were	  assessed	  in	  a	  symmetrically	  reinforced	  Go/No-­‐Go	  test.	  This	  constituted	  a	  well-­‐structured	  study	  with	  control	  tests	  that	  are	  in	  line	  with	  the	  ideas	  presented	  in	  the	  current	  thesis.	  	  	  Material	  and	  methods	  Animals	  A	  group	  of	  24	  male	  rats	  (12	  hemizygous	  BACHD	  (TG5),	  12	  WT)	  were	  bred	  for	  the	  study.	  Housing	  was	   in	   line	  with	  what	   is	   presented	   in	  Publication	   I	   for	   the	   group	  used	   in	   the	  Progressive	  ratio	  test.	  Rats	  were	  maintained	  on	  food	  restriction	  during	  experiments,	  and	  given	   free	  access	   to	   food	  between	   tests.	   Food	   restriction	  during	  experiments	  used	   the	  alternative	   food	   restriction	   protocol	   as	   presented	   in	   the	   current	   thesis,	   where	   food	  consumption	   rates	   of	   WT	   and	   BACHD	   rats	   were	   matched	   to	   minimize	   motivational	  differences.	   Body	   weights	   were	   measured	   weekly	   between	   experiments	   to	   monitor	  general	  health,	  and	  daily	  during	  experiments	  to	  monitor	  food	  restriction	  levels.	  	  	  Behavioral	  protocol	  Rats	  were	  assessed	  in	  the	  Go/No-­‐Go	  protocol	  at	  2,	  7,	  12	  and	  17	  months	  of	  age.	  The	  test	  was	  performed	  in	  a	  bank	  of	  six	  operant	  conditioning	  boxes,	  which	  are	  described	  in	  detail	  in	   Publication	   I.	   Four	   runs	   were	   required	   to	   assess	   all	   rats.	   Each	   run	   assessed	   three	  BACHD	   and	   three	  WT	   rats.	   Each	   rat	  was	   assigned	   to	   a	   specific	   conditioning	   chamber,	  although	   each	   conditioning	   chamber	   was	   used	   to	   assess	   two	   rats	   of	   each	   genotype.	  Training	  was	  performed	  during	   the	  early	  part	  of	   the	   light	   cycle’s	  dark-­‐phase,	  with	   the	  first	   run	   being	   performed	   roughly	   30	   minutes	   after	   dark-­‐phase	   onset.	   Duration	   of	  training	  sessions	  varied	  as	  described	  below.	  	  	  The	  behavioral	  protocol	  used	  a	  series	  of	  different	  training	  steps,	  which	  differed	  between	  the	   test	   ages.	   During	   the	   two-­‐months	   test	   age,	   rats	   were	   first	   given	   two	   habituation	  sessions	  to	  the	  operant	  conditioning	  boxes.	  During	  these,	  both	  levers	  were	  retracted,	  the	  house	   light	  was	   switched	   on,	   and	   a	   total	   of	   100	   reward	   pellets	  were	   delivered	   to	   the	  pellet	   receptacle	   at	   intervals	   that	   were	   randomized	   between	   10,	   15,	   20,	   25,	   and	   30	  seconds.	   Afterwards,	   rats	   were	   trained	   to	   perform	   lever	   pushes	   on	   a	   continuous	  reinforcement	  (CRF)	  protocol.	  During	  this,	  one	  lever	  was	  inserted	  into	  the	  conditioning	  box,	   and	   the	   house	   light	  was	   switched	   on.	   Any	   lever	   push	   performed	   by	   the	   rats	  was	  rewarded	   with	   the	   delivery	   of	   a	   reward	   pellet.	   Rats	   were	   initially	   given	   rewards	   for	  approaching,	  sniffing	  and	  touching	  the	  lever,	  but	  eventually	   learned	  to	  reliably	  push	  it.	  Training	   continued	   until	   rats	   performed	  100	   pushes	   on	   their	   own	  within	   30	  minutes.	  When	   rats	   had	   reached	   this	   criterion,	   they	   were	   trained	   on	   a	   second	   CRF	   protocol,	  where	  the	  previously	  retracted	  lever	  was	  now	  available.	  As	  the	  previously	  inserted	  lever	  was	   now	   retracted,	   this	   protocol	   forced	   rats	   to	   also	   associate	   the	   second	   lever	  with	   a	  pellet	  reward.	  Rats	  were	  once	  again	  trained	  until	  they	  had	  performed	  100	  lever	  pushes	  on	   their	   own	   within	   30	   minutes.	   Once	   this	   had	   been	   achieved,	   they	   were	   run	   on	   a	  protocol	  that	  trained	  them	  to	  initiate	  discrete	  trials,	  and	  to	  reliably	  respond	  to	  both	  the	  left	  and	  right	  lever,	  when	  they	  were	  inserted.	  The	  sessions	  were	  composed	  of	  100	  trials,	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  which	  followed	  a	  similar	  pattern.	  The	  protocol	  started	  with	  an	  inter-­‐trial	  interval	  (ITI),	  during	   which	   all	   lights	   were	   off,	   and	   both	   levers	   were	   retracted.	   Duration	   was	  randomized	  between	  5,	  7,	  9,	  and	  11	  seconds.	  At	  the	  end	  of	  the	  ITI,	  the	  light	  in	  the	  pellet	  receptacle	  would	   start	   to	   shine.	  When	   the	   rats	   entered	   into	   the	   pellet	   receptacle,	   the	  light	  would	  be	  switched	  off.	  At	  the	  same	  time,	  both	  the	  house	  light	  and	  the	  two	  cue	  lights	  positioned	   above	   each	   lever	   would	   start	   to	   shine.	   In	   addition,	   one	   of	   the	   two	   levers	  would	   be	   inserted.	   The	   protocol	   was	   designed	   to	   that	   the	   left	   and	   right	   lever	   were	  presented	   an	   equal	   number	   of	   times	   in	   a	   pseudo-­‐randomized	   order.	   At	   this	   point	   in	  training,	  the	  lever	  remained	  inserted	  until	  the	  rats	  responded	  to	  it.	  When	  rats	  performed	  a	   lever	  push,	   a	   reward	  pellet	  was	  delivered	   to	   the	  pellet	   receptacle	   and	   the	   cue	   lights	  above	   the	   levers	  were	   switched	  off.	   Retrieving	   the	   reward	  pellet	   resulted	   in	   the	   lever	  retracting,	   the	   house	   light	   being	   switched	   off,	   and	   a	   new	   ITI	   being	   started.	   Rats	  were	  trained	  on	   this	  protocol	  until	   they	  completed	  100	   trials	  within	  30	  minutes.	  When	  rats	  had	  reached	  this	  criterion,	  time	  limits	  were	  added	  to	  the	  protocol.	  Thus,	  the	  rats	  had	  to	  respond	  to	  the	  initial	  light	  signal	  in	  the	  pellet	  receptacle	  as	  wells	  as	  the	  inserted	  levers	  within	  ten	  seconds.	  If	  no	  response	  was	  made,	  the	  trials	  were	  omitted.	  This	  was	  trained	  until	   the	   rat	  made	   less	   than	   five	   lever	   response	   omissions	   during	   a	   full	   session.	   This	  protocol	  was	  also	  used	  as	  the	  first	  protocol	  trained	  when	  rats	  were	  reassessed	  at	  older	  ages.	  In	  later	  sections	  of	  the	  current	  appendix	  it	  will	  be	  referred	  to	  as	  a	  protocol	  with	  a	  series	  of	  Go	  trials.	  Once	  rats	  had	  learned	  to	  perform	  reliably	  on	  this	  protocol	  they	  were	  trained	  on	  a	  series	  of	  symmetrically	  reinforced	  Go/No-­‐Go	  protocols	  (Figure	  1).	  The	  aim	  of	   these	   protocols	  was	   to	   train	   the	   rats	   to	   recognize	   and	   discriminate	   two	   light	   cues,	  which	  signaled	  that	  they	  had	  to	  either	  perform	  or	  withhold	  a	  lever	  response	  in	  order	  to	  be	   rewarded	  with	   a	   food	   pellet.	   Each	   session	  was	   composed	   of	   100	   trials,	  with	   equal	  numbers	  of	  Go	  and	  No-­‐Go	  trials	  presented	  in	  a	  pseudo-­‐randomized	  order.	  For	  both	  Go	  and	  No-­‐Go	  trials,	   the	   left	  and	  right	   lever	  was	  presented	  an	  equal	  number	  of	   times	   in	  a	  pseudo-­‐randomized	   order.	   Each	   trial	   followed	   a	   series	   of	   similar	   steps.	   The	   protocol	  started	  with	  a	  ten-­‐second	  ITI,	  where	  both	  levers	  were	  retracted,	  and	  all	  lights	  were	  off.	  At	  the	  end	  of	  the	  ITI,	  the	  light	  in	  the	  pellet	  receptacle	  would	  start	  to	  shine.	  When	  the	  rats	  entered	   the	  pellet	   receptacle,	   the	   light	  was	   switched	  off	   and	  one	  of	   the	   two	   light	   cues	  was	  presented.	  For	  Go	  trials,	  the	  two	  cue	  lights	  above	  the	  levers	  shone	  together	  with	  the	  house	   light.	   For	  No-­‐Go	   trials,	   the	   house	   light	   shone	   alone.	   Both	   light	   cues	   shone	   for	   a	  total	   of	   five	   seconds.	   Afterwards,	   one	   lever	   was	   inserted	   and	   the	   rats	   had	   to	   either	  respond	   to	   it	   (on	  Go	   trials)	   or	  withhold	   a	   lever	   response	   (on	  No-­‐Go	   trials).	   Successful	  performance	  was	  rewarded	  with	  a	  food	  pellet.	  During	  the	  initial	  protocol,	  Go	  trials	  were	  set	  to	  be	  six	  seconds	  long,	  while	  No-­‐Go	  trials	  were	  only	  two	  seconds	  long.	  This	  protocol	  was	  trained	  until	  the	  rat	  showed	  above	  80%	  success	  rate	  on	  both	  Go	  and	  No-­‐Go	  trials	  on	  three	  consecutive	  sessions.	  When	  rats	  had	  reached	  this	  criterion,	  they	  were	  trained	  on	  a	  protocol	  where	   the	  No-­‐Go	  trial	  duration	  had	  been	   increased	   to	   four	  seconds.	  This	  was	  trained	   until	   rats	   showed	   above	   80%	   success	   rate	   on	   both	   Go	   and	   No-­‐Go	   trials	   on	   a	  single	  session.	  Finally,	  rats	  were	  trained	  on	  a	  protocol	  where	  both	  Go	  and	  No-­‐Go	  trials	  were	  six	  seconds	   long.	  Performance	  criterion	  was	  once	  again	  set	   to	  rats	  showing	  80%	  success	   rate	  on	  both	  Go	  and	  No-­‐Go	   trials	   on	   three	   consecutive	   sessions.	  At	   the	   end	  of	  this,	   rats	   had	   thus	   reliably	   learned	   to	   discriminate	   the	   light	   cues	   and	   respond	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  accordingly.	   To	   further	   evaluate	   their	   ability	   to	   withhold	   lever	   responses	   they	   were	  given	   a	   single	   test	   session	  where	   the	  duration	   of	   the	  No-­‐Go	   trials	   varied	   in	   a	   pseudo-­‐randomized	  manner	  between	  6,	  10,	  14,	  18,	  and	  22	  seconds.	  	  	  During	   the	   final	   test	   age,	   the	   rats	  were	   given	   extensive	   training	   on	   the	   protocol	  with	  varied	   No-­‐Go	   duration,	   to	   better	   evaluate	   their	   ability	   to	   learn	   to	   withhold	   lever	  responses.	  In	  addition,	  the	  rats’	  motivation	  to	  perform	  lever	  responses	  for	  food	  rewards	  was	   assessed	   in	   a	   progressive	   ratio	   test.	   This	   test	   protocol	   is	   described	   in	   detail	   in	  Publication	  I.	  	  	  	  Behavioral	  parameters	  Several	  different	  behavioral	  parameters	  were	  analyzed	  from	  the	  various	  protocols.	  The	  number	  of	  sessions	  needed	  to	  reach	  criterion	  on	  the	  different	  protocols	  was	  used	  as	  the	  main	   parameter	   of	   learning.	   Due	   to	   the	   difference	   in	   criterion	   (i.e.	   three	   consecutive	  criterion	  sessions	  or	  only	  one)	  the	  number	  of	  sessions	  to	  criterion	  was	  calculated	  from	  the	   first	   training	   session	   to	   the	   first	   criterion	   session.	   Additional	   parameters	   were	  analyzed	  from	  sessions	  were	  rats	  performed	  at	  criterion	  level,	  during	  the	  final	  Go/No-­‐Go	  protocol	   (i.e.	   where	   both	   trial	   types	   were	   limited	   to	   six	   seconds).	   These	   parameters	  included	   the	   mean	   success	   rate	   on	   both	   trial	   types,	   the	   latency	   to	   initiate	   trials	   (i.e.	  latency	   to	   respond	   to	   the	   pellet	   receptacle	   light),	   the	   number	   of	   entries	   performed	  during	   cue	  presentation,	   the	   latency	   to	   perform	  a	   lever	   response	   on	  Go	   trials	   and	   the	  latency	  to	  retrieve	  the	  reward	  pellet	  on	  Go	  trials.	  For	  the	  protocol	  where	  the	  duration	  of	  No-­‐Go	   trials	  was	   varied,	   separate	   success	   rates	  were	   calculated	   for	   each	   trial	   type.	   In	  addition,	  the	  latency	  to	  perform	  a	  lever	  push	  was	  analyzed	  for	  both	  successful	  Go	  trials,	  and	  failed	  No-­‐Go	  trials.	  	  	  Statistical	  methods	  Behavioral	  data	  was	  extracted	  by	  running	  the	  log	  files	  created	  by	  the	  system	  through	  a	  series	   of	   R	   scripts.	   Statistical	   analysis	   was	   performed	   in	   GraphPad	   prism	   (v.	   6.0)	  Analyses	  were	  performed	  with	  two-­‐way	  repeated	  measures	  ANOVAs,	  using	  genotype	  as	  between	  subject	  factor	  and	  either	  age	  or	  trial	  type	  as	  within	  subject	  factor.	  Sidak’s	  post-­‐test	  was	  used	  to	  evaluate	  genotype	  differences	  on	  individual	  data	  points.	  Some	  BACHD	  rats	  did	  not	  manage	  to	  reach	  the	  performance	  criterion	  on	  the	  final	  Go/No-­‐Go	  protocol	  (where	  both	  Go	  and	  No-­‐Go	  trials	  were	  limited	  to	  six	  seconds).	  These	  rats	  were	  excluded	  from	  analyses	  of	  sessions	  to	  criterion	  and	  criterion	  session	  performance.	  The	  rats	  were	  still	  assessed	  on	  the	  protocol	  where	  No-­‐Go	  trials	  varied	  in	  duration,	  and	  were	  included	  in	   the	   analysis	   of	   this	   step.	   This	   was	   done	   so	   that	   a	   comprehensive	   analysis	   of	   the	  BACHD	   rats’	   performance	   could	   still	   be	   obtained.	   A	   total	   of	   three	  WT	   rats	   became	   ill	  during	  the	  experiment,	  and	  were	  sacrificed	  before	  the	  final	  test	  age.	  Data	  from	  these	  rats	  was	  excluded	  from	  longitudinal	  analyses.	  Lever	  response	   latencies	  during	  the	  protocol	  with	  varied	  No-­‐Go	  trial	  duration	  had	  occasional	  gaps,	  as	  rats	  happened	  to	  show	  perfect	  success	  on	  some	  subtypes	  of	  No-­‐Go	  trials.	  The	  exact	  n	  for	  analyses	  is	  noted	  below.	  The	  extended	   training	   given	   on	   the	   protocol	   with	   varied	   No-­‐Go	   durations	   consisted	   of	   an	  additional	  24	  sessions.	  Analysis	  of	  this	  step	  included	  the	  initial	  test	  session,	  giving	  a	  total	  of	  25	  sessions,	  which	  were	  analyzed	  in	  five	  blocks	  of	  five	  sessions	  each.	  The	  progressive	  ratio	   training	   consisted	   of	   12	   sessions,	   the	   first	   three	   of	   which	   were	   excluded	   to	  construct	  the	  stable	  performance	  baseline.	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  Results	  Although	   there	  were	   some	  discreet	   performance	  differences	   between	  BACHD	  and	  WT	  rats	   during	   the	   initial	   habituation	   and	   lever	   training	   protocols	   these	   will	   not	   be	  discussed	   here.	   The	   noted	   phenotypes	   have	   not	   been	   consistently	   seen	   across	  experiments	  and	  are	  likely	  of	  little	  importance.	  Still,	  it	  should	  be	  noted	  that	  both	  WT	  and	  BACHD	  rats	  learned	  to	  reliably	  respond	  to	  the	  levers,	  and	  with	  few	  exceptions	  required	  more	  than	  one	  or	  two	  sessions	  to	  reach	  criterion	  on	  each	  initial	  protocol.	  	  	  During	  the	  Go/No-­‐Go	  training,	  BACHD	  rats	  were	  found	  to	  reliably	  require	  more	  training	  sessions	   before	   reaching	   criterion	   on	   the	   first	   protocol	   (i.e.	   when	   Go	   trials	   were	   6	  seconds	  long	  and	  No-­‐Go	  trials	  were	  2	  seconds	  long),	  but	  not	  the	  protocols	  that	  followed	  (Figure	  2).	  As	  noted,	  three	  BACHD	  rats	  did	  not	  reliably	  reach	  criterion	  during	  the	  final	  protocol,	  despite	  being	  given	  extensive	  training.	  One	  rat	  failed	  to	  reach	  criterion	  during	  bot	  the	  12	  and	  17-­‐month	  test	  age.	  One	  rat	  failed	  to	  reach	  criterion	  during	  the	  17-­‐month	  test	  age.	  The	  last	  rat	  failed	  to	  reach	  criterion	  during	  the	  12-­‐month	  test	  age,	  but	  managed	  during	   the	   17-­‐month	   test	   age.	   Regardless,	   all	   rats	   were	   excluded	   from	   the	   analysis	  shown	  in	  Figure	  2,	  giving	  an	  n	  of	  12	  for	  WT	  and	  10	  for	  BACHD	  rats.	  	  	  Among	  the	  rats	  that	  did	  reach	  criterion,	  there	  was	  no	  difference	  in	  overall	  success	  rates	  between	  WT	   and	   BACHD	   rats	   for	   either	   trial	   type	   (Figure	   3).	   Still,	   BACHD	   rats	   were	  found	  to	  be	  slightly	  slower	  at	  initiating	  trials,	  responding	  to	  the	  inserted	  lever	  during	  Go	  trials,	  and	  retrieving	  the	  reward	  pellets.	  Although	  the	  rats’	  specific	  performance	  changed	  with	  age,	   the	  noted	  phenotypes	  remained	  arguably	  stable.	   It	   is	   interesting	  to	  note	  that	  the	   slowed	   trial	   start	   and	   lever	   response	   among	  BACHD	   rats	  was	  not	   seen	  during	   the	  protocol	  that	  only	  contained	  Go	  trials	  (i.e.	  the	  protocol	  trained	  before	  introducing	  two-­‐second	  long	  No-­‐Go	  trials)	  (Figure	  4)	  (data	  from	  7	  months	  of	  age	  was	  excluded,	  as	  not	  all	  rats	  received	  the	  training	  on	  that	  occasion).	  	  	  When	  the	  duration	  of	  No-­‐Go	  trials	  was	  extended	  and	  randomized,	  both	  BACHD	  and	  WT	  rats	  showed	  a	  drop	  in	  success	  rate	  with	  longer	  No-­‐Go	  durations	  (Figure	  5).	  No	  difference	  was	   found	   between	   genotypes	   regarding	   their	   overall	   success	   rate,	   or	   the	   latency	   to	  respond	  to	  the	  inserted	  lever.	  As	  noted,	  some	  rats	  had	  to	  be	  excluded	  from	  the	  analysis	  of	  response	  latencies	  due	  to	  missing	  data	  values.	  Thus,	  the	  number	  of	  included	  animals	  at	  a	  given	  age	  varied	  between	  5-­‐9	  and	  11-­‐10	  for	  WT	  and	  BACHD	  rats	  respectively.	  	  	  When	  rats	  were	  given	  extended	   training	  on	   the	  protocol	  with	  varied	  No-­‐Go	  durations,	  there	   were	   no	   apparent	   differences	   in	   the	   WT	   and	   BACHD	   rats’	   abilities	   to	   learn	   to	  withhold	   responses	   (Figure	   6).	   The	   progressive	   ratio	   test	   also	   indicated	   that	  WT	   and	  BACHD	  rats	  were	  equally	  motivated	  to	  perform	  lever	  pushes	  for	  a	  food	  reward	  (Figure	  7).	  	  	  Discussion	  As	   noted,	   the	   BACHD	   rats	   showed	   consistent	   difficulties	   with	   initially	   learning	   to	  withhold	   lever	   responses,	   as	   indicated	   by	   the	   significantly	   higher	   number	   of	   sessions	  required	  to	  reach	  criterion	  on	  the	  Go/No-­‐Go	  protocol	  that	  used	  two-­‐second	  long	  No-­‐Go	  trials.	  However,	  once	  they	  had	  learned	  this	  initial	  response	  withholding	  they	  showed	  no	  deficit	  in	  withholding	  responses	  for	  longer	  durations	  of	  time.	  This	  was	  evident	  in	  several	  steps	  of	  the	  test,	  including	  the	  sessions	  to	  criterion	  for	  the	  other	  Go/No-­‐Go	  protocols	  (i.e.	  with	   four-­‐	   and	   six-­‐second	   long	  No-­‐Go	   trials),	   their	   performance	  on	   the	  protocols	  with	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  varied	  No-­‐Go	  durations,	  as	  well	  as	  their	  gradual	  improvement	  in	  that	  protocol	  through	  extended	  training.	  	  	  BACHD	  rats	  also	  showed	  slowed	  trial	  starts,	  lever	  response	  latencies,	  and	  pellet	  retrieval	  latencies.	   Interestingly,	   these	   phenotypes	   appeared	   to	   be	   unique	   to	   the	   Go/No-­‐Go	  protocol,	  as	  they	  were	  not	  present	  in	  the	  earlier	  protocols	  that	  presented	  the	  rats	  with	  only	  Go	  trials.	  Thus,	  the	  phenotypes	  are	  unlikely	  to	  be	  related	  to	  motoric	  impairments,	  but	  could	  rather	  be	  due	  to	  slight	  differences	   in	  motivation	  and/or	  attention	  (trial	  start	  and	  pellet	  retrieval)	  and	  cognitive	  processing	  speed	  (lever	  response	  latency).	  	  	  As	  the	  current	  test	  did	  not	  rely	  on	  establishing	  a	  stable	  baseline	  (such	  as	  the	  progressive	  ratio,	  delayed	  alternation	  and	  delayed	  non-­‐matching	  to	  position	  protocols),	  the	  control	  tests	   used	   in	   Publication	   III	   were	   not	   suitable	   for	   evaluating	   the	   Go/No-­‐Go	   readouts’	  dependency	   on	   motivational	   factors.	   Instead,	   we	   sought	   to	   establish	   food	   restriction	  levels	   that	   were	   likely	   to	   result	   in	   comparable	   motivation.	   To	   evaluate	   if	   this	   had	  worked,	  we	  assessed	  the	  rats’	  performance	  in	  a	  progressive	  ratio	  test	  at	  the	  end	  of	  the	  study.	  As	  noted,	  WT	  and	  BACHD	  rats	  showed	  similar	  motivation	  to	  perform	  lever	  pushes	  for	  a	  food	  reward,	  and	  it	  is	  thus	  unlikely	  that	  the	  phenotypes	  noted	  above	  were	  due	  to	  motivational	  differences	  between	  WT	  and	  BACHD	  rats.	  	  	  Although	  the	  slowed	  learning	  to	  withhold	  lever	  responses	  seen	  among	  BACHD	  rats	  could	  be	  due	  to	  a	  discreet	  inhibitory	  control	  deficit,	  one	  has	  to	  consider	  the	  possibility	  that	  the	  BACHD	   rats	   might	   have	   impaired	   attention,	   visual	   abilities	   or	   general	   learning	  impairments.	  Further	  behavioral	  characterization	  is	  needed	  to	  reach	  conclusions	  on	  this	  matter.	  	  	  Conclusion	  BACHD	   rats	   show	   a	   consistent,	   slight	   impairment	   when	   learning	   to	   withhold	   lever	  responses	  in	  the	  current	  Go/No-­‐Go	  protocol.	  This	  could	  indicate	  a	  discreet	  impairment	  in	   response	   inhibition	  control,	   although	  other	  cognitive	  and	  visual	  aspects	   should	  also	  be	  considered.	  Regardless,	   the	   impairment	   is	  not	  strong	  enough	  to	  result	   in	  an	  overall	  impaired	  response	  inhibition	  among	  BACHD	  rats.	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Figure	  1.	  Schematic	  of	  the	  symmetrically	  reinforced	  Go/No-­‐Go	  protocol.	  The	  different	  steps	   of	   the	   protocol	   are	   noted.	   Components	   of	   the	   Skinner	   box	   are	   indicated	   with	  circles	  for	  lever	  cue	  lights,	  and	  a	  pentagon	  for	  the	  house	  light.	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     Figure	  2.	  Number	  of	   training	  sessions	  needed	  before	  rats	  reached	  criterion	  performance.	  Curves	  indicate	  group	  mean	  plus	  standard	  error	  for	  each	  test	  age	  and	  Go/No-­‐Go	  protocol.	  Results	  from	  repeated	  measures	  two-­‐way	  ANOVAs	  are	  indicated	  inside	  each	  graph.	  Results	  from	  post-­‐hoc	  analysis	  are	  indicated	  for	  data	  points,	  where	  significant	  genotype	  differences	  were	  found	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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  Figure	  3.	  Selected	  parameters	  from	  criterion	  performance	  during	  the	  Go/No-­‐Go	  protocol,	  where	  both	   trial	   types	  were	   six	   seconds	   long.	  Curves	   indicate	  group	  mean	  plus	   standard	  error	   for	   each	   test	   age.	   Results	   from	   repeated	  measures	   two-­‐way	  ANOVAs	   are	   indicated	  inside	   each	   graph.	   Results	   from	   post-­‐hoc	   analysis	   are	   indicated	   for	   data	   points,	   where	  significant	  genotype	  differences	  were	  found	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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              Figure	  4.	  Selected	  parameters	  from	  the	  final	  lever	  training	  step,	  where	  rats	  were	  presented	  with	  a	  series	  of	  Go	  trials.	  Curves	  indicate	  group	  mean	  plus	  standard	  error	  for	  each	  test	  age	  and	  Go/No-­‐Go	  protocol.	  Results	   from	  repeated	  measures	   two-­‐way	  ANOVAs	  are	   indicated	  inside	   each	   graph.	   Results	   from	   post-­‐hoc	   analysis	   are	   indicated	   for	   data	   points,	   where	  significant	  genotype	  differences	  were	  found	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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  Figure	  5.	  Success	  rate	  and	  lever	  response	  latencies	  for	  all	  trial	  types	  during	  the	  Go/No-­‐Go	  test	  protocol,	  where	  the	  duration	  of	  No-­‐Go	  trials	  varied.	  Lever	  response	   latencies	  refer	  to	  successful	  Go	  trials	  and	  non-­‐successful	  No-­‐Go	  trials.	  The	  number	  that	  follows	  Go	  or	  No-­‐Go	  trial	   refers	   to	   the	   trial	  duration.	  Curves	   indicate	  group	  mean	  plus	  standard	  error.	  Results	  from	  repeated	  measures	   two-­‐way	  ANOVAs	  are	   indicated	   inside	  each	  graph.	  Results	   from	  post-­‐hoc	  analysis	  are	  indicated	  for	  data	  points,	  where	  significant	  genotype	  differences	  were	  found	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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  Figure	   6.	   Change	   in	   success	   rate	   through	   extensive	   training	   on	   the	   Go/No-­‐Go	   protocol,	  where	  the	  duration	  of	  No-­‐Go	  trials	  varied.	  Graphs	  show	  mean	  success	  rates	  on	  blocks	  of	  five	  consecutive	   sessions.	   Curves	   indicate	   group	   mean	   plus	   standard	   error.	   Results	   from	  repeated	  measures	   two-­‐way	  ANOVAs	  are	   indicated	   inside	  each	  graph.	  Results	   from	  post-­‐hoc	   analysis	   are	   indicated	   for	   data	   points,	   where	   significant	   genotype	   differences	   were	  found	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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               Figure	  7.	  Performance	  on	  a	  progressive	  ratio	  control	  test	  during	  the	  17-­‐month	  test	  age.	  A	  series	   of	   break	   points	   were	   assessed.	   Curves	   indicate	   group	   mean	   plus	   standard	   error.	  Results	  from	  repeated	  measures	  two-­‐way	  ANOVAs	  are	  indicated	  inside	  each	  graph.	  Results	  from	  post-­‐hoc	  analysis	  are	  indicated	  for	  data	  points,	  where	  significant	  genotype	  differences	  were	  found	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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  Appendix	  III	  BACHD	  rat	  performance	  in	  two	  DRL	  protocols	  E	  K	  H	  Jansson,	  L	  Yu-­‐Taeger,	  O	  Riess,	  H	  P	  Nguyen	  	  Introduction	  As	   part	   of	   a	   larger	   project	   to	   characterize	   the	   BACHD	   rats’	   performance	   in	   several	  inhibitory	   control	   tests	   they	   were	   assessed	   in	   two	   different	   protocols	   based	   on	   a	  differential	  reinforcement	  of	  low-­‐rates	  (DRL)	  schedule.	  	  	  Material	  and	  methods	  	  	  Animals	  The	   first	   study	   used	   a	   total	   of	   36	   male	   rats	   (13	   hemizygous	   BACHD	   (TG5)	   rats,	   11	  hemizygous	  BACHD	  (TG9)	  rats,	  12	  WT	  rats).	  The	  rats	  were	  housed	  in	  mixed	  groups,	  so	  that	  each	  cage	  contained	  one	  rat	  of	  each	  genotype,	  although	  due	  to	  the	  uneven	  genotype	  distribution	  there	  were	  two	  cages	  where	  this	  was	  not	  the	  case.	  Other	  aspects	  of	  housing	  condition	  were	  in	  line	  with	  what	  is	  presented	  in	  Publication	  I	  for	  the	  group	  used	  in	  the	  Progressive	  ratio	  test.	  Rats	  were	  maintained	  on	  food	  restriction	  during	  experiments,	  and	  given	   free	  access	   to	   food	  between	   tests.	  Food	  restriction	  during	  experiments	  aimed	  at	  restricting	  rats	  to	  85%	  of	  their	  free-­‐feeding	  body	  weights.	  Body	  weights	  were	  measured	  weekly	  between	  experiments	  to	  monitor	  general	  health,	  and	  daily	  during	  experiments	  to	  monitor	  food	  restriction	  levels.	  	  	  The	  second	  study	  used	  a	  total	  of	  24	  male	  rats	  (12	  hemizygous	  BACHD	  (TG5)	  rats,	  12	  WT	  rats).	  The	   rats	  were	  housed	   in	  genotype-­‐matched	  groups	  of	   three	   rats	  per	   cage.	  Other	  aspects	  of	  housing	  conditions	  were	  in	  line	  with	  what	  is	  presented	  in	  Publication	  I	  for	  the	  group	   used	   in	   the	   Progressive	   ratio	   test.	   Rats	   were	   maintained	   on	   food	   restriction	  during	  experiments,	  and	  given	  free	  access	  to	  food	  between	  tests.	  Food	  restriction	  during	  experiments	  used	  the	  alternative	  food	  restriction	  protocol,	  which	  aimed	  at	  matching	  the	  rats’	  apparent	  hunger	  levels.	  Body	  weights	  were	  measured	  weekly	  between	  experiments	  to	   monitor	   general	   health,	   and	   daily	   during	   experiments	   to	   monitor	   food	   restriction	  levels.	  	  Behavioral	  protocol	  The	   two	   studies	   used	   different	   operant	   conditioning	   systems.	   The	   first	   study	   used	   an	  older	  system	  manufactured	  by	  TSE	  systems	  (259900-­‐SK-­‐RAT-­‐LA/1,	  TSE-­‐systems	  GmbH,	  Bad	  Homburg,	   Germany).	   The	   operant	   conditioning	  boxes	  measured	  48.5x38.5x22	   cm	  (length	  x	  width	  x	  height).	  They	  contained	  a	  red	  house	  light	  and	  a	  pellet	  receptacle	  trough	  throughout	   all	   behavioral	   protocols.	   During	   some	  protocols,	   a	   single	   lever	  was	   placed	  next	  to	  the	  pellet	  trough,	  10	  cm	  above	  the	  cage	  floor	  and	  protruding	  4	  cm	  from	  the	  wall.	  A	   tri-­‐colored	  cue	   light	  was	  positioned	  over	   the	   lever.	  The	  system	  did	  not	  use	   isolation	  boxes.	   The	   second	   study	   used	   the	   same	   operant	   conditioning	   boxes	   as	   described	   in	  Publication	  I.	  In	  both	  studies,	  a	  total	  of	  six	  boxes	  were	  used.	  Thus,	  six	  and	  four	  runs	  were	  needed	  to	  assess	  all	  rats	  in	  the	  first	  and	  second	  study	  respectively.	  Each	  run	  of	  the	  first	  study	  assessed	  two	  rats	  of	  each	  genotype,	  while	  each	  run	  of	  the	  second	  study	  assessed	  three	   rats	   per	   genotype.	   Each	   given	   rat	   was	   assigned	   to	   a	   specific	   operant	   chamber,	  while	   each	   chamber	   was	   used	   to	   assess	   equal	   numbers	   of	   rats	   from	   the	   different	  genotypes.	   Rats	   were	   assessed	   during	   the	   dark	   phase,	   with	   the	   first	   run	   starting	  approximately	  30	  minutes	  after	  dark	  phase	  onset.	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  The	  two	  studies	  used	  slightly	  different	  training	  protocols.	  	  	  In	   the	   first	   study,	   two	   months	   old	   rats	   were	   first	   given	   two	   30-­‐minute	   habituation	  sessions,	  where	  no	  lever	  was	  present,	  the	  house	  light	  switched	  on,	  and	  a	  single	  reward	  pellet	  was	  delivered	  to	  the	  pellet	  receptacle	  with	  30-­‐second	   intervals.	  Afterwards,	  rats	  were	  trained	  on	  a	  continuous	  reinforcement	  (CRF)	  protocol.	  During	  this,	  a	  single	   lever	  was	  present	   inside	   the	  conditioning	  chamber,	  and	  each	  push	  resulted	   in	  a	  pellet	  being	  delivered.	   A	   green	   cue	   light	   situated	   above	   the	   lever,	   and	   the	   red	   house	   light,	   shone	  throughout	  the	  sessions.	  The	  system	  did	  not	  allow	  for	  manual	  pellet	  deliveries,	  meaning	  that	   rats	   had	   to	   learn	   to	   push	   the	   lever	   on	   their	   own.	   Still,	   a	   paste	   made	   of	   mashed	  reward	   pellets	  was	   placed	   on	   top	   of	   the	   lever	   during	   initial	   CRF	   sessions	   to	   promote	  lever	  investigation.	  The	  rats	  were	  given	  CRF	  sessions	  until	  they	  managed	  to	  obtain	  100	  reward	  pellets	  within	  30	  minutes	  on	  seven	  consecutive	  sessions.	  When	  rats	  had	  reached	  this	   criterion	   they	   were	   trained	   on	   the	   DRL	   protocol.	   In	   this	   protocol,	   the	   lever	   was	  initially	  active,	  as	  indicated	  by	  the	  green	  cue	  light.	  Responding	  to	  the	  lever	  thus	  resulted	  in	  the	  delivery	  of	  a	  reward	  pellet,	  although	  it	  also	  resulted	  in	  the	  start	  of	  a	  five-­‐second	  long	  time-­‐out	  phase,	  which	  was	  indicated	  by	  the	  cue	  light	  being	  switched	  off.	  During	  the	  time-­‐out,	   lever	   responses	  were	   not	   rewarded	   but	   only	   served	   to	   restart	   the	   time-­‐out	  phase.	  Thus,	  rats	  had	  to	  withhold	   lever	  responses	  for	  at	   least	   five	  seconds	  in	  order	  for	  the	   lever	   to	   become	   active	   again,	   which	   was	   indicated	   by	   the	   green	   cue	   light	   being	  switched	  on	  (see	  Figure	  1).	  It	  should	  be	  noted	  that	  it	  is	  uncommon	  to	  include	  cue	  lights	  in	  DRL	  protocols.	  The	  main	  reason	  why	  cue	   lights	  were	  used	   in	   the	  current	  study	  was	  that	   the	  ultimate	   aim	  was	   to	   reverse	   the	   cue	   light	   in	  order	   to	   study	   reversal	   learning.	  However,	  that	  part	  of	  the	  study	  did	  not	  reveal	  any	  interesting	  phenotypes,	  and	  will	  not	  be	   described	   here.	   Each	   DRL	   session	   lasted	   30	   minutes,	   regardless	   of	   the	   rats’	  performance.	   Rats	   were	   given	   a	   total	   of	   seven	   DRL	   sessions.	   When	   data	   had	   been	  gathered	  for	  the	  two	  months	  old	  rats	  they	  were	  put	  back	  on	  free	  feeding.	  The	  rats	  were	  then	  reassessed	  at	  about	  six	  months	  of	  age.	  The	  retesting	  followed	  the	  same	  protocols,	  although	   training	   started	   with	   the	   CRF	   protocol,	   and	   DRL	   training	   lasted	   only	   six	  sessions.	  	  In	  the	  second	  study,	  two	  months	  old	  rats	  were	  first	  given	  two	  habituation	  sessions	  in	  the	  operant	   conditioning	   boxes.	   During	   these,	   both	   levers	  were	   retracted,	   the	   house	   light	  was	   switched	   on,	   and	   a	   total	   of	   100	   reward	   pellets	   were	   delivered	   to	   the	   pellet	  receptacle	   at	   intervals	   that	  were	   randomized	  between	  10,	  15,	  20,	  25,	   and	  30	   seconds.	  Afterwards,	  rats	  were	  trained	  to	  perform	  lever	  pushes	  on	  a	  CRF	  protocol.	  During	  these	  protocols,	  one	  lever	  was	  inserted	  into	  the	  conditioning	  box	  and	  both	  the	  cue	  light	  above	  the	   lever	  and	  the	  house	   light	  were	  switched	  on.	  Any	   lever	  push	  performed	  by	   the	  rats	  was	  rewarded	  with	  the	  delivery	  of	  a	  reward	  pellet.	  Rats	  were	  initially	  given	  rewards	  for	  approaching,	  sniffing	  and	  touching	  the	  lever,	  but	  eventually	   learned	  to	  reliably	  push	  it.	  Training	  continued	  until	  rats	  performed	  100	  pushes	  on	  their	  own,	  within	  30	  minutes,	  on	  three	  consecutive	  sessions.	  Afterwards,	  training	  stopped	  and	  the	  rats	  were	  maintained	  on	  free	  feeding	  conditions	  until	  they	  were	  six	  months	  old.	  At	  that	  age,	  the	  rats	  were	  first	  retrained	  on	  a	   single	  CRF	  session.	   	  Afterwards,	   the	   rats	  were	  run	   for	  15	  sessions	  on	  a	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  DRL	  protocol.	  The	  structure	  of	  this	  was	  similar	  to	  the	  protocol	  used	  for	  the	  first	  study.	  Thus,	  one	  lever	  was	  inserted	  into	  the	  operant	  chamber	  at	  the	  start	  of	  the	  session.	  At	  this	  time,	  the	  lever	  was	  reinforced,	  as	  indicated	  by	  the	  cue	  lights	  that	  shone	  over	  both	  lever	  panels.	  Pushing	  the	  lever	  resulted	  in	  a	  pellet	  being	  delivered,	  and	  a	  time-­‐out	  phase	  being	  started,	  indicated	  by	  the	  cue	  light	  being	  switched	  off.	  The	  duration	  of	  the	  time-­‐out	  varied	  in	  a	  pseudo-­‐randomized	  manner	  between	  0,	  5,	  10,	  15	  and	  20	  seconds.	  Pushing	  the	  lever	  during	  this	   time	  was	  not	  rewarded,	  but	  resulted	   in	   the	  time-­‐out	  being	  restarted.	  Thus,	  the	  rats	  had	   to	  withhold	   lever	   responses	   for	   the	   full	  duration	  of	   the	   time-­‐out.	  The	  cue	  lights	  were	  switched	  on	  at	  the	  end	  of	  the	  time-­‐out	  phase,	   indicating	  that	  the	  lever	  was	  once	   again	   active	   (see	   Figure	   2).	   Sessions	   ended	   after	   30	  minutes,	   or	   when	   rats	   had	  obtained	  100	  pellets.	  	  Behavioral	  parameters	  Only	  the	  main	  readouts	  have	  been	  analyzed	  from	  the	  two	  studies.	  This	  included	  the	  time	  needed	  to	  complete	  100	  lever	  pushes	  during	  CRF	  sessions,	  and	  the	  overall	  success	  rate	  during	   DRL	   sessions.	   For	   the	   second	   study,	   additional	   analysis	   was	   made	   to	   obtain	  separate	  success	  rates	  for	  trials	  with	  different	  time-­‐out	  durations.	  	  	  Statistical	  methods	  Behavioral	  data	  was	  extracted	  by	  running	  the	  log	  files	  created	  by	  the	  systems	  through	  a	  series	  of	  R	  scripts.	  Statistical	  analysis	  was	  performed	  in	  GraphPad	  prism	  (v6.0).	  Analyses	  were	  performed	  with	  two-­‐way	  repeated	  measures	  ANOVAs,	  using	  genotype	  as	  between	  subject	   factor	   and	   either	   age	   or	   trial	   type	   as	  within	   subject	   factor.	   Different	   post-­‐test	  were	  used	  to	  evaluate	  genotype	  differences	  on	  individual	  data	  points	  when	  two	  (Sidak’s)	  or	  more	   (Dunnett’s)	  groups	  were	   included.	  One-­‐way	  ANOVAs	  with	  Dunnett’s	  post-­‐test	  were	  used	  for	  analysis	  of	  baseline	  performance	  during	  CRF	  and	  DRL	  sessions	  of	  the	  first	  study.	  Finally,	  analysis	  of	  performance	  during	  CRF	  retraining	  on	  the	  second	  study	  was	  done	  using	  student	  t-­‐test.	  	  Results	  In	  the	  first	  study,	  BACHD	  rats	  were	  found	  to	  be	  slower	  than	  WT	  rats	  in	  completing	  100	  lever	   pushes	   during	   the	   CRF	   protocol	   (Figure	   3).	   This	   phenotype	   was	   present	   both	  during	   the	   two-­‐	   and	   six-­‐months	   test	   age,	   although	   it	   was	   slightly	   more	   pronounced	  during	  the	  second	  test.	  BACHD	  rats	  were	  also	  found	  to	  perform	  significantly	  worse	  than	  WT	  rats	  during	  the	  DRL	  protocol	  at	  both	  test	  ages	  (Figure	  4).	  Once	  again,	  the	  phenotype	  appeared	   to	  be	  more	  pronounced	  during	   the	   second	   test	   age,	   although	   this	  was	   likely	  due	  to	  rats	  not	  really	  reaching	  a	  stable	  performance	  during	  the	  first	  test	  age.	  There	  were	  no	  clear	  differences	  between	  BACHD	  rats	  of	  the	  TG5	  and	  TG9	  line,	  although	  there	  was	  a	  trend	  indicating	  that	  TG9	  rats	  were	  more	  impaired.	  	  	  In	  the	  second	  study,	  BACHD	  rats	  were	  found	  to	  only	  initially	  be	  slower	  than	  WT	  rats	  in	  completing	   100	   lever	   pushes	   during	   the	   CRF	   protocol	   (Figure	   5).	   This	   phenotype	  disappeared	  with	  training,	  and	  was	  also	  not	  present	  when	  the	  rats	  were	  retrained	  at	  six	  months	  of	  age.	  There	  were	  no	  differences	  in	  DRL	  performance	  between	  WT	  and	  BACHD	  rats,	  despite	  trials	  using	  up	  to	  20-­‐second	  long	  time-­‐outs	  (Figure	  6).	  	  	  Discussion	  As	   noted,	   BACHD	   rats	   were	   found	   to	   be	   slower	   than	  WT	   rats	   at	   completing	   the	   CRF	  protocol	  during	   the	   first	   study,	  but	  not	   the	  second.	  This	   is	   comparable	   to	   results	   from	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  other	  studies,	  where	  we	  have	   found	   that	  BACHD	  rats	  on	  occasion	  are	  slower	   than	  WT	  rats	  at	  completing	  100	  lever	  pushes.	  When	  present,	  the	  phenotype	  appears	  to	  be	  caused	  by	  BACHD	  rats	  being	  slower	  at	  returning	  to	  the	  lever,	  after	  retrieving	  the	  reward	  pellet,	  rather	   than	   a	   change	   in	   other	   motor-­‐timing	   parameters.	   A	   detailed	   analysis	   of	  performance	  during	  the	  first	  study	  could	  not	  be	  performed	  due	  to	  the	  limited	  data	  being	  stored	  in	  the	  log	  files	  of	  that	  system.	  However,	  as	  the	  phenotype	  has	  been	  found	  to	  not	  be	  fully	  reproducible	  or	  stable	  it	  is	  of	  little	  interest.	  	  	  In	  the	  first	  study,	  BACHD	  rats	  were	  found	  to	  show	  a	  stably	  impaired	  performance	  during	  the	   DRL	   protocol,	   indicating	   that	   they	   had	   problems	   withholding	   lever	   responses.	  However,	  due	  to	  the	  design	  of	  the	  study	  the	  exact	  nature	  of	  the	  phenotype	  was	  unclear.	  Specifically,	   as	   rats	  were	   given	   extensive	   CRF	   training	   prior	   to	   the	   DRL	   training,	   it	   is	  possible	   that	   their	   apparent	   impairment	   was	   due	   to	   them	   having	   difficulties	   with	  adjusting	   their	   behavior,	   rather	   than	   an	   underlying	   impairment	   in	   general	   response	  inhibition.	  The	  second	  study	  aimed	  at	  further	  evaluating	  this,	  by	  only	  using	  a	  very	  brief	  CRF	   training.	   As	   noted,	   BACHD	   rats	   were	   not	   impaired	   during	   this	   test,	   despite	  experiencing	  time-­‐outs	  that	  were	  up	  to	  20	  seconds	  long.	  The	  results	  thus	  supported	  the	  hypothesis	   that	   the	   initial	   impairment	   was	   based	   on	   a	   difficulty	   of	   adjusting	   an	  established	   behavior,	   rather	   than	   a	   general	   response	   inhibition	   impairment.	   Still,	   the	  results	  could	  also	  be	  explained	  by	  differences	  in	  selective	  attention	  and	  visual	  acuity.	  It	  is	  therefore	  also	  important	  to	  note	  that	  the	  cue	  lights	  used	  in	  the	  first	  study	  were	  more	  discreet	   than	   the	   ones	   used	   in	   the	   second	   study.	   This	   could	   explain	  why	   BACHD	   rats	  showed	   impaired	   performance	   in	   the	   first,	   but	   not	   the	   second	   study.	   Additional	  characterization	  tests	  would	  be	  needed	  to	  further	  investigate	  this.	  	  	  Conclusion	  BACHD	  rats	  do	  not	  appear	  to	  show	  a	  generally	  impaired	  performance	  when	  withholding	  lever	  responses	  in	  the	  DRL	  test.	  However,	  impaired	  performance	  might	  be	  present	  when	  the	   rats	   need	   to	   adjust	   their	   behaviors,	   and	   apply	   inhibitory	   control	   to	   a	   previously	  learned	  behavior.	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 Figure	   1.	   Schematic	   of	   the	   first	   DRL	   protocol.	   The	   different	   steps	   of	   the	   protocol	   are	  noted.	  Components	  of	  the	  Skinner	  box	  are	  indicated	  with	  circles	  for	  lever	  cue	  lights.	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  Figure	  2.	  Schematic	  of	  the	  second	  DRL	  protocol.	  The	  different	  steps	  of	  the	  protocol	  are	  noted.	  Components	  of	  the	  Skinner	  box	  are	  indicated	  with	  circles	  for	  lever	  cue	  lights.	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  Figure	  3.	  Performance	  on	  the	  CRF	  protocol	  during	  the	  first	  study.	  Graphs	  indicate	  the	  time	  needed	  to	  perform	  100	  lever	  pushes.	  Curves	  indicate	  group	  mean	  plus	  standard	  error	  for	  each	   individual	   session,	  while	   scatter	   plots	   indicate	  mean	  performance	   of	   individual	   rats	  during	   the	   final	   three	   sessions.	   For	   curves,	   results	   from	   two-­‐way	   ANOVA	   are	   indicated	  inside	  graphs.	  Data	  points,	  where	  post-­‐tests	  indicated	  a	  significant	  difference	  between	  WT	  and	  BACHD	  rats	  are	  also	  indicated,	  with	  *	  for	  WT	  and	  TG5	  comparisons	  and	  #	  for	  WT	  and	  TG9	   comparisons.	   For	   scatter	   plots,	   results	   from	   one-­‐way	   ANOVA	   are	   indicated	   inside	  graphs.	  Post-­‐tests	   that	  detected	  a	   significant	  difference	  between	  WT	  and	  BACHD	  rats	  are	  also	  indicated,	  with	  *	  for	  WT	  and	  TG5	  comparisons	  and	  #	  for	  WT	  and	  TG9	  comparisons	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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  Figure	   4.	   Performance	   on	   the	   DRL	   protocol	   during	   the	   first	   study.	   Graphs	   indicate	   the	  percentage	   of	   successful	   responses.	   Curves	   indicate	   group	  mean	   plus	   standard	   error	   for	  each	   individual	   session,	  while	   scatter	   plots	   indicate	  mean	  performance	   of	   individual	   rats	  during	   the	   final	   three	   sessions.	   For	   curves,	   results	   from	   two-­‐way	   ANOVA	   are	   indicated	  inside	  graphs.	  Data	  points,	  where	  post-­‐tests	  indicated	  a	  significant	  difference	  between	  WT	  and	  BACHD	  rats	  are	  also	  indicated,	  with	  *	  for	  WT	  and	  TG5	  comparisons	  and	  #	  for	  WT	  and	  TG9	   comparisons.	   For	   scatter	   plots,	   results	   from	   one-­‐way	   ANOVA	   are	   indicated	   inside	  graphs.	  Post-­‐tests	   that	  detected	  a	   significant	  difference	  between	  WT	  and	  BACHD	  rats	  are	  also	  indicated,	  with	  *	  for	  WT	  and	  TG5	  comparisons	  and	  #	  for	  WT:	  and	  TG9	  comparisons	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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        Figure	  5.	  Performance	  on	   the	  CRF	  protocol	  during	   the	  second	  study.	  Graphs	   indicate	   the	  time	  needed	  to	  perform	  100	  lever	  pushes.	  The	  curve	  indicates	  group	  mean	  plus	  standard	  error	  for	  each	  individual	  session	  run	  at	  two	  months	  of	  age,	  while	  the	  scatter	  plot	  indicates	  performance	  of	   individual	  rats	  during	  the	  single	  session	  run	  at	  six	  months	  of	  age.	  For	  the	  curve,	  results	  from	  two-­‐way	  ANOVA	  are	  indicated	  inside	  the	  graph.	  Data	  points,	  where	  post-­‐tests	  detected	  a	  significant	  difference	  between	  WT	  and	  BACHD	  rats	  are	  also	  indicated.	  For	  scatter	  plots,	  results	  from	  Student	  t-­‐test	  is	  indicated	  inside	  graphs	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	          Figure	  6.	  Performance	  on	  the	  DRL	  protocol	  during	  the	  second	  study.	  Graphs	   indicate	  the	  percentage	  of	  successful	   responses.	  Curves	   indicate	  group	  mean	  plus	  standard	  error.	  The	  graph	  on	  the	  left	  shows	  the	  overall	  mean	  success	  rate	  over	  the	  15	  sessions	  that	  were	  run,	  while	  the	  middle	  and	  right	  graph	  show	  the	  mean	  success	  rate	  on	  trials	  with	  different	  time-­‐out	  durations	  on	  the	  first	  and	  last	  session,	  respectively.	  Results	  from	  two-­‐way	  ANOVA	  are	  indicated	   inside	   graphs.	   Data	   points,	   where	   post-­‐tests	   detected	   a	   significant	   difference	  between	  WT	  and	  BACHD	  rats	  are	  also	  indicated	  (*	  p	  <	  0.05,	  **	  p	  <	  0.01,	  ***	  p	  <	  0.001).	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